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SENATOR DIANE E. WATSON 
STATE CAPITOL BUILDING I SACRAMENTO, CALIFORNIA 95814 
CONTACT: Dr. Lenore Tate/TELEPHONE (916) 445-5215 
FOR IMMEDIATE RELEASE 
PR-127 Sac:to 
AIDS IN ETHNIC-MINORITY COMMUNITIES II: A REASSESSMENT 
The Senate Health and Human services Committee will hold 
a public hearing on "AIDS in Ethnic-Minority Communities II: 
A Reassessment" on December 17, 1991, the Committee's Chair, 
Senator Diane E. Watson, Ph.D. has announced. The hearing 
scheduled from 9:30-4:30, will be held at the Museum of 
Science and Industry, Kinsey Auditorium, 700 State Drive. 
For many years now, AIDS has been viewed primarily as a 
white, gay male, disease. Unlike this myth, AIDS has 
consistently been a disease which has disproportionately 
affected ethnic-minority communities. In fact, the rate of 
HIV/AIDS infection in people of color is approximately double 
the rate of the general population. 
It is expected that the numbers of ethnic minorities 
with HIV/AIDS will continue to increase over the upcoming 
years. While the white gay community has been fairly well 
educated about the modes of transmission of the virus and the 
types of behavior which must be avoided; the same cannot be 
said about California's ethnic minorities. 
According to the National Minority AIDS Council: "If 
allowed to continue unchecked, disease and death from AIDS in 
minority communities will continue to mount into the next 
century; the social and economic impact of this projected 
loss to minority communities is almost incalculable." 
Continued---
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The senate Health and Human Services Committee will 
study the amount allocated for AIDS research, treatment, 
prevention, education and outreach; the manner in which 
funding is allocated on a federal, state and county level; 
how and why AIDS is spreading at such an alarming rate; and 
measures to improve the quality of life for HIV/AIDS victims, 
their families and our communities. The committee will hear 
testimony from AIDS experts, such as physicians, educators, 
health workers and various organizations about the 
recommended ways to increase the state's role in slowing or 
halting the transmission of the virus. 
"We know that we must improve our outreach efforts to 
reach people with basic information about stopping the spread 
of HIV and AIDS," Senator Watson said. She recommended, 
Monogamous relationships, regular use of condoms, and refusal 
to share needles would dramatically reduce the incidence of 
AIDS. We as policymakers are taking a leading effort in 
letting people know about the prevention behaviors that 
people should adopt to put themselves at much lower risk of 
getting AIDS." 
The hearing will be open to the public. 
# # # # # 
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"AIDS IN ETHNIC MINORITY COMMUNITIES II: 
A REASSESSMENT" 
TUESDAY, DECEMBER 17, 1991 
9:30 A.M. -- 4:30 P.M. 
MUSEUM OF SCIENCE AND INDUSTRY 
KINSEY AUDITORIUM 
700 STATE DRIVE 
Los ANGELEs, CA 
OPENING STATEMENT 
SENATOR DIANE E. WATSON 
GOOD MORNING AND WELCOME TO OUR STATEWIDE INTERIM 
HEARING ENTITLED "AIDS IN ETHNIC MINORITY COMMUNITIES 
II: A REASSESSMENT." THIS HEARING IS SPONSORED BY THE 
SENATE HEALTH AND HUMAN SERVICES COMMITTEE. TODAY, WE 
ARE GOING TO HEAR TESTIMONY FROM MANY EXPERTS ON THE 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND THE ACQUIRED 
IMMUNE DEFICIENCY SYNDROME (AIDS), ON COMMUNITY OUTREACH 
TO PERSONS OF COLOR WHO HAVE BEEN EXPOSED TO AIDS OR WHO 
ARE AT RISK OF EXPOSURE, AND MOST IMPORTANTLY FUNDING 
FOR THIS DISEASE (FROM PREVENTION AND EDUCATION TO 
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IN 1987 (APPROXIMATELY 4 YEARS AGO), THE COMMITTEE 
SPONSORED A SIMILAR STATEWIDE HEARING IN WHICH WE HEARD 
TESTIMONY FROM EXPERTS ON THE MANY ISSUES THAT CONFRONT 
OUR COMMUNITIES. SINCE THAT TIME, OUR STATE HAS SEEN AN 
INCREASE IN THE NUMBER OF REPORTED AIDS CASES IN ETHNIC 
MINORITY COMMUNITIES. UNFORTUNATELY, THE RATE OF GROWTH 
IN THESE COMMUNITIES IS CAUSE FOR ALARM IN CALIFORNIA. 
FOR EXAMPLE, ALTHOUGH AFRICAN-AMERICANS REPRESENT 24% OF 
THOSE WHO HAVE BEEN DIAGNOSED WITH AIDS, AND HISPANICS 
REPRESENT 14%, THIS RATE IS GREATER THAN THEIR OVERALL 
PROPORTION IN THE COMMUNITY (12% AND 6% RESPECTIVELY). 
MOREOVER, AFRICAN-AMERICANS ARE THREE TIMES MORE LIKELY 
TO HAVE CONTRACTED AIDS THAN WHITES. THE STATE OFFICE 
OF AIDS AND OTHER AIDS ORGANIZATIONS, WILL PRESENT DATA 
ON THIS GROWTH DURING THEIR TESTIMONY. 
OUR AGENDA IS ORGANIZED INTO SEVERAL SECTIONS, 
BEGINNING WITH STATE AND LOCAL GOVERNMENT PERSPECTIVES, 
TESTIMONY FROM HEALTH CARE PROVIDERS AND RESEARCHERS, 
FOLLOWED BY OBSERVATIONS FROM COMMUNITY-BASED AIDS AND 
ETHNIC MINORITY ORGANIZATIONS. IN ADDITION TO OUR 
OVERALL GOAL, WHICH IS TO LEARN MORE ABOUT THIS DISEASE 
CONTINUED---
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IN ORDER THAT WE MAY BETTER SERVE HUMANKIND, THE 
COMMITTEE AND PARTICULARLY MY OFFICE, ALONG WITH 
MEMBERS OF THE SENATE LEADERSHIP, AND OTHERS WILL BE 
DEVELOPING A MAJOR LEGISLATIVE PACKAGE (THAT WILL BE 
INTRODUCED NEXT SESSION)ON AIDS. THIS HEARING WILL 
SIGNIFICANTLY CONTRIBUTE TO THESE MEASURES. 
IF TIME PERMITS, AFTER OUR EXTENSIVE AGENDA, WE MAY 
BE ABLE TO HEAR ADDITIONAL TESTIMONY FROM THOSE NOT ON 
THE AGENDA. IF WE RUN OUT OF TIME, WE WILL INCLUDE IN 
THE TRANSCRIPT ANY WRITTEN TESTIMONY THAT IS SENT TO US 
WITHIN THE NEXT TWO WEEKS. 
AGAIN, WE APPRECIATE YOUR ATTENDANCE AT THIS 
HEARING, AND ANTICIPATE LEARNING MUCH MORE ABOUT THE 
EXTENT OF THE PROBLEMS AND ISSUES ASSOCIATED WITH HIV 
AND AIDS THAT CONFRONT ETHNIC MINORITY COMMUNITIES. 
lASTLY, MAY I TAKE THIS OPPORTUNITY TO WISH EACH OF YOU 
HERE TODAY AND YOUR LOVED ONES, HAPPY HOLIDAYS! 
* * * * * * 
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DR. LENORE TATE: We're going to go ahead and begin. Senator Watson and 
possibly other members of the committee should be coming in momentarily. But 
because we have such a long and extensive agenda, I think it would be best for us 
to begin. 
Let me say that all your testimony will be recorded, and all the committee 
members of the Health and Human Services committee of the Senate will review this 
recording, as well as all written testimony. But because our agenda is so 
extensive, Senator Watson has said we would like to start as an unofficial 
subcommittee. And so with that, let me just say that basically we're going to go 
in the order of the agenda. I think most of you have the agenda. If time permits, 
towards the end of our hearing, we will allow for testimony from other people in 
the audience. 
So at this time, I would just like to begin with Mr. Wayne Sauseda who is the 
Director of the Office of AIDS for the State of California. 
Mr. Sauseda. Is he here? 
MR. WAYNE B. SAUSEDA: Yes, I'm here. 
DR. TATE: Okay. 
MR. SAUSEDA: Good morning. My name is Wayne Sauseda. I'm the Chief of the 
State Office of AIDS for the State of California. 
Dr. Tate and members of the audience, on behalf of the Department of Health 
Services, thank you for the opportunity to discuss the state's AIDS program today. 
During my testimony, I'm going to overview the programs administered by the State 
Office of AIDS, to set in context the discussion of epidemiologic trends, and also 
discuss state funding for education and prevention, testing, care and treatment, 
and research. 
You have my written testimony. I believe that there are three copies of it on 
the table there in a black binder. I'm going to, for purposes of brevity, as well 
as -- some of this information is somewhat dry in nature -- I'm going to abbreviate 
some of my comments. But certainly the written testimony there is provided for the 
record. 
DR. TATE: Thank you. 
MR. SAUSEDA: As an overview of the Office of AIDS, the objective of our 
office is to provide information and education, testing, epidemiological 
investigation and surveillance, research, and treatment to address the public 
health problems resulting from Acquired Immune Deficiency Syndrome. 
-1-
The Office of AIDS provides a complete AIDS-case registry. It provides 
educational information for high-risk groups, health professionals and the public, 
and policy direction and development of pilot projects for the care of people with 
AIDS and early intervention of projects to provide services to HIV-infected 
persons. 
Additionally, the office conducts surveillance activities to identify risk 
groups and patterns of transmission and epidemiology for selected cases. The 
office also administers a program which testa for the antibody to the AIDS virus at 
over 100 alternative test sites, which are free and anonymous. In addition to 
that, we provide a substantial amount of HIV testing and confidential test sites 
which number over 450 throughout the State of California. 
Local assistance block grants are also provided to local agencies for AIDS, 
epidemiological investigation and surveillance. 
I'd like to comment briefly on five significant legislative measures which 
were passed by the California State Legislature and signed by Governor Wilson. 
These measures reflect the Governor's commitment to prevention, patients' rights, 
integration of services, and expanded access to health care. 
To begin with, AB 11, authored by Assemblywoman Hughes, which is AIDS 
In-School Education, beginning with the 1992-93 school year, instruction for the 
prevention of AIDS will be provided by trained teachers to students in grades 7-12, 
at least once in junior high or middle school, and once in high school. 
AB 11 fits into the current California Department of Education Healthy 
Kids/Healthy California Project which is funded by the Office of AIDS to provide 
training to teachers and school administrators on providing instruction on HIV 
transmission to students in the 7th and 8th grades as well as high schools. 
Studies on youth have shown increases in drug use and sexually transmitted 
diseases, which are major co-factors for HIV infection. Surveys on youth out of 
mainstream schools indicate that nearly all of their health and HIV- and 
AIDS-related knowledge and information was obtained from their school experiences. 
SB 1070 was authored by Senator Thompson, known as the Patient Protection Act 
of 1991. This is a measure that deals with HIV-infected health care workers. It 
requires the Department of Health Services to develop written guidelines and 
regulations as necessary to minimize the risk of transmission of blood-borne 
infectious diseases from health care worker to patient, from patient to patient, 
and from patient to health care worker. SB 1070 reinforces the Department of 
Health Services' leadership role in establishing consensus-baaed recommendations 
for the prevention of transmission of HIV and Hepatitis B virus between health care 
workers and patients. 
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There are three other bills I'll briefly describe. One is AB 305 authored by 
Assemblyman Friedman. It redefines the term chronic, life-threatening illness to 
mean HIV disease or AIDS. It also provides that the Department of Health Services 
may provide supplemental funding to residential AIDS shelters and to residential 
care facilities. 
AB 1281 authored by Assemblymember Filante updates current law prohibiting the 
use of HIV antibody blood tests as a prerequisite for determining eligibility for 
health insurance. 
AB 1287 authored by Assemblymember and Chairman of the Assembly Ways and Means 
Committee, John Vasconcellos, with respect to HIV test disclosure, ensures that 
those individuals who are involved with HIV -- or AIDS vaccine clinical trials 
as a volunteer who test HIV antibody positive or negative as a result of their 
participation in those clinical trials -- will not be denied health care, 
disability, welfare, or life insurance coverage. 
one other item I'd like to highlight for you is this last November, the Office 
of AIDS, in keeping with its theme of prevention, secondary and tertiary 
prevention, also was successful in expanding the AIDS drug program Formulary. 
Previously, the AIDS drug program consisted of two drugs only. We added an 
additional 11 drugs, and we also are now the largest state AIDS drug program in the 
United States. 
California's contribution in state funds is $9.1 million which also is the 
largest state contribution of any other state in the United States. 
I'm going to briefly go to epidemiology. To place my testimony into 
perspective, I'd like to give some information about the scope and course of the 
AIDS epidemic in the state and Loa Angeles County. As indicated, I'm going to 
abbreviate some of my comments in this section particularly. 
As of November 30, 1991, 38,660 cumulative cases of AIDS and 26,369 
AIDS-related deaths have been reported in California. As of this date, Loa Angeles 
county has reported 13,672 cases of AIDS; and deaths totaled 9,576. Statewide, 
during the most recent 12-month period, 7,683 new cases were diagnosed; and 6,036 
deaths were reported. An average of 640 new AIDS cases were diagnosed and 503 
AIDS-related deaths reported each month. 
There are an estimated 12,500 Californians living with AIDS at the end of 
1990. At the end of 1993, two short years from now, there will be an estimated 
16,200 people alive with an AIDS diagnosis. 
The incidence of AIDS continues to increase in all ethnic and racial groups 
within the state. Of the cumulative total AIDS cases reported in California 
through this past June 1991, whites have accounted for 71 percent of the total; 
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African Americans, 13 percent; Latinos, 14 percent; and Asian/Pacific Islanders, 2 
percent. In contrast to statewide racial and ethnic distributions, 62 percent of 
AIDS cases reported in Los Angeles county 
total of 71 percent in Los Angeles County 
again, that's compared to a statewide 
62 percent have been among whites, 16 
percent among African Americans, 19 percent among Latinos, and 1 percent among 
Asian/Pacific Islanders. 
Between 1986 and 1991, you can see a very dramatic shift in the proportion of 
AIDS cases reported among whites in California decreased from 77 percent to 65 
percent. conversely, among African Americans, the percentage of new cases 
increased from 10 percent in 1986 to 14 percent in 1991. Latinos accounted for 11 
percent of new cases reported in 1986 and now represent 18 percent in 1991. The 
percentage of new cases reported among Asian/Pacific Islanders also increased from 
1 percent in 1986 to 2 percent in 1991. 
The proportion of new AIDS cases among different transmission categories, 
however, has remained relatively stable over time. The majority of new AIDS cases 
continue to be reported among gay and bisexual males. Approximately 83 percent of 
California AIDS cases diagnosed in 1991 were among this group. Cumulatively, 
nearly nine out of every ten California AIDS cases have been diagnosed among gay 
and bisexual men. 
The number of cases attributable to heterosexual injection drug use continues 
to increase. Nearly 1,250, over half, of the 2,211 cases in this transmission 
category, that of heterosexual injection drug use, have been reported in just the 
last two years. Notably, African Americans account for 12 percent cumulatively of 
all AIDS cases in California, but 40 percent of all cases among injection drug 
users. 
The number of new cases attributable to heterosexual contact with an infected 
person also continues to increase. As of November 30, a total of 702 AIDS cases 
have been reported among persons who cite heterosexual contact as their primary 
risk for infection. More than half of the reported cases have been diagnosed in 
the past two years. To date, 204 cases of AIDS have diagnosed among hemophiliacs; 
802 cases have been diagnosed among transfusion recipients. 
Children, 258 AIDS cases diagnosed among children in California being evenly 
distributed among white, 34 percent of those cases; African American, 29 percent; 
and Hispanic, 33 percent. Because of under-reporting and mis-diagnosis, the actual 
number of children with AIDS may be as much as 50 percent higher. 
We estimate that there are currently 146,000 Californians living with HIV 
infection in California in 1990. An estimated 83 percent of the people are gay or 
bisexual men; 9 percent are heterosexual injection drug usuers; 2 percent are women 
-4-
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infected through heterosexual transmission; and 6 percent transfusion recipients, 
hemophiliacs, men infected through heterosexual transmission, or infants infected 
perinatally or vertical transmission. 
The National Centers for Disease Control estimate that at least 40,000 new HIV 
infections occur each year nationally. This could imply that as many as 8,000 new 
HIV infections occur each year in California. An estimated 100-150 new infections 
occurred annually in newborns as a result of perinatal HIV transmission in 1988 and 
in 1989. 
We estimate that AIDS cases will continue to increase through 1993, 9,700 in 
1993. And by 1993, the cumulative number of AIDS cases diagnosed in California --
recall that currently we have an AIDS case of a cumulative total of 38,000, that by 
the end of 1993, without any changes in the CDC definition of the AIDS cases, that 
there will be as many as 68,000 individuals in California with an AIDS diagnosis or 
have -- excuse me. I should say that there will be as many as 68,000 cumulative 
AIDS cases reported in California. 
I'd like to move quickly now yes. 
DR. TATE: Yes. Cumulative. So are you saying from the time that the state 
started collecting data, the numbers-- so from what? 1981 or ••• 
MR. SAUSEDA: Prom 1981 till now, there have been a diagnose and reported 
38,000 cases of AIDS in California. By the end of 1993, what we've seen in the 
first ten years we will see again within two years; and we'll reach, we're 
estimating, 69,000 cases of AIDS ••• 
DR. TATK: And then out of -- so that's basically almost double? 
MR. SAUSEDA: Almost double within the next two years. 
DR. TATE: Has your office at all looked at what types of people will be 
acquiring the disease though? Will it still look similar to the way it is now? 
MR. SAUSEDA: The epidemic is changing. We're seeing -- although I've 
indicated in my testimony previously, we're seeing the cumulative number of cases 
being relatively stable among different transmission categories. We are, however 
-- and that's because of the sheer volume of numbers early on in the epidemic -- we 
are seeing the increased numbers being reported among heterosexual injection drug 
users and also heterosexual, either through heterosexual injection drug -- excuse 
me -- injection drug use or heterosexual contact as a means of transmission. That 
increase is particularly increasing in communities of color. 
DR. TATE: Thank you. 
MR. SAUSEDA: With respect to state AIDS funding, the funding for AIDS 
programs administered by the state -- and I should qualify that by saying that 
there is direct funding that's provided to certain localities within the State of 
-5-
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California, including the major metropolitan areas of San Diego, San Francisco, and 
Loa Angeles. But of the funds that are administered through the state, that total& 
$124.6 million for 1991-92, the current fiacal year. Of thia amount, $76.6 million 
represents state funds, and $48 million are federal funds. And there are aome 
attachment& that provide aome graphic representation of that. 
Funding for education and prevention projects began during fiscal year 
1983-84. At that time, $450,000 was available. Since then, the education and 
prevention budget has grown to $16 million for 1991-92. While the specific numbers 
of client& served are unavailable at the moment, the numbers of education and 
prevention contractors increased from 15 in 1983-84 to 137 in fiscal year 1991-92. 
The Office of AIDS began diatinguishing between education and prevention 
services to minoritiea and other groups during fiacal year 1988-89. During that 
fiscal year, the total education prevention budget was $16 million, as it is today, 
of which 38 percent waa targeted for minority projects. In fiscal year 1991-92, 
the amount available again is $16 million. Of the 137 contractor& funded, 52 
percent are from minority-owned and/or serve more than 50 percent minority 
populations. 
State-funded HIV antibody testing is provided through various sources in the 
state. Free and anonymous testing is provided through the alternative test site, 
also known as the Anonymous Teat Site program. Additionally, confidential HIV 
testing is provided through various county primary care clinics and other 
free-standing community primary care clinic&, such as family planning clinics, 
rural and community health clinics, and the State Department of Alcohol and Drug 
program administered testing sites. 
Of all testing and counseling services provided during January-December 1990, 
that is, calendar year 1990, 25 percent of the aervices were received by Latinos, 
and 13 percent were received by African Americans. 
The testing program is also conducting an outreach campaign to provide 
information on testing and the services available to the public. Of the $300,000 
earmarked for this campaign, one-third is being used in the Latino community, and 
one-third is being used in the African American community. 
I might comment briefly that this past year, aa part of our campaign for 
testing, we ran, in certain parts of the states, including Los Angelea, a teating 
campaign. As a result of that, and we recognized that there was a aubstantial 
increase in testing, we were able to measure it before the campaign started with 
testing activity at testing sites in those locations of the testing campaign. And 
as early as October, we noticed a tremendous increase in testing. Since that time, 
of course, the disclosure by Earvin Magic Johnson has further driven up demand for 
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HIV testing services. I believe in Los Angeles COunty, I understand that what was 
a two-week waiting period at one time instantly turned into a two-month waiting 
time for HIV-tested services. Many testing sites were faced with the prospect of 
running out of funds for testing, turning away people who sought to find out their 
HIV status, people who might not otherwise have presented for a test. 
We have gained the support of Dr. Coye, the Director of the Department of 
Health Services, and Mr. Russ Gould, the Secretary for Health and Welfare Agency, 
to push forward for increased funding for the testing program to ensure that people 
who are interested and who have examined their behaviors and believe that they have 
a reason to test are provided the opportunity to find out their HIV test status. 
The Early Intervention Program provides behavior change interventions, 
paychosocial support, health education, case management services, and early medical 
aasessment and treatment to HIV-infected persons. The goal of the program is to 
prolong the healthy and productive lives of those infected with HIV. Statewide, 22 
percent of the EIP, or Early Intervention Program, clients are Latino; and 11 
percent are African American. These percentages are even higher at some location&, 
auch as the Early Intervention Program in San Francisco where 52 percent of the 
clients are Latino and South/South-central Los Angeles where 49 percent are African 
American. The total funding for the Early Intervention Program is $2.6 million. 
Pilot care and home and community-based care projects began in 1985-86. At 
the time, the budget was $1.6 million. Since then, the budget is now $6.6 million. 
The Pilot Care Prject Program has officially targeted 25 percent of their funds for 
aervices to minorities; however, the actual percentage has been over 35 percent 
aince fiscal year 1988-89. 
There are a number of projects throughout the state which our office funds 
addressing ethnic minority groups, including Latinos, African Americans, 
Aaian/Pacific Islanders, and American Indians. All minority-based projects provide 
education and materials in the target groups' native language with a special 
emphasis on cultural values. Some examples -- I'll pass over this -- identified in 
my testimony -- certain examples of AIDS-funded minority projects, including the 
Minority AIDS Project, or MAP, in Los Angeles, as well as others in Los Angeles and 
other parts of the state. 
I'd like to comment briefly on other Office of AIDS' efforts. The Office of 
AIDS began working last fall to develop a comprehensive plan in response to the 
Ryan White comprehensive AIDS Resources Emergency -- or CARE Act of 1990. As a 
reault of that, we sought to include a very representative working group to advise 
the state on the appropriate allocation of resources. Fifty percent of that 
working group, representing a very geographic distribution, was represented by 
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communities of color on that working group. Also, as part of the development of 
the formula, we identified eight factors that would impact how the formula would 
actually translate into services in a local community. In recognition of the 
Lmpact that HIV and AIDS has taken into communities of color, one of the factors, 
weighted at 20 percent of the total, was a non-white index factor. 
The Minority AIDS Resource Center is a program funded by the Office of AIDS 
providing information, training, and technical assistance to our education and 
prevention contractors. It includes a library, a computer database, bulk 
literature, and a resource guide. 
The Office of AIDS also provided funding to Multicultural Training Resource 
center in sponsoring multicultural AIDS consensus and collaboration workshops. The 
participants are Office of AIDS contractors currently providing direct education 
and prevention client services. 
The purpose of the workshops is to discuss barriers and find solutions to 
providing quality and education and prevention services to minority communities. 
Workshops focus on barriers as they pertain to rural, urban, communited-based 
organizations, and health department issues. 
The Office of AIDS also provided funding for a statewide "People of Color" 
conference this past summer of 1991 with the goal of improving the survivability, a 
very real issue, for service providers in minority-based communities and focusing 
on strategies to improve outreach and prevention activities to ethnic minority 
populations. At the conference, the group elected representatives to serve on the 
newly formed Office of AIDS Multicultural Liaison Board. This elected group, which 
is composed of 12 members, 3 each from the major ethnic racial minority groups --
African American, Latino, Asian/Pacific Islander, and Native American -- will serve 
as an effective and important liaison between the Office of AIDS and multicultural 
providers and community. 
Before I conclude with my remarks, I'd like to comment on another issue which 
impacts on the issue of survivability of service providers. The Department of 
Health Services this past year, because of budget reductions, reduced over 500 
positions in its department. It would equate roughly to about one of every five 
positions that are state funded. The Office of AIDS took a commensurate cut. One 
of every five positions state funded were reduced from the budget. 
In order to try to continue to provide funding in a geographically balanced 
way, the contractors were reduced also in local assistance because of the trigger 
reduction, because of the state budget crisis. 
The problem has occurred, however, that because of the department's cuts, 
because of the threat of potential layoffs, the department is also, as many 
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positions that are unfunded in the Office of AIDS alone, we see after our budget 
cuts, we still have a 40 percent vacancy rate overall which is having a very 
dramatic impact on those contractors and providers in the community we work with. 
From a department-wide perspective, it also means that contracts are slowing 
down, that payments to providers are slow, slower than is reasonably to be 
expected. And that threatens very seriously the survivability of community-based 
organizations, many of whom do not have the financial resources to float the money 
necessary to provide periods of service, sometimes long periods of service, without 
reimbursement. Dr. Coye has convened eight of her top managers who have experience 
in both programmatic issues, as well as very expert knowledge of administrative 
practices, both at department level, as well as control agency levels. I'm 
fortunate enough, in representing the Office of AIDS, to be one of those eight 
individuals selected by Dr. Coye. 
The purpose of this -- the objective of this group is to try to streamline the 
contractive process, to try to expedite the invoice processing, and reimburse our 
providers in the community who, without whose support, without that infrastructure 
out there, the services to communities simply would not take place. 
We have a commitment to our providers. We are going through a difficult 
period of time because of the state budget process. Dr. Coy and our office, as 
well as other offices in the Department of Health services, are very committed to 
correcting what we believe to be currently an intolerable situation. 
In closing, the Office of AIDS is committed to stopping the AIDS epidemic in 
all parts of California, particularly in communities of color. We recognize that 
this must be done, not in isolation, but in concert with a comprehensive approach 
to addressing overall health care issues and needs. 
I'd like to thank you for this opportunity to appear before you today. I'm 
available to answer questions from the audience. 
CHAIRPERSON DIANE E. WATSON: I want to thank you, Mr. Sauseda, for coming 
here and giving us this comprehensive update on what the Office of AIDS is doing. 
I want to apologize to the office for being tardy, but we were on another issue as 
epidemic as AIDS is, and that was breast cancer; and we had to be out at UCLA for 
that. 
I think that you probably have addressed many of the concerns that I have, but 
I'd like to fine-tune some of them. First, I'm concerned about the amount of 
dollars that has been targeted into minority communities. You did give us the 
exact amount. I'd like to know what the department can do in terms of limited 
funds to address the growing need, particularly among African Americans and 
Latinos, of AIDS. The Minority AIDS Project sits in my district, and we've been 
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working closely with them for several years now. 
There is some lack of immediate response to the pain of their claims. Since 
Magic Johnson made his announcement, they were getting thousands of calla per week 
asking for testing. Now because it is a community-based organization that grew out 
of the grass roots, the expertise to fill out the forma, the way the Department of 
Health would require them, and the ongoing expertise to be able to handle the 
paperwork within your framework is sometime, most oftentimes, very difficult. But 
these are serving the people and they're serving the need. 
can you respond to what the Office of AIDS can do, and I know 500 positions 
have been cut. But can you respond to what they can do to get the funds to th .. in 
a timely fashion, to keep those doors open, in spite of the paperwork, and what 
kind of commitment will be made in the year '93, or 92-93, to MAP and other 
organizations like it. It's not the only one suffering from lack of funding, but 
they all have the high-risk community of major concern. How can you help? 
MR. SAUSEDA: I agree with, Senator, agree with you completely. Even before 
the budget reductions, I think that the contracting process and the invoice, or 
reimbursement process, was slow. Minority organizations and other small 
community-based organizations don't have the resources to effectively front the 
money for services that are being contracted in good faith by those organizations 
on behalf of the state. 
In our office, one of the things that we've done just recently, because it did 
reach an intolerable perspective, proportions, although we could not recruit 
individuals into our office because of the threat of overall layoff, we did provide 
additional resources to the department's accounting office directly, devoted 
exclusively for our contractors. Now that doesn't solve the problem for other 
contractors outside of AIDS contractors. It did for us, and that was our 
commitment to our contractors. And I do have a chronology of what occurred in the 
invoicing process or the contract process for the Minority AIDS Project. But it is 
a very prime example of what was occurring. We've now made the resources available 
to both our contact management section of the Department of Health Services, as 
well as the county section, to expedite our claims, our contracts, to ensure that 
we can now work for the State Controller's Office who are also a key, a player in 
the process, to get the funds out to community organizations. 
An overall issue that the department is addressing currently is that of 
categorical programs. we have a tremendous number of vertical programs within the 
state. one contractor may have several contracts with the state and subject to 
many different rules and regulations and payment timetables. What we're looking at 
is some way of being able to minimize administrative burden that places on 
-10- 023 
contractors, to try to remove, to truly try to identify those things we need to 
have to be accountable as a public steward of funds and those things that we really 
don't need to have that only serve as barriers to providers who have spent an 
inordinate amount of time on administrative paperwork instead of delivering the 
services. So we're taking a very hard look at that. I hope to draw from the, 
benefit from the expertise of those providers in reworking our RFP process -- let 
me digress for a moment. 
This last year, it's still not perfect, but our RFP process, or Request Por 
Proposal process, for education and prevention projects was tremendously 
streamlined. It's going to get better next year -- excuse me. Next year, we're 
not going to -- in fact, next year -- it got better already. We didn't do one. In 
yeara out, we have established an education and prevention evaluation group who's 
looking at the relative success of education prevention efforts but who is also 
looking at different ways of getting money out to the community, ways that are less 
cumbersome, ways that are less time consuming, and ways that do not just impose or 
interject barriers to the provision of service. 
CHAIRPERSON WATSONt I appreciate that response, and I have a lot more faith 
and confidence in the Department of Health Services now that Dr. Molly Coye is at 
the head; and we've worked together on other projects, and we will work together in 
the near future. 
I'm pleased to know that you're looking at the obstacles in the way. I think 
there's too much bureaucracy. I think the need is documented over and over again, 
and I would hope that we would find some way to provide contractors with resources 
without all the paperwork because of the need. If these community-based, 
graaaroots projects have to close down, who's going to aerve those in need? COunty 
hoapitals can't do it; public health can't do it. Those programs that you've 
listed here, and I do appreciate your summary, are those that are fashioned to 
aerve that particular clientele; and we've got to give them the support. I've got 
to call all the time to help MAP and other programs to get their funding. And 
they're having to turn people away. There are people dying in their homes without 
the kind of care that they can give them through some of these programs. So 
whatever you can do to strengthen that effort, we would appreciate it. 
Let me go and backtrack over some of the things that you had mentioned. I'm 
concerned about what the department is doing on promoting information about safe 
behavior for our youngsters. Now we have battled in the legislature, as you know, 
over the years trying to implant in the educational system a program that would 
follow the child through primary, elementary, the middle, and the senior high 
school, somewhat to very little avail, because of the resistance we get on the 
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outside. But how are you planning to promote a safe sexual behavior and about the 
way to ensure protection against the HIV virus, and how it's transmitted? What are 
you going to do as a department? 
MR. SAUSEDA: Let me first, and in responding to that question, indicate that 
this, of course, is a tremendous issue of need. In the past legislative measures 
that would discuss HIV and AIDS within the public education system failed. They 
were -- they didn't failed passage in the Legislature. They failed signature. 
This year ••• 
CHAIRPERSON WATSON: Let me just interject this here --
MR. SAUSEDA: certainly. 
CHAIRPERSON WATSON: -- because we're talking about strategy now becauae I 
know where the policies are made. So I want to talk with you about how we do it. 
Would you be willing through the department, your unit, the department, Molly 
COye, to sit down with the Governor and talk about the need to train our 
youngsters? I don't think any sex is safe. We talk about abstinence -- is that 
realistic? But we ought to have a strategy worked out from the Office of AIDS, the 
Department of Health Services, to the executive branch. we in the legislative 
branch will do our role and play our part, me in particular. That's how we're 
holding the hearing. But I think more effective and putting more clout and force 
behind it would be for your department, your unit, working with the administrative 
executive branch, saying we've got to do it. There's no reason why youth should be 
contracting AIDS. They understand the risks they're under. We need help because 
you know where it's been blocked. So I think that approach, if you feel, could be 
feasible. 
MR. SAUSEDA: Let me just say that there's no question as to the willingness 
of the department to do that. Dr. coye this last year, let's say, cycle, talked to 
the Governor personally on four measures. 
One of those measures was Assembly Bill 11 authored by Assemblywoman Hughes, 
that provides for education in schools for BIV. She strongly supported that with 
the Governor. We worked with the Department of Education, shepherd the bill 
through, joining not only the executive branch, of course, but the superintendent 
of education. We joined forces together in helping to secure passage of that bill. 
Dr. COye is very committed to that; we are committed to that in the Office of AIDS. 
We recently negotiated a memorandum of understanding between our office and 
department and the State Department of Education to ensure in fact that students in 
school and teachers who are very critical to this process are trained in BIV and 
AIDS effectively to educate our students in school at an early age. 
It's very clear from the information that we've seen and the number of 
-12- 025 
individuals who are diagnosed with AIDS who incur their infection as a teenager, 
particularly those people who are homeless -- excuse me -- I should say the 
homeless youth or out-of-mainstream youth, those who are runaways, or also some are 
considered throwaways -- that most of these individuals receive their health 
education in school before the eighth grade. So that very clearly points out the 
fact that if this particularly at-risk population of young people are going to get 
the message, it has to occur at an early stage. 
CHAIRPERSON WATSON: Right. Let me respond to a strategic point. You went to 
the Governor on a specific piece of legislation. What happens there is that you've 
got provisions in that piece of legislation upon which the Governor can respond to, 
well, I don't like this provision or there's not abstinence at the top of the list 
and so on. What I'm talking about is a philosophy and a strategy attached to that 
philosophy, going to him and saying, look, let's come out with a position for the 
State of California as to how we approach AIDS education, outreach, and so on; and 
then let's go find members to carry legislation. So what we want to do is try to 
build the attitude in the executive branch, that we've got to do something -- we've 
got to start early. Why deprive youngsters from the knowledge about their own 
safety, about sexual practices, about their own biology? Why keep youngsters away 
from that information? That's the kind of approach that I think might work with 
Governor Wilson. I do believe he is committed to prevention; he is committed to 
services for children; and I think if you approach him, not on a particular piece 
of legislation but on overall philosophy for the state, it might bold some promise. 
Let me move on because I don't want to keep you on the hot seat too long. We 
have other witnesses here. 
I'd like to know a little more about the type of set-asidea for the ethnic 
minority provider& in terms of outreach. I think what we experience ia that the 
four major ethnic communities -- Latinos, African Americans, Asian&, American 
Indians, and others -- what we find each one of thoae ethnic categories respond 
differently, understand the problem differently, or lack the underatanding of the 
problem. 
What are you doing in terms of aetting aaide resources to meet the outreach, 
the education, the treatment, and ao on? Can you briefly ••• 
KR. SAUSEDA: Certainly. Thia last year, in developing the request for 
proposals for education prevention and efforts, we for the very first time, and 
it's hard to imagine but I've got to say that for the first time, the Office of 
AIDS combined epidemiologic information and targeted those to where we were seen 
the trends of HIV infection in AIDS-case diagnosis. And our epidemiologic 
information suggested that there are three primary groups of emphasis, and those 
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being women of childbearing age, particularly among women in communities of color, 
those homosexual, bisexual men who are closeted, or not necessarily gay-identified 
men, and then also adolescent youth. so for the 1991-92 fiscal year, last year, 
and we developed our RFP, we specifically targeted those three groups of emphasis 
so that contractors who would be competing for funds and who are on a competitive 
basis would tailor their proposals very specifically to these three groups of 
emphasis with specific risk behaviors. 
CHAIRPERSON WATSON: How's the RFP drafted to catch the attention of these 
categorical groups that might come after those funds? 
MR. SAUSEDA: It's broadly distributed to existing contractors, as well as 
through other publications we have through the minority-trained resource center and 
also through our contract monitors working in different parts of the state. There 
was also some public notice regarding those, and also within the California AIDS 
information network. So I believe that there was a substantial distribution of 
that. 
I'd like to further indicate that we very clearly acknowledge that there are 
barriers to successful education-prevention programs in communities, particularly 
communities of color. 
CHAIRPERSON WATSON: Yeah, let me just interject these things because your 
explanations are in depth and I appreciate those. 
The contract monitors, I don't sense enough real community work. I don't 
sense that grassroots people understand the risks. In fact, I know they don't. 
And what really concerns me is how we get into the community by people who reflect 
the ethnicity of their community, the language patterns, and behavior patterns. 
That is something I just want to put on your mind if there's a gap. And I know 
you're trying to do the right things, but it's still coming from a bureaucratic 
level of how it should be done. 
We've got to probably recruit people off the streets, like we do drug addicts 
and we give them treatment and then we train them to go back and be workers in the 
community. We've got to get people that live day by day, that experience, and try 
to get them to talk to like kind. 
Look at this room, practically, empty. Everybody in here is an expert. We're 
talking to each other. What we're saying, we already know. This room ought to be 
packed. We still haven't found yet the way to reach that particular level. 
Dr. Jordan was just in here, but I was appalled when we had a hearing with 
him. And there was a woman who had three children, was HIV positive, and was HIV 
positive by diagnosis before she even had the first one. so somewhere wa are 
missing out. And the people who he brought in to talk to us had no clue as to how 
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they contract this, regardless of what we do on television and the paper and what 
you do. So I just share these things with you. 
We have a serious problem, and I'd like you to get out on the streets; and if 
you haven't visited these programs, do so. I know I took a bit of Dr. COye'a time 
when she was trying to spend a day out here in the streets. And I commend that, 
but you've got to do more of it. And I know we're short-handed. We're all working 
together to try to solve this problem. 
One last question, and you can be very brief, we're hearing, now that there's 
an increasing number of people acquiring BIV from tattooing and ear piercing, 
particularly among teenagers and other various youth groups. Can you comment on 
that? Do you have any evidence of that? 
MR. SAUSEDA: In the interest of being brief, I'm going to have to say that we 
are aware -- we have anecdotal information indicating that needle sharing, not just 
the injection of drug use, but needle sharing does carry the risk of transmitting 
HIV. 
CHAIRPERSON WATSON: When they use that same needle to do the tattooing, is 
that what you mean by needle sharing? 
MR. SAUSEDA: That's correct; yea, that's correct. 
CHAIRPERSON WATSON: Yeah, we better be real clear on that because needle 
sharing meana you're injecting aomething aa we formally have used -- you're 
injecting aomething into your veins? 
MR. SAUSEDA: Injection. 
CHAIRPERSON WATSON: But when we talk about needle sharing, I think you've got 
to be real specific, saying that needle that they use over and over. They 
sterilize it, in quotes, but they use it over and over again? That'a the needle 
you're talking about? 
KR. SAUSEDA: Right, right. 
CHAIRPERSON WATSON: Okay. 
KR. SAUSEDA: And that's occuring not only on the street; it's occurring in 
detention and correctional facilities as well. It's very important that as we 
communicate needle use, that we don't just atop with, as you've pointed out, 
injection and drug use, but all needle, or needle-aharing behaviors, including 
tattooing and ear piercing. 
CHAIRPERSON WATSON: Can you do something out of the Office of AIDS that will 
clarify what we mean by needle use or sharp-instrument use on the akin, of 
penetrating the akin or in the veins and so on? I think we need to broaden that 
out. 
KR. SAUSEDA: As we develop our material and review our existing material, 
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we'll keep that in mind. 
CHAIRPERSON WATSON: Because I know in prisons, you know, that's the thing to 
do, and California Youth Authority, the thing to do is come out with all these 
tattoos meaning you belong to this set or that set or you've been through this 
experience and so on. our kids really don't know what they're doing. 
So if we can send something to the Department of Education that can at least 
get this out, whenever you puncture or scratch the skin with a sharp instrument, 
you're at risk. And particularly where fluids are being exchanged, I think 
something like that would be a beginning. 
one last and final question, audience, to the current speaker, and what is the 
Office of AIDS' role in ensuring that, and the department's role, ensuring that 
experimental drugs, will be made available doing clinical trials to low-income 
persons who might be on Medi-Cal, Medicare, or those who don't have any health 
coverage at all? That's my final question. 
MR. SAUSEDA: That's an area that we've not yet covered, I think, in terms of 
our efforts, and we're looking at doing that. I believe that one of your witnesses 
today is going to comment a little bit more specifically about the representation 
of ethnic and racial minorities in women and children in AIDS clinical trials. I 
believe Mr. Alan Harris will be covering that. 
Let me just conclude my comment by saying that the Department of Health 
Service& does have some research funds, the AIDS vaccine research and the Block 
Grant Fund, AIDS Vaccine Clinical Trials funding. This, laat year, in awarding our 
contract to CYRON Corporation, for the clinical trials, we made as a stipulation in 
that contract that they have very aggressive outreach to women and ethnic and 
racial minority communities as participant& in their clinical trials. We are now 
verified with them -- in fact, it is the role of individuals that they are in fact 
are aggressively recruiting individuals. It's a very important need, not just 
because of the vaccine perhaps that they're being studied for but because by and 
large these research groups gain access to a wider variety of health care, health 
care that they might not otherwise be able to access, very important resource to 
the communities. 
CHAIRPERSON WATSON: Thank you so much, Mr. Sauseda. We appreciate your 
in-depth presentation this morning, and we'll be looking forward to the continued 
work with you and the Department of Health Services. 
MR. SAUSEDA: Thank you very much. 
CHAIRPERSON WATSON: You're welcome. 
I'd like to ask for these three people to come up at the same time. Jim 
Kooler, Dr. Kooler, is the Deputy Director, Prevention Division, with the 
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Department of Alcohol and Drug Programs; and Eddie Yamamoto, Program Analyst IIJ 
and Askia Abdulmajeed -- is Askia here? 
DR. JIM KOOLER: Askia is not with us today. 
CHAIRPERSON WATSON: Okay. Fine. Thank you. Dr. Kooler. 
DR. KOOLER: Thank you. Good morning. I'm Dr. Jim Kooler, Deputy Director 
for the Prevention Division for the Department of Alcohol and Drug Programs. And 
as you mentioned, Eddie Yamamoto is a Program Analyst working on our AIDS/HIV 
Counselor Program. 
You have before you the written testimony. I would like to summarize some 
points of that for you, specifically around some of the principles by which our 
operation and our departments work, and that is, to provide a statewide effort, we 
must be focusing on a partnership of community governments, private and public 
agencies, and groups of individuals. And the cornerstone of our effort is the 
California Master Plan, one which you are very supportive of in that developmental 
process, that our emphasis reflects an awareness that effective policies have to 
come from local communities, and that we need to honor and respect local 
communities and counties in their ability to select the programs and policies that 
did beat for them. 
Currently, 55 counties have been participating in a Master Planning process, 
and Los Angeles is one of those counties in Phase VI; and their Master Plan is due 
to us in June of '92. Thirty-one counties are in Phase I and Phase II. And at 
this point, of those 31, almost a third of them have focused on HIV and IVDU, 
Intravenous Drug Use, as priority populations in their community. 
In regards to the HIV/AIDS issues, the department formally addressed this 
first in 1986. And we did that with some emergency regulations which are still in 
place. The first of those is allowing programs to exceed their capacity by 10 
percent when the need is documented. Secondly, upon our approval to waive the 
requirement that the clients document that they have at least two years of narcotic 
addiction. And finally, again with our approval, to waive that they must document 
two unsuccessful attempts of withdrawl and having return back to narcotic use. 
By the next year, we started to use our ADMS, Alcohol and Drug (Abuse) and 
Mental Health Services, dollars specifically targeting again the IVDUs. This 
process brings money to the counties through the subvention process reflecting our 
relationship with the counties and the state. our hope is to give maximum 
flexibility to the counties in determining the best way in which they can use those 
dollars while still meeting the federal regulations. 
During 1987-88, a total of $5 million was allocated to the counties of which 
Los Angeles County received nearly $2 million of those. 
031 
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currently, 35 percent of the department's total Alcohol and Drug (Abuse) and 
Mental Health Services' Block Grant is dedicated to drug programs. Half of that is 
set aside specifically for the IVDU. Right now, the department has over $23 
million available for this, a 360 percent increase from just four years prior. And 
of this, Los Angeles County receives over $8 million or a 300 percent increase 
since 1987. 
In addition to those IVDU set-asides, there are several issues which may bring 
other funds, versus the AB 1903, the augmentation to the Budget Act of 1988. 
CUrrently, there are approximately $1.2 million allocated to counties of which Los 
Angeles received nearly $400,000. And this money is allocated to those counties 
which have the highest numbers of AIDS cases. 
The next is our HIV/AIDS counselor program which is an inter-agency agreement 
with the Office of AIDS. We have approximately $1.8 million going to this program 
to do training for counselors, to do precounseling, to do the tests, and do the 
post-counseling, allowing clients to access services more readily. This program 
operates in 20 countiea throughout California. Of those populations, approximately 
12 percent of the clients are Black, 27 percent Hispanic, and the other 4 percent 
representing 43 percent of the clients in that program of people of color. 
Statewide, we have an AIDS-training program for counselors and people working 
in the treatment programs to be trained to understand the HIV/AIDS issue. That 
operates on ADMS funds, approximately $100,000 a year. That program is in its 
third year, and we're currently doing an RFP to put that out to bid for another 
three years. 
And finally, our Continuation Waiting List Reduction Program, the intent of 
this grant was to rapidly expand treatment capacity here in California, and that's 
consistent with the National Commission on AIDS Report earlier this year. 
Approximately $13 million of continuation funding is available through this 
program, of which $2 million must be targeted to IVDUs. For this year, Loa Angeles 
received approximately $3.7 of that continuation funding, and $750,000 of that 
targeted towards IVDUs. 
So in closing, the department funds approximately $28,000,000 in programs 
targeting IVDUs throughout the state, Los Angeles County receiving approximately $9 
million of that. For California, that's a 460 percent increase; for Los Angeles, a 
450 percent increase. our department looks forward to continuing to focus on the 
issue, and I appreciate the questions that you brought up earlier around the youth. 
There are some areas in which I think we as a department can participate in 
bringing information to young people. To those would be through our Club Live or 
Friday Night Live Program which are intermediate and High School Programs reaching 
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approximately 1 million high school students, another 750,000 intermediate school 
students, bringing to the coordinators who work in the 44 counties who provide that 
program, I think, that we can raise the issue around HIV and AIDS to our younq 
people in ways that have not been done before. 
CHAIRPERSON WATSON: Thank you very much. Have you discovered in the 58 
counties programs that you feel are effective are doinq the job; and if so, can you 
describe just very briefly what the elements are? 
DR. KOOLER: For the elements for the prevention efforts or for the ••• 
CHAIRPERSON WATSON: Yeah, prevention efforts, the outreach programs, those 
particular efforts reaching ethnic minorities. Do you know of some particularly 
effective programs throuqhout the 58 counties? 
DR. KOOLER: Well, many of those would be here in Loa Anqeles, as you've 
already described. They're effective in workinq from the qrassroots level. OUr 
belief is consistent with yours, that before programs to be effective, they must be 
baaed in the community; and they must have people from that community providinq 
those services. I believe that's consistent with our Kaster Planninq process. I 
personally could not hold up a particular program other than to reinforce the 
philosophy by which we concur as to how best programs can operate in communities. 
CHAIRPERSON WATSON: What do you see the difference between tarqetinq 
programs, say, to the broad general white male qay community versus the ethnic 
minority social, lower socioeconomic communities? What's the difference there in 
approach? Have you been able to fiqure that out? 
DR. KOOLER: The approach must reflect the participation of that community, 
that we've qot to make sure that the people working in those programs are from that 
community, that they understand the issues there, that programs in different areas 
were developed to meet the needs of those different areas. So specifically the 
difference between a white gay male program and a program centered in the black 
community would have to reflect the differences in those areas. So I could not 
qive you the programmatic differences that we would outline and develop a criteria 
by which ••• 
CHAIRPERSON WATSON: They'd have to qrow out of the efforts? 
DR. KOOLER: out of that community itself. 
CHAIRPERSON WATSON: Your opinion now. I carried a bill last year that dealt 
with needle exchanqe and allowinq a test pilot to do needle exchanqe. Your opinion 
as to: (A) Do you think it would go a distance to prevent contracting the spread 
of AIDS; (B) Is this an effective approach; (C) How do you sell it to the other 
communities? Opinion. 
DR. KOOLER: Thank you. And we are also addressinq and doing the research 
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within our department, along with the Office of AIDS, as to the feasibility of such 
an effort. The research, I think, is showing effectiveness in reducing the 
transmission of the disease. So the implementation of that type of program is in 
the interest of the public health slowing down the transmission of the HIV disease. 
The political issue as to whether you are encouraging more drug use by making 
needles available will continue. The use and the selling of that kind of program 
to a community is a difficult issue. some communities will view it as a moral 
issue and that the drug abuse is the issue that we want to address; and if you're 
providing needles, you're encouraging drug use. Other communities will say that if 
you provide the needles, you will slow down the transmission. 
In my opinion, we have to fall back into a position of honoring communities' 
needs and listening to them. I think one of the things that we can look at as a 
state is getting out of the way of those communities who feel that it is most 
appropriate for that program to operate in their area. Right now, we don't have 
that opportunity because of statutes and the availability of needles. 
CHAIRPERSON WATSON: I intend to reintroduce that particular bill again. I 
think even more so, because of the discussion I just had with Mr. Sauseda about 
sharp instruments scratching the skin, and I think that the -- we know how AIDS is 
contracted, and we know how it's spreading rapidly and why it's spreading rapidly. 
We know all that information, we who are enlightened, know it, and we're afraid to 
enlighten others and to provide a safer way. I guess it's like the condom whole 
thing. 
DR. ~LER: The condoms at high schools. 
CHAIRPERSON WATSON: You're up against these archaic attitudes. I'd like you 
to start exploring ways of dealing with the community on that issue, also dealing 
with the Governor on that issue. I don't know if he's going to be a friend on this 
particular one. But I'd like your department, a preventitive sense, to get real of 
these people. You know, we've got to come and face reality as we find it on the 
streets. 
I don't care -- you know, those of us on high who make the policy -- many of 
us don't have a clue. You've got to come down here and face what's going on. And 
AIDS among, particularly black women, heterosexual women, is epidemic. So ••• 
DR. KOOLER: And listening also to our young people. We have the California 
Youth Council which is planning a conference. And one of the tracks that they 
chose themselves was HIV/AIDS. So we will open the doors ••• 
CHAIRPERSON WATSON: You know, if we haven't gotten the word to Magic Johnson, 
then we're in deep, deep trouble. And I think that we're going to see funding from 
the athletic associations nationally; because if the thought is in their minds, 
-20- 034 
like it's in mine that AIDS can spread through their whole team -- and the industry 
of athletics in this country is like next to the entertainment industry -- they 
both can be lumped into the same category it's entertainment. And the threat of 
AIDS running through a team, I'm sure, will probably motivate them to share 
resources with those of us in the public sector. I'm hoping that that will be the 
case. 
But I want to come back again, and I'm going to come back again and again 
until we can catch the attention of all those people that beat us up with the 
bible, beat us up with, you know, the morality and the ethics of all this. I'm 
dealing with science. 
DR. KOOLER: From a public health perspective. 
CHAIRPERSON WATSON: From a public health perspective. Thank you very much. 
DR. KOOLER: Thank you. 
CHAIRPERSON WATSON: Yes. 
DR. TATE: I just have a very short question. With regards to Friday Night 
Live, I understand, I think you said, that it reaches over a million high school 
kids, maybe even more, but moat of those kids are Anglo kids, middle-class Anglo 
kids. What is the department doing to outreach to kids of color or low-income kids 
for Friday Night Live and those sorts of outreach programs? 
DR. KOOLER: A great deal. And the perspective that it's a white middle-class 
program is reflective of where the program began in 1984. I think, if we take a 
look at where we are today, there is much more going on in ethnic communities. 
Here in Los Angeles, just last month, there was an event here at the Palace in 
Hollywood where they bussed in 1,300 kids from all over Southern California; a 
tremendous mix of young people had a chance to see Boys to Men. It was Doritos' 
25th Anniversary, a great event, mixing young people from all over. So we're doing 
some good ••• 
DR. TATE: Is the State Department, though, doing any very specific outreach 
to ethnic minorities to that, you know, for them ••• 
DR. KOOLBR: One of the ways that we're doing that is, again, consistent with 
the Master Planning process, working with the 44 counties, to make them available 
and doing that kind of outreach because it's not a state-operated program but a 
locally operated program which we're a partner in. So part of budget language 
talks about any new programs going specifically into high-risk communities. So 
we're supportive in encouraging that we focus in those areas. 
CHAIRPERSON WATSON: Thank you so much for your testimony.. We appreciate it. 
DR. KOOLBR: Thank you. 
CHAIRPERSON WATSON: I'm going to ask for the next four panelists to come up 
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as a block. First, I'm qoinq to ask Alan Harris, AIDS Regional Coordinator, u.s. 
Public Health Services; Bob Frangenberq, Director of AIDS Program for for L.A. 
County Health Department; Phil Wilson, AIDS Coordinator, City of Los Angeles; and 
Galen Leung who will take the place of Sandra Hernandez, Director of Office of 
AIDS, City and County of San Francisco. 
I'm qoing to ask that we indulqe Mr. Leung because he must leave. So if that 
panel will come up now, and we'll lead off with Mr. Leunq. 
Would you repeat your name at the mike, please. 
MR. GALEN LEUNGa Yes. My nama is Galan Launq. Honorable Chairwoman Watson, 
Members of the Commmittea, Ladies and Gentlemen, and invited speakers. As I've 
said, my name is Galan Leung. I've come to testify on behalf of Dr. Sandra 
Hernandez who's Director of the San Francisco Department of Public Health AIDS 
Office. Dr. Hernandez sends her reqrets but wanted to make the most of this 
opportunity. 
Of all the HIV-related issues facinq San Francisco, five stand out. 
one. The funding trends for prevention and health-related services has not 
kept up with the epidemic. Chairwoman Watson, you have alluded to thia already. 
What is of particular concern is the shift of prevention funds to health services 
thereby cutting funds for behavorial surveys and major prevalent surveys. This 
comes at a time when prevention efforts must be focused on the most 
difficult-to-reach populations -- communities of color, injection druq users, 
youth, men who have sex with men but do not self-identify as gay or bisexual, and 
last but not least, women. 
So basically what I'm sayinq is that we have very little or no information to 
guide us as to what kinds of programs, educational messages, prevention messaqes, 
what sort of media, how to qo about tarqeting many of the prevention messaqes that 
we would like to make, that we have services out there that we've been talkinq with 
the communities; but we don't have anything to strongly guide us as to which would 
be our top priority. We have a million priorities, and we have ten but it becomes 
problematic. This is of particular concern because of the cutbacks at the centers 
for Disease COntrol. 
As you are probably well aware, the centers for Disease control reduced 
funding to contracts throuqh the Office of Minority Health for prevention messaqes 
to minority communities. And that had a direct impact in San Francisco and with 
the Black coalition on AIDS and several other contracts similar to those. So we 
are trying to find the resources to make up for the lose of funds there. 
Two. The needa of the communities of colora for culturally and linguistically 
appropriate AIDS services, both prevention and health services, will continua to 
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grow exponentially while resources remain limited on the national, state, and local 
levels. All three levels face deficits. And we don't -- we are not optimistic 
about increased levels of funding, as in the past, in terms of percentage 
increases, which means we then have to turn around and re-prioritize, re-evaluate; 
and we are spending as much time as we can possibly do on evaluating and 
re-evaluating our programs today. 
As the epidemic shifts and more people of color are affected, resources will 
have to shift and providers will need to be trained to serve the HIV-infected 
individuals in their community. This is basically the focus that we are going 
toward, to train providers that are in the community, already existing in the 
community, on HIV, on issues of transmission, on issues of what is available in San 
Francisco related to early intervention, support services, issues related to death 
and dying, a whole gamut of issues. 
We are fortunate in that many of the providers that have participated in the 
past are fairly up to date about the latest breaking news. However, this tends to 
be a little bit more on the technical, medical side as opposed to the let's provide 
the information and resources to the physicians and other providers as to what is 
out there in terms of social workers, case managers, support services, et cetera. 
This is a stop-gap measure at this point. As the epidemic continues to grow, 
we will be straining our resources. There will be waiting lists. We are facing 
that right now. They come and go, and they are in different groups -- or in 
different communities, I should say. And right now, with the district health 
centers that the department runs, some of our district health centers do have 
waiting lists related to HIV-related care and others do not and in fact have some 
capacity to spare. So we are also looking at re-programming or shifting resources 
around and trying to accommodate where the demand is as opposed to where the 
resources are at this point. 
DR. TATE: Let me ask you, is there a greater demand -- what communities have 
the greatest demand and the longest waiting list in San Francisco? 
MR. LEUNG: currently, the greatest demands are still at our district health 
center number one which serves the castro/DuBois triangle area. The second 
greatest demand area is the area served by Western Edition, which is a -- in terms 
of the number of living cases of AIDS, it's the second highest neighborhood in San 
Francisco. We curently have about 500 there and we have about 500 -- I'm sorry --
600 in the castro/DuBois triangle. 
In terms of our capacities, they are in, remarkably enough, in the Chinatown 
area and Potrero Hill, Bayview, Hunter's Point area. We are not sure if that has 
to do with marketing, a perception, in other words, that these clinics only provide 
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a certain kind of service as opposed to the full range of services or if there is 
possibly -- and I'll address this later a stigma attached to going to the local 
one or going away from your local area and your local provider to a place that is 
known as a place where HIV is treated and AIDS is addressed. 
Three. The twin epidemics of substance abuse and AIDS may intertwine and come 
up over and over again. But the funding -- this is very important -- the funding 
must be unlinked in order to provide enough funds or resources for both epidemics. 
In San Francisco, the Department of Public Health has drafted a comprehensive 
plan to prevent transmission of HIV among injection drug users. This plan calla 
for the involvement of community members, the expansion and enhancement of 
susbstance abuse treatment services, repealing laws which hinder needle exchange 
programs, augmentation of activities, and a round needle exchange, like the 
provision of bleach kids, and providing treatment information, slot information, et 
cetera, what is available, and referral slips. 
The plan also calls for utilizing needle exchange when it is legalized, either 
as a pilot program, as your bill had proposed, and basically as a bridge to reach 
two out-of-treatment injection drug users and bring them into treatment or bring 
them into the system and provide information, whether it be prevention information, 
treatment information, early intervention information. 
Drug treatment on demand is the most effective strategy for reducing HIV 
infection among injection drug users. However, that costs a lot of money, no doubt 
about it. Estimates at this point for San Francisco are $30 million in terms of 
our comprehensive plan. But San Francisco is roughly 700,000 people. It could be, 
if you tried to expand it statewide, it would be quite a lot of money, no doubt. 
And we understand this, and so we have in the plan taken -- it calls for -- excuse 
me. It calls for steps that can be taken right now; for instance, more efficiently 
utilizing the current slots that are available, identifying them, and making use of 
them. And we can expand from our current treatment slot capacity of around 3,000 
by an extra 400-500 depending upon the numbers of people that we actually do bring 
into treatment. We currently serve about 6,000 people in treatment. There's an 
estimated 16,000 injection drug users in San Francisco. 
A privately based underground needle exchange program named Prevention Point 
does exchange around 9,000 needles a week. They estimate that they serve actually 
around 900 people in that week. So depending upon your estimates, either reach all 
those people we do not reach in treatment right now through this underground 
program, or we actually have an extra, let's see, 4,000, 5,000 people left to 
reach. 
Going on with our plan, our comprehensive plan, the department supports a 
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significant expansion of treatment slots. The resources must be identified for 
additional treatment slots, no doubt. And because the plan calla for 
comprehensive, integrated-linked services, it actually does build upon services 
that are already in place, namely, street outreach, HIV testing, and early 
intervention services. 
Four. Like the National Commission on AIDS, we believe that universal health 
insurance must be enacted or else the problems of financing that we've seen so far 
will only double and triple in the next two years. Dr. Sauseda has spoken about 
how the caseload of AIDS will go up by roughly 30,000 to 35,000 people in the next 
two years, and most of these people will be living in the next two years; and many 
of these people will be coming from socioeconomic statuses that are lower than in 
previous years, and they will have a great impact on Medi-Cal as well as general 
assistance. 
The policies, however, of Medi-Cal, Medicare, and the Social Security 
Administration for disability will in the next few months actually go into flux. 
In fact, the announcement today of the Social Security Administration's new 
policies, it's actually being printed in the register, and they're going through 
the two months' worth of open-comment period. It's all being driven by the new 
definition of AIDS, and that new definition is going to strain our resources 
because we will basically see a doubling in the number of cases of AIDS, defined 
AIDS, in San Francisco. We're estimated to go from 3,300 current living cases to 
about 6,000 cases overnight. 
So social security and Medi-Cal, Medicare, all have an incentive to redefine 
their definition of AIDS and who is eligible, not to say that these policies are 
naturally rational; but this will cause more delays in trying to find resources for 
people with AIDS. If Medi-Cal does pay for case management for persons, then how 
do we get them onto Medi-Cal if their definition of AIDS is different from a 
medical definition, et cetera? 
With relation to Medi-Cal and irrational policies, San Francisco does have an 
example of one that is very unusual. Gangcyclovir is a pharmaceutical product, is 
reimbursable, if given on an outpatient basis. However, the first two weeks of 
therapy are normally an inpatient infusion therapy. And because it's inpatient, as 
opposed to outpatient, you can't get reimbursed; so we're left high and dry. 
However, if the reimbursement does become available for the outpatient, for the 
inpatient aide, it's not necessarily going to be able to cover our costs. And that 
is one of the other recommendations of the national commission, that in the 
interim, before, if 
reimbursement rates ••• 
the next steps before the universal health insurance 
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CHAIRPERSON WATSON: Let me ask you, is that a state-reimbursement regulation? 
MR. LEUNG: The reimbursement regulations related to Gangcylovir or overall, 
yes, it is a state ••• 
CHAIRPERSON WATSON: Now can the department do something about this? I mean 
it seems a bit ridiculous. You're trying to keep people out of the acute-care 
facilities, and then we have ••• 
MR. LEUNG: In order to start, you have to have a 12-hour period of infusion 
therapy, which is normally given on an inpatient basis. 
CHAIRPERSON WATSON: Well, Mr. Sauseda, this is something that you might want 
to take a look at. 
MR. LEUNG: The National Commission did call for the amounts of reimbursement 
to be at least commensurate or at least enough to bring out of the woodwork 
providers who would then be willing to participate because what we would then find 
is that people would then go to their natural provider, their neighborhood 
provider, as opposed to overfilling to above capacity, the local health district 
clinics, the county hospitals, et cetera, which is what's happening right now, that 
we have waiting lists and waiting lines at San Francisco General Hospital for our 
clinic services primarily because Medi-Cal's reimbursement rates are so low that 
nobody could even barely make the costs of producing the forms at $9 an hour and 
things like that. 
one last thing to consider in any legislation or measures related to universal 
health insurance is an examination of appropriate profit margins for therapies and 
for drugs that have been licensed to date. Most of the focus to date has been on 
AZT and the related drugs -- DDI, DOC. But other drugs are also now becoming part 
of the arsenal in the fight against AIDS. Brythropoitin, or BP, is a drug used to 
fight anemia, and AZT tends to bring on anemia. That drug is more expensive than 
AZT, about twice as expensive now. That drug was originally licensed for end-stage 
renal failure, people on kidney dialysis machines. But once it got approved, it 
can be prescribed for other illnesses, for instance, anemia, from taking AZT. 
The appropriateness of the cost -- I'm sorry. The appropriateness of the 
charge allowable for that drug is subject to review, but it hasn't been reviewed by 
the FDA because they have other things on their docket at this point which is part 
of the problem that we all face now. 
And in conclusion, I'd like to say that we are quite honored to have been 
invited here to testify before you. And with regard to what San Francisco provides 
and things like that, I can provide you with some of that information. And again, 
I am sorry that Dr. Hernandez was not able to attend and she does send her regrets. 
CHAIRPERSON WATSON: I think that you have pointed out some critical obstacles 
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that tend to be somewhat bureaucratic, that stand in the way of treating this 
deadly disease the way we should. I'm hoping that our efforts would result in a 
higher priority and less in bureaucracy and more understanding. And let's cut 
right through it and get right to trying to find ways to treat and to prevent, as 
well as cure, this dreaded disease. 
Thank you so much. 
MR. LEUNG: Thank you very much. 
CHAIRPERSON WATSON: Now we're going to get back to the agenda, and we're 
going to call for Alan Harris to make comments now. 
Thank you. And I hope you catch your plane in time. 
MR. ALAN HARRIS: I am Alan Harris, the AIDS Regional Coordinator for the 
United States Public Health Service. I'm also a commissioner on the Loa Angeles 
County Commission on AIDS and a Member of the Los Angeles County HIV Health 
Services Planning council. 
I want to thank Senator Watson and her staff not only for the invitation to 
share with the committee preliminary Public Health Service fiscal year 1991 AIDS 
financial data for California recipient organizations but also for the leadership, 
Senator, that you and the committee have provided for public health in this state. 
We certainly commend your efforts in that respect. 
I hope the information that I'll be sharing today will be of some interest to 
state government, local governments, and local AIDS planning agencies prepare their 
budgets in 1992 for the forthcoming year. 
Based on preliminary data, for federal fiscal year 1991, which was the year 
that ended September 30, 1991, the Public Health Service awarded nearly $191 
million in support of AIDS program activities among 348 California organizations. 
At that level, California received slightly more than 10 percent of the $1.885 
billion 1991 national PHS AIDS appropriation. our support includes new financial 
and direct assistance -- direct assistance is personnel, equipment, and supplies --
which is provided prospectively for generally a 12-month budget period in support 
of AIDS and related activities. 
our assistance was provided through grants, cooperative agreements, and 
contract&. In some cases, particularly for reserach projects, the financial 
assistance includes program funding from appropriations other than AIDS. In all 
cases, the financial assistance does not include previously awarded and unuaed 
funds which PHS generally would reauthorize to recipients in support of subsequent 
years of their multi-year projects, which generally are three to five years in 
length. 
I've prepared two exhibits that describe the preliminary PHS '91 funding. And 
-27- 011 
there are some extra copies here for members of the audience as well. 
The first exhibit outlines the fiscal '91 preliminary funding by PHS awardinq 
agency and by general purpose. 
The second exhibit describes that funding by awarding agency in contrast to 
prior-year levels fiscal '89 and fiscal '90. 
OVer the three years, you can see the public health services provided more 
than half a billion dollars in assistance to California orqanizations for AIDS and 
BIV-related activities. The largest share of that money has been provided by the 
National Institutes for Health at $261 million over the three-year period. 
Givan questions that have come up earlier, as well as the focus of the 
committee's hearing, I'd like to identify very briefly the service that the 
National Institutes of Health AIDS Clinical Trial Groups are providing to 
cumulatively nearly 3,500 adult and adolescent volunteers who've enrolled in those 
clinical trials and 182 children who've enrolled cumulatively in California's 
Pediatric AIDS Clinical Trials and trial groups. These eight clinical trial qroups 
are university and medical school organized networks of hospitals and clinics whose 
participating physicians accept patient volunteers to enroll in clinical trials of 
experimental therapies for HIV disease and for opportunistic infections. Specific 
clinical trials of AIDS and HIV experimental therapies are sponsored and supported 
by the Rational Institute of Allerqy and Infectious Disease, which is the aajor 
AIDS component of the NIH. 
These statistics that are reflected in the last two exhibits, one on children 
and one on adults and adolescents, indicate that in all cases, except for women and 
for blacks who were under-represented by comparison with California's cumulative 
AIDS cases, the ACTGs were generally the volunteers, or the enrollees in the ACTGs, 
were generally representative of California's cumulative AIDS cases. That's amonq 
adults and adolescents. 
Por children, the representation was, in my opinion, fairly representative 
across the board, both on sex and race characteristics. 
It should be noted that California's adults and adolescents in volunteers 
represented 23 percent of all of the volunteers who enrolled in clinical trials 
nationwide. And the 182 children from California represented 16 percent of the 
cumulative nationwide enrollment. 
I hope this information has been interesting and may be helpful. I look 
forward to answering any questions you may have now or working with your staff in 
the months ahead. Thank you. 
CHAIRPERSON WATSON: In looking at the California AIDS 'Clinical Trials, when I 
look at the African American group, it looks like the clinical trials are very low 
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comparatively. Almost no research is going on at a time when it seems like this is 
one of the highest risk group at the current time. Maybe that's the reason because 
very few of the clinical activities have really addressed the African American 
community. Can you explain? 
MR. HARRIS: These are only the AIDS Clinical Trial Groups. They do not 
include volunteer enrollees and the Compassionate Youth Trials, which are sponsored 
by individual drug companies. They do not include volunteers. 
CHAIRPERSON WATSON: Do you have any of that information available to us? 
HR. HARRIS: No, I don't. I can't ••• 
CHAIRPERSON WATSON: Can you get what's available and share it with us, 
please. 
HR. HARRIS: I can try. I'm not aware that it's generally available publicly. 
CHAIRPERSON WATSON: See, I guess what I would surmise from all of this is 
that the clinical drug trials done in the private sector and in the academic 
community have not really been addressing what's going on in the minority 
communities. And I guess what we see with the increases is a result of the lack of 
the trials dealing with those communities. And I would say to the private sector 
why7 and I would say to academia and the public sector we've got to do something 
about it. We've got to increase the study groups. You've got to go out there in 
the grassroots, bring these people in, and have them be part of the study groups, 
if we're ever going to get a clue as to how we addresa prevention and treatment and 
other kinde of activities relative to AIDS. 
HR. HARRIS: My thought and suggestion would be that it's terribly important 
for the King/Drew Medical center to be able to participate in clinical trials. 
CHAIRPERSON WATSON: It certainly is. And Dr. Jordan who is in the room is 
going to testify a little later. I don't think there's anyone that knows the 
dearth of activities in this area any better than him, and particularly the few 
number of doctors even willing to treat these cases, it's appalling and it's really 
scandalous. And I can understand why AIDS is raging throughout our community and 
other communities like ours because of the lack of attention. I wanted to bring 
that to your attention and ask you to take a look in this area, supply us with any 
information you can gather as to what the pharmaceutical companies are doing. 
HR. HARRIS: I will. Thank you. 
CHAIRPERSON WATSON: All right. Thank you for your testimony. And I'd like 
to go on to the next presenter. Bob Frangenberg, Director of AIDS, L.A. COunty. 
HR. ROBERT E. FRANGENBERG: Good morning, Senator Watson. 
CHAIRPERSON WATSON: Good morning. 
HR. FRANGENBERG: I'm pleased to have the opportunity to address you today, 
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and I'm going to go through some statistics as well as both about the disease 
itself and about the funding of the disease here in Los Angeles County. 
Los Angeles County is the second-ranking metropolitan area in the United 
States in terms of both the present and cumulative AIDS cases. As of OCtober 31, 
we have approximately 4,000 individuals living with AIDS and about 36,000 people 
who are infected with the virus. our cumulative totals are 13,647 cases. 
The County Department of Health Services has two mechanisms that fund AIDS 
programs in Los Angeles. one is through the AIDS Program Office, and the other is 
through the medical facilities, particularly four facilities. 
The AIDS Program Office is responsible for policy and program development of 
prevention and treatment services, while the department's medical facilities 
provide direct patient care to persons with HIV/AIDS. The majority of funding for 
these services fall into the budget of each individual facility; however, soma 
funds for dedicated outpatient services are provided to certain facilities through 
the AIDS Program Office. 
Projected expenditures for fiscal year 91-92 for the AIDS Program Office is 
$38 million; $14 million of this, or 37 percent, comes from county funds, $18 
million from federal funds, and $6 million from state funds. 
The county funds expended through the program office are for education and 
prevention programs, community-based outreach clinical services, case management, 
home health care, residential care, drug-abuse treatment for people with HIV, day 
care, and dental care. 
The $18 million in federal funds will be spent in two broad programmatic 
categories. Ten million of this money comes to us through the Sutters Disease 
Control for prevention and education activities, counseling, and testing 
activities, and surveillance activities. And nearly $8 million comes through us 
from the Title I of the CARE Act which support medical outpatient services by and 
large and some other support services and outreach services. 
Seventy-one percent of the CARE Act Funds are being expended on patient 
services through contracts with community-based organizations. Twenty-four percent 
are supporting services in county facilities, while the remaining five percent are 
for administrative services. We already know that our 1992 CARB Act Formula grant 
will be $5.4 million, up from $3.9 (million) for next year, and the year starts 
February 1, 1992. 
The State Office of AIDS allocates money to the county. we get $737,000 for 
our anonymous test si~es. We get about $4 million for the AIDS drug program which 
funds a variety of drugs. And then we have $287,000 that go to Martin Luther 
King/Drew Medical Center for primary care or early intervention services. We get 
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another $1.1 million from, through the State Block Grant, and that goes for a 
variety of services as well, including counseling and testing in juvenile halls, a 
prevention center at the Gay and Lesbian Community Services Center, an injection 
drug use program with the Los Angeles center for Alcohol and Drug Abuse, and in 
some surveillance and epidemiology services in our department. 
HIV- and AIDS-related expenditures for inpatient and outpatient care at the 
county medical facilities are supported by several revenue sources. The primary 
revenue supporting care is Medi-Cal whose smaller amounts come in from Medi-Care, 
patient revenue, and insurance. 
During fiscal year 1990-91, the medical facility spent a total of $34 million 
on HIV- and AIDS-related care, with $9 million spent on inpatient care and $25 
million on outpatient care; and, $16 million while $34 million total was spent out 
of general funds, county general funds. 
It is important to note that a trend toward greater reliance on outpatient 
medical services rather than inpatient services have been taking place in the 
county. This should inherently provide a more effective and efficient use of our 
financial resources, even though it provides inpatient services, that is -- I'm 
sorry. OUtpatient services provide a lower reimbursement from Medi-Cal. Average 
is about 80 cents on the dollar, inpatient; and about 20 cents on the dollar, 
outpatient. 
Thirty-seven percent of the cumulative adult AIDS caseload in Loa Angeles 
County is comprised of people of color. When you relate that to the county census, 
you have 11 percent of the county residents are Asian/Pacific Islanders and Native 
Americans; and 2 percent of the AIDS cases are among that group, those groups. 
Hispanic represent 38 percent of the county population and 20 percent of the AIDS 
cases. African American people represent 11 percent of the population and 16 
percent of the cases. And whites represent 40 percent of the population and 62 
percent of the cases. 
The behaviors which put adults and adolescents for all ethnic groups at risk 
in Los Angeles County are as follows: Male-to-male sexual contact is 80 percent of 
the cases coming from that behavior; male-to-male sex with injection drug use is 7 
percent; injection drug use 5 percent; transfusion recipients 2 percent; 
male-to-female sexual contact 2 percent; and hemophilia or coagulation disorder 
less than 1 percent. 
CHAIRPERSON WATSON: Excuse me. Which category would you put the transmission 
of AIDS from a professional health provider to a patient? 
HR. FRANGENBERG: I would say that it's not in here, I suppose. I mean these 
are -- we don't really have a category that's outlined, you know, that keeps track 
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of that. 
CHAIRPERSON WATSON: We ought to start looking at that category, since we've 
had a case and a death and who knows. Maybe we can start at least bringing aome 
attention to that particular category too. 
MR. FRANGENBERG: Los Angeles is significantly different from East Coast 
cities and somewhat different from other cities in California in the lower 
percentage of cases which are related to injection drug behavior. Even when the 
behavior categories are examined within each ethnic group, gay and bisexual men 
comprised the predominant group affected by the BIV epidemic and at risk for HIV 
infection. 
For example, 68 percent of the African American adult and adolescent caaea, 73 
percent of the Hispanic cases, and 80 percent of the cases among other people of 
color are attributable to male sex. An additional 10 percent of African American 
cases, 6 percent Hispanic cases, and 3 percent of cases among other people of color 
are attributable to a combined behavior of male-to-male sex and injection drug use. 
The statistics are useful ••• 
CHAIRPERSON WATSON: Excuse me. Your last statement on page 6 says: "Loa 
Angeles ia significantly different from--" other "--Bast Coast cities" and eo on. 
What's the backup information? I didn't know whether the following paragraph 
would back that up or if that stands alone. If it does stand alone, you might want 
to expand on it. 
MR. FRANGENBERG: Okay. We've been doing studies in Loa Angeles County for 
sometime on people in treatment. And ever aince 1986, we have found that about 5 
percent of those people have been, 5 to 6 percent of those people are infected. 
In the studies that we've done in people outside of treatment, on the street, 
we've done some studies, and we find that that number is about 8 percent. In Mew 
York, the number of people who were infected through injection drug use or aharing 
of needles is 60 percent, eo it's dramatically different on the Bast Coast, in Mew 
Jersey and New York. San Francisco, I don't know precisely what the percentage is, 
but I think that it's more in the 15 percent range than it is in the 6 to 8 
(percent) that we have here. So that's the basis for that comment. 
CHAIRPERSON WATSON: Is your point here that the instance of AIDS being 
contracted through injections is lower here in Los Angeles? 
HR. FRANGENBERG: It seems so. 
CHAIRPERSON WATSON: More than other cities in Los Angeles? 
MR. FRANGENBERG: I'm sorry? 
CHAIRPERSON WATSON: Lower than other cities in Los Angeles? 
MR. FRANGENBERG: In Los Angeles County or ••• 
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CHAIRPERSON WATSON: Excuse me. In California. I'm sorry. 
MR. FRANGENBERGz In California, yes, it's my understanding that it is lower 
than San Francisco. I couldn't tell you about other 
cities in California, but I can tell you about San Francisco and Loa Angeles. 
Well, we used these numbers that I've just given to you to look at trends and 
to target our prevention and education program. Prior to 1987, 83 percent of the 
adult cases for all races were attributable to male homosexual/bisexual contact. 
This figure now has dropped to 77 percent in 1990. conversely, the percentage of 
cases linked to injection and drug use rose from 2 percent prior to 1987 to 6 
percent in 1991. 
Over the same period, cases linked to injection and drug use, in combination 
with homosexual or bisexual contact actually dropped from 8 to 6 percent. Cases 
attributable to homosexual contact rose from 1 percent in '87 to 2 percent in 1990. 
Thus, though, homosexual and bisexual contact may be viewed as the riskiest 
behavior for HIV transmission, injection drug use and heterosexual contact have 
increased in recent years. 
The ethnic distribution of new cases has also changed over time. Prior to 
1987, 70 percent of new cases in the county were white cases. And in 1990, only 56 
percent of the new cases were diagnosed in whites. These statistics for African 
American are 14 percent prior to 1987 at 18 percent of new cases in 1990. For 
Hispanics, they are 15 percent prior to 1987 and 23 percent in 1990. 
Another way of looking at these are through the trends of the incidents. And 
as you can see in the white community, the incidents have changed. From 1984, it 
was 22 per 100,000; and in 1990, it was 89 per 100,000. For male, African 
Americana, the statistics were 19 per 100,000 in '84 and 122 per 100,000 in 1990. 
Hispanics were 7 in 1984, 7 per 100,000, and 53 per 100,000 in 1990. 
I don't have earlier statistics for women, but I have the 1990 incidents for 
women. It's 2 per 100,000 for white women; it's 4 per 100,000 for Hispanic women; 
and 9 per 100,000 for African American. 
Primary behaviors which put women at risk are heterosexual contact, which is 
33 percent of the cases, injection drug uses, which is 28 percent, and transfusion 
recipients which constitutes about 23 percent of the female cases. And moat of 
these transfusions occured prior to the assessing of blood supply. 
As the local face of HIV/AIDS has changed, so has our approach to the 
prevention and related medical services. For instance, community-based 
organizations serving people of color and women now constitute a majority of our 
contractors for our HIV education and risk-reduction programs. We firmly believe 
that our preventative aspects on high-risk persons of color will be maximized 
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through the expertise of community-based organizations. These organizations have 
vast experience in targeting programs to their communities and providing effective 
outreach at a culturally adept context. 
We have 15 contracts with community-based organizations that are specifically 
targeted to people of color. I've listed them and I put the targets down, but I 
won't read them. And I've listed also the number of, the amount of money that goes 
to each contract. 
CHAIRPERSON WATSON: Yes, there's a question. 
DR. TATE: Bob, I have a question. 
MR. FRANGENBERG: Sure. 
DR. TATE: You mentioned earlier in your testimony that approximately 38 
percent of individuals in Los Angeles County are ethnic minority. And you've given 
the providers and the amount of allocations you give them, but generally speaking, 
approximately what percentage of your budget is dedicated or given to ethnic 
minority providers? 
MR. FRANGENBERG: I think it's a little later in the speech, but 65 percent of 
the prevention and education and education money goes to minority providers. 
DR. TATE: So that's prevention and education. 
MR. FRANGENBERG: That's correct. 
DR. TATE: And then does the county also do, give money for treatment? 
MR. FRANGENBERG: Yes, we do. I have indications of what that would be, but I 
don •t have ••• 
DR. TATE: Yeah, I would just like, even if it's just a ballpark figure in 
terms of just like a percentage of your budget. 
HR. FRANGENBERG: Well, what I have is the percentages of people who are 
getting AIDS drugs through our medical facilities. And, for example, at Loa 
Angeles County, USC Medical Center, 47 percent of the AIDS drugs that are dispensed 
through there are to African Americans; 35 percent are dispensed to whites; 12 
percent to Hispanics; and 1 percent to Asians. So that's an indication at LACU. 
You see, there are four different locations that I have, statistics like that on, 
but it's an indication of who's being served, what ethnic groups are being served 
at those facilities. 
DR. TATE: Just one last question. 
MR. FRANGENBERG: Sure. 
DR. TATE: Then I'll let you continue. In terms of treatment, do you define 
treatment, or could you define what treatment is for AIDS victims? Is it just the 
drug, or do you also provide counseling, other kinds of forms of therapy, mental 
health? 
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MR. FRANGENBERG: Well, yeah, that's a very good question because it's 
changing pretty dramatically, I think, not only here in Los Angeles. But actually 
it's a broad spectrum of services that are available. I mean we have -- in Los 
Angeles, we have a fairly good continuum of care. It has -- it's very spotty in 
some ways in terms of what, whether or not there are enough slots available for 
residential care or primary care or mental health care. But there's at least 
something happening all along the continuum. But that's the challenge here, at 
least, ia to not only increase the alots that are available in each of thoae kinde 
of care. 
One of these we're finding is that people are much more acutely ill when they 
first come into the system than we had anticipated. And we're finding that many of 
them are coming in with T-cells that are below 200, generally indicating that they 
are going to need and would require pretty extensive care, not always, but 
generally speaking, you can say that they would provide, be in need of more care. 
So that's been something that we've had to try to work with, especially with our 
CARE Act dollars which are funding primarily primary care. And by primary care, we 
mean whatever that person walks through the door with. I mean if they have needs 
that are HIV-related, they're to be taken care of in our primary-care centers. 
DR. TATE: Thank you. 
MR. FRANGENBERG: Well, I would also say that we have a variety of contract& 
that are not specifically contracted with minority-owned or specifically for an 
ethnic group. But many of the contractors work with people of color as well as a 
broad spectrum of people. 
CHAIRPERSON WATSON: Let me ask this: How much effort have you been placing 
in finding people of color to contract with for these programs? 
MR. FRANGENBERG: In my view, a lot. We have worked with the community and 
with advisory groups, the AIDS Regional Board, our own HIV Planning Council, the 
CARE Act Planning Council, the Commission on AIDS -- I mean a whole host of 
providers to try to identify community-based organizations that can, are interested 
in, can and are willing to contract with us to provide services. We do it on a 
sole-source basis in some cases, and we also do it through an RFP process. 
CHAIRPERSON WATSON: What is the percentage of non-minority providers that are 
working on the minority communities? 
MR. FRANGENBEG: I'm sorry. I really don't have a figure of that. 
CHAIRPERSON WATSON: I would be interested in knowing that figure because I'm 
seeing maybe a pattern here. Number one, there's been very little research done on 
these minority groups. contracts are going probably in larger numbers to 
non-minorities that deal with the minority community; and the gap that is occurring 
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in outreach, knowledge given to the people in the streets about their behavior and 
how to prevent certain things from happening. So I'd like to be able to document. 
I'm just seeing a pattern, from what I'm hearing this morning, trying to figure out 
what the problems are and how we address those problems. And I think the 
information that you could provide would be very helpful. Maybe if we could give 
extra points to those minority providers and an extra effort, we might be able to 
find like kind that can relate better to the problema that are faced and the risks 
that are running rampant in our communities. 
MR. PRANGENBERG: Well, I'm just going to touch on anonymous testing briefly. 
We have a contract with the State Department of Health Services and then contract 
with community-based organizations ourselves to provide anonymous testing. And 
they are Regional center in East Loa Angeles, Valley community, and North 
Hollywood, South Bay Clinic in both Manhattan and Gardena, Bast Valley Community, 
and Minority AIDS Program. 
We're very interested in some of the things that Wayne talked about this 
morning, about the additional funds that he's trying to get for these projects 
because it's very important. As he mentioned, some of our waiting times before 
Magic made his announcement, we didn't have any waiting time in some of our 
clinics; and now we have two-month waiting periods. 
To give you an idea about who are going for testing, about 2 percent of the 
people who are being tested in our anonymous teat sites are Native American; 4 
percent are Asian and Pacific Islanders; 6 percent are African American; about 20 
percent are Hispanic; and about 67 percent are white. 
This is a little bit of what we're projecting as an unmet need in our 92-93 
budget. We approximate that we have a $29 million unmet need for AIDS and HIV 
service in Los Angeles County, and we think that that's roughly in these kinds of 
categories: $3 million in education and outreach and prevention services, $23 
million for outpatient and inpatient services; $2 million for testing, about 
$900,000 for residential, and about $800,000 for dental care. 
We have tried to look at these and make some decisions about which groups we 
think need to be addressed, and we think that those groups are adolescent women, 
substance abusers, gay men of color and gay white men. 
CHAIRPERSON WATSON: We were just commenting on page 13 at the top. And for 
the month of October 1991, there's a picture that you provide of the racial 
distribution for anonymous testing and counseling services. 
MR. PRANGENBERG: Right. 
CHAIRPERSON WATSON: Sixty-seven percent of those receiving services were 
Caucasian; only 6 percent were African American. 
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I think that tells a story; and as I mentioned before, it's a pattern that I 
see occurring here that says that we, rather than neglect these areas, we've got to 
increase the services to these areas or else the numbers are going to grow 
epidemically. 
MR. FRANGENBERG: Yes, I agree. We saw the same thing when we looked at these 
numbers. And one of the things we're also interested in and concerned about in 
trying to get some strategies to deal with are the high rate of infant, African 
American infants, that are born HIV-positive. And we're going to start to work, or 
one of the ideas is to work with the WICK Program because in Los Angeles county, 
for a variety of reasons, most of the African American women do not come to county 
facilities for prenatal care. And so we have to find other strategies to try to 
reach young African American women and at least provide them with counseling and 
testing information about how the virus ••• 
CHAIRPERSON WATSON: That's the reason why you'll hear many of my questions 
going to outreach because it's becoming clearer and clearer to me that a concerted 
effort has to be made to meet the needs of these high-risk communities. And as I 
understand it, that the fastest spread of AIDS is among African American women 
during their childbearing years. We're seeing them in the county hospitals now, 
the neonatal wards, costing us up to $100,000 a year to keep them there. And I 
would certainly hope that you could design a program in the county which gives a 
priority to these underserved communities who are at such high risk. 
MR. FRANGENBERG: We do have outreach programs, Southern California Youth and 
Family Services ••• 
CHAIRPERSON WATSON: Yeah, I know you do. 
MR. FRANGENBERG: We do have some. 
CHAIRPERSON WATSON: But your own statistics are saying that probably you 
don't have enough of the programs or they're not well funded enough or you don't 
have the expertise because of -- even with your own distribution of testing, it's 
very, it's the lowest among the top three groups. 
MR. FRANGENBERG: I agree. I understand. 
CHAIRPERSON WATSON: And so something is not right with these figures. Maybe 
something's not right with the priorities you've set. 
MR. FRANGENBERG: We're certainly aware ••• 
CHAIRPERSON WATSON: In spite of what you have already, you've got to do more. 
MR. FRANGENBERG: Let's see. 
CHAIRPERSON WATSON: Can we skip over to 15. We're going to have to move 
along. 
MR. FRANGENBERG: Sure. 
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CHAIRPERSON WATSON: Page 15. Let's talk about unmet needs. 
MR. FRANGENBERG: Oh, I'm well into unmet needs. 
CHAIRPERSON WATSON: I was ready for unmet needs too. 
MR. FRANGENBERG: I really just, I've really told you that we have a $29 
million unmet need, and I've sort of outlined what they're in. 
I think that some of your comments are relevant and important. I do think 
that there have been some significant progress in Los Angeles County over the last 
few years. I think there's a long way to go, and I think there are a lot of things 
that can be done and need to be done. I think that some of the initiatives that 
the state has done, and also the federal government, especially the CARE Act, has 
at least helped us get additional resources to provide additional services, both 
prevention and services and treatment services. And I'd be willing to answer any 
questions you may have. 
CHAIRPERSON WATSON: Yeah, I would agree with you that you've done, made some 
progress1 and I think we have to make more and, in terms of the funding. We don't 
have enough funds, but we've got to look at the funds we do have and the equitable 
distribution. Now some communities require more than others. But I think the 
emphasis in the beginning, in the early '80s, was on the white male gay population. 
And trying to turn that around -- because they went after the problem immediately. 
And we saw almost immediate decreases in the spread of AIDS in the white male gay 
population. And at the same time, guess what? The other groups started to expand 
in terms of the infection of HIV. And I haven't seen the state, the feds, and the 
county turning around and looking at where the greater spread is. So what I would 
encourage the county to do is to start looking at your own figures and looking at 
the•• unmet needs and set some priorities that can go after the problem in theae 
under-represented groups, giving them a top priority. 
I think I've made that point several times now, and I think yo~ have it. 
MR. FRANGENGBERG: I think I do. 
CHAIRPERSON WATSON: So thank you for your testimony. 
MR. FRANGENBERG: Sure. 
CHAIRPERSON WATSON: All right. We'd like to call on now is -- I want to 
follow up with the county's testimony with Dr. Phil Jordan who is Director of the 
AIDS program at Martin Luther King Hospital. And following Dr. Jordan, do we have 
Phil Wilson here? I didn't see Phil. Okay. And then we'll take Dr. Tuckson. Is 
he here? Okay. Fine. 
Dr. Jordan, if you'll come right up, please. And then we'll follow down the 
agenda with Cleant Stain and Germaine Maisonnet; is that correct? Okay? Dr. 
Jordan, please. 
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DR. WILBERT JORDAN: Good afternoon, Senator Watson. 
I think we have to look at AIDS when we're dealing with the minority 
communities and to have an approach that emphasizes keeping the HIV negative, 
negative, as well as providing adequate and appropriate care for those who are 
positive but not waiting until the person becomes positive before we've done 
something to prevent them. 
As of December 30 in my practice, in both King Hospital and in South central, 
I had seen 37 women; that was December 30, 1990. As of June 30, 1991, that 
increased to 72 women. Two of those women had gotten infected through blood 
transfusions and two through IV drug use. Six to eight had become infected through 
heterosexual transmission. Of them, a great number were partners to men who are 
bisexuals and they did not know it. 
There are two issues when one looks at the issues of women. When that woman 
learns she's positive, moat often, in about 35 percent of our cases, they learn 
second-hand, i.e., that a child is born ill and they learn because the baby is sick 
or friends may tell them. What she learns, she learns that her male partner has 
known he was positive for sometime, maybe even being treated, and has never told 
her. So she has to deal with several issues: One, she has children; two, she's 
positive; three, her husband, her male partner, is bisexual -- she did not know it; 
and four, he has known that he had a deadly disease and never told her. She needs 
a lot of psycho-social support. She needs to see a psychologist or a psychiatrist. 
Moat of the patients we see come in with nothing. If they have Medi-Cal, 
that's a plus. Psychiatrists don't take Medi-Cal; psychologists don't either. And 
she is faced at that point with a great need. She has several severe, big pains to 
deal with. 
CHAIRPERSON WATSON: I just want to interject this; I can't help but telling 
you this. A friend of ours son committed suicide about three weeks ago. His 
companion did not know, A, that he was black. He was living as a caucasian. And 
she had had a baby and he was afflicted with HIV. So she got a triple whammy 
there. And she's devastated. And I don't know if, out where she lives, way out 
near San Gabriel, somewhere there, if there are programs available, I do think the 
psychological punch that carries, or that's carried with kind of revelation, is 
addressed. We carried legislation several years ago to provide a whole aeries of 
treatments. And number one, just by the fact that there's a revelation that my, 
God, this person that I had contact with is this, is this, is this, and I think 
that's a major part of the reason why people succumb so quickly because, number 
one, they don't have the strength to be able to stand up and cope and fight because 
they've been so devastated; and we haven't looked at providing the services. I'm 
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glad you raised that issue. I just had to say that. 
OR. JORDAN: Thank you. 
CHAIRPERSON WATSON: Or. Tate. 
OR. TATE: And I just want to piggyback on that because when Mr. Prangenberg 
was up here, and he mentioned about the continuum of care that's offered, I mean I 
would like you to talk about the real world then and these women that since L.A. 
County says that they do offer this continuum of care that would go from testing 
to, as far as I'm concerned, the psycho-therapy of some sort to hospice, why isn't 
it available for these women? 
OR. JORDAN: Maybe it's not a big deal. Let's see. 
OR. TATE: Yeah, you know, what's going on. 
CHAIRPERSON WATSON: Being hit from you is what you're saying. 
OR. JORDAN: (Gap in tape) ••• half of my patients. But I cannot say if that 
has been done definitely as a study. But we need to be able to either make a 
decision of testing all women, record their blood and see if they're positive, or 
being able to profile who is at high risk so that both they and their physicians 
will know who is at high risk and test those so we can identify them before it 
becomes too late. We're losing a lot of time. 
CHAIRPERSON WATSON: What I hear you saying is that you don't know of any 
studies that are focusing on women of all colors? 
OR. JORDAN: correct, that identify which of these --
CHAIRPERSON WATSON: As a category, women as a category. 
OR. JORDAN -- are at high risk of being HIV-positive. 
CHAIRPERSON WATSON: Okay. Would you make a note of that, because that's 
something I'm very interested in. And I just left a press conference where we were 
talking about breast cancer. Most of the cancer research has been done on men 
prior to the '90s. And breast cancer is at an epidemic level. So I equate cancer 
with AIDS. I think it's really kind of the same form of disease that attacks the 
body. I think you're pointing at something that is a great need that we have 
really not focused on, so we're going to follow up. We'll try to see what there is 
going on in the country, and then we might have a proposal or resolution or 
something. Thank you. 
OR. JORDAN: These are my black patients. And this date, I've shared with you 
previously, but I have not, because I'm the one doing it it may have to do with 
it -- my white, Hispanic, and Asian patients. Bighty-seven of my patients are 
married men; 23 of the wives know it -- they have married knowing they're husband 
is bisexual; and 64 of the wives did not know that their husband was bisexual. And 
again, so you have a large group, and this is an issue that has to be dealt with. 
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When you look at the 341 men who are homosexual of this group of patients as 
of December 30, 202 identified as being bisexual; 105 identified as being strictly 
homosexual; 34 said they were neither, though they were having sex with men. And I 
found that interesting. When you look at where that group at 34 had that initial 
sexual contact, it was in jail. And again, jail is, jail is an institution in the 
Black community. We have to deal with that. That's a fact. A lot of Black men 
have been in jail. To be very graphic, if I'm married and I'm put in jail and 
three men grabbed me and threw me down and have sex, I am not going to go home and 
tell my wife. That's the last thing I'm going to tell her. You profile that 
person what he will do when he gets home, he will be rougher but very sexual to 
reaffirm his manhood. But if he does get infected, if he does go in and out and if 
he does play the part of the passive role in jail, when he comes home, she may be 
happy because he seems to be so amiable and sexual but he's also infecting her. 
I think it's important to understand that in terms of infection, the female is 
easy to get infected from a male than visa-versa. 
CHAIRPERSON WATSON: I'm becoming more and more cynical as the minutes go on. 
And what I think I might do is ask the Department of COrrections to do a study on 
sexual contact in their facilities, both at the adult level and at the CYA level. 
You know, they will tell you that, oh, we can't dispense condoms ·because it's 
illegal to have sex in prison. 
DR. JORDAN: That was my next point. Thank you for saying that. 
CHAIRPERSON WATSON: I think I'll put the responsibility on the Department of 
COrrections because they have supported bills that would require testing throughout 
the entire system without a program to address. Once they have all this data, what 
are you going to do about it, was my question. I got no satisfactory answers, 
except we'll isolate them or quarantine them. But I didn't hear the steps in 
treatment. And so I think that what I will do is hold the department responsible 
for giving us a picture of sexual activity. And then we can get some other 
community-baaed group maybe to do research on what happens when these people return 
back into the community. 
DR •. JORDAN: Thank you. That's very important, because the two other points I 
wanted to mention, in terms of jail, is one. Some jails do not provide condoms 
because, again, men don't have sex in jail. I think it is stupid for us to allow 
that philosophy to go on when we know it does happen, and these men are coming back 
out to your sisters and your daughters, and in some instances, you know, and once 
in his room. That's important. 
The other issue is drug users. And though we're seeing an increasing number 




we have a problem. When I have a patient who's a drug user, I can scare the 
hell out of him and make him want to go to be treated at that moment. But most 
times, if at that point in time, he says I'm ready to go let me go get rehab 
right now, dry me out -- I have no place for him to go to. So if I succeed in 
getting him to where he wants to now and then he has no place to go for six weeks, 
or sometimes longer, in that period of time, he's going to spend drinking or 
drugging himself worse because he's scared even more. 
If I succeed, and I'm lucky to get him into a place and he comes out dry, I've 
done very little but prolonged time because in our situation, we're not talking 
about one person in a very middle-class structured Beverly Hills environment where 
he or she is using drugs but the rest of the family are stable and are good 
supports. We're talking quite often about one person who happens to be HIV 
positive and using drugs. But he has a whole support system who are also HIV 
negative but also using drugs. So when he comes out and goes back to the same 
support system, what are we to expect? How do we really expect him to go out to 
the same group and refrain when his whole support system are all using drugs? 
We have to deal with drugs in this country like we did smallpox in India and 
Africa. We vaccinated around the infected group. The best way is not just to deal 
with getting that HIV-infected patient into a program but getting his whole support 
group into a program. Either we decide that they all are worth it or not. It is 
costlier to have them go back and forth in the hospital, getting medicine, being 
treated for AIDS, than it would be to put him and his whole support group in a drug 
rehab program. 
CHAIRPERSON WATSON: I think a key word, I just heard you say is: Are they 
worth it or not? I think we have to do a lot with that attitude: Are they worth 
saving? 
DR. JORDAN: Yes. 
CHAIRPERSON WATSON: And if they are worth saving, then you're going to see a 
redistribution of resources. And I think that's the main question. As I see it 
within this area of California and in this county, that question comes up time and 
time again because I don't see the resources going to those poor people. And we're 
poor people -- we were out at Martin Luther King yesterday. That's a hospital that 
serves nothing but minorities, and we don't have the same resources that we have in 
some of the other hospitals. And I guess it all boils down to is what the concept 
of worth is by the people making the decisions and how then we distribute the 
resources. 
So I think fundamental to everything you're saying is the question of, do they 
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feel they're worth it. 
DR. JORDAN: It's very important. Mental health, as I mentioned earlier, ia 
an Lmportant issue. And just in the community itself we need to have more 
available mental health practitioners to be able to work to help those persona. 
Now two other issues I want to mention. About a month ago, a drug called 
clorithromyacin became FDA approved. It is a drug that you use to treat a 
particular type of infection in AIDS patients. Before then, there were several 
drug, combination drugs, you had to use and you got very little results. MAI was 
one of those illnesses that when the patient got it, it was bad news because it was 
very hard to treat. 
Well, about a year-and-a-half before this drug became available, it was 
available. It was made by Abbott Laboratories -- it's still made by Abbott 
Laboratories in Indianapolis. And if you had money to fly to Ireland for it and 
come back here and take it. Congress has passed legislation that allows for AIDS 
patients to be able to buy these kinds of medicines for their personal use. And we 
have established in most of the major cities' buyers• club as the only buyers' club 
here, that for those persons who could afford it, they could get it. And so what 
has happened for the past year-and-a-half prior to this past month, those 
middle-class patients, and moat of them are white, were able to buy it. And it 
coat about $450 a month. It went down, at the end, before it became available, to 
$300 a month. 
Of all the patients I had, I had only four who could afford to get it. The 
other patients that I got it for, I paid for it myself. The same is true right now 
for DDC. It's available through a buyers' club. And my point is we're going to 
see a lot of drugs becoming available that are effective. But unless the person 
haa the available funds, we're going to see the drugs available for a year or 
year-and-a-half but only those who can afford to purchase them be able to take 
opportunity of it until it finally becomes available. And the majority of people 
who will suffer or who will still die when they could be alive will be minority 
patients. And there has to be established to me some kind of slush fund that would 
address this issue and allow those persons to take advantage of those medicines too 
when it's there. 
I do not think we can really make the impact we have to make in the minority 
community unless we also deal with self-esteem. I don't know what the Friday Night 
Live Program is. I understand it's in some of the middle-class areas. We need a 
Sunday through Friday Night Live Program in the minority community. We're talking 
about kids who have no self-esteem to offer. And when one self-esteem is 
destroyed, is low, et cetera, often their sexuality is the one thing they have. 
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And we have to understand it and deal with that. And education has to be coupled 
with empowering patients' self-esteem. And we cannot provide the same kind of 
educational model that works very well in Beverly Hilla, that works very well in 
West Hollywood and put it in Watts. It will not work. It may provide some of us 
with jobs, but it will not work. And that's important. The issue here is keeping 
those HIV-negativea, negative, not simply providing some of ua with joba. And if 
we do not deal with self-esteem in a way that we need to deal with it in South 
Central, it won't work. And what will work in Watts may not work in East L.A. It 
has to be flexible enough that public work in those communitiea, they can use it, 
rather than being forced to adhere to one structured program. That makes no sense. 
And when we keep doing that, we lose out, particularly, minority communities. 
It was mentioned earlier that the definition of AIDS will change. Many of the 
patients we see come in with low T-cells. And we will see an increasing number of 
AIDS patients when the definition changes. The problem we have now, if a patient 
comes in with 200 T-cells and he has pneumonia, that qualifiea him, pneumocystis 
pneumonia, for AIDS. He then, if he has been diagnosed, he can get to the 
hospital. If he's been lucky enough to not get an infection and he or she comes in 
with a T-cell count of 10, which means they have much leas of an immune system, 
which means if they get an infection, the chance of living through it then is zero, 
so you want to do everything you can to keep that person from getting an infection. 
At the same time, they become penalized because if you keep them healthy, they 
can't get that benefit. And if they don't get that benefit, Medicaid follows 
social security disability. So if disability says no, Medicaid says no, so we're 
sort of trapped. If I sit back and let this patient get an infection, which would 
then qualify him or her to get the Medicaid, we're paying severe Russian roulette 
with five bullets in the gun. And that is a huge problem that minority patients 
face all the time. We need to have that system changed so that patients whose 
T-cell counts are 200 can get their benefits without having to run the risk of 
dying from a disease, which is what we're doing right now. 
CHAIRPERSON WATSON: Let me raise this question with the Office of AIDS. Is 
there a treatment model, comprehensive treatment model, for the minority community 
based on all the elements that have been described by Dr. Jordan as being 
necessary? Is there anyone in the Department of AIDS who has the same kind of 
knowledge on what's happening in the minority communities as Dr. Jordan? Can you 
respond? 
MR. SAUSEDA: The second part of your question is easier for me to respond to; 
and the answer is no, we don't have anyone in our office that's as familiar as Dr. 
Jordan is, clearly. 
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CHAIRPERSON WATSON: Why don't you give Dr. Jordan a grant to do a study, to 
provide you with the information or you can then model a program that will meet the 
needs of this community that clearly has not received the kind of resources? And 
our hospitals are filled with the babies born of the mothers that have not the 
information and know how to take care of themselves. Could you do that? Could you 
br~ng him on so that he can -- he's the only doctor that I know in the African 
American community that has the information. He came to me years ago and said, 
look, this is the picture. And we've been going on the road, but there's nothing 
be~ng done. I don't know of anyone else in the Department of Health Services 
that's been able to describe the program needed and the problem as existing in Dr. 
Jordan. 
MR. SAUSEDA: I agree with you. I think that the kind of experience, the 
day-to-day experience that Dr. Jordan has, is tremendously important for us in 
developing our programs. I certainly 
CHAIRPERSON WATSON: You ought to be talking to him. 
MR. SAUSEDA: Yes. 
CHAIRPERSON WATSON: You ought to sit down and spend hours with him, as we 
have done. You ought to get into his psyche because, believe me, he is closer to 
the problem than anyone. There are only two doctors out in the Watts area who are 
willing to treat patients. And one doctor was shakey. 
So if the department really wants to do something, you ought to be talking to 
Dr. Jordan forget the other one. You need to be talking to that man. Any other 
contracts you put out there, in this area, are not going to be as effectively 
researched as the one that you put into the hands of a man that's been doing this 
on his own, with no outside help. And he's been clamoring at our doors, you know, 
knocking, would you please listen to what I have to say? And finally, we got moat 
of the members of the Black Caucus to come down and sit for a few minutes to 
listen. This man knows it, and he's described it better than anyone I've seen. 
And the bureaucrats need to really start listening to someone like him because he's 
given you the clue as to how you put together a program that will meet the needs of 
the people who are carrying that virus, who are at risk of carrying that virus. So 
you don't need to respond. I'm just giving you a message. 
MR. SAUSEDA: The point's taken. 
CHAIRPERSON WATSON: Thank you. 
Did you finish, Doctor? 
DR. JORDAN: One last point. And thank you for the nice words. 
What Magic did, it obviously shocked all of us; but it finally made many 
people care. And unfortunately, if people had cared ten years ago, as hopefully as 
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many people are caring now, maybe we wouldn't have had to have Magic do what he had 
to do at this point in time and deprive us of many more years of fantastic 
basketball. 
I think it's important for us to understand that we have to learn to take an 
attitude of not being so judgmental as a "civilized society" and in the process 
forgetting how to care. 
CHAIRPERSON WATSON: But you know what, doctor? We've got to stop glorifying 
Magic because Magic told you what he was doing. You know, he got calls and letters 
and comments from all kinds of women that wanted to have sex with him just because 
he's Magic Johnson. He says I feel good. Once that virus is in the body, you're 
going to die. And he might be feeling good at that point in time, but I think much 
more needed to be said. And I resent Wilt Chamberlain saying, well, I had sex 
maybe with 22,000 -- you know, the cavalier way that this is being treated and the 
glorification. Yeah, we all love Magic, but he's got AIDS because he ignored --
and he's in a position to have the information. And I think somewhere along there, 
we've got to stop glorifying this -- and women throwing themselves at the feet of 
these people. What kind of message is that sending out there, women who are the 
bearers of our children, are saying, I'm willing to run the risk. My, God, that's 
sick. It is really sick. And when I saw that, I said, oh, boy. All these little 
k;ds are going to say it's all right to go out there and do the same thing because 
we all want to be like Magic Johnson. That's real sick. 
I think Magic's lifestyle was wrong, and you can tell everybody you heard it 
from me. And I think all these other athletes who, you know, start putting the 
stripes up their arm because the women throw -- boy, we've got to turn that around. 
And now all these athletes are drug addicts. You know, I mean, my, God, no wonder 
our kids are nearing the same behavior because look who gets all the attention and 
the gratification and the bucks. 
You see, we equate our success in life by the amount of money we are paid. 
And athletes and entertainers are paid more than teachers and doctors. And so we 
better start changing these messages around. Those of us that get the press better 
start telling the true story or else we have a lost generation, and particularly 
the esteem level of our kids. We're losing them; we're losing this whole battle. 
And, you know, I'm talking to the general audience. 
You have been able to point some of these things up, and I get a little angry 
when I see us talking about the glorification, you know. Magic is a human being, 
and that's one thing that really came across. And if he can get AIDS, anybody can 
get it. But he did a little more to go after it, okay? He went after it, and he 
knew, we've been saying, you know, you guys better be careful. No sex is safe, so 
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you better protect yourselves. 
DR. JORDAN: Thank you. Getting back to the point of self-esteem again, until 
we do something in terms of incorporating self-esteem in our education program, 
teaching kids that they are important, not someone else, but they are, and allowing 
them to see the beauty in themselves, this will continue, which ia why it's 
ultimately important that we appreciate self-esteem. The patients that we've done 
the beat at King have been those who we've sent to a self-esteem section. Those 
patients have behavior change; those patients see themselves differently and act 
better. And until we can do those things, we are not going to see a significant 
change in a large number of patients because they don't aee themselves as being 
worth anything. Thank you. 
CHAIRPERSON WATSON: Too many people laughed at John Vasconcellos when he's 
talked about self-esteem -- we need to study it. And there were cartoons that made 
fun of it; there were people in high places that made fun of it, and I would say 
the general public did. But he proved them all wrong. And I think what you're 
telling us is getting to the truth of why we're at such risk. And as long as you 
don't care a thing about yourself -- you don't care a thing about others -- that's 
why this guy on the news today could spit blood at everybody else -- he didn't care 
about himself -- he knew he waa dying. So he's going to take a lot of people with 
him. And I think that's the mentality of a lot of our kids: You know, my life is 
worth nothing; and when I go, I'm going to take you with me. I'm going to dust 
you, and too much of that's going on. 
Thank you so much for your sensitive testimony, and I would hope that the 
people in the Department of Health Services and the AIDS office will talk to you 
and will spend time with you and will bring you in aa an in-field expert to advise 
them. Thank you, Dr. Jordan. 
As a word to the wise, I'd like to call up now Cleant Stain, Director of South 
Central AIDS Program, Watts Health Foundation. Is Clement here? All right. Dr. 
Germaine Kaisonnet, Director of the AIDS programs for Vacaville. He's not here. 
All right. Is there a Phil Jackson? I thought it was Phil. I don't think Phil 
is Phil Wilison here? 
Okay. Then we're going to move into -- no, he's not here -- our 
community-baaed organizations. I don't see Doctor -- or the Reverend Carl Bean. 
Okay. Blma Colbert is represented. All right. We have -- I know Paul Davia, 
Valarie Taylor. Would you like to come up in lieu of Dr. Bean? If so, just come 
right up to the mike. 
All right. You may decide who's going to apeak first. 
MR. DARRYL LUDD: I will start first. My name is Gerald Ludd. They had a 
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miaprint in the agenda. I'm Gerald Ludd, the Operation& Adminiatrator for Minority 
AIDS Project. 
My main concern here is dealing with the financial aspect of AIDS and the 
funding. I want to thank Dr. Jordan for hie preaentation based on his information 
really led into what my concern is, your comment& to Hr. Sauseda and to 
Frangenberg, also with the statistics, really led into what I have to say. 
I primarily deal with the financial aapect and the funding of the Minority 
AIDS Project and the concern• of other minority project& within South central. 
our main concern ia in the fundera themselvea and their proposals and what 
they're requiring in those proposals aa it relate& to thoae people in the 
people-of-color arena. We say South central; we have no boundaries as far aa the 
people we aerve. But we primarily serve aa minorities, and a majority of these 
minorities are comprised of the people out of the prison system, homelesa, and what 
have you. So we're also not dealing with just HIV, but we're dealing with dual-
and tri-diagnosis which is drug addiction or alcoholism. But as the funding 
sources prepare these grants for you, they write them in such a way that it'a a 
general grant. That's for overall AIDS agencies, but they're not really addresaing 
those issuea in the minority arena. 
As we write and ask for these funda, we have to write them in such a way that 
we can get the grants themselves. But along the way, the funding that we need from 
direct -- indirect aources -- corporation&, and what have you -- need to take up 
that slack. But in the funding sourcea themselvea, you need to re-look at the 
people of color themaelvea and the need, which I've heard aeveral timea here, the 
need which is necesaary to aervice theae people. 
The funds, as far as a percentage, we have increased in Minority AIDS Project, 
are in the South Central area as far as the people that we're aerving. But whether 
they're men, women, children, which we do have our increase in women and children, 
but the monies have not increased. And thoae are the type of things that we want 
to addreas today. And as we write these propoaals and as the fundera actually make 
theae funda available, they need to take into consideration the need is not the 
same; the need is different when you're dealing with dual- and tri-diagnoaia and 
the method in which the funding actually pays you. 
OUr problem is in the Black community; and why a lot of the Black buaineaaea 
close ia because we're actually open to fail based on how society or how the 
grantors set up the actual perimeters for, or your guideline• for, that particular 
program. We don't have the money to wait two to three, four months to be 
reimburaed. So we have a reimbursement problem at all levels that we're dealing 
with. Primarily, that's my main concern. And we do and we are planning on writing 
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up some type of statistics to send to you and others in government so that they can 
understand what we're talking about when we're talking about figures covering 
expenses. I think you know a lot about what's going on, and we're trying to 
readdress it so that if we really spoke the way we wanted to speak to some of theee 
grantors, we I don't think it would be funded. 
CHAIRPERSON WATSON: You know, I get real tired with the department coming in 
and saying but they are not sending up their proposals correctly. You know, we've 
got an epidemic out here, and I'm saying to the department, hey, don't bring that 
1n to me. What you need to bring into me is how we're going to get the funds where 
they're needed. We've got X number of dollars, and you find some way to correct 
the proposal. You find some way to have the application look like you want it to 
look. You find some way to have them account for those monies, but get the monies 
down there in a timely fashion so that we can try to save lives, apply treatment if 
we can; and, if we can help people as they go through their demise because of AIDS. 
And I think to use the excuse, well, they didn't dot an "i" -- they' didn't cross a 
"t• or put a period in the right place, or they didn't write in the right box -- is 
an excuse for not doing much. 
So I would agree with you and I've had to say this to the department and 
the Office of AIDS -- don't spend your time talking about the deficits. You spend 
your time with me talking about how we're going to solve the problem and get those 
monies down so services can be delivered. 
KR. LUDD: Thank you, Senator. Paul Davis, head of our Health Education 
Department, and Valarie Taylor, our nurse, will cover other aspects. 
KR. PAUL DAVIS: Good morning, Senator, and members. 
One of the things, in terms of education and prevention, is over the last five 
years, the numbers in terms of people-of-color community is increasing. And one 
may say, well, we've been doing education out here1 and therefore, for 1991, 
everyone should know AIDS does exist and how you're able to transmit it. 
But in the people-of-color community, we are still behind. And when the 
announcement of Magic Johnson came out and our phones began ringing off the hook, 
there were still people thinking that it was caught by mosquito, that it was still 
toilet seats and so forth. And so that sort of gives you a level of there is still 
a large amount of education that's needed in the people-of-color community. I know 
to a large degree that a lot is basically going to treatment and not saying that 
there's not money needed in that particular area. But particularly in the 
people-of-color community, there is still a great need for education. 
And one of the things I think we've made a misnomer is that, yea, it's on TV. 
But one of the things I've observed in terms of the people-of-color community, they 
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don't watch the 6 o'clock news or the 5 o'clock news or the 7 o'clock news. They 
turn to Channel s, Channel 9, Channel 11, and get the reruns of Lucy becau .. 
they've seen enough problema in their community already that they deal with on a 
daily basis. And it's like I don't need no more bad news. So a lot of times, they 
don't get this type program. They don't necessarily watch the specials on AIDS and 
so forth. And it took some of us a long while to begin to realize that in 1991 
persona should know all of this information. Many of them don't read the various 
periodicals and magazines. Many of them cannot read, period. And we need to take 
that into account when we're talking about the whole thing of education. 
When we're particularly talking in terms of the undocumented population, which 
is a population we work with in our AIDS project, again, if it is not in the 
appropriate language, they have not gotten the information. So a large media 
campaign to a large degree in our community does not work. The beat that we've 
found is the one-on-one, meeting with people, talking with them in small groups. 
Bolding group meetings, we've done that1 we've tried that. But a lot of 
persona in our community are not coming out after 6 o'clock. They've worked all 
day1 they are tired. They're not coming out because they're afraid of the whole 
thing of ganga and so forth, and they have to ride the bus. 
South Central is a very large area baaed on -- let's say, if you take from 
Pico on south. So it's a very large area. People are not necessarily going to 
come out in large groups that you may find in the West Hollywood or Hollywood area. 
So you don't have the advantage of getting that information. 
one of the populations that we service at the project very heavily is the 
population of the homeless, which I feel is a very under-served population. And it 
is an invisible population within our community because in some cases you cannot 
clearly distinguish those persons are homeless. But in fact, they are homeless. 
The homeless today are no longer the stereotype of the whino in a doorway, and 
they are found all through South Central. 
To a large degree in this particular under-served population, you have a 
problem of not just being you tell the person you need to practice safe sex. If 
the person is homeless, he has no money for condoms. condoms are not in his 
budget. And that's one of the reasons we need a program where we constantly visit 
certain areas of the homeless in passing out free condoms. 
Bven if the person feels that they are at risk, they do not have the money to 
go to get tested. I mean it requires $1.15, $1.25, to take that bus to come over 
to the Minority AIDS Project to get your test and then the same amount to come back 
the following week. And if. you're concerned, in terms of wpere you're going to eat 
and where you're going to sleep, that is very important. 
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Even if you find out somehow, if our van picks you up and you find out and you 
get your results back that you're positive, how do you go for treatment? For a 
long time, the only place we could refer persona is to Dr. Jordan's clinic which is 
all the way in South Central. Again, you have the money of transportation. 
There's also, I think Dr. Jordan raised, in the question of self-esteem which 
I think is an important part in the people-of-color community in prevention and 
education, that that is a piece. That needs to actually be worked on. And even if 
you say, well, the person gets G.R. here in L.A. County, the amount of money that 
person gets in G.R. usually only lasts the person for the first three weeks. And a 
large number of them, we find that, for that last week, they are on Santa Monica 
Boulevard to try to get enough money to maintain their room for the last part of 
the month. So those are some real issues that we have to look at in terms of that 
whole population. 
Even if we look at the issue of reaching gay men of color, we have to look at 
different strategies because the traditional strategies do not work. A large 
percentage, first of all, there's a very diversified community there; and secondly, 
that you have to look in terms of with that community how they perceive themselves. 
And a lot of them do not perceive themselves because early on in the whole thing of 
education and prevention, we made some major mistakes. We talked about certain 
groups. We talked about persona being gay, and we talked about persona who are IV 
drug users. And a lot of persons in the minority community says that's not me 
because there are a number of men who have sex with men but do not consider 
themselves gay. 
We need to look in terms of the PR that we have out because a lot of persona 
do not see people of color on the posters, on the brochures, in terms of -- so 
that's an area that needs to be looked at. 
Again, in terms of the basic needs in this area, more one-on-one street 
outreach to go where people are, to go out to the bars, to go out to where the 
homeless are, to go out to the parka, the people who are hanging around the liquor 
stores, and do a one-on-one in terms of getting information to them. 
Also, in terms of testing, we need more testing sites in the minority 
community. One of the things that happened after Magic Johnson made his 
announcement where we were doing testing at the project, about 15 people on a 
Saturday, the first Saturday; it increased to 115; the second Saturday, it 
increased to 123. And we've had to expand now to Tuesdays and Fridays, and the 
phones are still ringing in terms of people who want to come in. There's a backlog 
in L.A. County of people who now want to get tested and cannot because it ia booked 
up for three months, so that is an issue that needs to be looked at. And one of 
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the other things in the minority community is there is a need for more monies in 
terms of grants because most agencies do not have large sums of money that they can 
pay staff, pay the rent, and so forth, even if they get the grant, and then wait 
for the funding source to reimburse them; so some way of not looking just at the 
fee-for-services but some way to give an advance up front to get the agency off the 
ground. Thank you very much. 
CHAIRPERSON WATSON: Thank you. 
MS. VALARIE TAYLOR: Good afternoon, by this time, Senator Watson. Can you 
hear me? 
CHAIRPERSON WATSON: Yes. 
MS. TAYLOR: My name is Valerie Taylor. I'm currently the nurse case manager, 
acting Minority AIDS Project, and Director of our In-Home Nursing Services. We 
have -- that's called Pilot Care Program, and another In-Home Nursing Service that 
we are providing at the project is Medi-Cal Waiver. 
I'm here for a couple of reasons, one representing client services -- our 
project director was not able to be here. And the other is a patient-client 
advocate. By the time clients get to me, they're very depleted. These people are 
no longer just home-bound; they're bed-bound. Home-bound is one thing; bed-bound 
is quite another. 
My two programs, one is funded by the state, which is a pilot, CURB, and the 
other Medi-Cal Waivers, is funded by BURSA. 1991 was a devastating year for Pilot 
CARB programs. Anyone who was, who took the risk to even decide to provide In-Home 
Nursing Services took a risk in itself. That's a very costly thing. Health care 
is is costly; nursing hours are costly. 1991, we were told we will provide you 
with these hours, but we'll also cut those hours. 
When people come into, when my clients, people of color and minorities come to 
the point that they are bed-bound, they're coming into the system very late. There 
is no longevity usually once they get to that stage, so aggressive intervention 
needs to happen once we have taken them out of the acute facility who at this point 
want you to take them out of their bed. It costs a lot of money to maintain a 
client like this in the acute setting. So once you get that person home, we're 
obligated as health care providers to be an extension of what would happen in that 
hospital. We need to provide them with levels of care that the state or might the 
state is not willing to or is unable to provide us with. 
If we go into a home and a person requires eight hours of care and we can 
only, with the dollars available to us, provide four, we're either saying we'll 
give you four and hope and pray that you live to the next day; or we'll give you 
what you need, and we'll hope and pray we get reimbursed for four hours when we 
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gave you twelve. I have difficulty making the compromises in these areas. It gets 
back to are they worth saving. I thought that that was integral when that was said 
in this room. 
I've been a nurse for 25 years next month. I've never, in this particular 
arena, I hear that question a lot. Who's to say that; who's to judge? Most of my 
clients coming on into the program here, at the Minority AIDS Project, 35 percent 
of them have no health insurance. When they come to me, 80 percent of my client 
base has no health insurance. So that isn't even an issue. It's a big, big need; 
but it's a need that the entire country has. We have a health insurance; we have a 
health problem and a health care system that is not working. Even with that, with 
no health insurance, if you wanted nursing care, we went into something called 
Medi-Cal Waiver to at least give us the luxury of saying we can provide you with 
this care; we know you need it. And the government said fine, we'll let you have 
this. But before you can have this, you need to have a Medi-Cal card. My clients 
don't have Medi-Cal cards. They can apply, and we do offer that service at the 
project. It takes 30 to 90 to 120 days just to get that application through, and 
usually it takes six months before they actually have the card in hand. 
Unfortunately, moat of my clients have already expired. 
We have, but that's the option. We've given you something; and we told you, 
you can use it. But you have to be alive to use it. I don't know how fair that 
is, and I'm losing my -- this has been going on for two days, so excuse my voice as 
we go through this. But that's the option that we're left with. So either we 
provide care with not enough hours and not enough money, or we say, fine, the 
government will give you this if you can live long enough; and that disturbs me 
greatly because then I don't knQW are they worth saving. I think they are. 
The state is going to, again, in '92, we will be experiencing again another 
cut in nursing hours provided. The government on the Medi-Cal Waiver system, we're 
being forced to use a system that I really think is there but my clients are not --
I can't get them in it because the cards are not available or they can't get in the 
system to get the cards. So if we went to the Medi-Cal Waiver system, the 
reimbursement for a care-giver on that system for just an in-home attendant is $4 
less than a home attendant can make going through another agency. Why would you 
come to a community-baaed if you can get $4 more going someplace else? 
So you're saying, I've given you a card if you can get it. Now that you've 
got it and you live this long, I can't get you a nurse because the nursing 
services, they're in business, not that they're not compassionate, but they're in 
business. The reimbursement for those kinds of care-givers aren't really 
creditably licensed; home-care services is $4 below. our project has been 
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absorbing that cost. That ia not a long-term aituation. It is certainly 
short-lived with us because we don't have the funds to do it. But we are leaving 
people who are now not only just home-bound -- bed-bound. And In fact, as you said 
very visually, they are in fact dying. I don't know what happens when people get 
bedbound. Is the quality of their life considered leas worthy -- because you don't 
see that. They're at home; they're in a home. You don't see that. But the nurses 
that are there and wanting to help and the programs we must have in the minority 
community, there's only one pilot-care program in South Central. It's ours. 
I receive referrals from other agencies, and I'm not at liberty to say the 
other agencies at this point, and they are referring clients over because they will 
not absorb the cost, and they can't. But it has been our philosophy and our 
mission; and not just since I came to Minority AIDS Project, myself as an 
individual, health care provider and registered nurse, I could not in good 
conscience turn someone away because they cannot pay and because they don't have 
health insurance and because they don't smell so good and because they can't get 
anything else. That has never been the mission of the project. It has never been 
my own personal philosophy. 
And I'm here to say as the advocate for my clients who could not get here. If 
they could get here, they'd be here. If it was on stretchers, they'd be here. If 
you're going to say we'll give you nursing in your home, let's do it the right way. 
If you say we're going to have hours, make the hours available. 
going to say we're going to give you a Medi-Cal card, give it. 
to this level, you shouldn't toy with them. 
I thank you. 
And if you're 
But when people get 
CHAIRPERSON WATSON: Thank you very much. We certainly appreciate that 
testimony coming from one of those projects that's in the community and dealing 
with people who are dying every day. It baa a great impact on us. Thank you. 
MS. TAYLOR: Thank you for your time. 
CHAIRPERSON WATSON: Yea. I'm going to go through my agenda just to see who's 
here. I'd like to first ask Dr. Elsie Lu to come up; Blma COlbert, Cynthia Davia, 
Suzie Rodriquez, Mario Solis-Marich, Mike Neeley, xazue Shibata, Helen Fitzgerald, 
Joel Tan, COrinne Tanon, and Paula Starr. If any of those people are here, they 
may come up now to the table. And be sure that you identify yourself. Great. 
If you cannot sit here, then please sit in the front row. Then that will 
indicate to me that we have people here that are on this list. 
We'll start with you, Dr. Lu. 
DR. ELSIE GO-LU: Thank you very much, Senator. 
It's always an honor and a pleasure for me to speak before you and to provide 
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some information that may be helpful in decisions that you may be makinq. 
Specifically, I'm the Deputy Director for L.A. county Department of Mental Health. 
And I have primarily the forensic mental health services which relate to the 
incarcerated mentally ill as well as my responsibility for the HIV mental health 
services for the County of Los Anqeles. 
I also sit as an advisor to the AIDS COmmission of L.A. County for mental 
health issues, and I'm a member of the AIDS reqional board. So I come to this 
committee basically very briefly to tell you about the HIV mental health needs in 
the ethnic minority communities. 
The State Department of Mental Health throuqh the state budqet and the state 
legislature provided fundinq for mental health services four years aqo for about a 
million dollars for mental health services for the State of California. And aince 
then, there has been no auqmentation in that budget. L.A. County obtained $376,000 
of that to provide services for all of the mental health needs here in Los Anqeles 
county. And that is actually insufficient fundinq, so we have primarily used some 
BURSA funding, have worked with the AIDS program office, have gotten another 
$100,000 for the AIDS program office, to provide some services. And during this 
past year, throuqh the Title I of the supplemental funds, have actually lobbied to 
have another $641,000 added to the mental health needs of the people with HIV. 
Let me just tell you about what the funding currently provides for. We have 
actually provided funding through community mental health CBOs -- the Gay and 
Lesbian center, APLA, Minority AIDS, Milagros, sort of a little piece of fundinq 
spread out through the community, sort of like seeds so that they could spread and 
have some impact on the population. And yet we feel that barely scratches the 
surface of the great need that his here. Por example, of the population that we 
have in our HIV day treatment proqram, 29 percent of the population is 
Afro-American, and 29 percent of that population ia Latino. The rest of them are 
white and a small Asian qroup. 
But basically for someone to be mentally ill, that is a stiqma. Por someone 
then to be HIV-affected, that is an additional stigma. And for usually someone 
that have mental health needs, they are multiply diagnosed also with substance 
abuse. And, of course, added to that, is if you end up being mentally ill and 
having HIV and then beinq incarcerated, you have actually a lot of problem with 
almost very little help, shall be qiven to you. 
A couple of years aqo, we participated with the AIDS Proqram Office in a 
HIV-strateqic plan. And we meet a needs assessment for the mental health needs and 
a comprehensive plan also. If we have the money that is truly needed from this 
community, this is the level of services and programs that are needed here. And 
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just to give you some ideas of the target population that would be served, there 
are those that have advanced HIV brain disease. And that would cut across 
different ethnicity. 
For a specific purpose, for example, what we were able to help is someone with 
early dementia. They may need a psychologist or a professional person's help. In 
order to get them SSI or actually in soma cases, they may have been driving around 
and have forgotten their driver's license several times. And instead of being 
incarcerated, basically we could help by having diagnosed them and said that their 
problem is due to dementia. So to have sufficient mental health professionals to 
provide the psycho-neurological assessment in order to determine this would be very 
helpful for this population. 
Then we have the chronically mentally ill who then get affected with HIV. We 
have provided a lot of training to board-and-care facilities in order for them to 
be able to deal with this type of problems because they are mentally ill, 
chronically mentally ill, that are in board and care who are basically in board and 
care. You realize that there is consentual sex relationship that therefore you had 
to teach the board-and-care provider how to be able to deal with this kind of 
problem in order to have AIDS prevention. That's one of the areas we had focused 
in. And as I talked to you about the persons with multiple diagnosis; and right 
now, actually in all the programs that we have, there is very minimal mental health 
services in those programs. 
We have primarily concentrated on a lot of educational programs in order to 
use the minimal funding that we have. We have provided training to our own mental 
health clinics as well as the private clinics that have contracted with the county 
in how to deal with this population and deal with the services. 
The plan itself go into a full range of services from acute ••• 
CHAIRPERSON WATSON: Let me just ask this -- in listening to Dr. Jordan's 
testimony, he, providing services in Watts, are there programs are there places, 
facilities where the people he described can go, the people that he realizes are 
dealing with the psychological shock, where do they go and can they go into these 
programs? Are you training the county health professionals? To what extent are 
you training them in the mental health program? How many are available to treat 
the people that he described? 
I got the feeling from listening to him that there was almost nowhere for him 
to send these patients. 
DR. GO-LU: Actually, what he ••• 
CHAIRPERSON WATSON: Or that the waiting list was long. 
DR. GO-LU: Yes. He is actually correct in what he had presented to you. The 
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issue, as you're aware, is with the diminished funding in the community mental 
health programs, that we have to focus our services to a target population of the 
chronically and severely mentally ill. 
We have, primarily in our master plan, included crisis intervention. And we 
got it in through efforts of the CBOs and the HIV resource mental health group, 
that at least for those that have HIV-infected, that there will be eight crisis 
intervention sessions available to them. But, of course ••• 
CHAIRPERSON WATSON: How many sessions? 
DR. GO-LU: Eight sessions. 
CHAIRPERSON WATSON: And where are these sessions? 
DR. GO-LU: That would be at county-operated clinics. Of course, then there 
is a priority listing and the waiting list is long, as Dr. Jordan presented. They 
may be waiting a long time, and depending on where that availability of services. 
CHAIRPERSON WATSON: Yeah, I guess what you're doing is supporting the 
contingent, if there is a serious problem here. There's not enough of this 
training and not enough people to deal with the patients. The waiting lists are 
too long, and they're going to have to wait and maybe their lives will not last 
long enough to be able to be treated when they need the treatment. 
As you say, crisis intervention, and my definition for crisis is something 
that is happening right now. And if this is crisis intervention, then I think 
what's being offered cannot really deal with the number of people who are in 
crisis. That's one point I want to make. 
The next point is -- and I'm not blaming you. 
DR. GO-LU: I understand. 
CHAIRPERSON WATSON: I'm trying to describe the problem and the emergent needs 
aa they relate to that problem. 
We just realigned the way we appropriate monies to the county for mandated 
services which no longer are going to be mandated, but they are required of the 
county to deliver; and one of the areas is in mental health. 
How the counties appear to be elated over being re-aligned. I never showed 
that elation. I think you were up there when we had some of these discussions 
because the reality is you're going to get a smaller pot of money, and they said 
that's great. But what we did, we took our oversight away. There are no longer 
mandates, to be sure. How maybe you're going to do the right thing, but I'm 
worried about the other 57 counties. In reality, I was worried about my own county 
because I've not seen a lot of evidence in the past that they were going to do the 
job the way it needed to be done. But, however, all we're asking for is date of 
collection. 
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What I'd like to say, and I hope that you can do something along theae linea, 
ia lay out of a plan, a model for us, aa how you're going to -- the dollar• will 
not increaae, as you know. They probably will decrease. But now you can handle 
those dollars differently. It'a atump money; we put it on the stump; you run up 
and grab it. And we're aaying that thoae dollar• have to be spent in thoae 
categories for which they were attended. And you can only comingle 10 percent of 
that money. So what I'd like to see ia count the county ahowing aome kind of model 
or strategy for taking those aesaions you're talking about to the people. 
If we really zero in on the problems, you know, transportation problema -- not 
wanting to travel at night -- the fact that the atreeta indeed are dangerous and 
these people indeed are at riak, then how do you solve that? Bow do you put thoae 
program• for people who are in criaia to receive? 
DR. GO-LU: I realize that we went from 40 county-operated clinics to about 
22. 
CHAIRPERSON WATSON& Yeah, yeah. 
DR. GO-LU: So that there is a greater geographical distance. But on a 
monthly basia, from the funding that we did receive from the atate, we have every 
clinic identify a HIV liaiaon who comea; and we provide updated training to them. 
And in order to be at least aware of the most current way to deal with the HIV 
affected and their mental health needs. 
CHAIRPERSON WATSON: Yeah, but you're identifying one. 
DR. GO-LU: One area. In our day treatment program, we are aware of the 
transportation need. But basically, we know that. And ao we have a van. We have 
about a 20 --there's a certain radius you can pick up here only in L.A., and we 
need those day treatment center one exactly here in this community; but there is no 
funding currently right now for that becauae we do have that and that'a located 
in ••• 
CHAIRPERSON WATSON: Well, that'a going to be your deciaion, you know. We're 
saying: This is money for mental health; now you run the program. 
DR. GO-LUz I wasn't aware that in the target population HIV waa one of the 
ones, but maybe that'a ••• 
CHAIRPERSON WATSON: Well, I think you're hearing the need --
DR. GO-LU: Uh-huh. 
CHAIRPERSON WATSON: -- expresaed today. 
DR. GO-LU: Okay. 
CHAIRPERSON WATSON: You can't really separate them out any more. When we 
start targeting a population, we talk about mental health services, they ahould go 
to the homelesa, the HIV-positive, the person with cancer, you know, and all, that 
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whole radius, categories of clients out there that have real emergent needs and are 
in crisis; and I think that's where you're trying to zero in. How do you address 
the crises that they're in? 
DR. GO-LU: I understand that. 
CHAIRPERSON WATSON: Dr. Tate? 
DR. TATE: Yeah, I just wanted to piggyback on that because the dilemma that I 
think the county is in is that now, because funds are so tight, this targeted 
population definition that they're operating under is so, so narrow, that those 
people don't fit crisis as defined now by the county, that crisis now means, excuse 
me, however it's so narrowly defined, that, you now, you have to have, I don't 
know, hallucinations, delusions ••• 
DR. GO-LU: Danger to self and others. 
DR. TATE: ••• dangerous to self and others, and, you know. So I think that 
when you look at re-aligning L.A. County and appropriating dollars for various 
types of interventions, that, as the Senator was saying, certain populations, I 
think, need to begin to come to the forefront as really maybe opening up the door 
in some areas for crisis intervention for particular types of services so that when 
we integrate the Department of Health Services with the Department of Mental Health 
and the Department of Corrections and other county departments, we're working 
together in a whole continuum rather than a fragmented service delivery system 
specifically for HIV-positive and AIDS individuals. 
CHAIRPERSON WATSON: We have in our hand a double-edged sword. I remember 
when we sent some programs out to the county years back. And one of the counties 
said they took the definition, and they revised the definition and said we simply 
don't have any of those. So therefore, there was a whole population that went 
untreated. 
I am hoping that in L.A. county, the largest county with the most number of 
cases, that you might start to look at the definitions and see how restrictive they 
are and how can we broaden those definitions to serve people in crisis. And you'll 
have that in your hands. 
DR. GO-LU: I will have that; and as you're aware, I will be presenting this 
to our new mental health director when she arrives. 
CHAIRPERSON WATSON: Now the new mental health director is ••• 
DR. GO-LU: Dr. Areta Crowl. 
CHAIRPERSON WATSON: Yeah. All I know about her is what's on paper, and I 
would hope that we could meet with her and talk about designing a program 
DR. GO-LU: I will convey that to her. 
CHAIRPERSON WATSON: -- for meeting the needs of people in crisis, you know, 
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and particularly those who are in crisis because they learned they were BIV 
positive, as well as some of the other areas too. 
DR. GO-LU: Thank you for that support. 
DR. TATE: Just one other question, Dr. Lu. Before you arrived, Dr. Jordan 
spoke a little bit about studies, or the lack of studies, of prisoners and their 
sexual behavior, as well as BIV and AIDS victims and what we don't know about 
what's going on in the prisons. Since you're in charge of forensics ••• 
DR. GO-LUa Forensic mental health. 
DR. TATEs Okay. Just with regards to forensic mental health at the county 
jail, what's going on, if anything? Do we have any knowledge base, any data, with 
regards to BIV AIDS? 
CHAIRPERSON WATSONa Are cpndoms available? 
DR. TATE: Yeah, are condoms available? What about sexual activity? Just 
generally, can you give us a picture? 
DR. GO-LU: The medical director for the Sheriff's Department medical services 
actually is the person that works and establishes the policy regarding AIDS in L.A. 
County jail system, and he has collected some data. But you're aware that there is 
no required testing; and therefore, it would be only for those that had 
voluntary ••• 
CHAIRPERSON WATSONa I think she's going in a little different direction 
because I raised the question with Dr. Jordan. 
DR. GO-LU: Okay. 
CHAIRPERSON WATSON: And my question was -- well, he really started it. Be 
said, you know, in the prisons it is acknowledged by some of us that there is 
sexual contact, usually forceable sexual contact. These people come out of the 
prisons and the jails, and they go back to their partners in civilian society; and 
this creates a problem. So we were trying to find out what are they doing to 
acknowledge the fact that there is sexual contact in jails? 
Now, you know, I've heard this -- I'm putting you on the spot, or. Lu. But 
we've gone through this in Sacramento. We get people in from corrections that, oh, 
sex is prohibited. So this is a game we all play. And, you know, this is a game 
I'm playing right now by asking these questions. I know what the answers are. 
DR. GO-LU: My personal opinion is, yes, I do agree with you. Those types of 
behavior do occur in the jail. But you also realize that anything that is not 
given to the inmates by the sheriffs are considered as contraband. And therefore, 
until the sheriffs approve condoms, it cannot be brought into the jail setting. 
And actually, it could be used for a lot of acts that may be dangerous also to 
others. So I think that's part of the rationale provided. 
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CHAIRPERSON WATSON: Well, why does the administration allow personnel in the 
jails, the county jails, to allow this behavior to go on and do nothing about it? 
It goes on. I can bring you any inmate will say that he hears screams and all. If 
they hear it, why don't the guards hear it? And why doesn't the administration of 
the county jails do something about the problem? Do you have any idea? I know 
you're the wrong person to ask, but you hear rumors. 
DR. GO-LU: I believe that the -- if it's heard -- this is what I'm told, they 
do prevent it from occurring. 
CHAIRPERSON WATSON: But they don't hear it. They all of a sudden have a 
hearing loss. 
DR. GO-LU: The ratio between a deputy and an inmate is very high in L.A. I 
mean you have two deputies observing and watching a cell of 250 inmates. And if 
you have not come and visited the jail where the ability to see and hear all the 
time of every cell is not quite visible at all the times. But I'm told, and we 
have approached the subject, that when they hear it, they do prevent that too. 
CHAIRPERSON WATSON: Well, I don't understand how three or multiple inmates 
can get one inmate, and to have a sexual act. And the people who we pay to guard 
do not know that. 
If I know it on the outside and if I know that at any given day, you can have 
over 500 prisoners test positive for RIV, something's going on in that environment 
and somebody ought to be aware and doing something about it. You just happen to be 
the person here from the county who's on the hot seat, Dr. Lu. 
DR. GO-LU: I understand. 
CHAIRPERSON WATSON: And I'm not holding you to blame for these situations, 
but I'm making some statements that I hope will be heard. 
Okay. You wanted to finish. 
DR. GO-LU: Well, actually, I just -- you had asked if there was some kind of 
plan, and I believe that I'd like to share this strategic plan, the mental health 
piece of it, with your committee. 
CHAIRPERSON WATSON: Thank you. And we'll have someone pick it up. You don't 
need to go over in detail. Just tell us. 
DR. GO-LU: No, I won't do that. Well, I thank you. And if there are any 
other questions, otherwise ••• 
CHAIRPERSON WATSON: I think I've raised all the points that need to be 
raised. 
DR. GO-LU: I think-- I heard you loud and clear, and I'll convey this to 
both the Sheriff's Department and to my department. 
CHAIRPERSON WATSON: You know, years ago, I carried a bill to extend the 
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Robbins rape laws of evidence to prisons and jails and so on because I was alarmed 
at the number of homosexual rapes and the number of sexual contacts within lockup 
facilities. Most people here are going into the county jails -- the homeless, the 
mentally ill -- are going there, people with some kind of addiction and so on are 
going into the county jails. So I guess if we're going to look at a facility that 
is closer to home, we're going to look at the county jails. And I'm alarmed at 
what goes on inside. It's scandalous aa to what goes on in the county jail. 
DR. GO-LU: In addition to what you say, it's also primarily the largest 
ethnic population. 
CHAIRPERSON WATSON t You've got it. 
DR. GO-LU: And the county's concentrated in the jails. 
CHAIRPERSON WATSON: And when we use the figure one out of four African 
American males, a lot of them are sitting there; they're sitting in California 
Youth Authority; they're sitting in the state and federal prisons. And we're 
seeing the AIDS incidents going up, particularly in this population. We've got to 
start being sensitive and doing something, ao you've got the message. 
DR. GO-LU: Thank you. 
CHAIRPERSON WATSON: Thank you. All right. I'm going to go right down my 
list. Blma Colbert. All right. Cynthia Davia. 
DR. CYNTHIA DAVIS: Blma'a right here. She's coming. 
CHAIRPERSON WATSON: I beg your pardon. 
DR. DAVIS: There's Blma. 
CHAIRPERSON WATSON: Oh, okay. Blma Colbert. 
MS. ELMA COLBERT: Hello. I'm Elma Colbert. I'm with Charles Drew Medical 
center, NOBCO, Southwest College. 
CHAIRPERSON WATSON: You want to pull that mike right up in front of you, 
please. Just pull it right over so it's in the direction of your mouth. Thank 
you. 
MS. COLBERT: Okay. In Southwest College. I'm a community worker there and I 
do outreach. And I'm also a counselor for testing. 
CHAIRPERSON WATSON: You're talking in this direction. You're mike is in that 
direction. 
MS. COLBERT: Okay. Okay. Is this better? 
CHAIRPERSON WATSON: We're trying to pick up your testimony. 
MS. COLBERT: Okay. And I'm also a person that's living with HIV. I guess, 
first of all, I should say that my concerns are that more studies should be done 
for women. And it's too many times that women teat HIV or women are HIV-positive; 
and other things have gone on; they're not tested for other things. 
076 
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I'm a person that's been, received January 1, '84, and I have to yet, be, have 
GYN services or any other services through the county which I have been a patient 
there since being infected with the blood. There are 10 to 26 ••• 
DR. TATE: Excuse me. Let me understand that. 
MS. COLBERT: Sure. 
DR. TATE: Repeat that again. 
MS. COLBERT: I will. I received blood January 1, 1984. 
DR. TATE: Okay. 
MS. COLBERT: They informed me that the donor had died in '85. 
DR. TATE: Uh-huh. 
MS. COLBERT: At that time, I had been under medical care since '85. And 
since '85, not one doctor, not one, has given me a smear -- I haven't been to a GYN 
clinic. 
or ••• 
DR. TATE: You haven't had a Pap? 
MS. COLBERT: No. 
DR. TATE: Is it because they won't accept you because you're HIV-poaitive 
MS. COLBERT: I just think that we're on the back burner. 
CHAIRPERSON WATSON: Have you requested ••• 
MS. COLBERT: Pardon me? 
CHAIRPERSON WATSON: Have you approached the ••• 
MS. COLBERT: Yes, yea. And if it had not been that I have a friend that's a 
medical doctor, that has no knowledge about this disease, if not for him, I would 
not have had any physicals or anything else since I've been diagnosed as being 
positive for the virus. 
You complain; you talk about things that are happening with you. There's no 
money or they can't do anything about this until something, more major happens to a 
person. 
cella? 
How much more major can a person be than to be a person that has ten T-4 
I have ten. I have one helper cell, and everything else. I'm totally 
without moat things that would make a person function or make the immune system 
function. 
I'm an advocate for women, and I should say because I hope that not one other 
woman that's infected with this virus has to go through or deal with the same 
things that I've had, that I've gone through, or not being listened to or not being 
heard. I think that if you have one person that has ten T-4 cella, and then you 
have another person with 200 T-cella, the person with ten is alive, doing well, 
that more studies should be done on that person than opposed to the person that has 
died already with 200 T-cells. 
07? 
-63-
I hope I'm not sounding selfish, but deal with us that are living and that are 
doing okay because when I say I have ten T-cella, you would expect me to roll in a 
wheelchair at least, you know. So find out why we're doing well. More studies 
should be done for women; and then the ones that are doing exceptionally well, more 
studies should be done on that as opposed to just dumping us off with a bunch of 
medication that has been basically tested on men, not on women. We're just lucky 
so far that it's not causing other problema to happen. I'm on a new medication 
now. So sometimes it's, for the last three days, I'm sort of high and low. That's 
what's happening right now. I'm on I and B, which I feel I should have been on a 
long time ago. But due to the backup and due to the fact that I wasn't physically 
having any problema, then it was overlooked. It was something that just was not 
dealt with. 
So I'm sorry for the up and down. But a person that's living with this virus, 
we have a lot of concerns; we have a a lot of issues. I was sitting there laughing 
when you were talking about Magic because we have a lot of support systems that we 
kind of deal with each other. And we're all having negative and bad feelings about 
that because this man was getting glorified for being BIV-positive. And we then 
have been living with this disease all this time, still can't come out of the 
closet, you know. Issues where -- I work at southwest College. The women there on 
that campus is so unaware. More education, more understanding, more I don't 
know what more could you give them. But they need more because when we go out to 
lay out literature to talk about AIDS, it's even to the point -- some people feel 
like if they read that, if they touch that, then they're going to get the virus. 
That's how unaware they are, you know; as opposed to, and I go no, it's if you pick 
it up and you read it, then you'll find out how not to get it. 
Women need to be more in charge, more control. In my situation, my being in 
charge or my control would be me talking and demanding and asking about medications 
and things that are available for me to take. A woman that's not positive for the 
virus, her taking charge and her control would be being able to get more skills and 
communication to deal with partners. And women don't have that. And I was really 
surprised when I got to southwest College. More things like that need to be dealt 
with. Women need to see and hear more about how they can communicate and negotiate 
skills to deal with their sex partners. And women need to know that they have that 
control, they have that control, without hearing it repeatedly and someone 
continuously reassuring them and reaffirming the fact that if you stand up for what 
you believe in and what you think is right, I think leas women would be positive 
now because they would not submit to doing anything with their sexual partners that 
did not feel right or did not set well with them. And I'm just one of those people 
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that happen not to be a person that was infected sexually. But the issue still 
stands. The majority of women that are becoming infected today are women that are 
infected through heterosexual relationships, and they just need to take a better 
charge and a better stand. 
CHAIRPERSON WATSON: Thank you so much for your tetstimony. It is reaching 
home, and I think we've come to the same conclusions pretty much at the same time. 
All right. Cynthia Davis. 
MS. CYNTHIA DAVIS: Right here. 
First of all, I'd like to thank Dr. Tate and Senator Watson for giving me the 
opportunity to present to you this morning. 
My name is Cynthia Davis. I'm a health educator. I work for the Charles R. 
Drew University of Medicine and Science which is associated with Martin Luther King 
Hospital. 
I have worked in the community since 1984 developing family-life education, 
sex education programs, primarily for at-risk youths, Blacks, and Hispanics. I am 
currently coordinating two AIDS education and prevention programs for the National 
Organization of Black County Officials which is based in Washington, D.C. -- that's 
NOBCO. They received a grant from the Centers for Disease Control in 1987 to 
develop a model program targeting the Black community that could be replicated 
around the country where they had their constituency. So I coordinate two projects 
for NOBOO, and I provide technical assistance to two other programs. 
On a local level, one of the programs that Elma Colbert works for, I wrote the 
grant or wrote the proposal for that program at Southwest College which is 
primarily targeting women of childbearing age and a local program that's funded by 
the Department of Health Services, Office of AIDS, primarily targeting school-age 
populations in South Central, incarcerated populations in the general community. 
In my written testimony, I'm going to sort of skip around, since you have it, 
and you can refer back to it. In the packet of information that I've left with 
you, I've given you reference material focusing on AIDS and HIV and its impact on 
adolescents, young adults, and women because those are the populations that I 
primarily serve. 
Just as background information, as of October of 1991, there have only been a 
little over 758 cases of AIDS reported among adolescents. That's 13- to 
19-year-olds. That's on a national level. And locally here in L.A. County, we 
have approximately 30 cases of AIDS reported among adolescents. 
I think, that even though the numbers are low across the board, both on a 
national and local level for adolescent populations, that we should still be 
vigilant in terms of providing comprehensive education to that population, given 
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the fact, that with the long latency period, from the time of initial infection 
until one is diagnosed with AIDS, which can be from one to ten years, that many 
people who are in their 20's probably contracted HIV in their teens. For far too 
long, HIV has been considered a gay, bisexual, white male disease. In our 
community, that still is a misnomer. Again, I've been involved in doing direct 
community outreach for close to eight years now with school-age populations 
primarily in the Compton Unified School District and the L.A. Unified School 
District. 
When we first went into those schools in grades 5 through 12, just coming into 
the room, a lot of the students were thinking, well, why were we there? Did we 
have AIDS? Is that why we were there? There was a lot of misinformation 
concerning how the virus was transmitted, thinking you could get it from the toilet 
seats, mosquitos, et cetera. 
From anecdotal information that we have gathered, many of the kids are 
engaging in at-risk behaviors through sexual activity because of drug use. Kids 
who are in classes for mentally disturbed kids, we're finding that a lot of those 
kids are being, have been sexually abused. And so we know that it is going on. If 
you look at the rates of teen pregnancy in L.A. County, as well as the rates of 
sexually transmitted diseases among adolescent and young adult populations, we're 
at epidemic proportions. And as far as STD goes, the rates of gonorrhea and 
syphilis have been at epidemic proportions in South Central since the mid-80's. So 
it's all of these things are indicating to me that we have a whole community, a 
whole generation at risk for HIV infection. 
DR. TATE: Ms. Davis, let me just interrupt you here. Of the 30 reported 
cases of adolescents and youth that have acquired the disease, do we know what it's 
been attributed to, if it's sexual behavior, HIV -- I mean IV drug use? 
MS. DAVIS: some of it -- the numbers are low, but some of it has been due to 
same sex between men, homosexual, bisexual contact, and heterosexual contact, and 
IV drug use. You can get that information from the AIDS Program Office, the 
Department of Epidemiology. Unfortunately, in their monthly report that comes out, 
they do not break it down by gender. so we don't know the number of males, ratio 
of males to females. And they don't break it down again by transmission category 
for the adolescent population; and you have to go and make further inquiries on 
your own to get that information. 
I think other co-factors that have to be considered in implementing effective 
programs have to do with the fact that we're dealing with a population that has low 
literacy, a population unemployed, the incarcerated population, and again the drug 
use that is going on, and early sexual experimentation. Research has shown for the 
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paet 20 years that in major inner-cities annually that the rates of early sexual 
activity are just decreasing in where in a lot of major inner-cities you have 
children who are young as 10-, 11-, 12-years-old initiating sexual activity. 
I wanted to briefly, to talk about some of the barriers in terms of funding. 
I don't think none of the previous speakers really talked in depth about the Ryan 
White CARE Act and the fact that with this money being available for the next four 
years, how that is going to impact people-of-color communities. 
I serve as a board member of the AIDS Regional Board which is responsible for 
allocating Title II funding, and I serve as an alternate, recently identified as an 
alternate for the CARE Council, Title I funding. And I also chair the Minority 
AIDS Consortium which is a group of service providers primarily targeting medically 
underserved communities in L.A. County. And we have been meeting for three years, 
and we try to network and share information and resources and problem solve around 
the issue of AIDS in people-of-color communities. 
For the last several months, the consortium has made an attempt to access some 
of that money, and it has been a constant battle to "get our fair share" of this 
money aa it becomes available. And ao that's one major barrier that we feel that, 
in our communities, that we still are underserved in terms of getting our fair 
share of the resources. Again, the Ryan White monies was primarily for primary 
care, not primary prevention or education. The money was for treatment, early 
intervention, et cetera. And ao there's a need to do more lobbying and advocacy 
for money for education to prevent HIV infection, in the first place. It's just 
going to be more coat-effective in the long-run. Both at a local and a statewide 
level, we feel that again that there has been insufficient funds coming to minority 
communities to target women, adolescents, homeless populations, incarcerated 
populations. And we would hope that you can support us in our efforts to get more 
funding for those populations. 
I talk a little bit about strategies. But what I would like to do is, to save 
time, is to go over my list of recommendations. In February of this year, I 
participated in the first public hearing on women in AIDS in Loa Angeles County 
that was sponsored by the L.A. Commission on the Status of Women and Councilman 
Robert Farrell. And the recommendations that I presented at that time still hold 
true today. And I will not go through all of them, but I just wanted to indicate 
that there ia a need for more early intervention programs, for women and youth; 
there's a need to expand the AIDS Clinic at Martin Luther King Hospital, the Oasis 
Clinic. Dr. Jordan now is having specialized services for women, adolescents. And 
we would like to see that the services for adolescents be expanded at that clinic 
and services for women. 
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There is a need to develop a mobile unit to target street youth in South 
Central. There is not a lot of providers targeting kids who are on the street, 
which could be former parolees, kids on probation, as well as gang members. And we 
would like to have a mobile unit where we could send street outreach teams into the 
community and South Central, do testing and counseling, and referral to the clinic 
at Martin Luther King Hospital. And that is a concept that we would like to see 
Lmplemented as soon as possible. 
We feel that, still, that there's a lot of denial going on in our community, a 
lot of fear, ignorance, and homophobia. And it wasn't until Magic Johnson again 
made his disclosure that people really began to take ownership of the issue and 
really personalize it, that it could happen to them. And again, we were all 
inundated with requests for people wanting testing and counseling in our community, 
and there were not enough providers out there to meet that need. There was one 
local high school that called the clinic and wanted to know would they be able to 
provide free testing to their high school students because the kids were so 
concerned, they wanted to be tested. And this clinic was just inundated with, 
again, people wanting to come and be tested. Even if you test positive, where are 
you going to be referred if there are no, if there's no infrastructure in your 
community? So bottom line is what we feel that a infrastructure needs to be built 
in our community so that we who have the expertise in the community can be given 
the resources to meet the needs of that community. 
Thank you. 
CHAIRPERSON WATSON: I appreciate your comments, and certainly throughout the 
morning and afternoon we have been trying to zero in on the fact that it looks like 
the minority communities -- specifically the African American community has been 
somewhat set aside as we approach the distribution of resources. 
I'm interested in the packet that you've given me. I just flipped through 
out. But almost every item in here talks about women and AIDS and so on. Were we 
mistaken when we said there haven't been a lot of studies on women with AIDS? 
MS. DAVIS: No, you were right on track. And one issue that really concerns 
me has to do with the aero-prevalence. Again and you mentioned it and you 
seemed very well aware of what's going on -- but for women of childbearing age 
that's 14 to 44 -- I've been following that data for the last couple of years and 
trying to make more people aware of what's happening. But with the testing of 
these core-blood samples, doing random samples, last year I got the information 
that from the pool of women tested in Alameda County, they were projecting that 1 
out of every 100 Black women in that test group was HIV-positive. And for L.A. 
County, it was 1 out of every 300. Well, the most recent data, L.A. county now is 
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at the top of the list in that it has increased by SO percent, meaning that now 
they're projecting that 1 out of every 174 Black women of childbearing age, out of 
that population that were tested, came out HIV-positive. And that really should 
give people cause for alarm. If you have your childbearing population in that gene 
pool infected with HIV, you're really looking at genocide down the line because 
there will be no future generations if everybody's infected and if all the women 
are infected. 
CHAIRPERSON WATSON: I was just going over the titles that the audience might 
be interested in knowing what some of the titles are: "Epidemiology of Women With 
AIDS in the u.s., 81-90"; "Researchers Waking Up to the Needs of Women With HIV". 
And then there is a report put out by Act out, "Women's Treatment and Research 
Agenda, Women With HIV". 
So it looks like there's been a wake-up call and that it was called before 
Magic called it, but I'm going to have to look at this information very closely. I 
see there's some analytical reviews that have been done and so on. So maybe there 
is more attention being paid now at the current time to women with AIDS. We 
certainly will follow up, and I appreciate you supplying us with this information. 
MS. DAVIS: Well, we have a window of opportunity ••• gap in tape ••• at least 
the incidence and the prevalence to get like it is in New York ••.• (gap in tape) ••• 
in '87 in New York and New Jersey. 
CHAIRPERSON WATSON: If you don't mind, I would like to request of you that 
you do this, and that is, that you send us a letter to Sacramento outlining what 
you think the needs are in terms of research for women with AIDS or research on 
women as a whole. Can you do that ••• 
MS. DAVIS: Sure, sure. 
CHAIRPERSON WATSON: We'd appreciate that. 
MS. DAVIS: Thank you. 
CHAIRPERSON WATSON: Thank you so very much. 
All right. We're going to go down our agenda here. Suzi Rodriquez. 
MS. SUZI RODRIQUEZ: Yes. Good afternoon. And I want to start by thanking 
you for inviting me here today and to tell you a little bit about what I do. I am 
currently the co-chairperson of the Title I Care council in Loa Angelea County. 
I'm a member of the AIDS Regional Board. And along with Cynthia and Mario at the 
other end of the table, we're also members of the Mayor's City AIDS Advisory 
Committee. 
I work for a community-based organization in East Los Angeles called AltaMed 
Health Services. We've been providing services, predominantly primary care 
services, to a largely Latino population, for over 20 years in that same community. 
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Like Cynthia, I'm not going to go word-by-word of my testimony becau .. I've 
given you copies. But I'd like to talk a little bit about some of the problems 
that we're finding in the Latino community. We also feel that as people of color, 
we are underfunded and under-represented in terms of programming. 
One of the problems that we have currently within the Latino population that 
doesn't seem to be the same kind of problem that is occuring in the 
African-American community is that we don't have an overwhelming number of 
providers who are willing to get into the arena and provide HIV services. We still 
have a lot of denial in our community also, and the denial spreads not just within 
the realm of sexual preference and sexuality but also in terms of drug use. 
The community that I represent has, by conservative estimates, the largest 
number of injecting drug users in Los Angeles County. And yet, when we attempted 
to open a Methadone Maintenance and Detoxification program, it took us three years 
to be able to overcome the NIMBY syndrome because the people in our community were 
just absolutely convinced that there was no drug problem in the community. 
As I said, our agency is a primary care agency; we're a community health care 
center. And we've always done what is considered to be relatively safe 
programming. We have a teen pregnancy program. We do a number of programs for the 
Latino elderly, and we provide primary health care services. But when the AIDS 
epidemic, especially the way that we heard it being reported from back East in New 
York specifically, and how it was affecting the Latino populations, our agency made 
a concerted effort to get into the AIDS arena to be able to address the problems 
that would be facing our community. And again, there are not an overwhelming 
number of providers who are willing to get into the arena. 
We're pretty new in the direct-service arena. We've been given many -- most 
our money comes -- our Drug Services money comes from the Los Angeles County Drug 
Abuse Program office. And we receive federal funds from the Bureau of Health Care 
Delivery and Assistance, from the Office for Treatment Improvement, which for those 
of us that are involved in the drug arena, it's been like a blessing that there was 
a new entity developed for treatment. 
I dislike the fact that we're often, as treatment providers, pitted against 
prevention and education programs about which should take a priority and which is 
more cost-effective. I'm having -- I'm a recovering person and I know that 
treatment works, and so I'm always going to advocate for more treatment dollars; 
and I feel really fortunate that the Office for Treatment Improvement was 
established on a federal level. And then we were able to access dollars through 
the Ryan White CARE Act to provide community-based early intervention services. So 
I'd like to talk just a little bit about what we've learned in this short time that 
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we've been delivering services to our population. 
We find that most of our patients are of Mexican origin. Many, many of them 
are undocumented. Most have a relatively low level of formal education in 
schooling. So I agree with what Paul Davis was talking about earlier in terms of 
appropriateness with written and printed materials. We put a lot of money into 
those kinds of things without taking into consideration that people may not always 
have the literacy level to read what we're spending the dollars to put out. And 
some people, AIDS Project Los Angeles, for instance, there's been some very 
creative ways to reach into communities of color that I think need to be expanded 
on; and I hope they'll talk about some of their projects. 
Most of the people that we're dealing with are alone in the United States; 
they're not here with the support system. And all were infected, either by sharing 
needles or by having sex with men who are infected. We find that there's a 
definite gap in culturally appropriate services for gay and bisexual Latinos, 
especially those with drug problems and treatment needs. 
And I'm going to take a sidestep for a second to tell you that I used to work 
for the Loa Angeles County Drug Abuse Office. And my job at that time was to go 
into facilities of incarceration and speak to people who had been arrested on 
drug-related charges and make arrangements for them to go to treatment. What would 
happen in those cases was when I had clients that were gay or bisexual, there were 
no appropriate drug-treatment programs to service that population. And 
unfortunately, most drug treatment providers believe that changing your image is 
directly tied to rehabilitating yourself. And so if you're a gay or bisexual man 
and you have long hair or you're a transvestite, most times you'll go into a drug 
treatment program; and the first thing they'll do is tell you to cut your hair and 
to change the way you look. If you're a lesbian, you go into drug treatment 
programs, they make you wear dresses and send you to charm school. So we've got 
some real problems going on here. And there's a gap in the service base. There's 
not people that are doing outreach into the gay and bisexual community of drug 
users, and that's a real problem. And I would hope that people would pay some 
attention to that. We also feel that it's imperative that the clinic staff be 
culturally appropriate to the population that they're serving. 
I 
Recently, my agency went down to Olvera Street, and many of the people here 
know about the transient Latino population that's in Olvera Street. We had been 
told time and time again that there was no way to do follow-up testing with these 
folks. We tested 140 people at the Health Fair at Olvera Street. We had 120 come 
back for results, and we know that that is because the staff wa9 reflective of the 
target population. The majority of our staff are Latino. All of our staff are 
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bilingual, and we're well staffed with representation of gay and bisexual men. 
Some of the recommendations that I would like to put forth today is that we 
also believe that linkages must be made with historically gay HIV/AIDS programs in 
order to provide appropriate staffing, training, and service provision for gay and 
bisexual clients. In the case specifically of my agency, when we looked at where 
the gaps were in service and we recognized that there was a gap for Latino, gay, 
and bisexual men, we knew that we did not have the infrastructure to take care of 
the needs of that specific population. we were very fortunate to be able to link 
up with AIDS Project Los Angeles and develop a whole, entire innovative program 
that includes cross-training and for them to be able to give us the needs that we, 
to fill the needs that we had to find appropriate staff and that -- I just can't 
even tell you how valuable that was for us. But it's very difficult to get 
community-based agencies that primarily deal with people of color to look at those 
gay and bisexual agencies as being valid and there as a resource. And I think that 
we, those of us that are doing those kinds of things, need to help break through 
the stigma and role model for that kind of linkage. 
We believe that there must be continuous and on-going education for and to the 
community. In the Latino community, we've got to access the church on a much 
greater and broader basis. We have found that there are many people within the 
church who are willing to look at what their role should be, but it needs to be 
vastly expanded. 
We believe that there should be intensive training and pre- and post-test 
counseling required for all case managers and that again clinic personnel should be 
reflective of the population that they are serving. 
We believe that HIV-testing should be encouraged to all program participants, 
and we believe that a system of comprehensive care should be instituted that 
includes pre-test counseling, HIV testing, post-test counseling when delivering any 
results. Too often we find that if someone tests negative, they don•t get any 
post-test counseling; and that's really a shortcoming. If the client is found to 
be positive, there should be an expeditious way to admit that patient into a 
medically managed program where one case manager will follow the patient during the 
course of the disease. 
We believe that there should be increased outreach done to the injecting 
drug-using population. My agency feels very strongly that the sero-positivity 
rates remain low for this population only because the data being collected is 
gathered, is reflective only of those people who are accessing treatment. We would 
also like to ask that consideration be given to the legalization of needle exchange 
programs that are tied directly to increased treatment availability. I know it's a 
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really hot issue, but it's something that definitely needs looking at. 
DR. TATE: But Senator Watson is introducing that next session. 
MS. RODRIQUEZ: Well, again, I would like you to know that there is many of us 
that will do whatever we can to help you support that form of legislation. 
CHAIRPERSON WATSON: You missed my discussion about my bill early on. 
MS. RODRIQUEZ: Yes, I did. I'm really sorry because we have a whole network 
of people that would be willing to support that. 
We also believe that staffing and programs should include a financial analyst 
to assist patients with accessing appropriate programs, such as Medi-Cal and 
Medi-Cal -- Medi-Cal and Medicare. And that's about all that I have to talk about 
today. 
CHAIRPERSON WATSON: We certainly appreciate your testimony. 
Is there someone down there that wanted to say something? Okay. Because it 
zeroes right into the ethnic community and its treatment that is specific to the 
culture; and that's what we need to hear more about. This is a very valuable piece 
for us as we try to reform the system so that it will address those specific needs. 
Thank you. 
MS. RODRIQUEZ: Thank you. 
CHAIRPERSON WATSON: May I ask the indulgence of the other members that I have 
seated at the table here, if you will. Dr. Reed Tuckson has come into the room, 
and he was scheduled to speak at 3 o'clock. He's a little early. I'd like to 
indulge him now, if I may, because I know he has a heavy schedule. He is from Drew 
University, and he was scheduled with the Hospital and Physicians and Clinics 
panel. So if you'll allow us to do that, we'll take you up now, Dr. Tuckson. 
Welcome. 
DR. REED TUCKSON: Well, thank you very much. And I very much appreciate your 
indulgence, as well as the other members of the panel for allowing me to go 
forward. 
I will make some very brief comments. First, let me just say that I am, I've 
enjoyed my three months as President of Drew University of Medicine and Science. I 
emphasize the three months to say that my comments have to be tinged with a little 
humility. This community of Los Angeles, I'm still new to and I'm learning. And I 
have learned enough in my career, Senator, to know that it is very important to 
spend time in a community before you become arrogant enough to make too specific 
recommendations. However, please consider my testimony as part of a team at Drew. 
I think that Cynthia Davis Callahan, and also Wilbert Jordan, are certainly 
experienced and competent to be able to make very specific recommendations, all of 
which I endorse. 
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I would say this, though, that as a person who's been fortunate to be a leader 
in the national fight on this issue, and a number of national commissions and still 
active, there are some important principles I would hope that you keep in mind as 
you go forward and consider these issues. 
First is that, as you are well aware, the HIV disease exists in the context of 
a series of other very dramatic and contributory health problems, naturally the 
tragedy of it. As we think about funding for HIV disease, I think we always have 
to remember the context in which it occurs for people of color and people who are 
poor and the relative relationships between them. As you've just heard in the last 
speaker, HIV disease and the clear relationship to IV drug abuse is, of course, 
important. HIV disease is related ultimately in many ways to violence. I've been 
very concerned with the number of women who become addicted to drugs because of the 
violence in their community and thereby find their way to HIV disease. 
We find that the issues of self-esteem that lead to behavioral choices that 
are incompatible to survival are common throughout; and so that as we look at how 
we approach HIV disease, I only remind us that we have to look at the total health 
package and the total health set of challenges that confront people of color, and 
that is very important. Similarly, to do the education that we need to do to try 
to change behavior, to be able to support behavior, I think we have to face square 
ahead the issue of being realistic about learning the knowledge, the attitudes, and 
the behaviors of the people that live in our community. 
I am very concerned by the recent decision by the Secretary of Health and 
Human Services to cancel a study designed just to elicit such information about the 
knowledge, the attitudes, and the behaviors, of the sexual behaviors of our 
children. I would hope that as we go forward that we would be courageous enough, 
insightful enough, and thoughtful enough to really make sure we understand exactly 
where our young people are so that we can in fact tailor health education messages 
that will reach them where they are and not make assumptions and not burden this 
process with politics. 
I have been a health commissioner for a major urban metropolis for four years. 
I have had my hands tied all during my tenure and have been unable because of 
politics or because of all matter of competing interest, been restricted or limited 
in our belief to teach our young people in a way that we can reach them and save 
their lives. And I would hope that as we go forward we would not be bound by some 
of that. 
Similarly, the techniques that we use, I would hope that a comprehensive 
curriculum could be developed, a curriculum that was culturally specific and 
sensitive but was creative and dynamic and that could be incorporated into the 
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educational system not as a burden for the teacher to have to teach, in addition to 
many other problems, but could be incorporated into a curriculum in a constructive 
and positive and useful way, a partnership, a true partnership, between health and 
the educational system. I would hope that we would be able to be creative about 
some of the ways in which we do public service announcements. I would hope that 
funding wouldn't go just for another commercial that just does and repeats some of 
the, with the same technology but utilizes perhaps ways of empowering people. 
Example, I had a chance to participate not long ago in an experiment that I 
thought was fabulous where a live radio docu-drama was conducted on the radio that 
dealt with real-life issues of a woman who was a single parent whose man in her 
life was an IV drug abuser but she didn't know it. And she was reminded of the 
Lmportance of using a condom, given that he was also not faithful to her; and she 
had to have a conversation with that man. And they did it on the radio as part of 
the docu-drama, and then he was very good and convinced her that perhaps that 
wasn't necessary and was very smooth and very persuasive. And then we stopped the 
docu-drama at that moment and opened up the phone lines and allowed the women to 
call in and be the star. 
It's very fascinating to hear those women. What would you say to that man and 
what would you do and then put the man back on the radio and then have him argue 
with the woman. The women didn't always win. What happened was, that night, there 
were a lot of women who had been in the gymnasium practicing on their techniques, 
practicing on arguments. And they were very empowered that evening, in that 
particular city, and they knew exactly what to say. And so there are ways which I 
think we need to be a little more creative, a little more dynamic, as we think 
about those kinds of interventions that will empower people, not only that gives 
them information, Senator, but things that give you information in a way that 
facilitates the changing of behavior, acting on information, not just giving it 
out. 
I would say that I really am excited by Cynthia Davis Callahan's suggestion to 
you in education for mobile units. We need to reach out. I've spent many, many 
evenings and many different cities in this country walking the streets. And I will 
tell you that the people who are prostitutes or IV drug abusers don't listen well 
to health educators. They listen well to people who are from their constituency. 
I remember walking the street and having an addict on the street say to my 
coworker, another addict, "I remember when you overdosed right there on that spot.• 
And here that addict is now back to talk about the need to change behavior. So I 
think those kinds of mobile outreaches, efforts are important. 
And I would say to you also that what you know well, Senator, is the 
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Lmportance of community-based infrastructure and organization that will make a 
difference. I am very concerned that funding is about to run out from the federal 
government anyway, funding community-based institutions in the fight against AIDS, 
particularly our churches. And the reason why that it is in jeopardy is because 
they have been unable to prove effectiveness. They've been unable to do the kinds 
of studies that are required to show that in fact the money's been w~ll spent. 
Drew University has, I think, a responsibility as one player in this community 
to support in an intellectual and research capacity our community-baaed 
institutions that are on the front linea, to prove the point of what works. And 
when things don't work, to be able to make those suggestions to how to enhance that 
work. That's a research agenda that is not being addressed. 
University doesn't have any money to do that sort of thing. 
I know Drew 
This is not a 
commercial for Drew. It is a commercial for being more intelligent about how we 
conduct community-based programs and not continue to give lip service to community 
infrastructure but in fact to do it well. 
In the one minute that I'm sure is all I have left, let me just very quickly 
say that -- and again, my comments are a companion to my team's comments of Cynthia 
as well as Wilbert Jordan, so they'll cover things that I won't cover. But I would 
say to you that I am particularly concerned about the, as we move forward to 
develop the clinical trials for women and children and other people of color, men 
and women who are, the clinical trials to give us more information, there is a 
strange paradox. 
To get access to comprehensive health care now, you almost have to be 
HIV-positive for those women. And I'm very concerned about the ethics of that. 
Across the country now, what we find is the clinical trials are being developed to 
take care of people that are HIV-positiveJ yet they're the same women, if they were 
one week before diagnosis, wouldn't be able to get access to care. And so I remind 
you that this issue is, of HIV disease, again exists in the larger context. And, 
of course, once the study is over, then those comprehensive support services for 
the HIV-positive women go away. And so what we have to continually address is a 
lasting health care infrastructure for people of color, as we deal simultaneously 
with the overwhelming and extraordinary urgency. 
Lastly, I would just say to you that even as we work through these problema, 
the health care professionals who are going to be in our communities, they're 
unavailable to take care of the comprehensive and multiple needs of persona who are 
living with this disease. We have to be very, very attentive to that. I'a not 
sure where those practitioners are going to come from, and I think that we're going 
to need to be very supportive of those institutions that are dedicated to training 
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those professionals who will remain in our communities and be there to manage with 
compassion and care versus living with this disease. And so I will stop there. 
I've taken up my full allotment. I appreciate your indulgence as well as the rest 
of the members of my panel. 
CHAIRPERSON WATSON: Thank you, Dr. Tuckson. I think you have pointed out 
much of what has been said earlier today. And so you do have a handle on the gap 
of what's needed. What you will find as you try to learn this community in more 
depth is that we have some political problems, and we have attitudes that have 
prevailed. California is really a very conservative state, and one of the problema 
we face is trying to open up a debate in sacramento, large enough so we can put 
into that debate the resources that are necessary to do the kind of innovative 
things you've just described. We get stumped and stymied because of these 
attitudes that prevail. And the more conservative the administration is, the more 
stymied we become because once those bills get to the desk, they can be vetoed. 
And once that belt comes out, and beats us up with it, then they die in committee. 
So as you are going about trying to learn the community, you will be learning the 
politics of AIDS. And I think in some way the question has to be raised: Is there 
racism in the way we relate to AIDS? And I think as you go about doing your 
research and becoming oriented and acquainted, you'll find that maybe the answer 
will be yes. And there certainly is an attitudinal problem; there certainly is a 
cultural problem that we're dealing with. And so it goes to the social dynamics of 
this particular disease. 
DR. TUCKSON: Well, Senator, I would just quickly say that in my three months 
here in this State of California, it doesn't take much work to get a sense of what 
you're saying. I am amazed that the number of people that I have already 
encountered with this disease is quite extraordinary. And the degree of apathy 
relatively and the degree of urgency in addressing the Hispanic and the African 
American with this disease somewhat concerns me. And it doesn't take but a 
three-month sojourn here to reach that conclusion. And so I hope that we're all 
able to work together. 
CHAIRPERSON WATSON: Well, you said something that is of tremendous interest 
to me. You said Drew University ought to take on some of this. We don't have the 
budget, but we ought to be looking at some of these aspects of AIDS. And I would 
think that with your innovativeness that you would look at Drew as being a center 
to give some guidance and leadership. South Central is really all over L.A. 
county. But coming from South· central, I think you could be a beacon light. And 
you, coming from the nerve center from Washington, D.c., certainly have the 
national perspective on this. And when it comes down to the local area in which 
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your university is located, you can really be that light to give guidance to the 
county, to have a place where the researchers might come to do some research on 
this issue. 
DR. TUCKSON: Well, I appreciate the challenge, and I would say to you that 
you can fully expect us to reach that challenge. We will do it one way or the 
other. But I will tell you, Senator, that it is very, very hard when all of your 
resources are going towards just trying to maintain, seeing the patients that we're 
seeing now. And I will tell you that this is the tragedy that, the story that is 
not told. It's why I began my presentation very specifically by saying that HIV 
disease exists in a larger context. 
All of the resources in the health care system are devoted now towards meeting 
the needs that have long been there before HIV disease became prevalent. And to be 
honest, we're doing an inadequate job of meeting hypertension, cardiovascular 
disease, cancer, and so forth and so on. Now this new phenomenon drops in the 
middle of a system that is as weak as wet tissue paper. It is inevitable that you 
will have a disaster, and that is the disaster that we are now experiencing and 
will continue to experience. And so as we look to our smart people at Drew, I must 
tell them to be thoughtful and to develop new research ideas and new interventions, 
for HIV disease means that you cannot then be with your patient who has another 
disease. You must stop that work and do this other work. That is immoral set of 
choices to place on any health care provider or any institution. That's what we're 
talking about. And that's the picture that I think that is so often lost in all of 
this. We don't have enough resources to do the work we have to do now. Now we 
have to find some other way to add more hours of the day, find more people to be 
able to address these new needs; and we're not doing a good enough job of it, but 
we will continue to try. We look for others to give us some help. 
CHAIRPERSON WATSON: You have Drew/UCLA. Now there's an arm for you. And 
I've been trying to, for quite a while now, talking to the chancellor, to take a 
look at this sociological research that he says is not scholarly enough to start 
looking. 
You know, we've been talking about tenure of minority professors out at UCLA 
for a long time because they focus in on the sociological research. They find it 
not scholarly enough though to grant tenure. We've had this debate over a number 
of years. 
DR. TUCKSON: Senator, can you indulge me with one more comment then. 
CHAIRPERSON WATSON: Yeah. 
DR. TUCKSON: This is a critical issue. Everywhere --'I'm on the Board of the 
American Public Health Association. I serve on several committees of the Institute 
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of Medicine. Everywhere we go, we hear lip service to the rhetoric of how 
important it is to have a community-based infrastructure with which to solve 
problems. Yet, when we look at the way in which we spend our money in the health 
care research community, we spend lots of money to study the latest drug which will 
solve just a very small part of it. But to prevent the illness, to prevent the 
problem, which is an ultimately community-based initiative, we spend very little 
time and energy; and we don't respect that. But we give rhetoric to it as being 
important. And I am just amazed that anyone could be that short-sighted in this 
day and age to think that this is not worthy of scholarly pursuit. Ultimately, 
this is what's going to save our community. And I think that if we don't put that 
kind of intellectual attention and effort into it, we play games with people's 
lives and we do ourselves a disservice. 
The funding -- the last comment -- I promise will be the last comment. The 
issue that is of great concern is, when we fund community-based organizations to do 
this vital work, we fund the disease of the month. And if it's this month a 
certain disease, and the next month, it will be HIV disease and then it will be 
something else, the money runs out; the community institution goes away; then a new 
one springs up. What's not left is a viable, connected, stable, self-sustaining 
community infrastructure. And so this business, if we continue to approach this 
casually, intellectually, and financially, we wind up never having in place the 
mechanism and the tools and the resources and the intellectual brain power which 
will sustain us year after year after year. 
CHAIRPERSON WATSON: You might want to take advantage of your relationship 
with your parent organization, UCLA, the Department of Health Services, the Office 
of AIDS, and my office, and see what we can do through Drew to address the issue 
that you're mentioning. You know, the disease-of-the-month concept is very rea1 
and, you know, we put our resources where there is a great amount of political 
pressure. And so I think you're putting your finger right on the problem. But I 
think you have a broad enough base to call on to get something moving. So I will 
have Dr. Tate follow-up with you, and maybe we can put something like this 
together. 
DR. TUCKSON: I appreciate that, and I would never, ever find myself modifying 
anything that you might say. I would just half suggest a different choice of words 
other than UCLA being a parent. They are associated with us, but we have a 
tremendous pride at Drew, as you well know and share. And we are an institution in 
and of ourselves. But I think the point you make is an important one, and that is, 
UCLA has a responsibility. I go over there -- I was just there yesterday, and I 
couldn't believe -- I looked at those -- all those giant buildings with all those 
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people and all that money and they're solving, working on some problems of 
Lmportance; but they're not working on the problems of importance ••• 
CHAIRPERSON WATSON: My words were not coincidental. I chose them very 
carefully because UCLA, being part of the UC system, gets its funding from the 
state. 
DR. TUCKSON: Oh, in that context, yes. 
CHAIRPERSON WATSON: And we can move on the state university system to do 
certain things with Drew. 
DR. TUCKSON: I appreciate that. 
CHAIRPERSON WATSON: And therefore, you see, in the funds you don't have, and 
this is something we've been dealing with over the years and you know the 
history of how Drew came about. And we've been pushing and pushing and pushing. 
As I said, this debate started many years ago. And so that organization can see, 
if they prioritize correctly, that you at Drew had the resources to do what needs 
to be done. 
DR. TUCKSON: I continue to learn from you. 
CHAIRPERSON WATSON: I'll leave it there without exposing too much of my 
intentions. 
DR. TUCKSON: I continue to learn from you. 
CHAIRPERSON WATSON: Thank you, my dear, for being here. We'll continue this 
conversation later on. 
DR. TUCKSON: Thank you so very much. I appreciate it. Thank you very much. 
CHAIRPERSON WATSON: All right. Let's move on. Mario Solis-Marich, AIDS 
Project Los Angeles. 
MR. MARIO SOLIS-MARICH: Hi. Calvin Williams is going to start our 
presentation. 
CHAIRPERSON WATSON: All right. Very good. 
MR. CALVIN WILLIAMS: Senator Watson, Members of the Health and Human Services 
Committee, good afternoon. My name is Calvin Williams, and I'm a public policy 
specialist for AIDS Project Los Angeles. While it would be difficult to diseuse 
during thi• brief session all the issues relevant to bisexual and gay men of color, 
I would like to discuss one issue that I believe is of paramount concern. 
When the question of AIDS education is discussed, the general misperception is 
to focus on a limited segment of the population. However, AIDS is not specific to 
whom it will attack; and unfortunately, too many bisexual and gay men of color have 
become infected with HIV and/or have died from AIDS due to the lack of sensitive 
and tailored information regarding HIV and the AIDS epidemic. 
Presently, the number of people of color who have contracted AIDS continues to 
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rise. The National Commission on AIDS in its recent report declared, and I quotes 
Gay and bisexual men are the largest segment of people with AIDS among Black and 
Hispanics, 36 percent and 40 percent of cumulative cases respectively as of June 
1991. A total of 28 percent of gay and bisexual men with AIDS are Black and 
Hispanics nationally. 
Within the county, the numbers are even more staggering. Within the Hispanic 
community, the gay or bisexual men constitutes 73 percent of reported cases. In 
the Black community, gay and bisexual men constitute 65 percent of reported cases. 
And within the Asian and Pacific Islander community, gay and bisexual men 
constitute 80 percent of reported cases. 
Despite these realities, epidemiologic and behavior studies and HIV disease 
have virtually ignored gay and bisexual men of color. In addition, there is yet to 
be specific target programs funded either from the federal or state governments 
that address issues specific to bisexual and gay men of color. Those education 
campaigns that have been initiated by private social services agencies have been 
sporadic or limited at best. Leadership is needed from the top. State and local 
agencies must begin the process of addressing funding priorities if we are going to 
stem the growing numbers of people of color contracting HIV or dying because of an 
AIDS-related illness. The lack of leadership and the limited revenues available to 
social service agencies that are dealing on the front lines of the AIDS epidemic 
for this population must be addressed. 
The feasibility of servicing the needs of the growing HIV and AIDS population 
cannot be achieved through the work of only a few agencies, nor can a handful of 
agencies reasonably educate the public on ways to prevent the spread of this deadly 
disease. However, through joint efforts between social service agencies and the 
active participation of the state and local governments, our collective ability to 
save lives and bring about more coordination and the delivery of services for 
persons who are HIV-positive or who have AIDS can be realized. 
But before coordination between state and local agencies can occur, and before 
unity can be achieved, the state must take a leadership role in appropriating 
additional resources that will provide a meaningful base in which to provide 
services to gay and bisexual men of color who are impacted by HIV or AIDS. 
Moreover, the proliferation of the AIDS epidemic demands that sensitivity be 
required of all public and private entities that receive public funds. 
Since many gay and bisexual men of color are presenting themselves to 
community health centers throughout the state, specific contract language must be 
required for those agencies to ensure that gay and bisexual men of color receive 
sensitive, adequate, and professional medical services. Let us collectively move 
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forward in the war on AIDS. Let ua drop the meaningleaa rhetoric and dedicate 
ouraelvea to improve in the quality of life for all thoae afflicted. 
Time that is spent debating question& of policy can be more appropriately used 
by designing program& that benefit thoae who are ill and dying and preventing the 
further spread of this diseaae. Let us move forward. A large and a much maligned 
segment of our population is depending on us for their very lives. 
CHAIRPERSON WATSON: There i• a feeling that prevails that the AIDS project in 
Los Angelea is the recipient of the resources and that some of the community-baaed 
programs that really reach out to the grass-roots community received lese because 
that money goes through the AIDS Project of Loa Angelea. 
Would you comment on that. There aeema to be kind of a tug between thoae 
grass-roots organizations and AIDS Project. 
MR. SOLIS-MARICH: senator Watson, if I may, my name is Mario Solis-Marich, 
and I'm the Director of the Public Policy Department of AIDS Project Loa Angelea. 
I also sit on the executive management team of the agency. 
They are definitely our intentions within the community around funding isauea, 
and there will be continued pressures because there's not enough money for the 
growing epidemic and the intense crisis that we face, especially on the 
community-baaed level. 
currently APLA provides case management and psycho-social services to over 70 
percent of the people with AIDS in Loa Angeles county. We have the only dental 
clinic for our people with AIDS in Loa Angeles county. We have the largest Food 
Bank program and the Necessities of Life Program which provides food to 650 people 
with AIDS a week from all over Loa Angeles County. 
our client load, the demographic& of our client load, reflect or mirror the 
demographics of people with AIDS in Loa Angeles County. And eo, in fact, we do 
75 percent of our funding, we raise privately; 25 percent comes from government 
sources; and we do have a large budget; we do a big job; and there does need to be 
more money to go around to all community-baaed organizations. 
One of the things that we've attempted to do to address that need ia we've 
established massive public policy efforts, both in Sacramento -- excuse me -- in 
all areas -- the county, Sacramento, and in the federal government. We aupport the 
largest AIDS activist -- AIDS lobby in Washington, the AIDS Action Council. We 
provide them with a third of their budget. It was through their lobbying and their 
direct efforts in Washington, D.C., that Loa Angeles received over $7 million 
through the Ryan White Act. 
We've been able to therefore use some of our private donor dollars to effect 
public policy and to get more dollars for AIDS from the federal government 096 
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diatributed here in Los Angeles County, and that's one way that we've been, you 
know, trying to expand our resources and have an impact with other community-based 
organizations. We do realize we cannot be all things to all people, and we tried 
to establish cooperative efforts with those community-based organizations that are 
willing to work with us. And that kind of leads me, if I may, to the point that I 
wanted to talk about this afternoon, and that is, earlier, Suzi Rodriquez from 
AltaMed Health Services spoke. And when I heard AltaMed Health Services, their 
representative here speaking about gay Latinos, it made me feel really, really 
wonderful because in fact I am a gay Latino. And that institution is the largest 
Latino community-based clinic in the United States. And it makes me feel good to 
see them doing what they see as necessary, basing the issues that confront a 
community-based organization as they address issues surrounding homophobia and 
access to all members of their community. 
The particular project that we're jointly working on, we believe, will have a 
major impact on gay Latinos and especially gay Latinos who are injection drug users 
or have other substance abuse problems. Currently, 80 percent of Latinos in L.A. 
COunty that have HIV are gay and bisexual men. Two-thirds of gay and bisexual 
Latinos are actually gay and bisexual men, period, have some addictive behavior 
problem. Unfortunately, there has been no leadership from the administration here 
at the state or federal government with the Bush-, you know, Reagan-Deukmejian 
machine, to address the needs of substance-abusing, lesbian, and gay people. With 
HIV, this is a crucial, crucial issue. And it's not only the direct transmission 
of injection drug use, but it's also the correlation between being high and being 
able to maintain safe, sexual behavior. 
The program that Dr. Rodriquez alluded to was a program that was in fact 
inspired by a person with AIDS. And currently, we have the 3,200 clients at APLA; 
but this particular person with AIDS was a staff person. His name was Jose Perez. 
And he was a gay Latino who was a recovering injection drug user. Jose Perez 
worked constantly with me -- I should say constantly on me -- before he came to 
AIDS Project Los Angeles to serve as a policy specialist to get me to work more 
closely with, you know, pull together HIV services, substance abuse services, in a 
Latino cultural context. He worked very, very diligently to create a joint medical 
advisory committee where AltaMed had cultural sensitivity. And through APLA, we 
have access to some of the finest, you know, AIDS outreach in Los Angeles COunty 
pulling those resources together to create treatment protocols and to make sure 
that all people in East L.A. receive a very high degree of service. This is a 
long-term project that's been very, very difficult to pull both agencies together; 
and unfortunately, it still has a ways to go. But we believe that these are the 
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type of efforts throughout the county with other agencies joining together that 
really should be funded. 
Jose Perez died on November 11 of this last year. His efforts are sorely, 
sorely missed. But this next year, as we move forward to completing this project, 
we constantly hear his voice, and we constantly feel his presence as he's pushing 
this and other projects throughout the country along. Thank you. 
CHAIRPERSON WATSON: Thank you for that insight. We appreciate everything. 
Okay. Mike Neely. 
MR. MIKE NEELY: Good afternoon. 
CHAIRPERSON WATSON: Good afternoon. 
MR. NEELY: Before I begin my testimony, I'd like to say something before you 
go charging off to the Department of corrections on the problem of HIV transmission 
within the prison system. 
Sexual contact is a very important means of transmission. However, there is 
another very, very prevalent means of transmission within the prison system that 
nobody's looked at, and that is, through the tattoo machines. And I think that 
unless we look at all of those aspects, we're going to miss a part of the problem. 
Now to get on with my testimony, and in the interest of time, I'm not going to 
do all the reading like everybody else. We'll just hit on some of the high points. 
I'm Mike Neely. I'm the Director of the Homeless OUtreach Program. What I 
want to talk about basically is HIV and the AIDS epidemic and how it impacts the 
homeless community. 
One of the things I want us to understand is that by definition, the homeless 
individual has no resources except for public resources. However, as we begin to 
look at the public resources, those resources are definitely going into other 
communities which are not necessarily poor, which are not necessarily 
undereducated, or not necessarily under-represented. 
Homeless people have a very serious and unique kind of problem in terms of HIV 
infection and dealing with the care system. A person who is infected and who is 
homeless in Los Angeles, in the State of California, is without care. By that, I 
mean very simply that the system is designed on an either/or basis. Either they 
deal with the medical problems of the individual or they deal with the survival 
problems of the individual. 
The best way to illustrate this, I would imagine, would be by a small example 
that I've come up with, and that is an individual who goes to the clinic, gets 
their medication; they come pack to the shelter. The shelter then either takes the 
medication away from that individual or allows that individual to take the 
medication on the time schedule of the shelter. 
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Then the person -- let's say that person has night sweats or diarrhea or some 
other things where that individual just can't sleep that evening, one of the 
problems that eventually that person runs into is the next morning, they've got to 
get up because the shelter rules say you have to be up at 7 o'clock and you have to 
be out of the bed. 
Now if the individual takes medication and that individual has side effects, 
one of the things that happens is that now you have to leave the shelter and the 
clinic, or wherever he may have been getting hie medication, and says, well, that's 
just normal and there's nothing we can do with you. 
So then the individual says, well, wait a minute. This medication is making 
my life more difficult. And in that situation, the individual may then elect to 
not take the medication. And in not taking their medication, then that individual 
then has to make a real life-and-death kind of choice. This isn't the fault of any 
individuals. This is just the way the system is set up. This is real life. This 
is what happens every day. 
We have a very serious situation in terms of -- I'll probably be the only 
peraon up here that says that we don't need any more money. What we do need is a 
better allocation of the money, and that allocation of the money -- I just heard 
someone talk about the efforts of getting $7.8 million into the county or the City 
of Los Angeles, the County of Los Angeles, wherever it went to. For the homeless 
population, I think that the total allocation was like $120,000 or $140,000. At 
any rate, that was less than 2 percent. 
So we are totally and completely ignored. We don't have the ability to have 
the largest lobby in the country; we don't have the largest lobby in any place. 
One of the things that the Senator made very, very clear just a minute ago, one of 
the ways that Sacramento does business is who provides the most political pressure, 
gets the most results. Homeless people do not have that ability. Homeless people 
do not have the ability to even get to Sacramento Street, let alone to get to 
Sacramento, California. 
Those kinds of issues are issues that we have a real problem with. You take 
this and you couple it with just the normal problems of day-to-day existence, and 
then you infect us with a disease, a very serious disease, and then somehow or 
another, people ask us to compete, to compete for funds, to compete for attention, 
to compete for any kinds of services. We're not even in a position to compete for 
public health services aa they currently exist today. And this was our only source 
of public health services. 
And I want to make it very clear, that the population that I'm talking about 
is the population that was on the streets that is affected after they are on the 
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streets. A lot of times, people will try and confuse the issue by throwing in the 
sympathy factor, and that is, individuals who contracted the disease and then 
become homeless. I understand that that's a very serious problem, but that's not 
my population. Those are not the individuals that I have to deal with. I have to 
deal with the individuals who, according to our records and all of the stuff that 
I 
we see, about one in five of those individuals are infected. 
In the tuberculosis clinic, which is located right in the middle of skid row, 
25 percent of their patients are HIV-positive. This is the kind of problem that we 
have to deal with, and this is the kind of situation that we have to try and 
compete. And as it stands right now, the playing field is not very level. And as 
Dr. Tate can tell you, I'm a very big advocate for categorical funding. I think 
that the homeless population does need to be culled out. I think that some very 
serious, serious monies have to be devoted to that because when we look at it in 
the long-run, the basis of homeless service providers is to get people back into 
the mainstream as quickly as possible. If we're getting people back into the 
mainstream as quickly as possible and those individuals are undiagnosed, carriers 
of the HIV virus, then what we are doing is getting the HIV virus back into your 
community as quickly as possible. And that, we have to look at and that we have to 
act in some way or another. Thank you. 
CHAIRPERSON WATSON: Thank you for that insight on the homeless. I think it's 
very necessary to keep in mind that we've got a lot of people out there on the 
streets with needs as well as in institutions. We appreciate your comments. 
Kazue Shibata, Executive Director for Asian Pacific (Health) Care Ventures. 
Okay. Helen Fitzgerald. 
MS. HELEN FITZGERALD: Thank you. I'm Helen Fitzgerald. I'm with 
Prototypes-WARN. And we'd like to thank you for inviting us to take part in this 
testimony. I'm honored to be in the presence of Senator Watson. I had the 
opportunity to hear her speak at the Black Women's Conference held in Compton 
several months ago, and I was really empowered by your speaking. And I'd also like 
to thank Ruth Slaughter (?), the Director of Prototypes-WARN for feeling that I can 
come here and present our agency and the problems that we encounter on a daily 
basis while doing straight outreach. 
WARN is misspelled on the agenda. WARN is an acronym itself, and it stands 
for Women and Aids Risk Network. Okay. 
We were one of the first projects in the nation to provide AIDS prevention and 
education specifically for women of color. I wrote a piece describing many of the 
women of our targeted population, and I would like to share that with you in hopes 
that you can better understand the women that we work with. 
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It ia unanimous that all women are at risk for HIV and AIDS. However, the 
women of our targeted population are injection drug uaera, sex workers, and 
partners of injection drug users. They are considered by society to be hard-core, 
low-claas, and socially unacceptable. Our women come from broken homes, broken 
marriages, and they have children in the system or may have been of that very 
system themselves. They are mothers with and without children, teens without 
f~ilies. Many of our women are homeless. Some are undereducated and moat are 
unemployable. In their lives, they have experienced child abuse, sexual abuse, and 
sexual assault. They have been the victima of phyaical violence as adolescents or 
as adults. 
Our women suffer the loss of hopes and dreams, and they have become accustomed 
to broken promises. They have been set up to believe that they cannot truat anyone 
and that no one can be unconditionally interested in their welfare. As a result, 
these women have adapted behaviors that may be labeled pathological and 
psychological. But we realize that for them, these are probably the only means to 
cope with life. 
As an outreach worker with Prototypes-WARN, a senior outreach worker, and team 
leader for the South Central area, we are very familiar with HIV and with 
addiction. And we know that for our women in our target population of HIV and 
addiction is only a symptom of a much deeper, emotional, and psychological problem. 
Our staff of outreach workers have been trained in HIV pre- and post-test 
counseling. We have been trained to do outreach to partners of injection drug 
users as well as injection drug uaers. And we have been trained by the Foundation 
to offer emotional support for women or for people who are living with 
life-threatening diseases. 
The problema that we encounter on a daily basis while doing outreach ia that 
it gets very frustrating to do outreach for a community or to provide services to 
the women when there are no servicea to refer them to. 
We have -- I want to backtrack for a minute. We did, back in the summer, in 
one of the parte in South Central -- I'm very nervous I need to say that. One 
of the parte in South Central where we do AIDS outreach, AIDS prevention education, 
we had encouraged our women and men of that population to be tested. And we worked 
with another AIDS agency to have these people tested. We had 25 men and women to 
be tested for the HIV virus, and three of those were staff members, including 
myself. So it was 22 people to be tested. Out of those 22 people who tested, 12 
were HIV~positive; and only one showed up for the test results. And we feel that 
that was because of the fact that it took a very long time for them to get their 
reaults. Many of the people were homeless. And when we asked them and we knew 
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who they were, that they go to get their teat results -- they would say that they 
lost their paper so that there was no way of keeping track with them. 
Another thing ia that when, if you're BIV-poaitive and you're a woman, there'• 
no services for you; there are virtually none. And if you're BIV-positive and 
addicted, there are no services for you. So basically, it gets really frustrating 
in trying to do our job and trying to provide the AIDS prevention education and 
trying to promote the behavior change. And so we find some relief in meeting a 
woman as where she ia at the moment. If her problem may be that she need• food or 
shelter, this is what we would try to provide for her. We try to build a trust 
because we know that our women have been set up to believe that they can't trust 
the system. So our outreach workers are, including myself, were indigenous to our 
target population. 
I don't know. I'm a recovering addict, and I know what it was like for me to 
go into drug treatment. And I thank God that I had insurance, that I didn't have 
to deal with the county facilities. My understanding, there's 36 beds available 
with the county. And of those 36 beds, there are only a certain number for women; 
and our agency works specifically with women. So it gets to be very discouraging. 
There's only three of ua under the contract that I've worked for, so we have 
to work with the other projects within our agency to do our outreach, and we work 
with a state-funded outreach worker and are funded by the Children's Hospital to do 
teen outreach. 
So there's not enough outreach workers because if one of them -- our outreach 
worker, she does routine outreach work. When she's at the juvenile hall doing teen 
outreach there, then one of our aitea may go unvisited that day. We may not be 
able to provide education to a certain area. So we see the need for more outreach 
workers. We also see a need for more BIV test sites. 
We had an agreement -- not agreement -- but we did work with one of the 
testing facilities or clinics in East L.A.; and it worked very well for us because 
they would let us come in and we would bring our women in, and we had priority 
testing. But what happened was, as a result of our testing -- and they only had 
one phlebotomist. So she was not able to accommodate the clinic's need aa well as 
our needs for the women in the street. So they limited us to one day a week, which 
is on a Wednesday after 5 o'clock. And some of the areas that we do outreach in, 
because we're in South central -- were in Figueroa; and were in the Avalon Heights 
areas. So some of those areas that we're in during the day that we would want to 
be in after 5 o'clock, so it makes it difficult for our women to get tested. 
We also would like to see a receiving center, something like out, like a 
receiving center in the South Central area and in other areas that women or men who 
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are HIV-positive and are waiting for a slot in the drug treatment center can come 
in. They could start getting treatment; they could start getting detoxed while 
waiting for these drug treatment facilities. Like I said, when I went into drug 
treatment, I was really fortunate to have insurance. And what happened as a 
result, when I first went there, they couldn't find my insurance. So at home, 
feeling hopeless and helpless, feeling like there was no hope for me -- and what I 
did was continued to use more. But then they found my insurance record and their 
hospital called for me. And it took me from the day I went to go into the 
hospital, and from the time they accepted me, it took me at least a month to get 
back on my own and I had insurance. So I know what it's like for women and men who 
are dependent upon the county. our staff is multi-cultured and language sensitive. 
I don't know. There is a need for more Latino outreach workers. 
One of our women today had to -- our staff was -- we had to go to another 
facility because they needed someone to talk to, a person who's HIV-positive and 
who only spoke Spanish. So she was supposed to be here to support me this morning, 
but she got here late. And like I said, there's only three of us who's on this 
team. And I feel that we are really overworked; we're underpaid; and our job is 
very dangerous. I mean when I put on my tennis shoes and my sweatshirts and my 
Levi's and become color-conscious of the neighborhood that I'm in, I'm also 
sometimes afraid for my life. I put my life on the line on a daily basis. Thank 
you. 
CHAIRPERSON WATSON: Thank you for that testimony. Prototypes-WARN -- you 
said that's an acronym. What does it stand for? 
MS. FITZGERALD: Women and AIDS Risk Network. 
DR. TATE: Women and AIDS? 
MS. FITZGERALD: Women and AIDS. I have brochures here about our project. 
DR. TATE: Did you speak earlier about how you're funded? 
MS. FITZGERALD: We are -- the project -- I'm funded through the Drug Abuse 
Program Office. We also receive funds from the Los Angeles Children's Hospital. 
We're state funded. And there are projects that are funded by NIDA and NOVA, award 
the one project. 
DR. TATE: Which are these funds? 
MS. FITZGERALD: I wouldn't know. I'm not sure. 
CHAIRPERSON WATSON: Thank you so very much. 
MS. FITZGERALD: Thank you. 
CHAIRPERSON WATSON: All right. Joel Tan, United -- Colors United. 
MR. JOEL TAN: .£..,I.u.n_ra:..&ia.li&.P~~::;i,...nwo.:....------· ) Good afternoon. 
CHAIRPERSON WATSON: Good afternoon. 
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MR. TAN: My name is Joel Tan. I'm the founder and co-facilitator for COlore 
United Action Coalition of Los Angeles. I'm also an HIV educator for the Filipino 
Americans working on an Immigration and AIDS project that works specifically with 
immigrant families and Asian Pacific Islander youth gangs. 
I would like to acknowledge and thank Senator Diane Watson and the Senate 
COmmittee on Health and Human Services for giving me the opportunity to speak on 
behalf of the Colors collective and the issue that faces us in the community. 
COlors is fairly new to the lesbian and gay bisexual community, and so I'm 
going to give a little bit of a history; and it's somewhat of an activist culture 
of Act Up, Queer Nation, as well as other groups, colored groups also. COlors 
United Action Coalition is a co-gender, multi-racial collective that includes 
lesbians, bisexuals, transgenders, gays, heterosexuals, men who have sex with men, 
women who have sex with women, men who love men, and women who love women. We are 
dedicated to empowering and educating communities that have been marginalized by 
the Euro-centric-patriarchial establishment, through voter registrations, HIV/AIDS, 
prevention, education, and outreach, grass-roots political lobbying, and community 
educational forums. The group was founded shortly after the AB 101 veto marches in 
the lesbian, gay, bisexual, people-of-color communities, to confront the 
segregation that exists between the white establshment and people of color in the 
lesbian and gay community. our membership consists of women and men, lesbian, gay, 
bisexual, transgender, and heterosexual from the African American, Asian/Pacific 
Islander, Native, LatinajLatino, and Caucasian communities. Diversity is our 
ideal, and we believe that we can make positive changes by learning from and 
celebrating each other's diversity. 
We confront and process difficult issues, such as racism, AIDS phobia, 
lesbophobia, homophobia, heterophobia, and other social disorders that plague our 
society and keeps us separated as people. 
COlors United Action coalition is a rich stew of human resources that has 
members and supporters from the AIDS Health care Foundation, Black Men's Exchange, 
United Lesbians of African Heritage, Gays and Lesbian Latinos or Hidos, VIVA, Gay 
Asian Pacific Support Network, as well as many other groups that are committed and 
connected to their home communities. 
Since there is such segregation in the lesbian and gay community, people of 
color have different needs. I believe that the community still has more work ahead 
of them and education when confronting HIV disease and AIDS in the lesbian and gay, 
bisexual, transgender, people-of-color communities. 
CUltural-sensitivity policies must evolve into racial and ethnic competence 
and accountability. My experience has been that the sensitivity has only provided 
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translated materials that was written for the Euro-centric-patriarchial experience. 
Open-door policies are ineffective to people of color, since we need more than 
an open door to guarantee us a safety that everyone needs to access AIDS services. 
More facilities must be built in South central, Monterey Park, Lakeview Terrace, 
Montebello, Rosemead, Bast L.A., and Carson, just to name a few. These facilities 
ahould be staffed by locals of that neighborhood who are dedicated to the 
~provement of their communities. Cultural sensitivity and open doors has its 
limitations. It's now time for us as a world collective to renew our commitment to 
take a step beyond just being sensitive and to being competent. It is time to walk 
through these open doors and invite people into our agency through a needs base and 
effective outreach. 
People of color are dying, and sensitivity will not save our lives. 
competency, effectiveness, and our accountability will. There are smaller groups 
that are established in the heart of the people-of-color communities that have 
little to no access to local, state, and county resources. Much of the funding and 
attention that goes into the larger, well-known establishments are not often shared 
with these little-known, smaller organizations that are at the primary contacts and 
representatives of people in their community. 
Also, from my experience with the lesbian and gay community, I'm aware that 
people know very little about the subcultures that are neglected in lesbian and gay 
culture. These are bisexuals, transgenders, MSMs, men who have sex with men, women 
who have sex with women, who do not identify as lesbian, gay, or bisexual. These 
are people who may have been incarcerated, as it's been mentioned over and over. 
MSMs and WSWs are a recognized population -- the Asian and Pacific Islander 
communities, Latino/Latina, Native, and African American cultures, and they have 
been for a long time. These are also people of color who identify they're also 
people who identify, people of color who are identified, as MLMs, men who love 
other men, and WLW, women who love other women, do not identify with the Western 
Buro-centric label of lesbian or gay. 
These populations thrive in the Bcho Park area where many MSMs, who have wives 
and families at home, search for anonymous sex around the lake with other men. Men 
who love men and women who love women congregate in small private clans, in 
restaurants, in tight communities in the San Fernando Valley and Hollywood areas. 
They often don't participate in the lesbian, the white lesbian and gay community. 
There's a large population of gay men in the skid row area. There are MSMs, 
men who have sex with men, and WSWs in the low-income housing projects where there 
are women and men who may have adopted this sexual culture while they were 
incarcerated. Many downtown bars feature African American, Asian Pacific Islander, 
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and Latino drag queens and gender benders as their star performers. Many of the 
Hollywood streets are littered with drag queens who pose on the corner as working 
girls. 
Who reaches out to them? How many even know how to begin to understand these 
populations? Does HIV education reach them in a language they know and understand? 
These are the questions and challenges that we face. These smaller, hard-to-find 
populations do exist, and we must reward them with the same education, access to 
treatment and prevention that the mainstream community has been given. We must 
give more to people of color and women, women's communities, who are at least five 
years behind in the struggle against AIDS. 
In closing, I'd like to lay some challenges before this committee. I 
challenge everyone to recognize lesbian, gay, bisexual, transgender, KLK, WLW, MSM, 
WSW peoples as belonging to a sexual culture that dictates the specific needs. We 
can no longer settle with the narrow confines of sexual preference or orientation. 
We are a thriving, growing culture that has family systems, spirituality, 
traditions, language, herstory, history, and leqends. Investigate and be aware of 
populations that have been neglected by the Euro-centric-patriarchial 
establishment. 
Racism and classism is alive and well in all communities, even in the lesbian 
and gay community. Challenge yourselves on how we may all be able to service the 
marginalized within the marginalized within the marginalized. Keep challenging 
yourselves to access the wealth of knowledge that belong to organic intellectuals. 
These are people who may not have academic standings, but these are the true 
experts that live, work, and speak from the community's needs, issues, and 
integrity. Challenge education materials and program designs and see if they are 
effective, accountable, and competent to the communities they are assigned to. 
Challenge to advocate for hiring policies that will hire from within the community 
and promote peer education. Challenge outreach strategies and make sure that they 
come from a needs-base assessment. Let us make sure that these strategies will 
enhance and become part of a community's ecology rather than disturbing it with 
alien ideas and outsiders. 
We all have got a lot of work ahead of us, and I'm looking forward to the day 
that we'll have to look for other jobs, not because our AIDS contract was not 
refunded. And, you know, the one thing that I'd like to say is the other syndrome 
that I keep hearing here -- and coming from an Asian Pacific Islander perspective 
as a man who loves other men, I'm still a little discouraged about how Natives and 
Asian/Pacific Islanders are put in the "other" category because we haven't shown 
enough dead bodies. There are dead bodies. They're decomposing in homes where 
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there's a great deal of fear in the Asian/Pacific Islander cultures -- or they're 
being sent home to the Philippines, to Thailand, where they are made to pray 24 
hours a day to get rid of this disease. So I hope we could break out to this other 
syndrome because in lesbian and gay cultures, these transgenders, MSMs, are also 
broken into that. 
There's a great deal of profit, monetary profit, to be made with 
marginalizing, but that is unethical and immoral. 
Cin Filipino ,) Thank you very much. 
CHAIRPERSON WATSON: You certainly have placed in front of us a great 
challenge because you described structures and substructures and sub-substructures 
that most people are not even aware of in terms of a breakdown. And we have to 
become educated. I think the need is so great, we treat those with AIDS. But when 
you start looking at the sub-sub-substructures, we don't even know how to move into 
those categories. 
I think this very new group that has come up around the veto of AB 101 could 
be very instructive to society because you just broke it down. I thought I was 
pretty sophisticated. You know, you talk about homosexuality and lesbianism. Then 
you broke out a category called men who love men and women who love women who don't 
consider themselves in that category. And I guess that's one of the reasons why 
the information we have doesn't reach, because when we say this is targeted towards 
the gay male or the lesbian female, we miss some who don't consider themselves in 
that category. 
MR. TAN: These are -- men who love men and women who love women -- these are 
categories that are alive and well in a lot of tribal cultures, in the Philipines. 
I hear also that's in African American culture. And when you come up to somebody 
and say are you gay or lesbian, what they see on TV, because TV is very racist, 
they see white lesbians and gays and they don't associate that with that because 
they can't break away from their community as easily and they have another system 
that they work under. 
CHAIRPERSON WATSON: Now I heard you mention "Queer Nation". Is that not a 
derogatory reference? 
MR. TAN: Oh, that whole thing with Queer Nation is -- I'm not going to speak 
about Queer national. 
CHAIRPERSON WATSON: I think that, I don't know why Queer Nation, unless it's 
kind of satirical thing they're doing, because Queer Nation conotates that it 
deviates from what I hear you saying, brings people together and saying this is, 
for some people, a very normal way of life. I think "queer" does not connotate 
that particular ••• 
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MR. TAN: Well, I mean, as far as I hear from other Queer nationals -- Colors 
United is its own autonomous body. Queers, it's also all-encompassing, they feel. 
By not putting the negative power back into the word, they feel like they would, 
that's their opinion. And like I said, right now we use people of color, and I 
hear a lot of sisters and brothers saying, "They're colored", with pride. 
CHAIRPERSON WATSON: Well, I don't think the definition as we all understand, 
"queer", like "weird", does what you want it to do. That's coming from my opinion 
and my standpoint. I don't think -- these other breakdowns make sense to me. But 
that one does not, and I just throw that out. You don't even have to respond. 
MR. TAN: Okay. 
CHAIRPERSON WATSON: Thank you very much. We appreciate your testimony. 
DR. TATE: Joel, can we get a copy of your testimony, either now; or could you 
send me a copy. 
MR. TAN: I'll send you a copy. 
DR. TATE: Okay. 
CHAIRPERSON WATSON: Corinne Tanon, Health Educator, with the American Indian 
Free Clinic, I understand has been here since about 9:15 this morning. 
MS. CORINNE TANON: Right. 
CHAIRPERSON WATSON: We want to commend you for your tenacity and your ability 
to sustain all this information thrown at you and still be here willing to testify. 
So we'll call on~you right now. 
MS. TANON: Okay. Great. 
CHAIRPERSON WATSON: And give you your opportunity to do what others have been 
doing all day. 
MS. TANON: First of all, I want to thank you for inviting me to come and 
share this information which is so important to all of us here. I'm kind of 
nervous, so I want to -- first of all, I want to talk about the demographics, 
community demographics. And then I'm going to go into health issues and then gaps 
in health care and AIDS and how that's affecting us as Indian people. 
According to the 1980 Census -- I'm referring to the 1980 Census because the 
1990 Census, we feel, are not a good count of our population. According to the 
1980 Census, California has the largest Indian population. There are approximately 
225 American Indians from 200 different tribal affiliations. In L.A. County alone, 
there are 90,000 urban American Indians and is the largest urban community in the 
nation. out of the 90,000 American Indians in L.A., 54,000 are below the poverty 
level, and there is approximately 45 percent unemployment. 
The Indian population is a young population; and the nationwide average age is 
20.4. In L.A. County, the average age is 17.3 years of age; 67 percent of the 
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Indian population are 25 years or younger. 
Indians are three times more likely to die young, between the ages of 24 and 
40, the Nunn Indians. Average life expectancy is 44 years of age. This is 
lower than the migrant farm worker. 
According to the L.A. Unified School District, the Indian High School dropout 
rate is 23 percent. This figure increases when you include those that never 
attended, enrolled into high school. The average age of Indians living in Los 
Angeles is 17.31 67 percent of our urban Indian adolescents are drunk -- or use 
drugs moderately to heavy. 
Health issues, Indian suicide rate is seven times that of the national rate. 
Indians have the highest rates of heart disease and diabetes. Twenty to 25 percent 
of all American Indian children suffer from mental illness, just as alcoholism 
rates is 41.3 deaths per 100,000 versus 17.4 deaths for African Americans. In the 
white population, it is 6.4 deaths per 100,000. 
Gaps in health care: Health care is expensive to nearly all segments of 
society but especially to many Indian people. They may not be able to afford 
health care due to the lack of insurance or other needs that are more pressing. 
They will go to a health care facility only when a need is acute. Therefore, they 
will not hear about the message of AIDS prevention. And that's why it is so 
pressing to have outreach at those places where they congregate -- sport events, 
pow wows, community functions. But the high rates of sexually transmitted diseases 
and alcohol and IV drug use among American Indians, hopefully the State of 
California, may understand the importance of funding as a preventative measure. 
The source of continued funding is always contingent upon the outcome of 
census demographics and socioeconomic and political strategies. Because we are a 
small population of 90,000 American Indiana in Loa Angeles County, we are sometimes 
mistaken for Hispanics, Filipino, white, African Americana. The community is well 
dispersed, and this may contribute to the political under-representation and social 
misrepresentation in the communities. We are poorly represented in every segment 
of society. I can only speak for myself. We have no political clout, and our 
voices aren't being heard. The theme is reflected in the decision-making of our 
city fathers and government. 
According to the HIV/AIDS and American Indiana' Handbook for Tribal Leaders, 
stated the following: Since September 1991, the center for Disease Control has 
approximated 305 American Indiana diagnosed with AIDS. Dr. Emmett Chase, AIDS 
coordinator for Indian Health Service, estimates that there are 12 to 13 new Indian 
AIDS cases identified each month. The fact is the annual rate of increase of new 
AIDS diagnosis is greater for Indian people than for any other racial group. The 
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number of Indians diagnosed with AIDS grew by 91 percent from (19)89 to (19)90. 
While other racial groups have a higher number of individuals with AIDS, the number 
of Indians with AIDS is rising at a rate proportionately faster than for other 
groups. 
Percentage increase in AIDS cases from '89 to '90a whites, 8 percent; African 
Americans, 13 percent; Hispanics, 5 percent; Asian/Pacific Islanders, 17 percent; 
and Indian/Alaska Natives, 91 percent. 
The time of prevention is now. Indian people can benefit from the experiences 
of other populations which have dealt with the AIDS virus for the past eight years. 
we must act now before the virus wipes us out like the smallpox epidemic of the 
early 1800s. 
According to the center for Disease Control, found that Indians and Alaska 
Natives have experienced a higher rate of gonorrhea and syphilis. This study 
indicates that we are at risk. The transmission categories for these cases are 54 
percent, were homosexual/bisexual transmission, and the rest by blood product 
transmission. This contrasts with white transmission which is 76 percent 
homosexual/bisexual; 15 percent shared needle; and 2 percent heterosexual. 
The percentage of Alaska Native and American Indian women with AIDS is 13 
percent of the total number of American Indian and Alaska Native cases, in contrast 
to 4 percent of the white women. According to CDC, has been working with Indian 
Health Service to evaluate the HIV in the American Indian population. It is 
estimated that for every 1 million American Indians and Alaska Natives, 
approximately 1,000 individuals are currently HIV-infected. Then it could be 
estimated that for over 85 percent of these individuals do not know that they are 
HIV infected. 
The time of prevention is now. We must act now before the virus wipes us out 
like the smallpox epidemic of the early 1800s. 
I have quote here from Chief Funnycoups (?) -- he's Crow, or was Crow: "With 
the white man's education, you are his equal. Without it, you are his victim. 
Please stop us from being the victims of the disease of AIDS by funding our 
communities." 
T~ank you. 
CHAIRPERSON WATSON: Thank you very much. Something that we picked up when we 
had other hearings and we listened to representatives of the various ethnic groups, 
is that among Indians -- and correct me if I'm not correct -- is that there is a 
higher propensity towards addiction? 
MS. TANON: Right. That's true. That's correct. 
CHAIRPERSON WATSON: And having that higher propensity, and I don't know if 
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it's genetic or what it is, there necessarily would come along with it an increase 
in the risk of AIDS? 
MS. TANON: Bxactly, because we have a high rate of alcoholism. And with 
that, you have the high-risk behaviors involved with that which leads to sexually 
transmitted diseases. So at this point right now, we have a high rate of STDa, 
sexually transmitted diseases -- gonorrhea, syphilis. So that means, yea, we have 
a high risk of contracting AIDS right now. 
CHAIRPERSON WATSON: I think if we look at addiction itself, we might be able 
to learn something about the increase among American Indians. It's startling to 
see that you've gone up 91 percent in a two- to three-year period. And I guess 
that's because you have fewer cases. 
MS. TANON: Right. 
CHAIRPERSON WATSON: 
MS. TANON: Exactly. 
CHAIRPERSON WATSON: 
And now more cases are being detected. 
That's true. 
But I think, and one of the things that keeps coming back 
to your theme, is that we don't know that much about addictive behavior. 
I, you know, if I can just look at it historically because the purity of the 
system of the Native Americans; therefore, once the toxins gets into the body of 
the addictive substance, it's a quick reaction. And that's off th~ top of my head. 
But we need to look at it, and I don't think we know enough about addictive 
patterns among the various ethnic groups and why do some become addicted much 
quicker than others and why is the high-risk behavior then increased with that 
addiction. so I think these are some of the things that we need to learn more 
about as we look at the various cultures and how we deal with them, particularly 
with this disease. 
MS. TANON: Exactly. 
CHAIRPERSON WATSON: Thank you so very much. We appreciate your long wait and 
your testimony. 
I'd like to now go back to Cleant Stain, the Director of South Los Angeles 
AIDS Program at the Watts Health Foundation. Welcome. 
MS. CLEANT STAIN: Thank you. 
CHAIRPERSON WATSON: We did call on you earlier. 
MS. STAIN: Okay. I'd like to thank you for the opportunity for being present 
here today, and I'd also like to concur with my other colleagues and echo some of 
the same ~oncerns, and that is, that HIV/AIDS does not occur in a vacuum. There's 
still many other health and social problems that exist within our community, which 
is South Central. 
Oftentimes while my staff and myself are involved with people infected with 
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HIV or AIDS, we find ourselves overwhelmed with the number of problema that exist 
within their situation. And oftentimes, prior to working with AIDS-related issues, 
we must first assist with other social problems. For example, there was one case 
when we were going into an individual's home. We thought we were going to assist 
the pereon with AIDS with housing issues, which ie a social concern. When my etaff 
and I arrived to the individual's home, we walked into a 3-bedroom home with 18 
people living in that home, massive overcrowdedneaa. There was battery going on. 
The lady we were talking to had, you know, bruises under her face. And eo when you 
go into a home or many times when you're working with people with HIV, you want to 
know will the real issue please stand up or will the real client please stand up 
and everyone stands up. So before we can even begin to deal with many AIDS-related 
issues, we have to deal with other issue& first. 
As you know, south central Los Angeles is geographically dispersed and 
ethnically diverse, and many of the people living in that community are 
economically depressed. Within this community, there's only one anonymous test 
site, and that's at the Minority AIDS Project; and they're open two days a week. 
So anonymous testing is a big concern in our community. There's only one drug 
reimbursement program for people to access clinical trial drugs within the 
community. 
There's also a lack of coordination between the federal, state, and county 
government. For example, we've just received funding from the Ryan White Title 
III-B which came directly from the federal government. And one of the goals or 
objections of this program is to provide primary care to people infected with HIV 
and also to increase the number of people who get tested within the Watts Health 
Foundation system so we can identify what our aero-prevalence rate is. 
When we -- and prior to doing any testing, we have to first do pre- and 
post-test counseling. So as I was on the telephone trying to access this service 
through the State Office of AIDS and with our local AIDS Program Office, we were 
unable to get anyone to come out and actually do training for our staff so that we 
could follow the guidelines of our contract, which is, you know, testing. And 
ethically, there is no way that we should be drawing blood for HIV without doing 
the pre- and post-test. 
DR. TATE: Why weren't you able to get someone from the Office of AIDS to come 
out? 
MS. STAIN: We were told that their priority, the priority for training, was 
for people who, for contractors who were state funded under the early-intervention 
program. 
DR. TATE: And yours came straight from CDC? 
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MS. STAIN: No, it came from the federal government. So we're all Ryan White 
funds, Emergency Act funding. But because we got ours diverted from another 
direction and we were not able to access some of the same services, and that was 
About a month-and-a-half ago, so what we had to do is look within the community; 
and we were very fortunate that Martin Luther King Hospital had people who were 
trained and certified for pre- and post-test counseling. And they came out and 
gave, took time away from their caseload and from what their regular job was, to 
come and train staff so that we could go out and perform our contract. That's a 
big problem. 
The drug reimbursement program is another problem. As we start identifying 
more cases who are HIV-positive within our system and within the community, people 
who are coming in, not only from within our system but from outside of our system 
who are coming in for services, we're finding that, you know, drug reimbursement is 
going to be a problem to have the clinical drugs on site for our program. When the 
telephone calls were made to the county, and hopefully that will be worked out that 
we will be able to disperse the medication. But what ends up happening with the 
Drug Reimbursement Program as it stands now, is you can have the drugs on hand; but 
then the eligibility paperwork is very time consuming, so there's no funding to pay 
for a staff person to actually do the eligibility screening, which is very 
~portant to see who actually qualifies for the drugs. 
I guess within our system it may not be too terribly bad of a problem. But if 
we have people who come from outside of our system who present a voucher, then we 
can be overloaded, because when you look at the geography of South Central, we are 
at the southern end of South Central. And if we are distributing drugs, and the 
next place that's distributing drugs is at Hubert Humphrey, which is like maybe ten 
miles away, so that can present a problem. 
CUrrently, at Watts Health Foundation, we have six funded AIDS programs. 
We've just been funded with three new programs that we're very excited about. And 
I'd like to just list the programs briefly. We're funded by the Los Angeles county 
AIDS Program Office to ••• 
CHAIRPERSON WATSON: Can you kind of bypass that. 
MS. STAIN: Okay. 
CHAIRPERSON WATSON: And just hand us that in print. 
MS. STAIN: Okay. Well, basically although the programs that we have funded 
meets some of the HIV needs, the funding is very l~ited; and we're unable to hire 
enough staff to actually make an impact within the community. For example, with 
the education grant, we're only funded for three staff people. When you look at 
not only Watts Health Foundation, but you look at South central, the number of 
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agencies who are actually funded to do education, there are very few. So we've got 
maybe four or five programs in South central that have two to three staff people, 
you know, to do the education; and the area is very large, so that's another 
problem. So we would like to see within the funding mechanism that when funds come 
down for agencies, not only for our agency, that enough funding is allocated to the 
agencies to actually hire staff people to do the work. That's about it. 
CHAIRPERSON WATSON: We appreciate your comments also. I've heard you testify 
before, and that's been several years and the need is even larger now than before. 
What would you say the percentage of increase in the area where you work has 
been, say, in the last five years, the increase in HIV-positive? 
MS. STAIN: Well, as you know, with HIV-poaitive, many of the clients are not 
coming in for testing. So, you know, I can only apeak to what we know which is the 
actual AIDS cases. I think with the education that's going on right now, I know 
for us right now, we've just started confidential testing. And we're already 
backed up two weeks, so we need more staff people. I was reviewing budgets this 
morning prior to coming here to see how we can, you know, what can we do with the 
money to bring more staff people in so we can actually meet the need of the people. 
We're starting to see families who are coming in. We're seeing young women, young 
pregnant women, who are coming in with risk factors of having sex with men who are 
incarcerated. 
So, you know, from what I'm seeing right now, the cases are increasing; but I 
don't see the whole picture for South Central. And we don't -- the demoqraphic 
profile or the profile information on people who are actually HIV-positive is not 
really showing up. I think that outreach -- we need to have outreach, and the 
outreach that we need to have is to educate about testing. You know, people have 
information about AIDS, what is AIDS, and how to contract it. People are not 
internalizing their own risk factors. So we need to have some targeted outreach or 
targeted education with specific risk-assessment questionnaires, you know, toward 
specific populations like for women. If you ask a woman to look at her risk 
factors and, say, if you had multiple sex partners, well, for that woman, you're 
asking her if she's a slut. So she may say in her mind, no, I don't have multiple 
sex partners. But if you ask a woman have you, have you aver exchanged sex for 
money or have you exchanged sex for drugs or if you, you know, just really 
specifically asking about sexual behaviors that they may have been involved in, a 
ride home. I mean, you now, they may not be honest in answering the questions when 
you're asking them, but it's something that will provoke a thought for them that 
may motivate them to get tested. 
I think what we need to do is increase the number of people who get tested, to 
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identify who they are, because with the early intervention treatment that's 
available, there's no reason for anyone to, in the old days, which was four years 
ago, to ••• 
CHAIRPERSON WATSON: When you say "identify who they are", you mean in the 
population identify who is a carrier. 
MS. STAIN: Right. Identify who the carriers are. Not for me to identify but 
for them to know who they are, for them to know for their own sake so that they can 
be referred or go into some early intervention programs, because when I spoke four 
years ago, what we were seeing was people falling into the emergency room with 
chest pain thinking they had a bad cold, only to find out that they had 
pneumocystis pneumonia which gave them an AIDS diagnosis. Do you understand what 
I'm saying? 
CHAIRPERSON WATSON: Yeah. Do you think we ought to require blood testing 
before one gets a marriage license? 
MS. STAIN: I don't know. I think if I were getting married, I would want my 
partner to be tested. But that's a personal thing. I can't speak for the 
general ••• 
CHAIRPERSON WATSON: You think that's an idea we ought to pursue? 
MS. STAIN: I think so. I think that if it was, that maybe one way to stop 
some of the transmission. It's something to consider. 
CHAIRPERSON WATSON: All right. Thank you very much. 
MS. STAIN: Okay. 
CHAIRPERSON WATSON: We appreciate you coming and testifying for us. 
Paula Starr. Is Paula here? 
Okay. Let me go back over. Phil Wilson, I don't think is here. Germaine 
Maisonnet, Doctor. Kazue Shibata. And Paula Starr was the last one we had. 
Is there anyone with new information that feels that he or she needs to come 
to the mike? And if you can give us some new information, I think we've heard 
almost everything. 
MR. CLEO MANAGO: I'll attempt -- I mean what happens usually at these type of 
testimonies, people who are invited are the ones that you usually see. The ones 
that you usually see are there for sometimes for political reasons or various 
reasons. What happens a lot is that -- I think it's been reiterated here that 
language and geography has a lot to do with the barriers. 
The reason that AIDS has increased in the Black community is because of 
barriers. And I want to introduce who I am so you can know that I'm not just 
somebody who sells toys, but I work in this field. 
My name is Cleo Manago, and I'm the founder of the Black Men's Exchange. 
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is a national organization that primarily provides support servicea, empowerment 
services, and general education about health with AIDS emphasis to African American 
men. Usually these African American men are the ones who are referred to aa hard 
to reach -- men who love men, men who love men and women, men who don't identify 
with the mainstream populations in the so-called gay and lesbian community. 
I think it's important to understand that, when it comes to the African 
American community, the majority of the people who are so-called homosexual are not 
in those places that are called lesbian and gay. They don't identify with those 
places. And because of the lack of support of services for so-called gay men or 
men who love men in the African American community, some choose to go to the white 
lesbian and gay community, be empowered, for their sexuality and who they are. 
Often some of them just totally separate from the community because they feel a 
sense of ownership and acceptance there, and they are the ones who you see usually. 
At these hearings, you don't hear from people who are in the community all the time 
and often. 
BMX was developed in 1989. My work history has been in collaboration with Dr. 
Wilbert Jordan. I've done work with him, with the Watts Health Foundation, with 
Dr. Maisonnet, and Cynthia Davis. I've been working with these people since early 
1985. The primary location for the Black Men's Exchange is in Oakland, California. 
That's where our headquarters are located. Oakland has a major epidemic going on 
there that's been hardly addressed at all. 
One of the problems has been homophobia because San Francisco is right across 
the bridge, and the city government in Oakland doesn't want to identify itself with 
that homosexual reputation that San Francisco has; so it doesn't deal with the 
issues that talk about AIDS at all because we cannot identify with that kind of 
population. You understand what I'm saying? Is that clear? So there's a lot of 
political things going on. 
In South Central Los Angeles, BMX is ran through Faith United Methodist Church 
which is in South Central Los Angeles. And in San Francisco, it's ran through the 
Bayview Hunter Point Foundation. In Sacramento, it's ran through the Project 
Survival Foundation which is part of Women's Civic Improvement Center. In Oakland, 
it's ran through an Institute, which is the African American AIDS Support Services 
Institute in Oakland, California. The Black Men's Exchange serves up to 2,000 men 
per year statewide. And again, there's a national addendum, so an organization in 
Denver, Minneapolis, and in Atlanta. 
We have found it difficult to acquire funds due to racism, due to politics, 
and due to hidden agendas. Again, a lot of people who do this work who are men who 
love men, for example, tend to identify with the mainstream community, trying to 
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get their foot in the door to get funds so they call themselves lesbians and gay. 
And some of these programs are, such as the.Minority AIDS project, and AIDS Project 
Loa Angeles. 
I think it's important to understand that, and I wish the guy from the AIDS 
Project Los Angeles was stil\ here. AIDS Project Los Angeles provides fine 
services. They provide very good services. But Black folks are not going to go to 
APLA and get services, until they're on their last leg and they're so desperate to 
go anyplace. It's kind of like what we do when we don't take care of our teeth and 
we wait till it becomes a toothache, and then we don't care if the doctor's a 
Martian. We just want the tooth out of our head. Well, that's how a lot of people 
in South Central are dealing with AIDS. And one thing that keeps being said, you 
see, if we don't look at the barriers, we will not resolve this. The reason we 
have not resolved this problem is because we keep saying the same thing over and 
over and over again, and no innovation is implemented. 
There's been one thing that keeps being said that disturbs me because it's not 
true, from my experience. A lot of people keep saying that a lot of people in the 
Black community think AIDS is a white gay disease. That's not true. A lot of 
Black people in the community know that AIDS is not a white gay disease. The 
problem with internalizing these messages is the fact that people.in our community 
are distracted. Like the doctor from Drew said, there's other issues going on. 
There's other issues such as guilt around being a good Christian, guilt around not 
being good enough, not making enough money, guilt around not being a good enough 
wife, not being a good enough man, especially if you're a bisexual or a man who 
loves men who feels like you failed the Black male litmus test of being man enough. 
All these issues have a lot to do with why men do not come forward and why people 
in our community do not come forward. 
One thing that might sound overwhelming -- I know you mentioned being cynical, 
potentially cynical, earlier, Senator Watson, is that -- oh, gosh, so much going on 
with me; it's hard to concentrate -- is that people of color are set up for 
distractions and failure from a very young age by not having their culture and 
anything that validates them in the curriculum of their education. 
In collaboration with the distraction such as gang violence, such as 
institutional racism, all these things together set us up for being distracted from 
self preservation. So the issue from my point of view, which is going on a 
ten-year point of view, is not that the Black community thinks that it's a white 
gay issue. That's not true. It's just that we need excuses not to take care of 
ourselves because we're so distracted. A lot of women in our community are being 
served through AIDS programs that are part of WICK clinics, but they go home to men 
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who are not educated. so they come home with all this knowledge, and the man is 
offended by being challenged on anything because he has not been educated and he's 
distracted. 
There was a comment made earlier that a lot of the men who go to prison who 
come out having homosexual behaviors, don't identify with the community, the 
so-called gay community, please don't think that everybody who doesn't identify as 
gay, who are men who have sex with men, are people who have been incarcerated. 
Some people just don't like the terminology. The white gay community tends to be 
very inclusive excuse me -- exclusive. And just as racist is the mainstream 
community, and so there's not a real attraction to that community, no matter what 
it offers. I mean if there's a million dollars available to Black people at APLA, 
many of them won't get that money because they don't want to go to APLA. Though 
service providership is not the issue, they provide a high quality of service. But 
a lot of Black people would not wind up there, not unless they're so desperate that 
they're almost dying anyway. And there's minimal things that can be done to keep 
them healthy. 
I think it's important to understand that a lot of the people who do not come 
to you in our communities, obviously because you don't see them, they're not being 
well funded. The Minority AIDS Project is way on the other si~e of town. And 
also, I don't want to say anything bad about them because they're doing some 
excellent work, but they're geographically inaccessible to a large segment of the 
population in the Black community. 
The United Fellowship Church is right on 109th and Western. It's centrally 
located. But because of politics, hidden agendas, and personalities, it's very 
difficult for this program to get the monies that it needs. And also somebody made 
reference to language that's needed to properly create an RFP or a proposal or a 
grant. Some of that language is very stymie; it stymies people; it's very limited. 
It's hard to express ourselves fully with the language that the RFPs require 
because they don't -- they're not appropriate in our community. So again, if a dot 
is not, you know, dotted, and the "t" is not tied, or whatever the terminology is, 
many times those RFPa are put aside. And many times agencies would have a larger 
name, such as APLA and others, will get that money just because they have a big 
name. But listen to me, the fact they have a big name does not mean they're 
providing adequate services. Most of these services, including APLA and others 
which will not be mentioned, are providing a Band-Aid approach to AIDS that does 
not cause any prevention at all because by the time they get there, as you know, 
they're already dying. These are not preventive efforts. These are multi-million 
dollar, crisis-dying institutes for Black people and other people to get their 
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hands held until they die, until they die. 
There needs to be innovative and culturally competent programs funded, that 
are already working in South Central, such as the Black Ken's Exchange, to be 
advocated for and supported. Again, the over thousand plus men that we deal with 
in Southern California alone, the work that we do is hardly ever recognized because 
we're not part of the lesbian and gay clique. We're not part of the high-profile 
clique because frankly those cliques have turned off a lot of people and don't 
invite a lot of people who are in the Black community. 
So if we really want to do something about the AIDS issue, we have to stop 
being impressed by glamour and glitz of the million-dollar agencies and find out 
who's doing things in South Central. And I have some recommendations, believe it 
or not, or after all this talking. 
CHAIRPERSON WATSON: Yeah. Can you get to the ••• 
MR. MANAGO: Yes, I will get ••• 
CHAIRPERSON WATSON: I'm going to give you just a few more minutes because 
we're over our time limit. 
MR. MANAGO: Okay. I'm sorry. Okay. I recommend that there be some advocacy 
and support provided to programs that are in South Central Los Angeles and that are 
not necesarily connected to the high-profile agencies but who are individually and 
independently and innovatively providing some great services in South Central Los 
Angeles. I think we should include persons who are from the grass-roots and who 
have ongoing contact with hard-to-reach populations in research and data collection 
projects. 
It was mentioned earlier -- you asked about IV drug use in the Black community 
and were there any documentation that assess what is going on. Most of the people 
doing the research do not have a cultural understanding of the community, and they 
can't even get adequate information because they're not from the community. And 
people tell -- either they don't see the people at all, or people don't trust them 
enough to tell the truth. So there's a lot of IV drug users out here who are not 
even part of the statistics, as well as people with AIDS who die and get other 
diagnosis because the family doesn't want anybody to know about it, and they do not 
trust these agencies who have all this glamour. 
Also, I think it's important to include persons identified by the community as 
representing the community to be involved in the consortiums and city-wide and 
county task force and involved in the language that's developed for RFPs and 
grants. People from those communities should be in that system to tell you this 
language is not appropriate; this language is a barrier; it's going to get in the 
way. 
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Again, innovative programs that are holistic and effective, like the doctor 
from Drew said, you cannot go to someone and say AIDS 101 and give them an AIDS 101 
education and expect them to take care of themselves. They need to be dealing with 
the psycho-social issues; they need to have support. You asked should people be 
tested before marriage. No one should be tested if there's not any appropriate 
counseling or a psycho-social support system there to help them deal with whatever 
their diagnosis might be after the test results. 
I think, and this is essential. This is my most favorite and important 
recommendation. Existing services, existing service to a provider should document 
and prove their ability to attract and serve, underserved, and unserved populations 
by some kind of tool that must be developed to prove that. And the goal of this 
recommendation is to not fund or to provide technical assistance to existing 
organizations who have been incompetent as it relates to minimizing this epidemic 
in our community, because as you said many times, it has not been minimized; it's 
getting worse. And it's because of these barriers that I'm addressing. I probably 
could go on with others, but we don't have time. 
I also think that holistic, culturally sensitive health care and AIDS 101 
program should be institutionalized in public and civil servant populations, people 
who serve people who are in public service. I'm a former deputy sheriff. And 
inside the prison, you were talking about asking the people who work in prisons and 
in jails to assess homosexuality in the prisons. Now I may get in trouble for 
saying this. But what's difficult about that is that there's a morale problem 
going on with law enforcement. You've heard about Rodney King and the dog bites, 
and I can go on and on and on. Everybody who's in the positions of "power" in 
legislation are not necessarily culturally sensitive or concerned about the life 
and death or comfort of people of color. That's why they let dogs bite them and 
beat them up with canes and stuff. 
Inside of the jails, there are people who work for law enforcement who are 
bringing in IV drug needles who work, who have on a badge. There are people who 
make sexuality in the prison a joke -- well, let's see who's going to get who 
tonight. It's like they bet, you know. It's a game, because if you don't respect 
faggots and homosexual and faggot behavior -- you know how we treat -- you now how 
there's racial jokes and there's homophobic jokes and there's jokes made on how 
many Black people get killed. You heard about how the police use the KKK over the 
radio station to talk about what they're going to do somebody Black. You've heard 
that. That's been made publicly -- that's been public knowledge based on reports 
from the news. 
CHAIRPERSON WATSON: You said they don't respect faggots. Do you want to 
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refer to that group as faggots? 
MR. MANAGO: Not at alL I'm putting that in -- I'm, paraphrasing. I mean 
when you're being disrespectful, you don't go, oh, I don't have any respect for 
homosexuals. You don't have no interest of being respectful. The whole thing is 
disrespectful. That's why I used the language that's disrespectful, just like when 
the KKK it's going to kill niggers. They don't say I'm going to kill African 
Americans. It's a disrespectful process, so the language is disrespectful. I'm 
just trying to give it to you the way it is so you can see what I'm talking about 
so we can get rid of these barriers and save lives because people are dying from a 
disease that's preventable. And there's all of these barriers and all these 
cliques. Some of these agencies are serving cliques, friends. A lot of the AIDS 
work for the past ten years, even among so-called people-of-color agencies are 
serving a clique of people, not the whole community. 
CHAIRPERSON WATSON: Right. 
MR. MANAGO: And that has to be addressed or else we're not going to publicly 
serve everyone. 
CHAIRPERSON WATSON: Can you finish your recommendations in just another 
second. 
MR. MANAGO: Okay. I really infer with the young man or the man who talked 
about a mobile unit in the community. What we did when I went down to Atlanta as a 
consultant was came with an ice-cream truck with the music and everything where 
people would run out to it, and they would get AIDS information and AIDS education. 
And, of course, kids were very young. We asked, was your mother home, could she 
come out here, before we gave them information, because we need parental consent. 
But, you know, using the social behavior of a community as an educational apparatus 
works. Try to bring white gay devises and approaches to our work in our community 
does not work. And that's another reason why the epidemic has increased. We've 
got to use organic skill and social behavior that's already organic to our 
community as part of the educational format. And that has not been done. 
Again, all these labels and stuff are a barrier -- gay and lesbian and all 
those other kind of stuff. I believe I'm finished. 
CHAIRPERSON WATSON: Now we just heard from a speaker who broke it down into 
sub-sub-sub-sub-sections, and it gets a little confusing because who on the outside 
really knows that this is a subset that hasn't been served when you say people who 
are at high risk? 
KR. MANAGO: Well, see, what people tend to do is follow trends. And I'll 
make this real quick because I know I don't have a lot of time. But the white gay 
community are the ones who are empowered to do a lot of this work. Then people who 
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identify with that community as gays and the people-of-color community jump on that 
bandwagon to do work. So we became this vacuum of lesbians and gays, white, people 
of color, who are doing all this work and •erving each other. And the language now 
waa promoted politically and through the media was lesbian and gay. So that waa 
required in the grant. When people from south central who referred to themaelves 
by the grant and talked about the fact that our language is not appropriate because 
the people who provide the funds are not familiar with men who love men, that 
language, women who love women, that language, the grant is put aside. The Black 
Men's Exchange has been using that language for several years; it's not new. It's 
just that we have not been invited. Again, the Black Men's Exchange was not on the 
list. 
CHAIRPERSON WATSON: Well, what you could do to help us is clarify for us how 
we can identify all these different groups who don't get served because they don't 
fit the definitions. I mean every time we hold one of these hearings, we get an 
education. 
MR. MANAGO: Right. 
CHAIRPERSON WATSON: Because unless you are in the streets every day working 
with these programs, you know, the vernacular changes. The descriptions change. 
It's trendy. 
MR. MANAGO: Well, you know what? Let me tell you something. The vernacular 
has not changed, just like someone keeps saying in these meetings that the epidemic 
has a second wave. That's a misnomer. The epidemic was always in the Black 
community, always, from the very beginning. 
CHAIRPERSON WATSON: Well, what I'm trying to get you to focus on is how can 
we identify who needs to be served. 
MR. MANAGO: Okay. The way you can identify ••• 
CHAIRPERSON WATSON: And I don't want you to tell me now. 
MR. MANAGO: Okay. 
CHAIRPERSON WATSON: I want you to put it in writing because we really have to 
bring the hearing to a conclusion. We're way over time for the use of thia room. 
So if you could send it to us, if you just want to send us a memo or a letter 
describing what the problem is in terms of the way the request for applications and 
so on goes out, it would help us if we want to broaden the impact --
MR. MANAGO: Right. 
CHAIRPERSON WATSON: of the funding. And you've got to be sure we know how 
you're going to ask for it. 
MR. MANAGO: Okay. Just one last thing. 
CHAIRPERSON WATSON: And conclude because ••• 
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MR. MANAGO: I sure will. People tend to use language as a way to get funded 
too, once they learn the the political terminology. 
CHAIRPERSON WATSON: You're going to help us with that by --
MR. MANAGO: Okay. 
CHAIRPERSON WATSON: -- broadening out our understanding. 
MR. MANAGO: Right. And that's why it's important to target and understand 
and locate ••• 
CHAIRPERSON WATSON: 
today. 
MR. MANAGO: Right. 
CHAIRPERSON WATSON: 
Well, we can only target if we know what's being used 
And I'll help all I can with that. Thank you so much. 
Thank you very much, and I want to thank all of you. We 
appreciate your attendance; we appreciate you staying with us. And as we -- our 
attempt was to learn more about what's happening in the streets as it relates to 
AIDS. And we held a hearing years back. And every time we hold these hearings, we 
get updated. 
our intention is to go back and put together a package of legislative measures 
that will address some of the issues that were raised here today. I thank the 
people from the department and the Office of AIDS for staying with us. I think you 
learned a lot. And in learning, we're able then better to address the needs out 
there in the streets. 
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ETHNIC MINORITIES AND AIDS 
* A HIGHER PROPORTION OF AFRICAN-AMERICAN AND HISPANIC AIDS 
PATIENTS ARE WOMEN, CHILDREN, AND HETEROSEXUAL MEN, DUE TO 
DRUG-RELATED TRANSMISSION. 
* AFRICAN-AMERICANS ARE THREE TIMES MORE LIKELY TO HAVE 
CONTRACTED AIDS THAN WHITES. 
* NEARLY 90% OF AMERICAN BABIES BORN WITH AIDS ARE AFRICAN-
AMERICAN OR HISPANIC. 
* 57% OF PEDIATRIC CASES WITH AIDS ARE AFRICAN-AMERICAN OR 
HISPANIC. 
* AFRICAN-AMERICANS REPRESENT 24% OF THOSE WHO HAVE BEEN 
DIAGNOSED WITH AIDS, AND HISPANICS REPRESENT 14%, WHICH IS 
GREATER THAN THEIR OVERALL PROPORTION IN THE COMMUNITY (12% AND 
6% RESPECTIVELY). 
* INTRAVENOUS DRUG USE IS THE SOLE RISK FACTOR FOR 34% OF 
AFRICAN-AMERICANS AND 35% OF HISPANICS WITH AIDS, BUT ONLY 
ACCOUNT FOR 5% OF WHITES WITH AIDS. 
* 60% OF ALL WOMEN WITH AIDS ARE AFRICAN-AMERICANS. 
125 
THE CHANGING COMPOSITION OF AIDS CASES 
1990 1991 
RACE mb_ PERCENT mb_ PERCENT 
WHITE 3030 71.6 2830 65.1 
BLACK 536 12.7 627 14.4 
HISPANIC 579 13.7 774 17.8 
ASIAN 64 1.5 76 1.8 
OTHER 22 0.5 39 0.9 
* * * * * * * * * * * 
PATIENT 
GROUP mb_ PERCENT t«l. PERCENT 
GAv/BI 3351 79.7 3223 74.7 
IDU 280 6.7 392 9.1 
GAv/BI IOU 288 6.8 326 7.5 
HEMO 21 0.5 17 0.4 
HETERO 80 1.9 99 2.3 
TRANS 70 1.7 71 1.6 
NIR 115 2.7 189 4.4 
SOURCE: OFFICE OF AIDS 
AUTHOR: Jim creeqer, Chief, IDS case Reqistry 
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AIDS BY ETHNICITY AND TARGET GROUP IN CALIFORNIA 
ETHNICITY PERCENTAGE 
WHITE. . . • • • • • • • • • .72% 
HISPANIC ........... 14% 
AFRICAN-AMERICAN ....... 12% 
ASIAN. . . . . . . . . . . . . 2% 
NATIVE AMERICAN ....... 80 CASES 
RISK GROUPS PERCENTAGE 
HOMOSEXUALS. . . . . . . . . .82% 
I.V. DRUG USERS ........ 6% 
HOMOSEXUAL I.V. DRUG USERS .. 9% 
HEMOPHILIACS . . . . . • • • 1~ • 0 
HETEROSEXUALS. . . . . . . . . 2% 
TRANSFUSIONS . . . . . 
NONE OF THE ABOVE. . . 
• • • 
• • • 
2~ • 0 
3i-• 0 
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AIDS AMONG CALIFORNIA ASIAN 
AND PACIFIC ISLANDER SUBGROUPS 
INTRODUCTION 
!111ft.::::.: ( he number of new acquired im-
. I .)\:[:I munodeficiency syndrome (AIDS) cases 
among Asians and Pacific Islanders in 
California has been steadily increasing. However, 
little is known about the impact of the AIDS 
epidemic among the more than forty ethnic groups 
within this population. Refinement of AIDS repor-
ting practices can provide valuable new data about 
Asians and Pacific Islanders who have or may be 
at risk of developing human immunodeficiency 
virus (HIV) infection. 
Diagnoses of persons with AIDS are reported by 
physicians and other health professionals to the 
State Department of Health Services through local 
health departments. AIDS case information is 
ascertained using the confidential report form 
developed by the Centers for Disease Control, 
which includes data on demographics, risk 
behaviors, diseases indicative of AIDS, and 
laboratory results. Currently, the form allows for 
the reporting of Asians and Pacific Islanders only 
as a combined racial/ethnic group, making it 
difficult to plan prevention and treatment services 
targeted to specific ethnic subgroups within this 
population. To address this concern, Assembly 
Member Roos drafted Assembly Bill 3815 which 
passed during the 1990 legislative session, re-
quiring enumeration of specific population 
subgroups among Asians and Pacific Islanders 
with AIDS reported in California. The Office of 
AIDS designed and administered a survey to 
obtain this information. Analyses of AIDS case 
trends among Asian and Pacific Islander 
subgroups based on the survey are presented in 
this report. 
METHODS 
As of February 14, 1991, 24 counties in California· 
had reported a cumulative total of 476 Asian and 
Pacific Islander AIDS cases. These counties were 
requested, by a survey, to identify the specific 
ethnic groups of those cases. A data collection 
. 12D 
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form listing identifiers for the reported Asian and 
Pacific Islander cases from each county was 
developed and tested. The form was mailed to 
each of the 24 counties on February 22, 1991. All 
24 counties responded to the request for Infor-
mation. Survey results were merged with the 
demographic and risk factor information for each 
case already collected and stored in the com-
puterized AIDS database, the AIDS Reporting 
System (ARS). Trends in AIDS cases reported 
among Asian and Pacific Islander ethnic 
subgroups were then analyzed. Detailed analyses 
were not completed for some subgroups due to 
the small number of reported cases. 
RESULTS 
Of the 476 reported cases, the specific ethnicity of 
22 (4.6%) could not be identified. An additional 
four newly reported Asian and Pacific Islander 
cases were included, and 11 cases were coded as 
Asian and Pacific Islander in error, reducing the 
- actual number of cases to 469. Table 1 shovvs the 
cumulative number of Asian and Pacific Islander 
AIDS cases reported by county. Due to the 
miscoding of racejethnicity information, only 22 
counties reported Asian and Pacific Islander AIDS 
cases out of the original 24. Statewide, AIDS 
incidence among Asians and Pacific Islanders is 
lower than among other racial/ethnic groups. 
However, the AIDS incidence rate is much higher 
in San Francisco than in other counties, among 
Asians and Pacific Islanders as well as for other 
racial/ethnic groups. 
Table 2 shows the number of cases, deaths, 
mortality and incidence rates of the 22 identified 
subgroups in California. Cumulative AIDS in-
cidence rates indicate the impact of the epidemic 
relative to population size and varied substantially 
among subgroups. However, these rates should 
be interpreted cautiously because of the 
somewhat small numbers of both Asian and 
Pacific Islander AIDS cases and populations. 
Also, large population increases occurred in 
California for some Asian and Pacific Islander 
subgroups since 1980, so that substantially dif-
ferent rates would be generated using 1980 versus 
1990 census data. 
Trends in AIDS incidence for Asian and Pacific 
Islander subgroups are shown in Table 3. The 
differenc0in the average number of AIDS cases .. lr'} .,t...J-
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for three year intervals, which was used to com-
pensate for fluctuations in small numbers of 
annual diagnosed cases, shows recent increases 
in Incidence for most subgroups. The large 
Increases seen among some subgroups may be 
due to the small number of AIDS cases within 
these subgroups. This is most notable among the 
Southeast Asian ethnic populations. 
Exposure Categories 
As with all racial/ethnic ;roups, 
homosexual/bisexual men constitut~ . ---.a highest 
proportion of AIDS cases among Asians and 
Pacific Islanders, making up more than three 
fourths of the reported cases (Table 4). The 
second most common mode of transmission 
among Asian and Pacific Islander men is 
transfusion with HIV infected blood, which involve 
almost 8% of the reported Asian and Pacific 
Islander AIDS cases compared to 1% among other 
racial/ethnic groups in California. Conversely, the 
proportion of Asian and Pacific Islander AIDS 
cases attributed to injection drug use is lower than 
the proportion among other racial/ethnic groups. 
Among Asian and Pacific Islander women, the 
largest proportion of cases (41%) are associated 
with heterosexual contact. Of these 14 cases, 6 
(43%) reported sexual contact with bisexual men 
while 3 (21%) reported sexual contact with men 
who injected drugs, 4 reported sexual contact with 
an HIV infected person, and 1 reported sexual 
contact with a hemophiliac. Injection drug use, 
which is the most common exposure category 
among female AIDS cases in other racial/ethnic 
groups, is less prevalent among Asian and Pacific 
Islander women with AIDS. 
Age Categories 
Among Asian and Pacific Islander subgroups, as 
well as other racialjethnic groups, the most fre-
quently occurring category of age at AIDS diag-
nosis was 30 to 39 years (Table 5). A higher 
proportion of AIDS cases among Chinese and 
Japanese were over age 59, reflecting the higher 
proportion of transfusion cases in these 
subgroups. The proportion of AIDS cases diag-
nosed at 20 to 29 years of age was highest 
among the 'Other A/PI' subgroup (20.3%), com-
pared to the Chinese (5.9%), Filipino (13.8%), 
Japanese (13.9%), and racesjethnicities other than 
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Asians and Pacific Islanders (16.7%). 
Regional Trends 
Table 6 shows the distribution of AIDS cases 
among subgroups throughout five regions of the 
state·. More than one third of all Asian and Pacific 
Islander AIDS cases are found in San Francisco, 
which has the highest proportion of cases among 
the Chinese (50.6%), Filipino (40.2%) and 
Japanese (41.7%) subgroups. Nearly 40% of the 
Asian and Pacific Islander AIDS cases from the 
'Other A/PI' subgroup were from Los Angeles, 
with 12 out of those 54 cases (22%) of Thai des· 
cent. Half the 40 Asian and Pacific Islander cases 
from the Southern Metropolitan region were 'Other 
A/PI' cases, with 11 of the 20 (55%) of Southeast 
Asian descent. Filipinos make up the largest 
proportion of Asian and Pacific Islander AIDS 
cases in the San Francisco, Bay Area, and 
Remaining regions. 
The number of AIDS cases among Asians and 
Pacific Islanders increased through 1989 in all 
regions, with a possible plateau or decline in 1990 
(Figures 1-4). AIDS incidence increased in San 
Francisco after 1985 primarily among Chinese and 
Asians and Pacific Islanders who are other than 
Chinese, Japanese, or Filipino ('Other A/PI'); in 
Los Angeles among 'Other A/PI'; and in rest of 
the state among Filipinos and 'Other A/PI'. Of 
recently diagnosed (from 1988 through 1990) 
Asian and Pacific Islander AIDS cases, 34% were 
from Los Angeles, 31% from San Francisco, and 
35% from the remainder of the State. 
* Bay Area region (Alameda, Contra Costa, Marin, 
Napa, San Mateo, Santa Clara, Solano, and 
Sonoma counties); Los Angeles county; San 
Francisco county; Southern Metropolitan region 
(Orange, Riverside, San Bernardino, and San 
Diego counties); Remaining region (remaining 
counties in the State). 
DISCUSSION 
As of March 1, 1991, 469 Asian Pacific Islander 
AIDS cases were reported in California, comprising 
less than 2% of the total AIDS cases in the State. 
Completeness of reporting is thought to be about 
85% statewide for all race/ethnic groups and is 
not known to be different among Asians and 
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Pacific Islanders. Although comprising a small 
proportion of ttle total AIDS cases in California, 
45% of the nation's Asian and Pacific Islander 
cases are from California 1• The detailed break-
down of racial/ ethnic subgroup information in-
dicates that the AIDS epidemic has affected nearly 
all Asian and Pacific Islander populations. This 
information can be used by health care providers 
in the development of culturally sensitive treatment 
and support services for Asian and Pacific Islander 
AIDS patients. 
The number of Asian and Pacific Islander AIDS 
cases increased through 1989 throughout the 
State with specific subgroups increasing at higher 
rates than others. An increase in incidence of 
AIDS among Asians and Pacific Islanders in San 
Francisco was noted by Woo, et al2 in 1988. In 
Los Angeles and San Francisco counties, the 
increases are seen predominately in subgroups 
other than Filipinos, Chinese and Japanese. The 
apparent plateau or decline in incidence seen in 
1990 may be due to inadequate reporting delay 
adjustments, random variation, or the effect of 
early drug treatment strategies similar to that seen 
among white homosexual/bisexual men in San 
Francisco and Los Angeles. 3 
Currently, there are too few cases to determine 
accurately trends for each specific subgroup in 
each region. To continue to monitor these trends, 
the AIDS Case Registry is implementing methods 
to collect the subgroup information as each AIDS 
case is reported. This information can be placed 
in the comment area of the AIDS Case Report 
form. Also a local field variable for subgroup 
information has been created so that the 23 local 
health jurisdictions which have the AIDS Reporting 
System (ARS) can then enter specific ethnic 
information directly into the computer when a new 
Asian and Pacific Islander AIDS case is added. 
In addition to those with AIDS, an estimated 3,000 
Asians and Pacific Islanders may be HIV positive4 
and many more are likely to be at risk of HIV 
infection. To effectively target and plan education 
and preventiOJl strategies for Asians and Pacific 
Islanders, AIOS case data must be incorporated 
with HIV seroprevalence data, behavioral risk data, 
knowledge, attitude and beliefs data, and the 
wisdom of the community service providers. 
Homosexual/bisexual men, the predominate 
' 1"1 1 l :'1 
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patient group among all Asian and Pacific Islander 
men with AIDS, would benefit from culturally 
appropriate AIDS intervention programs. Although 
several studies have found Asian and Pacific 
Islanders to have the lowest HIV seroprevalence 
rate compared to other racial/ethnic groups s.s, the 
San Francisco Young Men's Study found that 40% 
of the young Filipino men surveyed engaged in 
high risk sexual behavior7• Since 60% of 
homosexual/bisexual Asian and Pacific Islander 
men with AIDS were diagnosed before age 40 and 
the median incubation period for AIDS diagnosis 
is approximately ten years8 , programs for preven-
ting HIV transmission targeted to younger men are 
needed. 
H IV seroprevalence among Asian and Pacific 
Islander childbearing women was found to be two 
to six times lower than for childbearing women of 
all other racesjethnicities9• Nevertheless, 
HIV I AIDS education and prevention programs 
stressing safe sex and the risks of injection drug 
use are needed for all women of childbearing age. 
Among the Asian and Pacific Islander subgroups 
significant differences exist which relate not only to 
their diverse cultures, but also to their knONiedge, 
attitudes, beliefs, and behaviors concerning 
AIDS10• Cultural taboos result in the denial of the 
existence of the disease in their communities. 
Finding appropriate methods to present infor-
mation regarding the disease and disseminating 
the messages must be specific for each subgroup. 
Multicultural, multilingual service providers are 
needed to earn the trust of the clients. 
Further AIDS case analyses among Asians and 
Pacific Islanders can examine country of birth to 
see how the degree of acculturation may be 
related to the risk of HIV infection. Also, the 
diseases indicative of AIDS can be examined to 
determine which diseases occur most frequently 
among Asians and Pacific Islanders. Additionally, 
further analyses of several statewide knowledge, 
attitudes, beliefs, and behavioral surveys can be 
conducted. These analyses and the additional 
subgroup information gathered on "Asian and 
Pacific Islander AIDS cases can be used to assist 
in the development of culturally sensitive services 
and prevention strategies. 
By Sally Jew, Research Analyst I, Office of AIDS 
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TABLE 1. C&a.llative AIDS Cases Mong AsiMS and Pacific Islanders (A/PI) in Cali fomi a, as of March 1, 1991, 
by CCUlty of Residence when AIDS Diagnosed 
C1.111.1lative Cli1Ulative Cli1Ulative 
Cli1Ulative Incidence AIDS Cases Incidence 
~ A/PI per 100,000 all Races/ per 100,000 
AIDS Cases A£PI POoulation* Ethnicities*** population*** 
Alameda 30 16.23 1,559 121.87 
Contra Costa 7 9.48 579 72.04 
Fresno ** ** 202 30.26 
Los Angeles 148 16.30 11,416 128.80 
Marin ** ** 390 169.49 
Merced ** ** 29 16.26 
Monterey 4 15.77 164 46.11 
Napa ** ** 52 46.95 
Orange 10 4.15 1,442 59.82 
Riverside 5 13.04 594 50.75 
Sacramento ** ** 600 57.62 
San Bernardino ** ** 559 39.41 
San Diego 23 12.42 2,500 100.08 
San Francisco 170 82.65 9,110 1,258.36 
San Joaquin 6 10.76 156 32.46 
San Mateo 17 16.10 577 88.82 
Santa Barbara ** ** 194 52.49 
Santa Clara 20 7.95 783 52.28 
Solano 8 19.76 248 72.85 
Sonoma ** ** 546 140.64 
Stanislaus ** ** 107 28.88 
Ventura ** ** __jM ~ 
TOTAL 469 17.91 31,971 120.57 
* Based on Census of Population and Housing, 1990: S~.~m~ary Tape File 1 
** Counties have three or less Asian and Pacific Islander cases 
*** Based on California HIV/AIDS Update, February 1991 
TABLE 2. Cl.allative AIDS Cases Mong Asian and Pacific Islander (A/PI) ~roups in Cal ifomia, 
as of March 1, 1991 
CI.J!lUlative 
Number of Total Percent Deaths Mortality 
AIDS Cases of Total SJ!2.:l Rate <X> 
SUBGROUP 
Filipino 174 37 118 68 
Chinese 85 18 59 69 
Japanese 72 15 54 75 
Unknown 22 5 8 36 
Thai 21 4 11 52 
Vietnamese 18 4 10 56 
Hawaiian 15 3 10 67 
Samoan 12 3 8 67 
Guamanian 10 2 8 80 
Korean 7 1 4 57 
Indonesian 6 , 3 50 
Cambodian 5 1 4 80 
Laotian 5 1 4 80 
Fijian 4 1 2 50 
Other** 13 .2 1.1 85 
TOTAL 469 ****100 314 67 
.. 
*** 
Based on Census of Population and Housing, 1990: Summary Tape File 1 
Includes 7 other subgroups each with three or fewer AIDS cases 
Census information not available 
Totals do not add up to 100% due to rounding 
Cumulative.AIDS Incidence 
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* Includes 7 subgroups each with 3 or fewer AIDS cases 

















TABLE 4. Cta~lative AIDS Cases by Exposure category and Sex for Major Asian and Pacific Islander (A/PI) 




















* Totals do not add up to 
Filipino 
No. <X> 
144 { 88) 
2 ( 1) 
5 ( 3) 
1 ( 1) 
0 ( 0) 
8 ( 5) 
_.!!. ( 2) 
164 (100) 
2 ( 25) 
4 ( 50) 
2 { 25) 








70 ( 85) 
0 ( 0) 
0 ( 0) 
0 ( 0) 
0 ( 0) 
10 ( 12) 
f._( 2) 
82(100*) 
0 ( 0) 
0 ( 0) 
2 { 67) 
1 ( 33) 
3 (100) 




52 ( 79) 
0 ( 0) 
3 { 5) 
2 ( 3) 
0 ( 0) 
6 ( 9) 
.2< 5) 
66 ( 100*) 
0 ( 0) 
3 ( 67) 
2 ( 33) 
Q ( 0) 





99 ( 85) 
2 ( 2> 
5 ( 4) 
2 ( 2) 
2 ( 2) 
2 { 2) 
_.2 ( 5) 
1 18( 100*) 
4 ( 22) 
7 ( 39) 
4 ( 22) 




All Not A/PI 
No. (%) 
25,359 ( 82) 
1,304 ( 4) 
2,816 ( 9) 
165 ( 1) 
198 ( 1) 
399 ( 1) 
___2§Q ( 2> 
30,921 (100) 
358 ( 34) 
338 ( 32) 
273 ( 26) 
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TABLE 5. Qallatfve AIDS Cases by Age Groups for Major Asian end Pec:ifiC Islander (A/PI) SU:lgroups in 
california, as of March 1, 1991 
RACE/ETHNICITY 
Fit ipino Chinese Japanese Other A/PI All Not A/PI 
No. lX! No. <X> No. <X> No. ~X} No. ~Xl 
AGE GROOP 
<13 Yrs 2 ( 1.1) 0 0 ) 1 ( 1.4) 2 ( 1.5) 215 ( 0.7) 
13·19 Yrs , ( 0.6) 0 ( 0 ) 0 ( 0 ) 1 ( 0.7) 59 ( 0.2) 
20·29 Yrs 24 (13.8) 5 ( 5.9) 10 (13.9) 28 (20.3) 5,377 (16.7) 
30·39 Yrs 74 (42.5) 36 (42.3) 24 (33.3) 60 (43.5) 14,493 (45.0) 
40·49 Yrs 53 (30.5) 24 <28.2) 22 (30.6) 38 (27.5) 8,127 (25.2) 
50·59 Yrs 14 ( 8.1) 11 (13.0) 6 ( 8.3) 7 ( 5.1) 2,831 ( 8.8) 
OVer 59 Yrs 6 ( 3.5) 9 (10.6> 9 (12.5> 2 { 1.5) 1.095 { 3.4) 
TOTAL 174 (100*) 85 (100) n (100) 138(100*) 32,197 (100) 
* Totals do not add up to 100X due to rOU'Iding 
TABLE 6. Qallative AIDS Cases A.:x1g Major Asian ~ Pec:ific Islander (A/PI) SU:lgroups by Regions of 
california, es of March 1, 1991 
RACE/ETHNICITY 
~ Filipino Chinese Japanese Other A/PI All Other 
No. ~Xl No. lXl No. {Xl No. {Xl No. ,xl 
Bay Area 33 (19.0) 13 (15.3) 10 (13.9) 30 (21.7) 4,550 ( 14.1) 
San Francisco 70 (40.2) 43 (50.6) 30 (41.7) 27 (19.6) 8,944 ( 27.8) 
Los Angeles 44 (25.3) 24 (28.2) 26 (36.1) 54 (39.1) 11,286 ( 35.1) 
Southern Metro 15 ( 8.6) 3 ( 3.5) 2 ( 2.8) 20 (14.5) 5,042 ( 15. 7) 





0 l 0 { 0 ! 0 ~ 0 1 8 ' 0 l 
TOTAL 174 (100) 85 (100*) n c100*> 138 (100) 32,197 (100) 
* Bay Area region (Alameda, Contra Costa, Marin, Napa, San Mateo, Santa Clara, Solano, and Sonoma 
counties); San Francisco county; Los Angeles county; Southern Metropolitan region (Orange, Riverside, 
San Bernardino, and San Diego counties); Remaining region (remaining counties in the State). 
:1,.,-l..J~ 
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Figure 1. Annual AIDS Incidence Among Asians & Pacific Islanders, 
San Francisco County, March 1, 1991 
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Figure 2. Annual AIDS Incidence Among Asians & Pacific Islanders, 
Los Angeles County, March 1, 1991 
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:t ~Dept Health Services, Office of AIDS September 1991 
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.. 
Figure 3. Annual AIDS Incidence Among Asians & Pacific Islanders, 
Rest of State, March 1, 1991 
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Figure 4. Annual AIDS Incidence Among Asians & Pacific Islanders, 
All of California, March 1, 1991 
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INFLUENZA IMMUNIZATION OF HIV-INFECTED PERSONS AND OF 
CARE-GIVERS TO PERSONS WITH CUNICAL AIDS 
California Department of Health Services 
Immunization Unit 
August, 1991 
The U.S. Public Health Service Immunization Prac-
tices Advisory Committee (ACIP) recommends 
influenza immunization eacn fall (ideally in Novem-
ber) for certain groups of high-risk persons, as 
well as for care-givers to these persons. 
Reproduced below are selected sections from the 
ACIP's influenza immunization recommendations 
for the 1991-92 season (MMWR 1991; 40:No. 
RR-6, 1-15). 
Persons Infected With HIV 





Physicians, nurses, and other personnel in 
both hospital and outpatient-care settings 
who have contact with high-risk persons in 
all age groups, including infants. 
Employees of nursing homes and 
chronic-care facilities who have contact 
with patients or residents. 
Providers of home care to high-risk per-
sons (e.g., visiting nurses, volunteer 
workers). 
Household members (including children) of 
high-risk persons. 
ding the frequency and severity 
of influenza illness in human 
immunodeficiency virus (HIV) 
infected persons, but recent 
reports suggest that symptoms 
Influenza Vaccine Dosage 
Influenza vaccine' dosage, by age of patient - 1991-92 season 
may be prolonged and the risk 
of complications increased for 
this high-risk group. Because 
influenza may result in serious 
illness and complications, vac-
cination is a prudent precaution 
and will result . in protective 
antibody levels in many 
recipients. However, the an-
Age Group 
6 - 35 mos 
3 - 8 yrs 
9 - 12 yrs 
2:: 13 yrs 
tibody response to vaccine may be low in persons 
with advanced HIV related illnesses; a booster 
dose of vaccine has not improved the immune 
response of these individuals. 
Groups That Can Transmit Influenza to 
High-Risk Persons 
Persons who are clinically or subclinically infected 
and who attend or live with high-risk persons can 
transmit influenza virus to them. Some high-risk 
persons (e.g., the elderly, transplant recipients, or 
persons with AIDS) can have low antibody respon-
ses to influenza vaccine. Efforts to protect these 
high-risk persons against influenza may be 
improved by reducing the chances of exposure to 
influenza from their care providers. Therefore, the 
following groups should be vaccinated: 
:~OQ 
Nunber of 
Product' Dosage' Doses Route• 
Split virus only 0.25 ml 1 or 2" IM 
Split virus only 0.50 mL 1 or 2' IM 
Split virus only 0.50 mL 1 IM 
Whole or split virus 0.50 ml 1 1M 
Contains 15 1-Lg each of A/Taiwan/1/86 
(H1 N 1), A/Beijing/353/89 (H3N2), and 
B/Panama/45/90 hemagglutinin antigens in each 
0.5 mL. Manufacturers include Connaught 
(Fiuzone• whole or split, distributed by E.R. 
Squibb & Sons); Evans Medical Ud.-Lederle 
Laboratories (Flu-Immune•, distributed by Lederle 
Laboratories); Parke-Davis (Fiuogen• split); and 
Wyeth-Ayerst Laboratories (Influenza Virus Vac-
cine, Trivalent• split). For further product infor-
mation, call Connaught (BOO) 822-2463, 
Parke-Davis (800) 223-0432, Wyeth (800) 
950-5099, and Lederle (800) 522-3753. 
2 Because of the lower potential for causing 
febrile reactions, only split virus (subvirion) vaccine 
should be used in children age 12 years and 
younger. lmmunogenicity and side effects of split 
and whole virus vaccines are similar in adults 
PAGE 100 
when vaccines are used according to the recom-
mended dosage. 
3 It may be desirable to administer influenza 
vaccine to high-risk children when they receive 
routine pediatric vaccines, but in a different site. 
Although studies have not been conducted, 
simultaneous administration should not lessen 
immunogenicity or enhance adverse reactions. 
Some avoid giving influenza vaccine within 3 days 
of giving pertussis (DTP) vaccine since both 
vaccines commonly produce mild local reactions 
and fever in children. 
4 The recommended site of vaccination is the 
deltoid muscle for adults and older children. The 
preferred site for infants and young children (under 
age 18 months) is the anterolateral aspect of the 
thigh. 
5 Two doses are recommended for children 
~ 8 years old who are receiving influenza vaccine 
for the first time. 
Sources of Influenza Immunizations 
Besides the private medical sector, local health 
departments in California conduct clinics offering 
low cost influenza immunizations each fall (late 
October through November) to persons at 
increased risk from influenza. Locations and times 
of these clinics can be determined by calling the 
local health department (c.f. county or city 
government listings in the telephone book). 
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AIDS CLINICAL TRIALS 
INFORMATION SERVICE 
The AIDS Clinical Trials Information Service 
(ACTIS) provides current information on federally 
and privately sponsored clinical trails being con-
ducted to evaluate drugs and therapies to treat all 
stages of human immunodeficiency virus (HIV) 
infection in adults and children and to treat related 
opportunistic infections. ACTIS is a Public Health 
Service project provided collaboratively by CDC, 
the Food and Drug Administration (FDA), the 
National Institute of Allergy and Infectious 
Diseases, and the National Library of Medicine 
(NLM). 
The ACTIS database includes information on more 
than 300 clinical trails and more than 1 00 drugs 
being tested. Information is available on the 
purpose of the study protocol, t~e Jo~ati~n, the 
eligibility requirements, the exclus1on cntena, and 
the names and telephone numbers of contact 
persons. ACTIS provides information on all AIDS 
clinical trails sponsored by the National Institutes 
of Health and on studies of all treatments under-
going clinical testing for effectiveness in privately 
sponsored trials approved by FDA. 
The AIDS Clinical Trials Information 
Service can be reached by calling: 
1-80o-TRIALS-A (1·800-874-2572) 
FAX: 1-300-738-6616 
1TY /TDD: 1-800-243-7012 
International Une: 1-301-217-0023 
CAUFORNIA HIV I AIDS UPDATE PAGE 101 
AIDS News 
NATIONAL CASE SUMMARY: 
DC announced that the cumulative num-
ber of individuals diagnosed with AIDS 
in the United States totaled 191,601 and 
122,905 persons have died at the end of August, 
1991. 
CAUFORNIA CASE SUMMARY: 
uring August 1991, 784 new AIDS cases 
and 614 AIDS related deaths were 
reported to the AIDS Case Regist{y. 
However, 154 cases were deleted from the registry 
leaving a net case increase of 630. From the start 
of the epidemic through August of 1991, the 
cumulative case total is 36,620 with 24,938 AIDS 
related deaths. One year ago, there were 854 new 
AIDS cases reported with 452 AIDS related deaths. 
Cases rE~ported in the latest twelve month period 
(September 1990 - August 1991) are compared 
with cases reported in the previous twelve month 
AIDS cases and ArnJal Incidence Rates per 100,000 
Population by ~etropol itan area with 500,0000 or .ore 
population, reported Septenber 1989 through August 
1990, Septf!llt)er 1990 through August 1991; and 
cumulative through August 1991 
METROPOLITAN 9/89-8/90 9/90-8/91 Oa.tlative 
Area of Res - llo. Rate llo. Rate Total 
idence 
San Francisco 1,782 111.1 2,361 146.2 10,845 
San Diego 699 28.0 523 20.4 2,657 
Los Angeles 2,231 25.2 2, 731 30.3 12,714 
Oakland 538 25.8 501 23.7 2,328 
Anaheim 345 14.3 321 13.1 1,520 
Riverside/ 
San Bernardino 243 9.4 326 12.1 1,241 
San Jose 160 10.7 176 11.6 833 
Fresno 56 8.4 61 8.9 234 
Sacramento 145 9.8 210 13.8 796 
Bakersfield 33 6., 50 9.0 149 
Oxnard/ 
Ventura 37 5.5 42 6. 1 175 
From the CDC's HIV/AIDS Surveillance Report, 
September 1991. 
period (September 1989 - August 1990) for both 
racejethnicity and mode of transmission in the 
tables that follow. 
LATEST 12 MONTHS PREVIOUS 12 MONTHS 
#Reported l of Total # Reported l of Total 
Race 
White 5,037 66.0 5,171 70.7 
Black 1,113 14.6 955 13.0 
Hisp 1,301 17.0 1,027 14.1 
Asian . 116 1.5 131 1.8 
Other 72 0.9 26 0.4 
Patient Gry 
Gay/Bi 5, 793 76.3 5,741 79.1 
IVDU 629 8.3 469 6.4 
Gay /I VDU 539 7.1 516 7.1 
Heme 27 0.4 32 0.4 
Hetero 185 2.4 151 2.1 
Trans 123 1.6 137 1.9 
NIR 298 3.9 216 3.0 
Women 361 4.7 261 3.6 
Children 45 0.6 48 0.7 
The more significant changes include the 
increased reporting of black and Hispanic cases, 
and the higher number of women reported. While 
fewer cases among homosexual or bisexual men 
are being received, more IV Drug User, 
heterosexual transmission, and No Identified Risk 
(NIR) cases are being reported. Of the 185 
heterosexual cases reported in the most recent 
twelve months, 69 occurred among men and 116 
among women. 
Overall, the net increase in reported cases for the 
epidemic was 7,639, in the past twelve months as 
compared to 7,310 in the previous twelve months. 
However, 850 cases were deleted during the past 
year. There were 6,121 AIDS related deaths 
reported in the most recent period as compared to 
5,269 in the previous twelve month period. 
By Jim Creeger, Chief, AIDS Case Registry 
Office of AIDS 
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1. Disease Category * ----------------
PCP 
Other Disease w/o PCP 
KS Alone 
No 0 i seases Listed ---------------
Total 
2. Age Cases ( X> 
... --- ....... .. ........................ 
Under 13 246 ( 1) 
13-19 78 ( 0) 
20-29 6074 ( 17) 
30-39 16418 ( 45) 
40-49 9305 ( 25) 
Over 49 4499 ( 12) 
Unknown 0 ( 0) ----- ........... 
Total 36620 (100) 
Acquired Immune Deficiency Syndrome (AIDS) 
AIDS Reporting System 
Sunreillance Report · 08/31/91 
Adult/Adolescent Pediatric Total 
Cases ( X> Deaths ( X> Cases < X> Deaths < X> Cases ( X) 
----------- .......................... ----------- ............................ -----------20583 ( 57) 14766 ( 72) 108 ( 44) 67 ( 62) 20691 ( 57) 
12108 ( 33) 7865 ( 65) 138 ( 56) 74 ( 54) 12246 ( 33) 
3683 ( 10) 2166 ( 59) 0 ( 0) 0 ( . ) 3683 ( 10) 
0 ( 0) 0 ( . ) 0 ( 0) 0 ( . ) 0 ( 0) ----- -- .. -.. ----- ............. ----- ----- ............ -----
3~74 (100) 24797 ( 68) 246 (100) 141 ( 57) 36620 (100) 
Adult/Adolescent Pediatric 
3. Race/Ethnicity Cases ( X> Cases ( X> 
.................................. .. .......................... ............................... 
White, Not Hispanic 26164 ( 72 ) 87 ( 35) 
Bleck, Not Hispanic 4477 ( 12 ) 72 ( 29) 
Hispanic 4996 ( 14 ) 80 ( 33) 
Asian 540 ( 1 ) 6 ( 2) 
Native American 76 ( 0 ) 1 ( 0) 
Unknown 121 ( 0 ) 0 ( 0) 
................................... ----- ----- ---- ... .. ....... -
Total 36374 (100) 246 (100) 
4. Patient Groups ** Adult/Adolescent 
H~sexual or bisexual Men 
Intravenous (IV) drug User 
H~/Bi IV drug User 
Hemophi l iec 
Heterosexual contact 
Transfusion with blood/products 
None of the above/Other 
Total 
Hemophiliac 
Parent at risk/has AIDS/HIV 
Transfusion with blood/products 
None of the above/Other 
Total 
Males ( X> Females < %) 
28691 ( 82) 
1567 ( 4) 
3136 ( 9) 
185 ( 1) 
240 ( 1) 
466 { 1) 
832 ( 2) 
35117 (100) 
Males < %) 
17 { 12) 
64 { 47) 
54 ( 39) 
2 ( 1) 
137 (100) 
Pediatric 
0 ( 0) 
438 ( 35) 
0 ( 0) 
9 ( 1) 
399 ( 32) 
299 ( 24) 
112 ( 9) 
1257 (100) 
Females < %) 
1 { 1) 
85 { 78) 
21 ( 19) 
2 ( 2) 
109 (100) 
*Disease categories are ordered hierarchically. Cases with more than one disease are 
tabulated only in the disease category listed first. 
**Cases with more than one risk factor other than the combinations listed in the tables 
are tabulated only in the category listed first. 
Case count reflects the deletion of 154 cases. 
Deaths ( X) 
............................. 
14833 ( 72) 
7939 ( 65) 
2166 ( 59) 
0 ( . ) 
----- -----
24938 ( 68) 
Total 
Cases ( X) 
26251 ( 72) 
4549 ( 12) 
5076 ( 14) 
546 ( 1) 
77 ( 0) 
121 ( 0) 
36620 (100) 
Total < X) 
28691 ( 79) 
2005 ( 6) 
3136 ( 9) 
194 ( 1) 
639 ( 2) 
765 ( 2) 
944 ( 3) 
36374 (100) 
Total ( %) 
18 { 7) 
149 ( 61) 
75 ( 30) 
4 ( 2) 
246 (100) 
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5. 
Acquired Immune Deficiency Syndrome (AIDS) 
AIDS Reporting System 
Surveillance Report - 08/31/91 
Reported Cases of AIDS and Case-Fatality Rates by Half-Year of Diagnosis: 
Half-Year NU'Iber of NU'Iber of 
of Diagnosis Cases Deaths 
------------ ................... ---------
Before 1980 1 0 
1980 Jan ·June 3 2 
July-Dec 7 5 
1981 Jan ·June 16 15 
July-Dec 44 40 
1982 Jan -June 70 63 
July-Dec 146 135 
1983 Jan -June 295 276 
July-Dec 402 376 
1984 Jan ·June 573 543 
July-Dec 799 746 
1985 Jan ·June 1118 1058 
July--Dec 1370 1278 
1986 Jan ·June 1783 1658 
July-Dec 2157 1946 
1987 Jan ·June 2654 2331 
July-Dec 2no 2317 
1988 Jan ·June 3072 2398 
July-Dec 3120 2282 
1989 Jan -June 3525 2308 
July-Dec 3241 1892 
1990 Jan -June 3453 1630 
July· Dec 3086 1084 
1991 Jan -June 2597 539 
July· Aug 31 318 16 
............................ .. ................... ... .................. 
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CUMULATIVE AIDS CASES and INCIDENCE 
1980 through 08/31/91 
AIDS Deaths Mortality INCIDENCE 
Cases Rate per 100,000 
CtlJNTY AIDS Deaths Mortality INCIDENCE 
























































































































































































































* Incidence Based on 1990 Census, California De rtment of Finance, Population Unit. 
Reported AIDS Cases and Deaths 
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Uorin 441 
Son Francisco 9889 --
Son Uoteo 625 --
Sonto Cruz 157 -
6 
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California AIDS Cases 
Cumulative Cases 
as of August 31, 1991 
Department of Health Services 
Office of AIDS 
13147 
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MEETINGS/ ANNOUNCEMENTS 
• November 7: "HIV Disease in Women and Children", a conference at Chico 
Community Hospital which will provide current medical information on HIV 
disease symptoms, diagnosis, treatment and care for women and children living 
with HIV disease. For more information call: (916) 265-1450. 
• November 14-16: ·raking Charge: Communities of Color in Solidarity Against 
the HIV/AIDS Epidemic", a conference sponsored by the U. S. Public Health 
Service, Regions IX and X. It will be coordinated by the Office of Minority Health 
and held in Seattle. For more information, call (206) 728-8911. 
• November 19-22: "Planning and Evaluating HIV Prevention Programs". The 
conference will be held in San Francisco. For information contact the STD 
Prevention/Training Center, 1372 Mission Street, S.F. 94103 or call (415) 554-
9620. 
• December 3: "HIV Disease and the Social Security System·. For information 
on this conference, contact: AIDS Project Los Angeles, 6721 Romaine St., L.A. 
90038 or call (213) 962-1600, ext 355. 
• December 9-10: "Clinical Care of the AIDS Patient•. Presented by the 
University of California, San Francisco. Please write UCSF Postgraduate 
Programs, 521 Parnassus Avenue, C405, S.F. 94143-0656, or call (415) 476-
5808. 
California HIV 1 AIDS Update is published on a monthly basis by the California 
Department of Health Services, Office of AIDS, 714/744 P Street, Sacramento, 
CA 94234-7320, Phone: (916) 445-0553, FAX Phone: (916) 323-4642. 
Editor: Aleck B. Darr, M.A., M.P.A. Circulation Manager: James Creeger. 
Editorial Advisory Board: Robert Benjamin, MD, MPH, Alameda County; Michele 
M. Ginsberg, MD, San Diego County; George W. Rutherford, MD, Department 
of Health Services, Infectious Diseases Branch; Peter Kerndt, MD, MPH, Los 
Angeles AIDS Epidemiology Program. 
Departmental Advisor: Betsy Hite, Chief, Office of Information and Public Affairs, 
Department of Health Services. 
1 .~-
Department of Health Services 
Office of AIDS 
714/744 "P" Street 
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Epidemiology of acquired immunodeficiency 
syndrome and human immunodeficiency 
virus infection in adolescents 
HELENE D. GAYLE, MD, MPH AND LAWRENCE J. D'ANGELO, MD, MPH 
Attention baa increasingly been focused on human 
immunodeficiency virus (HM infection and acquired 
immunodeficiency syndrome (AIDS) among adoles· 
cems. In the early years of the HIV I AIDS epidemic. 
adolescents received leu attention than younger chil· 
dren and adulta. This was due at least in part to the 
fact that most of the early knowiedp of the AIDS 
epidemic came from AIDS case reporting. Since ado-
1-=ents 13 to 19 yean old comprise leu than 1% of 
all people with AIDS, the risk of HIV infection in this 
group appeared mjnjmeJ relative to the pediatric (leu 
than 13 years) and adult populations. However, for 
purposes of prevention and care, adoletcents are a 
unique and important group to higldight. Adoletcence 
ia a time when semal behavior and drug use patterns 
are developing: clearly it is a critic:al time to have an 
impact on those behavior patterns. Also, there is a 
growing recognition that adolescents may be a group 
at considerable risk for HIV infection.1 ... However. 
information about this group is still limited. Many 
gaps in our knowledge remain. limiting our ability to 
provide appropriate health and social services and 
prevention efforts for the adolescent population. We 
will review the epidemiology of HIV infection and 
AIDS among adolescents and examine factors that 
place adolescents at risk and the current research 
needs related to these areas. 
EPIDEMIOLOGY OF AIDS IN ADOLESCENTS 
As of October 31, 1990, 604 cases of AIDS among 
adolescents 13 to 19 years of age had been reported to 
the Centers for Disease Control (CDC) AIDS surveil-
lance system. This represents 0.4% of the 152 231 
Accepted for publication Dec. 19. 1990. 
From the DivilioD of HIV I AIDS. Cencer of Infectioua Dileun. 
CeDtanfor DiaeueControl. AtlaDta. GA fHDG),anchbeChild.ren"s 
Ha.pttal National Medica! Center and the Georre WubingtOn 
UDiwmcy, Wuhin(ton. DC fWDl. 
Key words: Acqwred immunodeficienc:v vtrua. human i.mmuno· 
defiCiency VlNI. adolelcenca. · 
total reported AIDS cases. Another 6472 cases (4.3%) 
have been reported among young adults 20 to 24 years 
of age, many of whom were presumably infected with 
HIV as adolescents. Since 1982. the number of cases 
of AIDS among adolescents has increased steadily, at 
a rate of increase similar to that for adults and chil-
dren (Fig.l). This sugpsta that, as with the other age 
groups, AIDS in adolescents will be an increasingly 
important cause of morbidity and mortality. 
AIDS cases in adolescents have been reported from 
4latates. Puerto Rico, and the District of Columbia. 
F"dt;y-three percent of all adolescent cases have been 
reported from New York. Florida. California. Texas. 
Puerto Rico, and New Jersey, with 14% from New 
York alone. Thia geographic distribution has remained 
fairly stable over time with 46 to 59% of the cases 
being reported from these areas each year since 1984. 
Additionally, most (72%) ofthose for whom residence 
information was available were from Metropolitan 
Statiatic:al Areas with populations of 1 million or more. 
By contrast. only 42% of the total1980 United States 
population lived in metropolitan areas of this size. 
The proportion of cases reported from these large 
metropolitan areas has dec:reaaed. from 78% in 1986 to 
69% in 1988. Since the number of adolescent AIDS 
cues reported per year is still small. interpreting these 
trends is difficult. These data suggest, however. that 
HIV infection among adolescents is an issue for con-
cern regardless of place of residence. 
Overall. older adolescents, males, and racial and 
ethnic minorities predominate among adolescents 
with AIDS. Reported cases steadily increase with pa-
tient's age. Relatively few cases have been reported 
among adolescents younger than 17 years, with 75% 
of the reported cases occurring in those 17 to 19 years 
old. 
Eighty percent of the total number of adolescents 
with AIDS are male. The cumulative male to female 
ratio is 4:1 compared with a male to female ratio of 
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FIG. l. Cumulative Incidence oi AIDS ca.sea m children. adoU. 
cenu and adults: United Statu. 1981 to 1988. Reponeci throup 
October 31. 1990. 
to female ratio remained stable from 1985 to 1987 
(4.5:1 to 5:1), but in 1988, it dropped to 3:1. reflecting 
an 80% increase in the number of female cases re-
ported between 1987 and 1988. 
·: -: · As for AIDS cases overall. minoritv adolescents are 
·· ' disproportionately represented amo~ persons with 
AIDS. African-Americans and Hispanics make up 36 
and 18% of adolescents with AIDS. respectively, but 
represent only 14 and 8%. respectively, of the 1980 
U.S. population 13 to 19 years old. The cumulative 
incidence is highest for all other racial and ethnic 
groups compared with whites. 
MODES OF TRANSMISSION 
To date all reported AIDS cases among adolescents 
have resulted from transmission of HIV infection by 
the same routes as for adults, although in somewhat 
different proportions. By individual transmission cat-
egory, the largest proportion of reported adolescent 
AIDS cases were those resulting from transfusion of 
blood products for coagulation disorders. The second 
largest category is transmission by homosexual or 
bisexual contact, comprising approzimately 30% of 
cases. However, when behavior-related exposures are 
combined. sexual contact and intravenous drug use 
account for the majority (57%) of cases. 
Within the adolescent age group, there are distinct 
differences in modes of transmission by age, sex, and 
race or ethnicity. Among young adolescents 13 to 14 
years old. exposure to HIV through the transfusion of 
blood products for hemophilia accounts for 70% of 
cases. and blood transfusions another 21%. Under-
standably, in this age subset. 87% of AIDS cases are 
mong males. The proportion of cases attributable to 
exposure to blood or blood produets decreases mark-
edly with age to 72% of cases among 15- and 16-year-
olds and 25% in older adolescents 17 to 19 years old. 
Correspondingly, the proportion of cases due to be-
havior-related exposure increases with age from 9% 
·1 :.:.s 
among 13- and 14-year-otds to 24% among 15- and 
16-year-oids and 69% of cases among oider adolescents 
17 to 19 years oid. The largest single exposure category 
for older adolescents is sexual contact between maies. 
accounting for 36% of cases in this group. The impor-
tance of this progression is emphasized by the fact 
that over 90% of all cases among young adults 20 to 
24 years old are attributed to behavior-related expo-
sures. 
Modes of transmission· also differ by gender. Overall 
among males, blood product exposure accounts for the 
larpst proportion (38%) of cases. closely followed.-Dy 
sema1 contact between males (37% ). However. by 
adding tb.e overlapping categories of male homosexual 
or bisexual contact and IV drug use. up to 43% of 
caaea among males could be due to male-to-male sex-
ual contact. Among females. the most frequent expo-
sure category was heterosexual contact. accounting for 
44% of cases. followed. by IV drug use (28%). Male IV 
drug users were reported as partners in 60% of female 
heterosexual-acquired cases or 28% of all female cases. 
Therefore, in total. 56% of reported female cases were 
related to IV drug use. The male to female ratio is 
highest for cases due to blood product exposure and 
lowest for heterosexual contact. 
The mode of acquiring HIV infection among ado-
lescents also vary by race and ethnicity. More than 
half (53%) of cases among white adolescents are at-
tributed to transfusion of blood products for hemo-
philia; another 23% are due to homosexual or bisexual 
contact. By contrast. the two largest transmission 
categories are homosexual or bisexual contact (39%) 
and heterosexual contact (24%) for African-Ameri-
cana. and IV drug use (29%) and homosexual or bisex-
ual contact (28%) for Hispanics. The higher propor-
tion of cases due to heterosexual contact and IV drug 
use among the African-American and Hispanic cases 
account for the higher proportion of females and lower 
male to female ratios in these groups compared with 
whites. 
INDICATOR DISEASES AND MORTALITY 
Clinically, adolescents with AIDS are more similar 
to adults than to children. Adolescents with AIDS 
have been diagnosed with a wide spectrum of oppor-
tunistic diseases. conditions. and cancers. Pneumocys-
til carinii pneumonia was the most frequently diag-
nosed infectious disease, reported in 43.5% of cases. 
Wasting was the next most common condition ( 15% ), 
followed by Candida esophagitis (7% ), cryptococcosis 
(6.5% ), and toxoplasmosis (5% ). Kaposi's sarcoma was 
not diagnosed frequently among adolescents. 
Fifty-seven percent of adolescents with AIDS re-
ported to the CDC surveillance system are known to 
have died. Additionally, AIDS mortality data are 
available from the National Center for Health Statis-
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tics. Based on these data. AIDS accounts for less than 
1% of deaths among adolescents 13 to 19 years old. 
However. for young adults 20 to 24 years of age, AIDS 
accounts for 2% of all deaths and is now the fourth 
leading cause of death. 5 
HlV SEROPREVALENCE DATA 
Although AIDS case reporting is very useful for 
asaessing serious morbidity and mortality due to HIV 
infection. it does not provide as much information on 
the current, ongoing situation. Given the long incu-
bation period between HIV infection and the devel-
opment of AIDS, the number of AIDS cases alone is 
probably much too low to serve as an estimate of the 
prevalence of HIV infection among adolescents. 
Adults aged 20 to 29 yean represent 209'0 (N • 21834) 
of the total reported AIDS cases. Many of these adults 
were most likely infected as adolescents. Back-calcu-
lation is one method of estimating the number of 
persons previously infected with HIV by using re-
ported AIDS cases and the estimated incubation 
period between infection and development of AIDS. 6 
Applying this method, the probability of being infected 
with HIV as adolescents for people 13 to 29 years old 
can be calculated. 7 Based on these probabilities, it is 
estimated that from 1981 througb.1987, approximately 
17 000 persona aged 13 to 19 years were infected with 
HIV.7 Current knowledge about the incubation period 
and natural history of H1V infection is limited. how-
ever, and the number of adolescents with AIDS is 
small. These factors can affect the precision of esti-
mates derived from back-calculation. However, this 
estimate serves as a more useful indicator of the 
probable impact of HIV infection among adolescents 
than can be provided by AIDS cases alone. 
Estimates of HIV aeroprevalence in adolescents and 
young adults exist from multiple sources. As part of 
the CDC Comprehensive Family of Serosurveya, se-
roprevalence data have been collected for adolescents 
in different health-care settings.11 All of these surveys 
were conducted in a blinded manner by testing dis-
carded blood specimens that were collected for other 
routine medical purposes. Test results are linked only 
to limited. nonidentifying demographic information. 
This method is used to provide an unbiased estimation 
of aeroprevalence while preserving anonymity.• Sera-
prevalence data are also available to CDC from HIV 
screening of applicants for military service (U.S. De-
partment of Defense) and from applicants for residen· 
tial Job Corps programs tU.S. Department of Labor). 
Since all applicants for both of these programs are 
screened for HIV, seroprevalence data are available 
for the entire applicant pool. 
From 1988 to 1989. more than 108 000 specimens 
and demographic data from adolescents ( 15 to 19 years 
old) and young adults (20 to 24 years old) attending 
sexually transmitted disease (STD) clinics and wom-
en's health centers across the country were collected 
(9). In these surveys, the median seroprevalence was 
highest in the STD clinics for adolescents (0.5%, range 
0 to 4.6%) and young adults (1.8%, range 0 to 30.4%). 
Median seroprevalence in the women· s health centers 
was 0% (range 0 to 1~7%) for adolescents and 0% 
(range 0 to 3.1%) for young adults. The median rates 
for adolescent males and females in STD clinics were 
1.3 and 0.69'0, respectively.9 
From October 1985 to September 1989, the overall 
HIV aeroprevalence for applicants for military service 
wu 0.039'0 (range 0 to 0.69'0) among adolescents aged 
17 to 19 years and 0.19% (range 0 to 1.19'0) for adults 
aged 20 to 24 years.10 Among 17 • to 19-year-olda. the 
seroprevalence wu equal for men and women (0.039'0 ); 
among 20· to 24-year-olda. the proportion of HIV • 
infected males (0.199'0) wu approximately twice as 
high as that for females (0.099'0). The aeroprevaiences 
for 17- to 19-year-old African-Americans and Hispan-
ics were 5 and 1.5 times that of white recruits of this 
age, respectively. A similar trend was seen in the 20-
to 24-year-old age group. These data are an important 
source of national seroprevalence estim•._ for the, 
adolescent population but may underestimate the se-
verity of the problem in this age group since homosex-
ual and bisexual males. IV drug users. and persons 
with coagulation disorders are discouraged from ap-
plying for military service. 
The Job Corps, the major federal job training pro-
gram for socioeconomically and educationally disad-
vantaged youth, began screening all applicants to their 
residential training program for HIV infection in 
1987.11 Almost all (97%) of Job Corps entrants are 
aged 16 to 21 years. The overall seroprevalence in this 
group is 0.39%. The seroprevalence varied by age, sex. 
race or ethnicity, and geography. The highest aero-
prevalence occurred in African-Americana and His-
panic males (0.99 and 0.83%, respectively) and Afri· 
can-American females 19 to 21 years old (0.66% ). The 
male to female ratio wu 1:1 for 16· to 18-year-olda 
and approximately 2:1 for 19· to 21-year olda. Sera-
prevalence wu highest in the Northeast (0.639'0) and 
the South (0.42%). These data indicate that this pop-
ulation is at higher risk for HIV infection than those 
applying for military service. Since the Job Corps does 
not accept known IV drug users. this population may 
not neceuarily represent the total spectrUm of adoles-
cents at high risk for HIV infection. 
Other blinded seroprevalence surveys have been 
done in adolescent populations in several areas be-
tween 1987 and 1989. In a study of runaway homeless 
youth 16 to 20 years old, a aeroprevalence rate of 7% 
waa found. 12 Data from an STD clinic in Baltimore 
showed a 2.2% aeroprevalence among 15- to 19-year-
old adoleacents.13 In a study conducted among adoles-
l 
cents aged 13 to 19 years attendin~ an adolescent 
outpatient clinic in Washington. DC, the seropreva-
lence was 0.37%, with the highest prevalences occur-
ring in females W.47%) and in patients 18 to 19 years 
old (0.56% ). 14 Another study was done among individ-
uals who had blood drawn ior syphilis screening in the 
general medical or pediatric clinic or emergency room 
of a municipal hospital in the Bronx, New York.15 The 
seroprevalence was 1.2% among adolescents and 
young adults aged 15 to 24 years. Also in the Bronx. a 
seroprevalence survey among young women attending 
a family planning clinic for first-trimester abortions 
revealed a seroprevalence of 2.5% among young 
women aged 20 to 24 years.16 Although methods for 
these different surveys vary, they indicate that there 
is a heterogeneity in the seroprevalence among the 
adolescent and young adult population and that cer-
tain adolescents are at very high risk of HIV infection. 
These data suggest that adolescent females may be at 
higher risk for HIV infection than males of the same 
age and that African-American and Hispanic adoles-
cents also appeared to be at an increased risk relative 
to white adolescents. 
RISK OF HIV TRANSMISSION IN 
ADOLESCENTS 
Data from AIDS case reports and selected seroprev-
alence surveys indicate that behavior is a major factor 
for placing adolescents at risk for HIV infection. Since 
the risk of transmission of HIV through exposure to 
infected blood or blood products has been drastically 
reduced with the advent of blood screening, blood 
donor self-deferral. and heat treatment of clotting 
factors, virtually all new infections among adolescents 
will result from semal or drug-use exposures. Infor-
mation on risk behavior among adolescents will be 
important for developing prevention efforts in this 
population. 
Studies indicate that many adolescents may be at 
risk for HIV infection through semal exposure. There 
has been an increase in adolescent semal activity over 
the last 2 to 3 decades with both a declining age at 
fust intercourse and increasing number of partners 
over time.11-2o The median age at first intercourse is 
16 years old in this country, but it varies substantially 
by gender. race or ethnicity, and geographic loca-
tion.19· 21 In a 1982 study of never-married females 
living in metropolitan areas. the proportion reporting 
ever having had intercourse ranged from 17% for 15· 
year-olds to 70% for 19-year-olds reporting having 
had intercourse. ~z The impact of the increasing pro-
portion of males and females who have had intercourse 
during adolescence is heightened by the relatively 
small number who constantly use contraceptive meth-
ods that could also prevent HIV infection and other 
STDs.17• 18• 23 The presence of STDs indicates behavior 
that places one at risk for exposure to HIV infection. 
STD rates in adolescents are high and have increased 
over time. Since the early 1960s. the annual numi>er 
of reported cases of gonorrhea in teenagers taged 10 
to 19 vears 1 has increased dramatlcallv from a total of 
56 907 cases reported in 1960 to 25S 112 in 1980. "4 
Females had higher rates of gonorrhea and a faster 
rate increase than same-aged males. From 1960 
through 1970. 15- to 19-year-old males had a higher 
rate of infection than same-aged females. By 1973, the 
gonorrhea rate among females in this age group ex-
ceeded that of males and has remained conaiaten.UY 
higher. In 1987, gonorrhea was reported in 43 of 
100 000 persons 10 to 14 years old. in 1028 of 100 000 
persons 15 to 19 years old, and in 1527 of 100 000 
persons 20 to 24 years old, compared with s7 49 of 
100 000 persons aged 25 years or older.25 However. 
when adjusting for rates of semal activity among the 
different age groups, 15- to 19-year-olds actually have 
the highest gonorrhea rates of any age group.26 
Other features of adolescent semal behavior may 
influence the risk of HIV transmission in this popu-
lation. Receptive anal intercourse has been demon-
strated to be an important risk factor for transmission 
of HIV infection. Anecdotal evidence suggests that 
anal intercourse may be practiced frequently among 
some groups of adolescents as a method of avoiding 
pregnancy and of "maintaining virginity." In a recent 
study among African-American and Hispanic inner-
city adolescent females. 25% acknowledged having had 
anal intercourse. 27 Because homosemal and bisexual 
activity has been the major mode of HIV transmission. 
adolescent males engaging in sex with other males 
may place themselves at considerable risk of exposure 
to HIV infection. This may be particularly true since 
homosexual adolescent males who have intercourse 
tend to have older male partners. 26 Based on the 
Kinsey data from the 1970s, approximately 10% of the 
male population is predominantly homosemaL '.19 How-
ever, studies have described 17 to 35% of males having 
bad homosemal experiences during their lifetimes. 
Regardless of eventual sexual orientation, the earliest 
semal experiences of many adolescent males are ho-
mosexual in nature. 1a. 30 
Leu information is available about IV drug use 
among adolescents; however, this is clearly an impor-
tant risk factor. In a national survey conducted in 
1986 of approximately 15 200 high school seniors at-
tending 129 schools, 1% reported ever having used 
heroin and 16.9% reported ever having used cocaine. 
The proportion of students injecting these drugs is 
not known. Drug use can begin very early. Of eventual 
users of these drugs, 10% reported first using heroin 
and 1% reported first using cocaine in the sixth 
grade.J1 A 1987 national survey of HIV -related knowl-
edge, beliefs. and behavior provided information on 
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drug use from four of the participating sites. The 
proportion of students reporting ever having injected 
cocain, heroin, or other illegal drugs ranged from 2.8 
to 6.3%.a2 Since only students enrolled in school were 
included in these surveys, these figures probably un-
derestimate drug use among adolescents. The crack 
epidemic will very likely have an effect on HIV trans-
mission. Although crack use by itself has not been 
directly linked to the spread of HIV, increased high-
risk semal behavior that often accompanies crack use 
has been associated with an increase in STD rates and 
will undoubtedly have a similar effect on HIV trans-
mission. 33. 34 Additionally, injectable forma of cocaine 
and heroin may accompany crack use and increase the 
mk of HIV transmiuion. 3$ It is also important to keep 
in mind that alcohol and marijuana use, which are 
more prevalent than use of opiates among adolescents, 
can lead to impaired judgment about sexual choices 
· ., · and increased risky se:r:ual behavior.3a. 31 
.. , 
KNOWLEDGE. ATTITUDES. BELIEFS AND 
BEHAVIOR 
Although adolescents are at risk of becoming in· 
fected. with and tranam.itting HIV, many of them are 
misinformed about their risk of tran.smiuion. Infor-
mation on adolescents' HIV -related knowledge. atti-
tude, beliefs, and behavior is available from several 
studies. 37-43 Although these studies vary considerably 
in their methodologies and populations surveyed, cer· 
tain common results were found. Overall, most ado· 
lescents knew that se:r:ual intercourse and sharing 
needles for IV drug use are the main modes of HIV 
transmission. Adolescents were somewhat more likely 
to associate HIV transmission with homosexual as 
opposed to heterosexual contact. The most common 
misconceptions were about acquisition of HIV through 
caaual contact and blood donation and believing that 
one could tell if a person was infected with HIV. Even 
with adequate knowledge, many adolescents fail to 
translate this knowledp into appropriate behav-
ior.~7· 37-40 Although some adolescents report changing 
their behavior because of fear of AIDS. few reported 
changes in kinds of behavior that would decrease the 
risk of exposure to HIV (i.e., abstinence or condom 
use •· Perceived risk was found to be associated with 
decrease in risky behavior. Most adolescents expressed 
an interest in learning more about HIV infection and 
AIDS: schools and health professionals were preferred 
sources of information for many.n •2. 44 
RESEARCH NEEDS 
Knowledge related to AIDS and HIV infection in 
adolescents has definitely grown rapidly. Our knowl-
edge in this area. however, still lags behind what is 
known about the disease and infection in young chil-
dren and adults. Further information is needed about 
the clinical. epidemiologic, behavioral. and prevention 
aspectS of HIV infection among adolescents. For ex-
ample, very little is known about the natural history 
of HIV infection in adolescents. Evidence from studies 
of HIV infection in people with hemophilia suggests 
that infected adolescents may have a lower rate of 
progression to AIDS or a longer incubation period and 
may tolerate severe immunodeficiency better than 
adults. 45 More data from a wider range of patients are 
needed to better understand the natural history and 
to determine whether factors unique to adolescence, 
such as the hormonal changes accompanying puberty, 
influence the clinical course of infection and progres-
sion to AIDS. 1 
Further work should be done to evaluate health-
care models for adolescents, particularly since many 
of those at highest risk may have limited access to 
health-care facilities. For many adolescents. their sta-
tus as legal minors may act as a barrier to obtaining 
needed services, such as drug treatment. HIV testing, 
and. in some states, STD treatment. 44 HIV -infected 
adolescents have had very limited access to clinical 
trial&. since research protocols for adults often exclude 
minors and pediatric protocols are generally designed 
for children younger than 13 years of age. 
Epidemiologically more data are needed about dis-
tribution of risky behavior among all adoleecenta and 
about which subpopulations of adolescents are at high-
est risk. Of particular interest is the impact of the 
crack cocaine epidemic on HIV transmission through 
increaaing semal and other risk-taking behavior. As 
more data are gathered from seroprevalence surveys 
and AIDS case reporting, models are needed to provide 
better estimates of the number of HIV -infected ado-
lescents and to monitor the trends. Data on the an-
tecedents of high-risk behavior in adolescents are 
critically needed to prevent these kinds of behavior 
from developing. Evaluation of ongoing intervention 
efforts will provide information to improve our ability 
to prevent HIV infection. 
PREVENTION 
Preventing HIV infection among adolescents will 
require new, creative approaches. AIDS education 
combined with appropriate HIV counseling and 
testing" are critical elements for preventing new HIV 
infections in adolescents. AIDS case data indicate that 
educational messages should cover all risky behavior, 
be targeted to males and females of all racial and 
ethnic groups and sexual orientation, and begin as 
early as the preteen years. Public and private schools 
have a strategic role in educating young people about 
AIDS and specific actions they can take to prevent 
infection. CDC recently published guidelines for com-
prehensive school health education to prevent the 
spread of HIV infection.44 However, many adolescents 
will not be reached by school-based education pro-
grams. In 1984, about 615 000 adolescents ages 14 to 
-4 , • ..f 
17 years and 1.1 million 18- and 19-year-olds were not 
enrolled in school and had not comoleted high 
school.1~ These adolescents wiil need to ~eceive th~ir 
educational messages from other sources. 
Additionally, prevention efforts must go beyond 
imparting information and must help adolescents de-
velop the motivation, attitudes. and skills to avoid 
behavior that places them at risk for HIV infection. 
Clearly, adequate knowledge alone does not always 
translate into behavior change. Innovative prevention 
models that reach adolescents in an acceptable and 
appropriate way must be developed. 
Preventing further transmission of HIV infection 
and AIDS in adolescents will depend on the combined 
efforts of persons who have contact with adolescents. 
Pediatricians and other l!e,..lth profesaionala who un-
derstand and deliver care to adolescents can play a 
critical role by providing appropriate counseling and 
prevention messages. Counseling and ascertainment 
of potential risks for HIV infection should be ap-
proached in a straightforward. nonjudgm.ental manner 
(see Chapter 38). Undemanding the epidemiology of 
AIDS in adolescents may help identify those adoles-
cents at highest risk for HIV infection. However, 
clinicians should remember that any adolescent. par-
ticularly one who is sexually active, can be at risk now 
or in the near future. Counseling should include infor-
mation about risk reduction and waya of protecting 
oneself from HIV infection and, if infected, of reducing 
the risk of posaible transmisaion to one's sexual or 
needle-sharing partners. This second component of 
counseling is often overlooked and may be particularly 
important for adolescents who acquired HIV infection 
from blood or blood products. ;;o These adolescents 
were not infected as a result of their behavior but may 
place current or future sexual or needle-sharing part-
ners at risk of exposure to HIV. 
Targeting adolescents whose behavior places them 
at high risk of ·iiV infection is important. However. 
providing infor .ltion and helping to build skills that 
will prevent otner adolescents from beginning such 
behavior is also crucial. Information about appropriate 
prevention education and approaches for youth is 
emerging but still limited. " 1~ Helping preadolescents 
and adolescents to develop safe sexual behavior and 
to avoid drug use will have a major impact on the 
future of the HIV-AIDS epidemic. Hopefully, efforts 
to decrease the transmission of HIV will also have a 
major impact on other important problems in this age 
group, including teenage pregnancy, sexually trans· 
mitted diseases. and drug use. 
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:pidemiology of Women With AIDS in 
.1e United States, 1981 Through 1990 
. Comparison With Heterosexual Men With AIDS 
jd V. Ellerbrock. MD; Timothy J. Bush; Mary E. Chamoerland. MO. MPH: Margaret J. Oxtoby, MD 
the United States, women account for an increasing number and percentage 
adults with the acquired immunodeficiency syndrome (AIDS). Overall. 51% of 
>men with AIDS were infected through intravenous drug use and 29% through 
!terosexual contact; the proportion of intravenous drug users decreased, while 
e proportion attributed to heterosexual contact increased, between 1986 and 
190. Most women with AIDS were black or Hispanic (72%); residents of large 
etropolitan areas (73%), especially cities along the Atlantic coast; and of 
productive age (15 to 44 years} (85%). However, the proportion of women with 
DS reported by smaller cities and rural areas has increased from 22% in 1986 
28% in '1990. The male-to-female ratio of heterosexuals with AIDS has 
mained about 2.4:1 since 1987. A comparison of women with AIDS to hetero-
~xual men with AIDS showed that these two groups were similar by age, race, 
1d geographic distribution. Also, survival times from AIDS diagnosis to death for 
omen and heterosexual men with AIDS were not significantly different. 
I~CE 1981, when the first cases of the 
cquired irrununodeficiency syndrome 
~IDS) in women were reported in the 
;nited States, the number of women 
..::. .. \.. '-·---- :--·---.J-1! ... ! ... --.... ·-=·-·-' ....... ............. ¥·-·-·"'·"'-'""'•"'-""-'•• ... J • - .... ., 
~IV) infection has increased rapidly. 1 
n 1988-more than 1800 (0.7%) women 
rho gave birth in New York State were 
IIV seropositive, and in some areas of 
~ew York City more than 2% of child-
.earing women were infected with the 
irus.= As a result of this increase. HIV 
Las had a major impact on morbidity and 
nortality among young women. By 
.987, AIDS had become the eighth lead-
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ing cause of death in women of repro-
ductive age (15 to 44 years) in the 
united States and the leading cause of 
death in black women of the same age 
g':"~~;. :.;: ~: ~,, .. ~·v~·!: :.ud :\' c-;,~.! ~~ .. ~~::. 3 !~ 
addition, since HIV-infected women 
tran-<>!'l'tit the virus to about 259C to 35% 
of their children during pregnancy or at 
delivery, increasing HIV seropre>-a· 
lence rates in childbearing women has 
resulted in a gro\\ing number of chil-
dren \\ith HIV infection and AIDS ... , In 
1989, an estimated 6000 infants were 
born to HIV-infected women in\ the 
united States. and probably about 1500 
to 2000 of these infants were infected 
perinatally.' 
understanding the epidemiology of 
HIV infection and AIDS in women is 
essential for developing better public 
health strategies and allocating re-
<:nnrrP" mnrP pffpctivelv to ore\·ent the 
spread of HIV to women and children. 
National AIDS surveillance provides 
information on current HIV-related 
morbidity and mortality and continues 
to be essential in accurately predicting 
national trends and patterns of HIV in-
f.:ctior. in the l:nited S~at.:s! In this 
article, we analyze surveillance data for 
women \\ith AIDS in the United States 
and compare the epidemiology of AIDS 
in women \\ith that in heterosexual 
men. 
METHODS 
This descriptive analysis reviews 
AIDS cases in women reported to the 
Centers for Disease Control (CDC) 
through December 31, 1990. The CDC 
AIDS surveillance system includes all 
50 states. uS territories, and the Dis-
trict of Columbia. Cases of AIDS are 
initially reported to local and state 
health departments. which in turn for-
;;·OJ.·.::! r.:pvi.·~s ;;-ithou:. f.terson.:.l idt::n~if.­
ers to the CDC. '"I! Reports are updated 
to record date of death for persons who 
have died. The CDC defines a case of 
AIDS as an instance of a disease, a: 
least moderately predictive of a defect 
in cell-mediated immunity, occurring 
\\ith HIV infection or no known cause 
for diminished resistance to that dis-
ease.13 Increased use of the HIV an•i-
body test and greater understanding of 
the spectrum of HIV-related diseases 
led to a re\ision of the case definition in 
1987 that expanded the list of diseases 
indicative of AIDS and included some 
diseases diagnosed presumptively (ie. 
\1.;thout histologicai or laboratory con-
firmation). Each c~e of AIDS reported 
. !V ·-
it. 
in women and heterosexual men was 
placed in only one exposure category. 
by using the follO\\ing hierarchical or-
der: (1) intravenous drug use, t2l hemo-
philia or other coagulation disorder, 
(3) heterosexual contact \\ith a person 
at risk for AIDS, (4) transfusion \\ith 
blood or blood products, and (5) unde-
termined risk. Women \.\ith more than 
one reported mode oi exposure to HIV 
are classified in the exposure category 
listed first in the hierarchy. Women 
~lith AIDS were compared v.ith hetero-
sexual men \\ith AIDS, who were de-
fined for this analvsis as men whose re-
ported risk behavior did not include 
sexual contact with other men. Adult 
AIDS natients were 13 vears of ae-e and 
older, -and pediatric ~>\IDS patients 
were less than 13 years of age. 
Data were analyzed by year of report. 
Since only 1020 AIDS cases in women 
were reported during 1981 through 
1985, trend anah·s~s of exoosure cate-
gories were perf;r:-:-t~d on cases report-
ed prior to 1986 and then for each subse-
quent year. 
Geographic analyses were based on 
place of residence at the time of AIDS 
diagnosis. The denominators for rates 
were calculated from 1989 population 
estimates by age, sex, and race. The 
1989 estimates are an extension and 
modification of white/nonwhite age esti-
mates for 1982 and 1984 produced by the 
US Bureau of the Census from 1980 cen-
sus data. The denominators for rates of 
heterosexual men are estimates of the 
adult male population, including homo-
sexual and bisexual men. :Metropolitan 
areas are defined as the .Metropolitan 
Statistical Areas for all areas except the 
six New England states. For these 
states, the New England County )!et-
ropolitan Areas are used. )letropolitan 
areas are named for a central citv in the 
:.letropolitan Statistical A.rea ~r New 
England County flletropolitan Area. 
and they may include several counties 
and cross state boundaries. Kaplan-
:.Ieyer survival analysis was calculated 
by using AIDS cases and deaths report-
. ed through December 31, 1989. Persons 
V~-ith no date of death on the report as of 
December 31, 1989, were presttrned to 
be alive. Statistical testing included 
analysis by X2 tests for associations and 
linear trends. Unless othernise stated, 
all trends or comparisons were signifi-
cant at P<.OOL 
RESULTS 
As of December 31. 1990, a total of 
15 493 (10%) of the 158 279 adults re-
ported V~-ith AIDS in the United States 
were women. Between 1985 and 1990, 
the percentage of adult AIDS cases that 
occurred in women increased from 6. 6% 
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Taole 1.-Numoer and Percentage ot Reported Cases ano Mate-to-Female Ratto tor Women anc 
Heterosexual Men With AIDS tn the Umted States. Oy Year. 1981 Througn 1990' 
No. (~·.1 ot Casest Ratto ot 
tieteroscxual 
'-len to women Year Women Heterosexual Men 
1981t 6 !3 2\ 24 (12 7\ 
1982 47 ~7.4) 151 (23.6\ 3.2 
198J 14-1!70\ 4.35 !21.01 30 
1984 285 !6 4\ ·866 (19 41 30 
1985 538 (6 6\ 1553 (1901 2.9 
1986 960 (7.5\ 2523 {19 3\ 26 
1987§ 1701 (8.11 4127 (19.7) 24 
1988 3263 (10.41 7956 (25.3) 24 
1989 3639 (10.5\ 8836 !25.61 24 
1990 4890 (11 5) 11 632 (27 .3\ 24 
Total 15 493 (9.8) 38 103 (24.1) 25 
• AIDS ondocates the acQuored ommunodelielency synorome. 
tThe oenomtnator for the percentaoe ot cases os au reoonea AIDS cases. including l<.>nY..seJ:ual anc '"sexuat 
men. for tne resoectJve year. 
iReoorung began on mo0-1981. 
§The case oehnrtoon changed in Septemoer 1987 
"AIDS indicates the acQUifed immunodefiCiency synorome. 
tPer 100 000 women (1989 inteteen.SaJ populaliOO estimate). 
iPer 100 000 men. tneluOing hOmOsexuals and bosexuaiS (1989 imereensal populatiOn estimate). 
§Women vs heterosexual men. P<.OOt. 
!!Women vs heterosexual men. P< .OS. 
~Percentages have been rounded to the nearest whOle numbers. 
to 11.5% <Tabie 1). During the same 
period. the percentage of cases in het-
erosexual men also increased. Since 
1985. the largest percent increase of 
AIDS cases in both women and hetero-
sexual men occurred between 1987 and 
1988. Of the AIDS cases reoorted in 
1988. 1322 (41 Lj() cases in women and 
3269 ( 41%) cases in heterosexual men 
met only the 1987 case definition. sug-
gesting that at least part of the increase 
in AIDS cases in these two groups in 
1988 was due to the change of the AIDS 
case definition. Thus, while the propor-
tion of cases in heterosexuals increased 
from 28% in 1987 to 39% in 1990, the 
male-to-female ratio for heterosexuals 
with AIDS remained relatively con-
stant at about 2.4:1. 
Overall. sliszhtlv more than half of the 
women \\ith -AIDS were black, whiie 
about one fourth were white and one 
fifth Hispanic (Table 2). As a result, 
Hispanic and black women had cumula-
ti\·e incidence rates 8 and 13 times. re-
spectively, that for whites. Between 
1986 and 1990. the absolute number of 
women \\;th AIDS increased in all racial 
1[j5 
and/or ethnic groups; however. the pro-
portion of women with AIDS who wen 
black did not change s;rruficg,nrly, whi ! 
the proportion who were hispanic tr. 
creased from 18% to 229C and the pro 
portion who were white decreased fror. 
28'i'c to 25/!c. Although women w::. 
AIDS had a larger prspor:ion oi biac~: 
and a smailer proportion of Hispar.1c 
than heterosexual men v.ith AID~ 
overall these t\vo gr0ur- had simi' :u- n 
cial distributions. Heterosexual me 
who were Hispani~ or black had ..:u:1;;,:_ 
tive incidence ratr.:; 9 F··d 12 times. :-• 
spectively, that for wh!:es. 
At the time of diagnosis of AIDS. :: 
mean and median ages for women we. 
36 vears and 34 T.'L'S, re:e-;:>ectivei 
compared with 38 y~ars and 36. years !~ 
heterose:cual men. About 1 C1c of bo 
women and heterosexual men \\i 
AIDS were 13 to 19 Y""L.-s of age ar t 
time of diagnosis tTable 3). A . ....-g 
proportion of women compared "'~ 
heterosexual men were in their ~ 
when diagnosed (27% vs 16%). a 
many of these women were likely infe 
ed as adolescents. Overau, 85% of we 
Women With AIDS-E!lerorocK 
rith AIDS were of reproductive age 
.o 44 years) at the time oi diagnosis. 
ases of AIDS in women have been 
:nosed in residents of all 50 states. 
10 reporting areas v.ith the highest 
1ulative incidence rates of AIDS 
~s in women included Puerto Rico, 
.1t states located on the Atlantic 
st, and the District of Columbia (Fig-
). These 10 areas reported almost 
ee fourths (12%) of the AIDS cases in 
men. The geographic distribution of 
cerosexual men with AIDS by num-
r of cases and cumulative incidence 
te was similar to that in women. As of 
~cember 31, 1990, 26 657 (70%) of 
103 heterosexual men v.rith AIDS 
ere reported from the same 10 report-
g areas. Puerto Rico had the highest 
1muiative incidence rate of AIDS 
ISes in heterosexual men (224 per 
)() 000 adult male population), followed 
y New York (179 per 100 000), New 
ersey (158 per 100 000), Washington, 
>C (154 per 100 000), and Florida (75 
1er 100 000). New York had the largest 
1umber of both women (4830) and het-
!rosexual men (12 427) with AIDS. In 
Lddition, New Jersey had the second 
argest nwnber of AIDS cases for these 
:wo groups (2120 women and 4782 het-
erosexual men), followed by Florida 
fl923 women and 3802 heterosexual 
men). 
At the time of diagnosis, about 73% of 
women with AIDS were residents of 
large metropolitan areas v;ith popula-
tions over 1 million. Another 21% were 
from small-to-medium metropolitan ar-
eas (population 50 000 to 1 million), and 
the remaining 5% were from nonmetro-
politan areas (population <50 000). 
Large metropolitan areas also had the 
highest cwnulative incidence rate of 
women with AIDS (25 per 100 000 wom-
en), followed by small-to-medium met-
ropolitan areas (nine per 100 000) and 
nonmetropolitan areas (four per 
100 000). However. between 1986 and 
1990, the proportion of women with 
.!...!!)~ !i·v:-.~ srn;..!l-:v-w€Ci~ me:~rvpo!i­
tan and nonmetropolitan areas in-
creased from 22% to 28%. For hetero-
sexual men with AIDS, both the 
percentage of cases and the cumulative 
incidence rate v.-ere highest (71% and 62 
per 100 000 men, respectively) in large 
metropolitan areas and lowest (79C and 
12 per 100000) in nonmetropolitan 
areas. Since 1986, the proportion of het-
erosexual men 'lhith AIDS reported by 
small-to-medium metropolitan and non-
metropolitan areas increased from 249C 
to 299C. 
Slightly more than half of women 'lhith 
AIDS were intravenous drug users fTa-
., r- ~,;~;~;"!1 a!mo~t one third 
Table 3.-Number and Percentage of Reported Cases lor Women and Heterosexual Mef! With AIDS tn the 
Untted States, by Age and Rtsk Groups. as of December 31, 1990• 
No. <~•) of ~ses Ratio of 
Heterosexual 
Group Women Heterosexual Men . Mento Women 
Age group. y 
13·19 157 {1) 280 (1\ 18 
20-29 4171 (27) 6090 (16) 1.5 
30·39 7245 j47) 18541 (49) 2.6 
40-49 2298 115) 8536 122\ 3.7 
;;;50 1622 f11) 4656 (12) 2.9 
Ai$1< group 
IVDU 7858 (51) 26 537 (70\t 3.4 
Sex partner of IVDU 3\llJ (21) 1287 (3\t 0.4 
High·nsk. non·IVDU sex partner 1337 (9)~ 597 i?lt 0.4 
Born in panern II counlty§ 553 (4) 1483 (4):' 27 
Transfusion~ 1466 (9) 3604 (9) 2.5 
Undetermoned 1096 (7) 4595 (12\t 42 
Total 15 493 (100)# 38 103 (100) 2.5 
• AIDS ondiClltes 11\e ac:Quored tmmunodehoency synorome: and IVDU. ontravenous dl\lg user. 
tWomen vs heterosexual men. P< .001. 
;The sex pat111ers ot tnese women •nctuded 498137">) bisexual men. 175 (13%)...,.., wllo ~eeeweo transtusiOfls 
s.nce t9n. 53 (4"'•\ men wllO _,. born on a panern II country. and 611 (46"1.) men infected wrth human 
immunodeficiency vorus with no ,.ported ns1< factor. 
§In these countnes. most of ll'le reported AIDS cases occur on heterosexuals. and lhe male·to-lemale raoo iS 
lll)pr'Ox~~T~;~tely 1:1. 
1\Women vs heterosexual men. P < .0 1. 
,Includes adutt nemopl'uttacs. 
#Percentages nave been rounded to lhe nearest wllofe numDerS. 
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Cumulative in<:tdence rates of cases of the acauored ommunodeficoency synorome 1n women oy state of 
19stdence per 100 000 women. Uhlled Stales. through December 31. 1990. 
were sex partners of intravenous (IV) 
drug users and 99C were sex partners of 
men with other risk factors. lri compari-
son, heterosexual men \\ith AIDS had a 
larger proportion of IV drug users than 
women with AIDS (70lic vs 51%}. while 
a smaller proportion of heterosexual 
men with AIDS reported sexual contact 
\\ith high-risk partners (517c vs 29%). 
:.\lore than two times as many women 
, .. --. .. ,. -· .. ...: .. ;... -o .... ~,.:.\.. 
AIDS. reported heterosexual contac: 
\~ith high-risk partners. The propor-
tions of both groups were not sigrjfi-
cantly different for those who received 
transfusions of blood or blood compo-
nents or were born in a countr: \\ith a 
high rate of heterosexual trans~ssion .. 
From 1986 to 1990, the number of 
women with AIDS who were I\' dru~r 
users increased. but the proportion oi 





Table 4.-Percentage of Reoorted Cases tor Women and Heterosexual Men With AIDS in the Un.ted States. by R•sk Group and Year. as ot De<:embe• 31. 1990' 
A1sk Group :51985 1986 1987 
IVDU 
Women 56 50 50 
Heterosexual men 72 7'2 68 
Sex panner ot IVDU 
Women 14 20 20 
Heterosexual men 3 
H.gn-nsk. non-IVDU sex partner 
Women 8 9 
Heterosexual men < 1 
Born 1n pattern II country 
Women 7 6 4 
Heterosexual men ,, 6 5 
Transfusion reop1ent 
Women 10 , 13 
Heterosexual men 9 13 15 
Undetermmeo 
Women e 5 4 
Meterosexual men 0 ;, 
'AIDS indiCates tne acquoreo 1mmunoclehC1ency synorome; and IVDU. Intravenous orug user. 
users decreased (P = .01) (Table ~). 
During the same period, the propor-
tions of women with both IV dru11:-usin~r 
and other high-risk sex partners in: 
creased ( P =. 05 and P = . 02, respective-
ly). Similarly, the proportion of hetero-
sexual men v.ith AIDS who were IV 
drug users decreased from 72'} in 1986 
to 66% in 1990, while the proportion 
\~ith high-risk sex partners increased 
from 3% to 6%. In addition. during the 
same period the proportions of both 
women and heterosexua: men \\ith 
AIDS who were transfusion recipients 
or who were born in countries \\ith high 
rates of heterosexual transmission 
decreased. 
Survival times from AIDS diagnosis 
to death for 10 558 women and 26 362 
heterosexual men. reported to the CDC 
as of December :31, 1989. were not sta-
tisticallv different. The median survival 
time from AIDS diagnosis to death for 
women was 9.8 months. comoared with 
9.:3 months for heterosexual men. After 
a diagnosis of AIDS. the 3-year sun·h·al 
rate was 20% for women and 19</c for 
heterosexual men. 
COMMENT 
In the 'C'nited States. \Vomen account 
for an increasing number and ~rcent­
age of adults with AIDS. About 51% of 
women with AIDS were infected 
through IV drug use and 29% through 
heterosexual contact. )lost women with 
AIDS were young, black or Hispanic, 
and residents of urban areas on the At-
lantic coast. Although most women with 
AIDS were reported as residents of 
large metropolitan areas. the propor-
tion reported by smaller cities and rural 
areas has increased since 1986. Addi-
tionally, a comparison of \vomen v.ith 
AIDS to heterosexual men v.ith AIDS 
2974 JAMA. June 12. 1991 -Vol 265. No. 22 
showed that these two groups were sim-
ilar by age, race, geographic distribu-
tion. and sun-ivai time from AIDS diag-
nosis to death. 
Since severe, clinical manifestations 
of HIV disease are required for the di-
agnosis of AIDS and the median time for 
progression from HIV infection to 
AIDS may be as long as 10 years, pa-
tients with AIDS represent only part of 
the HIV epidemic." Persons infected 
v.ith HIV who are asymptomatic or 
have HIV-related symptoms not includ-
ed in the AIDS case definition represent 
the other, much larger part of the epi-
demic. In 1989, an estimated 1 million 
persons were i~fected v.ith HIV in the 
Cnited States.' Although the number of 
HIV-infected women at present is not 
known, HIV seroprevalence surveys 
and studies suggest that the epidemioi-
ogy of women who are HIV-infected but 
do not ha,·e AIDS is similar to that of 
women v.ith AIDS. For example. the 
highest rates of HIV infection in women 
have been found in IV drug users. \\ith 
rates greater than 10% reported pri-
mariiy from states in the i'ortheast. ·'" 
State\\ide screening programs of neo-
nate:: for passively acquired maternai 
HI\" antibody found much higher rates 
in states located along the Atlantic 
coast, where seroprevalence was high-
est in inner-city areas and lowest in ru-
ral areas.:.::.:, Routine HIV antibodv 
testing of female applicants for militar:.· 
service found the hi~rhest rates in ~ ew 
Jersev, Puerto Rico:~ew York. Wash-
ingto~. DC, and :>Iaryland: the rates in 
Hispanic and black women, respective-
lv. were four and se,·en times that of 
~-hite women in this group." 
:\lale IV drug users \\ith AIDS ac-
counted for about 80% of the absolute 
difference between the number of AIDS 
157 
1988 1989 1990 
Sol 52 .!.C 
7 J 70 66 
21 21 22 
3 4 .: 
7 9 10 
2 2 
3 4 2 
3 :1 ~ -··--· ---





cases in women and ~he numoer o~ caH:-5 
in heterosexual men. This difference i;: 
probably not the r~sult of distincti\'e 
drug-use behaviors by either group. be-
cause HIV seroprevalence rates among 
heterosexual IV drug users do not differ 
significantly by gender."' Thus, the 
greater number of AIDS cases in het-
erosexual men, as compared with wom-
en, is most likely the result of the larger 
number of men who are estimated to use 
IV drugs.:' 
The hi11:her number of women \\itr 
heterosexuallv transmitted AIDS w~ 
probably the -result of several iactor~ 
Since most IV drug users and virtual!; 
all hemophiliacs are men and some me1 
with HIV infection acquired througi 
sexual contact v.ith other men are bisex 
ual. women in the United States ar 
currently at hig!1er ru:~ than men c 
encountering an HIV-infected hete;c 
sexual partner. In addition. ::eve!'l 
studies of couples v.ith one infec:e 
partnPr :uggest tL:.:. :;he rel~:1ve e:f 
ciencv of sexual transmission of HI' 
from· male to female may be greatE 
than from female to male. :: . .:1 
Several case histories of possible f· 
maie-tr female sext•'ll transmi:::sion 
HIV rave heen renorted. "·.:.; Womt 
v.i .. n AID:: .-.-ho reJ._,ned sex~<.i rei 
tions only v.ith a female partner sir, 
19i7 represented about 0.8% of Ali 
case.: r women repor~ "d to the Cr:: 
through September 30, 1989.-'' ~inei 
five percent of these women with Ali 
were IV drug users. while the rema 
ing 5% were recipients of blood or bic 
prone: ·ts. · · J ca:::- ·in ·:!'leA If'~ 51·r;E 
lance uat.aus.se i1ave du::ur •. -::.h€.~ 
male-to-female transmission. 
)lore knowledge about the nat-.: 
historv of HIV infection in womer: 
needed. A previous study sugge:: 
.v'omcn Witr. f.J .05-E'Ier::lrcc~. · 
he median sur. 
diagnosis to deac .. 
men than in rr;~_ 
nand 357 days l<.. 
.s study of 5&'3:~ __ 
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11. Cent~., , '' '1\VR. 19132:31:50i·51~. 
e:l.$e denLJ,. '•is~au Control. Re•'ision oi the 
' '"C'J'"'d immunodeficiency syn· 
tions have been ascertained throug-h 
AIDS surveillance."' At present, few 
data are available that quantify under-
diagnosis or underreporting m different 
groups, including women and hetero-
sexual men IIlith AIDS. Differential 
completeness of AIDS case reporting 
for women and heterosexual men 'll.ith 
different demographic characteristics 
and risk beha\iors could potentially bias 
data obtained through AIDS surveil-
lance, thus affecting the validity and 
generalizability of the conclusions of 
this report. 
To improve surveillance. the AIDS 
case definition was revised in Septem-
ber 19Si to include several additional 
AIDS-indicative diseases, such as HIV 
encephalopathy and HIV wasting syn-
drome. and some presumptively diag-
nosed diseases. such as Pneumocyst1s 
carinii pneumonia. A higher proportion 
of persons who met only the 1987 case 
definition were female, black or Hispan· 
ic, or IV drug users compared Y.ith 
those meeting the earlier case defini-
tion."' However, many of these persons 
probably would have developed condi-
tions included in the pre-1987 case defi-
nition and been reported at a later date. 
Although additional AIDS cases were 
reported because the case definition 
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was revised in 1987. the ~pidemiologic 
trends for AIDS cases in women and 
heterosexual men that were significant 
prior to the revision continued after the 
revision. 
Mortality statistics, AIDS case sur-
veillance, and HIV seropre~-alence sur-
veys all document the increasing impact 
of HIV on the health of women in the 
United States. Through education and 
counseling, uninfected women can learn 
to protect themselves from HIV infec-
tion, and those with high risk behaviors 
can be referred for treatment of drug 
addiction and/or sexuallv transmitted 
diseases that contribute to transmission 
of HIV. For women alreadv infected 
with HIV. recent advances i~ therapy, 
including zidovudine and other antire-
troviral agents, as well as prophylactic 
measures such as pentamidine isethio-
nate to prevent P carinii pneumonia. 
suggest that early recognition of HIV 
infection with medical interventions for 
persons showing evidence of immuno-
deficiency can delay HIV-related mor-
bidity. Clearly, providing all persons at 
risk for HIV infection readv access to 
education, counseling, and HIV testing 
and appropriate medical follow-up must 
be health care priorities. 
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Women and HN: Feeing the 
Epidemic, a conference on 
women and HIV, will be held 
from 8:30 a.m. to 6:30 p.m. on 
Saturday, Nov. t, at the 
Faculty Center of UCLA. 
The conference, co-
sponsored by AIDS ProJect 
Los Angeles, Ia designed for 
women with HIV and anyone 
Interested or Involved with 
the Issue. Morning 
presentatlona on toplca auch 
as epidemiology, medical 
Issues and prevention will be 
followed by an afternoon of 
workshops on topics auch aa 
actlvlam, safer sex , living 
healthy, legallssuea, 
pregnancy and aubstanca 
uae. Guest apeakera will 
Include Eunice Dlaz, M.S., 
M.P.H., of the National 
Commission on AIDS and 
Mark Katz, M.D. of Kalaar 
Permanent• Medical Center. 
Presentations will be made 
In English and Spanish. 
Donations of $15 or more 
will be appreciated but not 
required. 
For Information, call 
Lori Levine at Being Alive/ 
People with HIV/AIDS Action' 
Coalition, (213) 667-3262 or 
Jeffrey Fricke at (213) 825-
3596. Callers who want 
Information In Spanish may 
call Angle Martinez at 
AIDS ProJect Loa Angeles, 
(213) 962-1600, Ext. 198. 
Researchers waking up 
to needs of women with HIV 
By STEPHAN KORSIA 
with AIDS 
are finally begin-
ning to be heard. 
At this year's 
7th International 
in Florence, Italy, several 
studies focused on health 
issues specifically encountered 
by women with HIV disease. 
These studies confirm what 
AIDS activists have been 
insisting for years: Women 
with HIV suffer from frequent 
gynecological manifestations 
with symptoms that are often 
worse than those observed in 
HIV -negative women. 
Common symptoms 
The two most common 
manifestations seem to be 
genital warts, due to the 
infection by the Human 
Papilloma Virus (HPV) and 
cervical cancers. Both these 
infections benefit from 
patient's diminished immune 
status, and seem to help each 
other's development. 
A study presented in 
Florence by Dr. Katherine 
LaGuardia from New York 
Hospital shows that 61 percent 
of female patients with no 
AIDS symptoms and fewer 
than 200 T 4 cells per mm3 
(cubic millimeters) suffer from 
cervical cancer, versus 38 
percent of patients with more 
than 200 T4 cells per mm3. In 
92 percent of the patients 
studied, these cancers are 
associated with genital warts. 
An analysis of21 studies 
shows that HIV -positive 
women are five times more at 
risk to develop cervical 
cancers. These results clearly 
indicate the need for Pap 
Smears and gynecological 
examinations every six months 
for women with no AIDS 
symptoms and every three 
months for women who 
experience symptoms. 
Genital warts seem to 
appear mainly in women with 
fewer than 250 T4 cells per 
mm3, and cervical cancers are 
more frequent in patients with 
fewer than 150 T4 cells per 
mm3. 
HIV -positive women also 
seem to suffer from a higher 
susceptibility to sexually 
transmittable disease, espe-
cially genital ulcers and Pelvic 
Inflammatory Disease (PID). 
The cervical inflammation that 
develops during these infec-
tions is responsible for an 
increase in the secretion of 
HIV particles in vaginal 
fluids. 
nterestingly, no study 
was presented in Florence 
regarding the incidence of 
recurrent yeast infections 
in women with mv. 
This topic is particu-
larly important because clotri-
mazole vaginal creams, the 
standard treatment for vaginal 
yeast infections, are now 
being sold over the counter. If 
vaginal yeast infections are an 
early symptom of HIV 
disease, repeated use by the 
patient would delay diagnosis 
and initiation of helpful 
therapy. 
A study conducted in 
Georgia shows that women 
with HIV are prone to develop 
oesophageal thrush, Myco-
bacterium Avium infection, 
wasting syndrome as well as 
urinary and neurological infec-
tions. Irregularities in the 
menstrual cycle, as well as 
loss of sexual drive, have also 
been reported. 
Despite earlier diagnosis 
and antiviral therapy, women 
with AIDS still have a shorter 
survival time. A study 
conducted in San Francisco, 
reported that an average of 11 
months passes from diagnosis 
to death in women AIDS 
patients, versus an average of 
15 months for male patients. 
Impact of pregnancy 
The effects of pregnancy 
on the progression of HIV 
disease are better known. 
In patients with no AIDS 
symptoms, pregnancy does not 
seem to have any negative 
consequences, except for a 
possible increased susceptibil-
ity to bacterial lung infections, 
which disappear a few months 
after delivery. 
For women with HIV 
symptoms, consequences seem 
to vary greatly, depending on 
the T4 cell counts and plasma 
levels of p24 antigen, a viral 
protein. Women with HIV 
symptoms seem to give birth 
to a larger percentage of 
infected children. 
Research on the manifesta-
tions of HIV disease on 
women remains limited. 
Especially needed is a preven-
tive treatment plan against 
opportunistic infections geared 
toward women. In terms of 
new HIV infection, women are 
the fastest-growing group. But 
still very little is known about 
the natural history of HIV 
infection in female patients. 
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Women's Treatment and Research Agenda 
The U.S. government's negligence towards women in the AIDS crisis has prompted this attempt to 
aeate a Women's Treatment Agenda. For the past four years, AIDS activists in different countries 
have been raising issues about women's exclusion from research, treatment and educational programs 
engaged in by various government agencies. This past year the focus intensified. In May 1990, ACT 
UP and other AIDS activists "Stormed the NIH• to demand changes in the way drugs were being 
researched by :be federal government. There were many affinity groups at that action, all with 
different foci, hopi'Bg to bring attention to the many levels of bureauaatic blundering, blatant 
discrimination and unnecessary deaths in the AIDS crisis. One affmity group took over the office of 
Dr. Daniel Hoth, Director of AIDS at NIAID. They demanded that the ACfG (AIDS Clinical 
Trials Group) form a Women's Committee. One month later Hoth was confronted by AIDS 
activists at the VI International Conference on AIDS where, again, the same message was repeated 
in the form of a banner reading •NIAID: FORM A WOMEN'S COMMITTEE NOW: Under 
continued pressure and with the threat of another sit-in, Dr. Hoth and Dr. Tony Fauci agreed to 
meet with women from ACT UP /NY and ACf UP /DC to discuss women's issues. At that meeting 
we were met with a great deal of professed ignorance about women's health and HJV as well :.::. with 
sexist belligerence. We demanded that NlAID have a Women and HIV conference within 6 weeks. 
ACf UP initially participated in planning that conference and in submitting names of women with 
HIV and women working with HIV + women in clinics and other settings on a day-to-day basis to be 
on the Steering Committee and to be presenters at that conference. ACf UP's representative on the 
Steering Commiuee formed to plan the conference, had to resign rather than have ACf UP's name 
attached to a process in which the government wrenched control of the conference from the planning 
group. In short, NlAID revised the initial structure and content for the conference. Meanwhile, 
meetings at the Centers for Disease Control (CDC) with Drs. Noble, Berkelman et aJ, revealed their 
intransigence towards changing the CDC definition to include women specific oppommistic 
infections, despite available research evidence. We heard no one solid scientific reason for their 
refusal. Their perspective was sexist and revealed the double standard pervasive in this pandemic. 
The first draft of this document was handed out at the rU'St National Conference on Women and 
HIV Infection (December 13-14, 1990) in Washington D.C. However limited, we believe it provided 
more information than the government bureauaats who were given the opportunity to address the 
1500 participants during plenary sessions. Instead of hearing from women with HJV about their 
symptoms and issues or from practitioners seeing hundreds of HIV + women daily in their clinics, we 
were subjected to an ·AIDs lOr lecture from Dr. Fauci, a presentation on clinical treatments by Dr. 
Daniel Hoth who began by saying he had no information about possible clinical treatments for 
women since NlAID had not researched any, and a presentation by Dr. James Curan of the CDC in 
which he once again refused to admit any problems with the CDC AIDS surveillance definition, 
although it does not contain one single woman specific O?pommistic infection. 
Since the conference NlAID has formed a Women's Health Committee, but it remains to be seen 
what will be accomplished for women through that system. 
In December 1990 we did another action at the CDC and have begun a campaign to obtain 1,000 
endorsements for a call to change the CDC defmition of AIDS. We have also continued to work on 
this agenda. 
1 r·.~ . ..J ... , • .._¥·\;.40 
W-! still consider it a work in progress though it certainly presents far more directions for research, 
education and treatment than what has come out of government agencies in the past ten and a half 
years. This agenda is part of our commitment to pressure the U.S. government until there is a 
concerted effort to actu.ally save the lives of women with HIV I AIDS. 
ACf UP! F1GHT BACK! F1GHT AIDS! 
The Acr UP Network Women's Issues Committee 
May 1991 
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HIV /AIDS: AD International Crisis For Women 
The global AIDS crisis has had a devastating impact on women. While this research and treatment 
agenda focuses primarily on issues specific to the United States, we recognize the international 
dimensions of the AIDS pandemic and are committed to advocating for expanded resources and 
treatmeut options for women worldwide. 
Globally, according to the most conservative estimates, eight to ten million adults are HIV positive. 
Three million, or one-third. are women. The fastest growing number of cases is among women. The 
World Health Organization predicts that by the year 2000 the number of HIV positive women will 
exceed the number of H1V positive men. Already in sub-Saharan Africa, H1V positive women 
outnumber H1V positive men. 2 In some countries of Central and East Africa. women and men have 
been affected by H1V I AIDS in roughly equal numbers since the beginning of the epidemic. The 
number or women expected to be diagnosed with AIDS worldwide during the next two years will 
exceed the cumulative total or all the AIDS cases reponed to the Worid Health Organization during 
the first decade of the paademic.3 
Unfonunat:ely, the response of economically powerful Western nations to the international scope of 
the crisis has been deplorable. The United States has scapegoated Third World countries, partic-Jlariy 
Haiti and the countries of central Africa, rather than providing adequate medical resources and 
financial assistance. By the mid 1980's. many Western scientists and researchers were claiming that 
the HIV virus originated in Africa. None of these claims have ever been scientifically substantiated. 
Fueled by racism and ignorance of local cultural practices, arguments promoting either the Afric:m or 
Haitian "origins" of AIDS were printed in widely read newsmagazines such as Newsweek. .lim, JDd 
U.S. News & World Report. In shon. the presence or h.ip rates or HIV inCecdon in certain Third 
Worid nations was not treated as a va:ing in&ernatioaal health issue. Instead. :Ureaed cities and 
counaies were blamed by the U.S. for •spreading disease• through prostitution and semaJ 
promiscuity.-' Thus. women in u.ese nations have been a-ealed as vectors of disease rather than as 
individuaJ.s with legitimate health concerns. 
In fact, the rapid spread of HIV I AIDS in many of the poorer nations of the world can be directly 
linked to lack of aa:ess to basic healthca.re. culturally relevant edue1tional information. JDd sterile 
medical supplies. All of which can. in turn, be linked to the extraction and exploitation of IOCll 
resources by politically powerful Western nations. The deteriorating economic sicuation in many Thirci 
World countries has adversely affected the health status of entire populations. The b.igh prevalence of 
HIV I AIDS in many nations is only one life-thre:nening epidemic 3.Dlong many others such as malaria. 
malnutrition. and dehydration. All of these life-threatening conditions disproportionately impact 
women and their children. 
1 "WHO Notes & News." World Hellth Forum. Volume 11. 1990. p. 3-'1. 
2 The Futurist. November-December, 1990. 
3 Netter, Thomas. ·world AIDS Day 1990; World Health. November-December, 1990. 
" Sabatier. Renee. Blaming Others: Prejudice. R~c;. ilnd Worldwide AIDS. P::mos, 1988. 
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In every known society worldwide, women are the primary caregivers to children and the elderly. 
Women with HIV I AIDS typically tend to the needs of partners, children, and dependent elderly 
family members before addressing their own healthcare needs. As the epidemic continues, more and 
more women in every country will find themselves caring for sick children and partners and neglecting 
their own needs. The burden of care-giving must be more effectively shared throughout families and 
communities in order to allow women with HIV I AIDS the time, energy, and resources to care for 
themselves. 
IDa:nlatioaal Scope or mv 1 AIDS Crisis 
The impact of AIDS varies tremendously from one country to the next. It would be impossible in this 
short piece to dOCUIIlent the impact of the pandemic in every country in the world. 
Because there has been so much mythology and misinformation about African AIDS promoted by the 
mainstream media in the United States, it is necessary to present a more accurate account of the 
pandemic on the African continent. 
ID Nigeria, for example, there have been relatively few cases thus far. More recently, however, testing 
in urban areas suggests that approximately 4% of urban dwellers in Nigeria may be HIV positive. 
ID Uganda, on the other hand, approximately 23% of the population has tested positive for the human 
immunodeficiency virus (HIV).5 Some villages in Uganda are comprised of only small children and 
the elderly; the vast majority of people between the ages of 20 and 50 have died of AIDS. There are 
200,000 orphans in Uganda, and the number is rapidly growing. 
The hardest hit African countries thusfar have been, in descending order, Uganda, Kenya, Malawi, 
Congo, Ivory Coast, Zaire, Burundi, Rwanda, Zimbabwe, and Zambia. 6 .· 
The following countries on the African continent have reported a case rate of less than one case per 
one hundred thousand residents: Algeria, Angola, Cameroon, Cape Verde, Central African Republic, 
Comors, Equatorial Guinea, Ethiopia, Guinea, Lesotho, Lberia, Madagascar, Mauritania, Mauritius, 
Mozambique, Nager, Nigeria, Sao Tome & Principe, Seychelles, Sierra Leone, South Africa, Swaziland, 
and Togo. 
Every region and every continent has reported AIDS cases to the World Health Organization. Less 
than 15 countries worldwide have reported zero cases of HIV I AIDS thusfar. Countries reporting high 
case rates in Latin America and the Caribbean include: Bahamas, Barbados, Bermuda, Brazil, 
Dominican Republic, Haiti, Mexico, and Trinidad & Tobago. In Southeast Asia, India and Thailand 
arc experiencing small but growing caseloads which should be of concern to the international AIDS 
community. In Europe, Romania, the United Kingdom, Italy, the Netherlands, Spain, and Switzerland 
are coping with relatively large and growing caseloads. 
There is some evidence to suggest that many countries are underreporting AIDS cases. The CDC in 
the U.S. admits to a 40% under count. U nderreporting can be the combined result of three factors. 
FU'St, there may be a reluctance on the part of government officials to acknowledge the growing 
epidemic. Second, many countries still have neither adequate resources to provide accurate testing 
nor health professionals trained to diagnose and treat people with HIV I AIDS. Fmally, because of the 
5 •Louis Sullivan's Health Mission to Africa,• ~Volume 19, #3, March 1991. 
6 All Statistics in this section have been drawn from the World Health Organization's Global AIDS 
Statistics as reported in AIDSCA&E. Vol 2, #4, 1990. They can be taken, at this date, as a rough 
approximation of the international statistics. 
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stigma of AIDS internationally, many people are naturally reluctant to be tested. This is particularly 
true for women. 
Currently, there are approximately 600 AIDS-related studies under way in Africa. Over half of them 
are being directed by researclaers from outside the continent. 7 The reality is that the vast majority 
or Africans will not benefit from most Western medical advances for two primary reasons. First, 
there is no profit in the African market for Western drug companies (and these companies are not 
known for their generosity to the poor). Secondly, many drug treatments and trials are designed to 
address opportunistic infections and HIV-reiated conditions more common in the industrial world.8 
It is no secret that the clinical manifestations of HIV I AIDS in women and people of color have been 
inadequately addressed in the Western industrialized nations. Therefore, many of the research models 
being implemented by Western researchers in Africa reflect the same narrow understanding of the 
parameters of HIV infection that bas plagued research in the West. 
Unfortunately, there bas been very little debate concerning the ethics of research in Africa. Many 
Western researchers see cenain countries in Africa and other parts of the Third World, with their 
large AIDS caseloads and high rates of transmission, as ideal "laboratory settings" for biomedical 
research. A draft repon of the World Health Organization indicates that many AIDS-related research 
activities "have been directed solely by the sponsoring country, with little or no input from local 
investigators. "9 In fact, only about half the AIDS-related studies now being undenaken in Africa 
were ever len own to national AIDS officials when they were begun! Moreover, local investigators are 
often exploited by Western researchers wbo use them to gain access to a population group and then 
never make the research results available to the host investigator. 
Regardless or societal and cultural differences, no researcher should ever be excused from the ethical 
obligation to provide dear, accurate, and culturally relevant informed consent. However, some U.S. 
researchers have argued that "it makes no cultural sense to have somebody give informed consent the 
way we often go about informed consent.• Warren Johnson, a tropical disease researcher at Cornell 
Medical Center claims "it's a little naive for us to expect the same procedures we utilize in Manhattan 
in an urban, educated population to be meaningful and relevant to a rural, largely illiterate 
population...it's not very meaningful to have a thousand sheets of paper with an 'X' on them."10 This 
type of view speaks volumes as to the dangers of Western researchers conducting HIV I AIDS research 
in Third World countries. 
Unfortunately, few researchers have educated themselves regarding the cultural values, customs, and 
languages of the populations from which they are drawing their research subjects. Too many Western 
researchers have naively "confused illiteracy with lack of intelligence and even education. You can 
always translate technical terms to levels that people will understand and encourage potential subjects 
to make an informed choice."11 
7 Palca, Joseph. "African AIDS: Whose Research Rules?" News & Comment. Oct. 12. 1990, p. 199. 
8 Patton, Cindy. lnventinK AIDS. p. 85. 
9 Palca. p. 199. 
10 Palca, p. 201. 
11 Peter I..amptey, Director of Family Health International, as quoted in Joseph Palca's "African 
AIDS: Whose Research Rules." p. 201. 
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Fmally, there is the issue of compensation for participation in research studies. In.one study of 
maternal HIV infection they offered a fhotograph of a child to women who participated in their study, 
and in another it was a bottle of milk.1 The rationale used to justify this exploitation of women and 
their communities is that "cash compensation would prove too tempting."13 More needs to be done 
to insure that women are adequately compensated for their participation in trials which, after all, are 
more likely to benefit the researchers than the actual trial participants in the long run. 
The growing international research interest in Africa finally prompted the World Health Organization 
and the U.S. Public Health Service to convene a group of researchers and health officials to discuss 
the ethical issues. This process began in Annapolis, Maryland in 1990. The idea behind the 
discussion was to take a "first step" towards drafting rules that will apply to all PHS-funded research in 
Africa and other regions in the Third World.14 
These discussions, not surprisingly, have failed to be inclusive or Third World researchers, health 
officials, and people Uving with HIV I AIDS. As activists we must demand that any agenda setting or 
ethical guidelines for Western research in the Third World be open to the participation or 
researchers, social workers, and people with HIV I AIDS from the countries in question. 
There are many actions those of us in the U.S. can take to support and advance the efforts of women 
with HIV I AIDS in the Third World. 
o Interrogate the research of North American scientists who rely primarily on African women, men 
and children as research subjects. What measures are they taking to insure the safer:y.and well-being 
of the populations being researched? Are they working collectively with local doctors and social 
workers? What cultural assumptions are they making about their research population? 
o We often confront researchers here in tlie U.S. with ethical concerns about HIV I AIDS trials 
designed for U.S. based populations of women. When doing so, we must malce it clear that our 
ethical concerns are internationally focused--they extend to all women with HIV I AIDS. Let them 
know that our objections should Jlmi be constrUed as an invitation to pack up their trial and "export" 
it to another country. 
o Demand that local researchers and people with HIV I AIDS be involved in every stage of U.S. 
sponsored research projects in Third World countries, from concept through design and 
implementation. 
o Researchers, government officials, and drug companies~ iYarantee that any beneficial 
treatments resulting from U.S. sponsored trials in the Third World be made available and realistic:Uly 
affordable to ALL people with HIV I AIDS regardless of gender, race, or country of residence. 
Demand worldwide access to treatment for women with HIV I AIDS! 
o Demand that the U.S. Congress increase the amount of humanitarian aid provided to countries 
with high infection rates. Demand a shift from military aid to humanitarian aid. 
o V~gorously challenge any individual who claims that AIDS ..,riginated on the African continent or in 
12 Palca, p. 201. 
13 Palca, p. 201. 
14 Palca, p. 199. 
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Haiti. Demand that they present scientific and sociological evidence to support their misinformed 
claim. 
o Demand that the United Nations/World Health Organization convene and fully fund an 
international conference on women and HIV 1 AIDS. Demand that conference participation accurately 
represent the demographics of the global pandemic. The majority of women attending such a 
conference should be women with HIV I AIDS from countries where women are disproportionately 
impacted. Other participants should include activists, educators, and healthcare providers from around 
the world whose work is focused on women. 
Womea ud mv I AIDS ia tbe Ua.ited States: 
IDtrodlldioa ud Ova view 
It is estimated that over 1 million15 people in the United States are infected 'With mv16 and that 
at least 100,000 of these persons are women. Because of the long incubation . period of the disease, 
the number of CDC defmed AIDS cases is expected to rise dramatically over the next few years17• 
From 1980 through 1990, there have been 100,000 AIDS deaths in the United States. In 1 
991 alone, there will be over 50,000 AIDS deaths in the US. In New York City and other major US 
cities, AIDS is the leading cause of death for women ages 15-44. Nationwide, AIDS is among the top 
five leading causes of death in women of "childbearing" age. 
Epidemiologists have been charting the demographic shift of the pandemic toward women, Hispanics 
and blacks for several years. Women are among the fastest growing groups of newly infected 
persons with HIV. There has been a 31% increase in the number of new AIDS cases in women in 
1990, versus a 22% increase in AIDS cases among men. 18 
Women are the most misdiagnosed, underdiagnosed, and underserved population in the AIDS 
pandemic. Statistics on life expectancy evidences the shortcomings of the health care delivery system 
in respect to women, especially minority women, who are most effected by AIDS. The life 
expectancy for men, from day of diagnosis, currently ranges from between 24 to 36 months. Life 
expectancy for women from day of diagnosis averages between 15 weeks and 6 months. The average 
life expectancy for a black woman in New York City, is approximately 15 days. In San Francisco, 
survival time for women after diagnosis is less than 8 weeks19• 
The reasons for the vast discrepancy in survival statistics are varied. Issues of access to proper 
medical care, treatment, information on early diagnosis and intervention, insufficient funding for 
women and the programs that assist women 'With HIV disease, the Department of Health and Human 
Services' criteria for disability insurance and the Center for Disease Control's classification system, 
are some co-factors for low survival rates for women with AIDS. Access to health care, treatment, 
and education for women is a broad social problem that is not limited to the AIDS pandemic. 
When these problems meet the AIDS pandemic however, the result is fatal. 
Recent seroprevalance data from New York indicate that in younger age groups (13-19; 20-24) an 
15 All of these figures come from the Centers for Disease Control (CDC) and other government 
agencies which admit at least a 40% undercount. We believe the undercounting of women is even greater 
since neither the CDC surveillance defmition of AlDS nor their classification system include a single 
woman specific opportunistic infection. 
16 It is estimated that one million people in the U.S. are infected with HIV. There may be along 
prodromal period before the development of symptomatic AIDS, and fulminant AIDS may develop in 
30% or more of infected persons within a 3-5 year period. Even if the spread of infection slows, the 
number of AlDS cases will continue to increase, unless effective early intervention strategies are 
developed. 
17 Broder, Samuel. "Pharmacodynamics of 2',3'-Dideoxycytidine: An Inhibitor of Human 
Immunodeficiency Virus," The American Journal of Medicine. Vol. 88, Suppl SB, 1990. 
18 HIV /AIDS Surveillance Report: August 1990. 
19 Current results of the Project AWARE natural history study being conducted at San Francisco 
General Hospital, Judith Cohen, PhD 
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equal or higher percentage of women, compared to heterosexual men, are seropositive20• And, for 
reported AIDS cases, the second highest percentage· of cases of women within an age grou~ are 
women 65 years of age and older ·23% of the cases at this age are reported among women 1. Of 
the women diagnosed with AIDS, 52% are black, Z7% are white, 20% are Latina, and Asians and 
Native Americans comprise a little less than 1%, though their numbers are increasing dramatically. 
Currently, the majority of women with HIV illness are low-income and rely.on Medicaid and public 
health care facilities for their primary health care needs. The AIDS pandemic has exposed the 
serious failures of the public health care system in meeting the needs of women. 
20 New York City Department of Health, Division of AIDS Program Se~ces, HIV Serosurvey Unit. 
AIDS and HIV Infection in New York City-Men and Women. Vol 1, #3, 1990. 
21 CDC, DOH, HIV /AIDS Surveillance. U.S. AIDS Cases Reported through Nov., 1990. 
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AIDS is a Crisis ror Womea.. What is tbe u.s. GoftrameDt'' Respoa.se? 
Edac::atioa 
The government has cut $30,000,000 out of the AIDS budget which would have gone for education 
and prevention specifically for women and children with HIV. Women are among the fastest 
growing groups of newly infected persons with HIV and therefore are among the most needy in terms 
of materials for education and prevention. It is not me: ely government inaction which is respons1ble 
for the spread of AIDS, the government it would seem is actually taking steps to insure the spread 
of AIDS among women by cutting back on preventative and educational services. 
The Center for Disease Control's (CDC) classification of AIDS does not recognize HIV-related 
opportUnistic infections which are specific to women. Pelvic Inflammatory Disease (PID), chronic 
vaginal candidiasis, chlamydia and Human Papillomavirus (HPV) are a few of the manifestations of 
HIV which are specific to women. Because the CDC does not recognize women specific 
opportUnistic infections, women are not accurately represented in national statistics on AIDS. If a 
woman dies of PID or HPV, even though she is HIV positive, her death is not registered as an AIDS 
death. 
The CDC is a government agency and other government agencies, such as the AIDS Clinical Trial 
Group (AcrG) and the Social Security Administration, use the CDC's information to form policies 
and set agenda:; for research. The CDC is not malcing responsible decisions in terms of women with 
HIV infection and their bias in policy malcing is responsible for the deaths of hundreds of women 
with HIV. In a study of the death certificates of women for whom HIV /AIDS was listed anywhere, 
recently conducted by the CDC, it was found that 48% of women died of conditions not listed in the 
CDC definition for AIDS22• This clearly illustrates that the CDC is not accurately representing 
how HIV is impacting women. Other institutions which in turn base decision making on the 
information provided by the CDC are excluding women's interest in their policy-making process. 
Funhermore, the CDC must make an all out effort to conduct responsible studies which establish the 
natural history of HIV in women. Physicians who treat women must be provided with materials 
which outline early symptoms and strategies for care. Physicians, especially in rural areas, rely on 
CDC guidelines for diagnostic information. Researchers set priorities based on natural history 
studies. Effective treatment for women with AIDS cannot be fully established until the CDC 
acknowledges and reports on how women are being affected by HIV. 
It comes as no surprise that opportunistic infections and indicator diseases related to HIV will be and 
are different in women. Possibly, the power of this document lies in its departure from continuously 
establishing that gynecological infections, for example, or metabolic consumption of pharmaceuticals 
are different in women. In this document, we auempt to begin to suggest a treatment agenda that 
gives direction to research, both in terms of drugs/treatments and basic science for women with HIV 
infection. 
Very little research has been done on women with HIV infection. Women are both technically and 
functionally excluded from AIDS clinical research. Because there are very few FDA approved 
22 Chu, Setal. •Impact of the Human Immunodeficiency Vtrus Epidemic on Mortality in Women 
of Reproductive Age, United States,• JAMA, July 11, 1990, 254(4):225-229 . 
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drugs/therapies to treat AIDS and its associated opportunistic infections, clinical trials are for many 
the only m :·:tanism for access to therapeutics. 
Many AIDS Clinical Trial Group (ACTG) trials require a CDC defined AIDS diagnosis as entry 
criteria. As women are not represented in the CDC's definition, they are barred entry into these 
trials. Most clinical trial participants fmd out about trials through primary Ca.re physicians. The 
majority of women affected by the AIDS pandemic are low-income and depend on public health 
facilities for their primary health care needs and often are not provided with information on bow to 
gain access to experi::uental therapeutics. Whlle the institution of parallel track programs are 
commendable, because of the vast amount of paper work required for these protocols, public health 
physicians are reluctant to enroll patients. The ACTG bas been negligent in the recruitment of 
women into trials. 
Women are often excluded from clinical trials because of their "child-bearing potential". Almost all 
ACTG trials require women to be on some type of contraceptive rather than having trial arms for 
pregnant women. Those with a contraceptive requirement do not offer specific criteria for 
acceptable forms of birth control, some of which could be dangerous for women with HIV (for 
example pills or IUDs). Researchers interpret the requirement as stringently as they see fit. 
Adequate birth control for some researchers may be word of mouth confirmation, others require 
measures as drastic as sterilization. Women's "reproductive potential" should not be held as trade 
for access to poSSible life-saving therapies. This is immoral. 
There are no women specific questions in protocol guidelines for case reports. Women experience 
many gynecological manifestations of HIV, yet pap smears and pelvic examinations are not part of 
standard research protocols. Routine pap smears and pelvic exams as a standard of practice in 
clinical research could provide a mechanism for gathering data on the progression of HIV in women. 
Women specific case questions would also provide a mechanism for more thorough and accurate 
drug evaluation. What effea, for instance, does ddl have on menstruation, pregnancy, or the 
development of cervical cancer? A drug's toxicity is not adequately established until these questions 
are answered. Toxicity is supposedly established in phase I clinical trials and therefore women mus~ 
be included from day one of phase one testing of drugs to treat life-threatening illnesses. 
The scope of AIDS in women is unknown because accurate means of tracking the pandemic in 
women do not exist. Statistics are showing a rapid rise of AIDS cases in women. despite poor 
diagnostic measures. Transmission risks and education are severely under-researched. Vutually 
nothing is known about woman to woman transmission of the virus, although there are increasing 
numbers of documented cases. Risk assessment procedures do not address or represent the real 
world of the AIDS pandemic. 
The government bas not responded to the AIDS crisis in women, therefore we, women with AIDS, 
their lovers and advocates are. In this document we will outline a strategy for a treatment and 
research agenda for women with HIV. We will address the following: 
o De.scripdoa ol Oiaic:al Manif'esaatioas 
o Standard ol Care Recommendations 
0 Critique ol Rtsearda 
o Tra·•smissioa 
o Centers for Disease CoaD'ol's (CDC's) Policy 
0 Additional Refen:na:s 
. ' 
Description or Some Clinical Manifestations or mv in Women 
o Pelvic Inflammatory Disease 
o Bacterial Pneumonias 
o Menstrual Irregularities 
o Tuben:ulosis 
o SemaJJy Transmitted Diseases 
• 11lia !ledi• is sdJI iD JII'OIICSS. It is Dot iDdasift ol aD diaical ID&Dif'c:stati.-s ol BIV diseuc iD. ............ 
Pdnc lnOammator:r J)iseue 
Pelvic Inflammatory Disease or PID is probably the most under-researched and life-threatening 
gynecological complication of HIV infection. Little is known about the pathogen most commonly 
causing this infection in HIV positive women. In fact, most of the scant AIDS literature published 
on PID still remains in the realm of epidemiology. Nonetheless, infectious disease spec::ialists and 
gynecologists seeing women with HIV infection anecdotally report an alarming rate of PID that is 
resistant to traditional t.-eatment resulting in tuba-ovarian abscesses and radical hysterectomy. 
On October lOth, Phillip J. Illits' article, "Growing Concern Over Pelvic Infection in Women• was 
published in the New York Tunes. According to the article, PID "must be counted as the most 
important sexually transmitted disease affecting women, excepting only AIDS: Probably it is 
unnecessary to sever the tie between the two seemingly separate illnesses. And the rates of PID have 
alarmingly sky-rocketed in the past twenty years, especially among young women. If we look at the 
increase in the number of cases of ectopic pregnancies (half of which are caused by PID) we see 
something more than a ripple effect. In 1970 there were 18,000 tubal pregnancies. Alarmingly, 16 
years later, the new number of cases hovers at 84,000. Dr. Patricia Kloser, director of the AIDS 
Program at the University of Medicine and Dentistry of New Jersey, reports that "seven percent (of 
her patients) have PID that is often so severe it is more likely to require hospitalization than some 
AIDS-defined infections. •23 
Although much anecdotal information abounds, and epidemiologically few studies have been 
completed, Dr. Howard Minkoff at SUNY Downstate Medical Center in Brooklyn suggests that 
further investigation of PID and HIV is needed24• In New York Ciry-in 1989-1990-there were two 
reported deaths due to PID. A single death from this disease was reported to the New York City 
Department of Health in the ten years prior. Could these women have died from a refractory PID 
complicated by HIV-infection? 
Unfortunately, PID diagnosis is difficult. According to Illits' article, "It takes ploce in a part of the 
body that is inaccessible to doctors: Furthermore, while PID diagnosis can be made by examining 
the abdomen with a surgically inserted instrument called a laparoscope, Mary Beth Caschella writes 
that, "HIV -infected women may be unable to mount an immune response, causing the inflammation 
and pain by which professionals are able to make a diagnosis. •25 This means that traditional modes 
of PID diagnosis must be re-evaluated for women with HIV -infection, as is the case with cervical 
neoplasia and HIV. 
Some clinicians have suggested that PID can present itself as a form of disseminated tuberculosis. 
This comes as no surprise. According to Dr. Kloser, chlamydia and gonorrhea, common cause 
pathogens in PID, are easily treatable in the HIV infected woman26• Thus, the cause of PID 
infection is quite possibly not related to GC or Chlamydia. If there were that relationship, 
presumably more traditional modes of treatment for PID would be effective in the HIV -infected 
23 Ms. July 1988, p. 67. 
24 Hoegsberg et al. ·sexually Transmitted Diseases and Human Immunodeficiency Virus Infection 
Among Women with Pelvic Inflammatory Disease,· American Journal Obstetrics and Gvnecoloc. 1990; 
163:1135-9, vol4, part 1. 
25 Treatment Issues, Vol S no. 1, p.5. 
26 Based on a conversation in Aprill990, at UMDNJ and her oral report at the Women and HIV 
Conference (Dec. 1990). 
woman, but they are not. Lab analysis of pathogens responsible for PID is crucial if we are to begin 
to research treatment modalities for HIV-infected women. Also, to unravel the mystery as to why so 
many HIV-infected women regularly experience amenorrhea we might look to PID and its resultant 
tubo-ovarian abscess as a cause. 
There are many unanswered questions about the relationship between HIV and PID. In the 
immediate future, certain pieces of information must be ascertained if treatments for 
HIV -complicated PID are to be further researched. What follows is a list of recommendations for 
research in thiJ area: 
o Determine the pathogem responsible for refractory PID. 
It comes as no surprise that HIV -related PID appears to be untreatable if the assumed 
pathogen is, for example, C. trichomatous, when in fact it is Tuberculosis. 
0- Develop new methods for diagnosis. Make laparoscopy more readily available. 
o When PID is suspected in the HIV -infected client, immediate referrals for accurate diagnosis 
and pOSSible hospitalization should be made. 
Primary respiratory illnesses account for the largest proportion of life-threatening opportunistic 
infections occurring in people with HIV disease, AIDS and AIDS-Related Complex (ARq27• 
Pneumocystis Carinii Pneumonia (PCP) is still the leading cause of death ~ people with Acquired 
Immune Deficiency Syndrome (AIDS), despite the availability of prophylaxis such as aerosolized 
pentamidine, Bactrim and Dapsone. Moreover, PCP is the most common AIDS defining 
opportunistic infection reponed to the CDC. Currently, reponed incidences of PCP presenting as an 
in..tial AIDS defining opportunistic infection are higher for women than men28• Similarly, of the 
major AIDS defming opponunistic infections, women present more frequently with Mycobacterium 
avium-intrac:cllulare (MAl) than do men29• The respiratory tract is the most common ponal of 
entry, though edlty through the gastrointestinal tract may OccurJO. Vutually no research has been 
done to examine why women present more frequently with PCP and MAl. Clearly there is a lack of 
research on the affects of therapeutic agents for these opportunistic infections in relation to women's 
physiologies. That women with HIV infection present more frequently with PCP and MAl begs the 
question: Do women have a greater suscepubility to pulmonary incidence of HIV related 
complications than do men? 
In the last ten years in the U.S. there has been an increase in the death rate of women from bacterial 
pneumonias31. Whether these women presented with HIV infection is unknown. Clearly it is 
possible as HIV infected persons are more suscepuble to bacterial pneumonia and other 
non-pneumocystis carinii pneumonias, including fungal pneumonias, than the general population32. 
Additionally, in a CDC study of the death certificates of women who had HIV /AIDS listed 
anywhere, pneumonias other than PCP were listed as the cause of death for 14% of the C3Ses33• It 
is estimated that 10-20% of pneumonias manifesting in people with HIV are community-acquired 
bacterial pneumonias, Hemophilus influenzae, Streptococcus pneumoniae and Branhamella 
catarrhalis being among the most common. When examining the non-AIDS fatal outcomes of HIV 
infection in women, bacterial pneumonias warrant much further study. 
27 Hadley WK, NG I, ·organization of Microbiology Laboratory Services for the Diagnosis of 
Pulmonary Infection in Patients with Human Immunodeficiency Virus Infection,· Seminars in Respiratorv 
Infections. Vol4, N2(June), 1989; 85-92. 
28 C Wofsy; data from a study at San Francisco General; presented at the National Conference on 
Women and HIV Infection, Washington DC, Dec. 13-14, 1990. 
29 G Friedlander, data from a 1987 study presented at the National Conference on Women and HIV 
Infection, Washington, DC, Dec. 13-14, 1990. 
30 Hadley, pp 85-92. 
31 "Women's Unexplained Deaths Cited,· Newsdav. 14 June 1988. 
32 Polsky B, et a1, ·Bacterial Pneumonias in Patients with Acquired Immunodeficiency Syndrome; 
Annals of Internal Medicine. 1986; 104:38-41. · 
33 Chu SY. et a1, •Impact of the Human Immunodeficiency Virus Epidemic on Monality in Women 
of Reproductive Age, United States. 
The true scope of bacterial pneumonias presenting in people with HIV infection has not been 
adequately researched. It is clear, however, that pyogenic bacteria are the cause of a substantial 
number of respiratory infections in patients infected with HIV. This is not as surprising as HIV 
infects macrop~s, B Lymphocytes and alters B lymphocyte function- -increasing a patients risk for 
bacterial infection . Incidences of H. Influenzae, S. Pneumoniae and Branhamella catarrhalis 
seem to be associated with underlying B-cell defects described in people with AIDS35• Incidences 
of serious pneumococcal infection are inversely relational to CD4 counts and in persons with HIV 
there is a high rate of recurrence, evidencing the need for ongoing therapy after initial presentation. 
Neutropenia seems to be related to increased suscepubility to bacterial infection. Neutropenia is 
not, at present, considered to be a symptom of HIV disease but has been seen directly associated 
with drugs used for the treatment of HIV infection such as ZDV, gancyclovir, and pentamidine. 
Absolute neutropenia is associated with bacterial infections in patients with HIV disease36• 
Epidemiology 
Bacterial infections have been recognized as a cause of pulmonary disease in AIDS patients since 
early in the pandemic. Health workers have been reponing increases in the rates of 
community-acquired pneumonias in patients with HIV disease, AIDS and ARc37• Similarly the 
incidence of nosocomial or hospital-related pneumonias are increasing in patients with HIV disease. 
In some sites, Methicillin-resistant Staphylococcus aureus (MRSA) is presenting in epidemic 
proportions. MRSA strains often spread quickly among the most seriously ill, antibiotic-treated 
patients38• MRSA strains are, of course, very serious as they are resistant to most therapies. 
Injection drug users (IDUs) are at increased risk for bacterial pneumonias39 This is ememely 
imponant to acknowledge when giving women information on treatment options as over 50% of 
women with reported AIDS are reported with injection drug use as a risk factor.w. 
Oinical Feata.n:s 
Signs and symptoms of bacterial pneumonias in seropositive individuals are similar to the typical 
.clinical finding of community-acquired pneumonias in non-HIV infected patients, though infections 
are often more severe and occur more frequently. Fever, a productive cough, dyspnea, chest pain, 
and focal consolidation are typical manifestations. HIV seropositive adults usually present with 
encapsulated H. In.fluenzae. Typically, though not always, patients presenting with bacterial 
34 Polslcy B, et al, ·Bacterial Pneumonias in Patients with Acquired Immunodeficiency Syndrome". 
35 Chaisson RE, •Bacterial Pneumonia in Patients with Human Immunodeficiency Virus Infection,· 
Seminars in Respiratorv Infections, Vol4, No 2 (June). 1989; pp133-138. 
36 Ibid. 
37 Ibid. 
38 [Letter], "Methicillin-Resistant Staphylococcus aureus: Do We Just Have to Live with It?; Annals 
of Internal Medicine. Vol114, #2, 15 January 1991; p 162. 
39 Des Jariais DC, Friedman SR. Stoneburner RL, "HIV Infection and Intravenous Drug Use: 
Critical Issues in Transmission Dynamics, Infection Outcomes, and Prevention,· Reviews of Infectious 
Diseases. Vol 10, Mo 1, Jan-Feb 1988: 151-164. 
«> HlV I AIDS Surveillance Report, 1991. U.S. Centers for Disease Control January 1991. 
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pneumonias have a higher white blood count (WBC) than baseline WBCs for patients presenting 
with PCP. The majority of patients with respiratory illness will have abnormal chest radiographs. 
Chest Radiograph. The chest radiograph (chest x-ray) is considered the best initial screening tests. 
HIV + patients with bacterial pncumonias most often have focal infiltrates characteristic of 
community-acquired organisms. Many patients have single segmental or patchy lobar infiltrates. 
Acute diffuse infiltrates arc reponed common in patients with H. Intluenzac. Dense lobar 
consolidation is seen frequently in patients with S. Pncumoniac41• 
Gram.Stain. Patients with abnormal radiographs should have sputum collected for gram-stain and 
culture. The presence of polymorphonuclear leukocytes (PMN) is not common in patients with PCP 
or mycobacterial pneumonias and is commonly seen with bacterial pneumonia. A predominance of 
gram-positive diplococci or pleomorphic gram-negative coccobacilli may be seen with pneumococcal 
and H. Influcnzae pncumonias, respectively. Cultures of sputum and blood offer more dcftnitivc 
diagnosis of a bacterial infection. Bacteria causing pneumonias in patients with HIV infection are, 
gram-positive: Streptococcus pneumoniae, Group B Streptococci, Staphylococcus aureus and 
gram-negative: Hemophilus in.fiucnzae, Hem~hilus sp, Branhamella catarrhalis, entcrobactcriaceac 
and, less frequently, Legionclla pncumophilia . Gram-stain is not conclusive in determining PCP 
infection. 
Open Lung Biopsy is not recommended as pan of routine evaluation. Though it may be the most 
complete diagnostic technique, it is very painful and costly. Other diagnostic methods, such as 
bronchoscopic procedures should precede open lung biopsy43• II sputum does not provide a 
diagnosis, bronchoscopy has been highly successful in detecting pathogens. Needle aspiration should 
be used as a last resort as pneumothorax can easily occur. Less invasive techniques should be 
employed first. 
Because of the large number of potential pathogens, an aggressive diagnostic approach to establish 
etiologic diagnosis and to help direct therapy is warranter. Antibiotic therapy should be carefully 
monitored because of possible kidney and hearing problems resulting from toxicities. Women 
beginning antibiotic regimens should be made aware of posstble side effects. If a yeast infection 
appears or worsens, it could be indicative of overly high dosages. Antibiotic therapy, if managed 
properly, does not cause yeast infections. Antifungal regimens to prophylax against yeast infections 
could only further disrupt the bodies natural flora. 
Empirical treatment of patients with strong clinical indications of bacterial pneumonias with 
cefuroxime or ampicillin may be warranted. H. Influenzac seems to be highly responsive to 
41 Polsky B, et al, "Bacterial Pneumonias in Patients with Acquired Immunodeficiency Syndrome: 
42 Chaisson RE, "Bacterial Pneumonia in Patients with Human Immunodeficiency VU'US Infection: 
43 Luce 1M, Clement MJ, "Pulmonary Diagnostic Evaluation in Patients Suspected of Having an 
HIV-Related Disease: Seminars in Respiratory Infections. Vol 4, No 2(June), 1989:pp93-101. 
44 Polsky B, et al, "Bacterial Pneumonias in Patients with Acquired Immunodeficiency Syndrome: 
ampicillin. In areas where beta-lactamase-producing H. Influenzae is high, amoxacillin-clavulanic 
acid should be used instead of penicillin. Penicillin resistant stains of Hemophilus are not 
uncommon. Antimicrobial treatments should be employed to see what the bacteria is sensitive to. 
Injection drug users who may have bacterial endocarditis or pneumonia should be treated with an 
anti-staphylococcal agent such as nafcillin, as well. Specific therapy for bacterial pneumonias should 
be tailored to the in vitro susceptibility of the organism. Resistant strains of H. Influenzae have 
been detected in western Europe, indicating the necessity for geographical monitoring for resistant 
strains. 
Response is prompt in patients with HIV infection. Improvement of symptoms and clearing of 
infiltrates usuallv occur in several days in adult patients. Patients with gram negative pneumonias 
other than H. Inftu110Zae, the most common bacterial pneumonia presenting in people with HIV 
infection, have a poor prognosis of short term survival time. Patients with HIV -related bacterial 
infections have a 25-50% rate of recurrence. Continued antibiotic therapy is recommended. 
Prnaatioa 
Because of the high incidence of bacterial pneumonias, bacteremia and recurrence of HIV-related 
pulmonary complications. prophylaxis and prevention methods should be utilized. Both prophylactic 
antibiotics and immunotherapy are proving to be useful in controlling and preventing bacterial 
cOmplications. 
Trimethoprim-sulfamethoxazole (TMP-SMX) has been used for prophylaxis against encapsulated 
bacteria and is advantageous as a PCP prophylaxis as well. It is not recommended, however, 
because of the increasing incidences of adverse reactions in people with AIDS to sulfa drugs. 
Adding ampicillin to pentamidine may be effective in prophylaxing against both PCP and bacterial 
infections. Bactrim may be useful in prophylaxing against bacterial lung infections as well. 
Immunotherapy such as PATH or HIVIG, to prevent bacterial pneumonias has been recommended 
in some settings. The efficacy of vaccines in patients with HIV infection is doubtful a.s protective 
antibody responses do no: typically occur45• 
Preventative therapies should be examined and considered in light of the context of each woman's 
life. Women should be informed of their risk for bacterial infection and their treatment options and 
then be let to make an informed choice on the specific course of prophylaxis. For instance, a 
woman who is an injection drug user should be informed that HIV seropositive IVUs experience a 
seven-fold increase in the rate of bacterial complications compared to seronegative IVUs, 
community-acquired bacterial pneumonias and hospital-acquired pneumonias should be adequately 
addressed and treatment options and risks should be outlined. 46 
Tbe followiag is a list ol guideli.aes ror resea.rda: 
o As women seem to be disproportionately affected by PCP than are men, women need to be 
actively recruited into BW566 trials. While PCP is presumably caused by a protozoan, it is 
45 Ibid. 
46 Other resources include 
Witt DJ, Craven DE, McCabe W, •Bacterial Infections in Adult patients with Acquired Immune 
Deficiency Syndrome and AIDS-Related Complex,· The American Journal of Medicine. Vol82, May 1987~ 
pp990-906. 
ed Devita VT, et ai.. AIDS Etioloc DiaiJ!osis. Treatment and Prevention. second edition. J.B. Lippincott 
Company, NY, 1988. 
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essential to address PCP when coosidering pulmonary incidences of HIV infection in women. 
o Abbott Laboratories must lmmedlately establish a compassionate use protocol for 
Clarithromycin for the prophylaxis of MAI. Women, who are disproportionately affected by 
MAI, should be actively reauited into existing trials. 
o Trials must be conducted to examine the efficacy and toxicity of Clarithromycin in combination 
with drug detox therapies such as Methadone, a similar approach musfbe employed with 
BW566. Additionally, arms of these trials must be designed to examine the efficacy and toxicity 
of these pharmaceuticals in combination with street drugs. This information is essential towards 
obtaining a clear profile of these therapies in the real world of the AIDS pandemic. 
o Gender relational research must be done to examine the suscepttbility of pulmonary incidences in 
people with HIV infection. 
o Research must be conducted to determine gender relational respooscs to current therapies for 
bacterial pneumonias. 
o Clinical trials of pneumococcal and other vaccines in patients with HIV infection must 
begin immediately. Women specific questions must appear on all case reports for all trials 
and pap smears, colposcopy and cervical examines must be conducted routinely. Women should 
be actively reauited into these trials. All trials should be located in centers that serve large 
numbers of women and child care must be provided during visits. 
MEDLINE searches reveal that the handful of studies which mention women with HIV do not 
address women's reproductive health-specifically menstrual irregularities. As this Treatment 
Agenda desaibes in other sections, the few medical reports which do exist largely treat women in 
terms of their capacity to transmit HIV to men and children. 
The lack of attention to women's health results in many unanswered questions. How does HIV affect 
women's menstrual cycles? How do HIV and drug treatments like AZr and ddl affect levels of 
progesterone and estrogen? When HIV infected women suffer from secondary amenorrhea 
(cessation of menstrual periods) or dysmenorrhea (difficulty with menstrual periods) what are the 
causative factor(s)? The laclc of gynecological care at clinical trials means that it is unknown which, 
if any, sexually transmitted diseases (STD's) or gynecological infections are present. 
Women's complaints about amenorrhea or dysmenorrhea are generally not recorded in medical 
records of HIV clinical trials. Because of this and because women are not usually asked about 
menstrual difficulties, it is difficult to draw conclusions. It is also impossible to conduct retrospective 
studies. 
HIV infected women frequently complain about painful periods and bleeding which lasts for weeks, 
as well as a laclc of bleeding. 
Women suffering from all chronic fatigue syndromes report an inaease in pre-menstrual syndrome 
(PMS) problems (breast tenderness, bloating, more aamps, longer periods, mood changes). It is 
also known that sub-acute, chronic Pelvic Inflammatory Disease (PID) and bacterial infections can 
cause longer periods, which are exacerbated for immunocompromised women. 
Some H!V infected women report that it is common knowledge among themselves that AZT is 
connected to worsening aamps, painful blood clotting, and menstrual periods which last 10 to 15 
days. Many women take themselves off AZr because of dysmenorrhea. Women on ddl and in other 
experimental trials often report common knowledge about similar menstrual problems. 
During which part of the menstrual cycle is the extended bleeding taking place? Is it related to 
ovulation bleeding? 
Do AZT or other drugs inaease estrogen? Do they inaease progesterone (which causes glands in 
the endometrium to seaete nourishing substances and which increases uterine blood supply)? 
Would these cause longer and heavier periods? Or are the arteries and veins in the uterus pinched 
off too slowly? later than they should be? 
Dysmenorrhea researcher Katherina Dalton theorizes that one type of dysmenorrhea (spasmodic) 
results from too much progesterone in relation to estrogen, and the other (congestive) as well as 
PMS result from too much estrogen for the amount of progesterone-from a progesterone deficiency. 
Amenorrhea is associated with stress, weight loss, and street drugs, particularly heroin. How does 
HIV-related wasting fit in? Or poor intake of food because of poverty or drug use? At a New York 
Community Health Project or Bronx-Lebanon Medical Center, where women frequently complain of 
amenorrhea. roughly 60% of the women are present or former drug users. 
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It is imperative that researchers and care providers begin to record women's complaints and begin to 
ask women about their reproductive health. Women who do complain of dysmenorrhea or 
amenorrhea should be taken seriously and diagnosed-menstrual problems should not be merely 
taken for granted. Women should receive a pelvic exam, pap smear, ultra sound, etc. Anemia 
should also be monitored in women who suffer extended bleeding. 
If HIV infected women share common knowledge about how AZr, ddl, or infections affect their 
reproductive health, why do researchers and care providers remain ignorant and unwilling to record 
women's complaints? Until clinicians become involved in the health of women they are treating, HIV 
infected women are likely to continue prescnbing their own relief from menstrual pain (such as 
taking themselves off AZT - sometimes without informing their clinicians) Clearly this benefits no 
one. 
Vaginal candidiasis also known as vaginal thrush or yeast infection, is a fungal infection generally 
caused by Candida a]bicans. Its most common symptoms are severe vaginal itching and a thick, often 
white discharge with the consistency of cottage cheese. It is a common probl~m which most women 
will develop at least once. It is often caused by antibiotic therapy, use of corticosteroids, birth control 
pills or immune suppression associated with pregnancy. Vaginal candidiasis is usually treatable by the 
use of common antifungal agents such as Gyne-Lotrimin (a trade name for the generic drug 
clotrimazole ). 
When a woman with mv I AIDS develops vaginal candidiasis however, much of this picture is altered. 
Although the initial symptoms remain the same, the infection is no longer easily resolved, is painful 
and sometimes results in lesions. Women with HIV /AIDS fmd that their vaginal candidiasis recurs 
within a short period of time after they stop using their medication. Frequently they will have this 
infection almost nonstop for a year or more. Some HIV positive women have reported that although 
they have symptoms of Candida albicans and initial microscopic evidence of such, confirmatory 
cultures fail to grow the organism-possibly indicating another organism as a cause of these symptoms. 
The infection is usually seen in conjunction with a decre3Sed CD4 cell count, often below 200, and a 
decreased T4/T8 cell ratio. Vaginal candidiasis will often predate the appearance of esophageal 
and/or oral thrush (also caused by Candida a]bicans) by at least a year. Resistance to treatment also 
develops with the persistent, recurring infection; which often leads to the use of more potent drugs 
such as AmphOlericin B. Drugs such as these present their own problems for women with 
HIV/AIDS. 
Researchers at Walter Reed Hospital believe that at least 24% of women with AIDS will have 
recurrent vaginal candidiasis as their presenting symptom. They also believe that it is often the only 
clinical indication of the severe underlying immunodeficiency and may present a serious risk for the 
onset of other AIDS-defining illnesses. 
Does this mean that the appearance or vaginal candidiasis may be an indication or advanced 
disease in women? Unronunately, the research bas not been done to answer this question. 
The persistent, recurrent vaginal candidiasis that women with HIV I AIDS contract may be a form of 
Candidiasis Hypersensitivity Syndrome (CHS). However, the medical profession has not been able to 
agree whether this type of syndrome really exists, and if it does exist, how it should be defmed. As a 
result, there are no studies being done on the best ways to treat it. What knowledge we do have, 
derives from the problems with oral thrush that cancer patients have been faced with, especially since 
the advent of chemotherapy. Common antifungal agents such as clotrimazole (now available over the 
counter as Gyne-Lotrimin) or Nystatin are most frequently used. If these drugs are not effective, 
usually a drug such as Amphotericin B will be used. Amphotericin B is usually given through an IV 
and has many side effects. It is an antibiotic, and antibiotics can increase yeast production unless 
acidophilus is taken with it. It can cause anemia, which often is caused by other medications taken by 
women with HIV I AIDS. It is also dangerous to the kidneys, creates sensitivity to light and also often 
causes high fevers and chills. Fluconazole is a new drug approved last year for the treatment of oral 
candidiasis, can be taken as a pill or through IV, and may be a safer and more effective treatment. 
However, it has never been tested for vaginal thrush. 
Vaginal candidiasis complicates the treatment of women with HIV /AIDS. It is known that it can be 
caused in healthy women by taking antibiotics; women with AIDS frequently have to take antibiotics 
due to other opportunistic infections. It can also be caused by taking birth control pills; women with 
AIDS who want to participate in ACfG trials are often required to use contraception as defmed by 
the researchers, and birth control pills are often the method required. It often appears during 
pregnancy; most of these drugs will have an unknown effect on pregnant women and fetuses. 
Since a drug such as Amphotericin B can cause anemia, does this mean that it can't be used by a 
woman taking AZT, which also causes anemia? Will the development of recurrent vaginal candidiasis 
inevitably lead to the development of esophageal or oral thrush? Do women develop this infection 
more frequently when their CD4 cell count falls below 200, or are we just not seeing these women 
sooner because they can't afford the medical costs? Will recurrent vaginal candidiasis which is 
resistant to treatment cause a more rapid progression of immunosuppression and therefore death? 
Since women in general, and HIV positive women in particular, are more likely to get a variety of 
fungal infections, can some type of broad spectrum anti-fungal prophylaxis be developed which is 
similar in treatment regimen to Bactrim or Pentamidine (for PCP)? W'ill taking such a regimen allow 
women to remain healthy for longer periods of time? 
Why is it that the CDC recognizes Candida albic:ans as an AIDS defining illness in esophageal thrush, 
but not in vaginal thrush? Why can't the medical profession decide whether Candidiasis 
Hypersensitivity Syndrome really exists and define it, so that research will begin on effective 
treatments? Why is the medical profession ignoring an illness that is believed to be the presenting 
symptom in one quarter of all women with HIV I AIDS? 
These questions remain unanswered more than ten years into the epidemic. Researchers need to 
establish priorities to examine these issues immediately~ order to save women's lives. 
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Cytolytic Vaginosis 
.Cytolytic Vaginosis, previously known as Doderlein Cytolysis, is an easily diagnosed and treated 
condition that is frequently missed since symptoms are often similar to those associated with vaginal 
candici.iasis. Cytolytic Vaginosis should be ruled out, especially in women with apprent chronic or 
recurrent candici.iasis. A wet smear (m.iaoscopic examination) negative for trichomona.s, Gardnerel.la. 
or Candida with fewer white blood cells (than normally associated with infection), ina-eased evidence 
of lactobacilli, and evidence of destruction of living cells (cytolysis) are all indications of Cytolytic 
Vaginosis. A hallmark of this condition is low vaginal pa usually between 3.5 and 4.5. Discomfort is 
usually most severe during a phase of the menstrual cycle knowu as the luteal phase. Suggested 
treatment is sodium bicarbonate douches, which inaeasc vaginal pH. · 
Practitioners who see women. especially HIV positive women. with vaginal yeast infections that do not 
respond to usual treatment should be alert to the possibility of Cytolytic V aginosis. Although there is 
no evidence to suggest that HIV positive women have an inaeased likelihood of developing Cytolytic 
Vaginosis, the difficulty in treating some vaginal infections in HIV positive women makes it imperative 
that this condition be investigated and that an accurale diagnosis be made.· 
• Source: International Society for the Study of Vulvar Disease (ISSVD Tutorial Reporter. March. 
1991). Leonard J. Cibley, :MD, Harvard Medical School, Clinical Professor. OB/GYN. ISSVD 
Tutorial Reporter, Gardiner-Caldwell SynerMed, PO Box 458, Califon. NJ 07830 
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BIV Aad S'I'D'S Ia Womea 
More than 20 organisms have been identified as causing sexually transmitted diseases (STD)47 Here 
we will focus only on those which at this time appear to have a panicular impact on women who are 
seropositive or have been diagnosed with AIDS. These include syphilis, chancroid and herpes simplex 
virus (HSV)48• Others, such as gonorrhea, chlamydia and trichomonas will be mentioned briefly. 
Human papilloma virus will be discussed in a later version of this treatment and research agenda. 
Syphilis, HSV and chancroid are the most common <:auses of genital ulcer disease. Since 1980 the 
U.S. bas seen rates of primary and secondary syphilis increase by more than 200%.49 The incidence 
of genital herpes in the U.S. is up 16 fold as reflected by visits to practitione~. Five thousand and 
one (5001) cases of chancroid were reponed in 1988 in the U.S. Approximately 2/3 of these cases 
were loc:ali:zed in New York Ciry51. 
Lymphogranuloma venereum (a disorder of the lymph tissues caused by chlamydia) and granuloma 
inguinale (a chronic bacterial infection of the genitals) are comparatively rare. Other causes of genital 
ulcer disease include cuts or open skin surfaces, gonorrhea and infectious mononucleosis.52 
Genital ulcer disease is important in discussions of HIV infection in women for a number of reasons. 
Genital ulcers and some cervical infections, notably chlamydia and trichomoniasis, are suspected of 
increasing the risk of HIV transmission (see Transmission Issues section). Whether HIV actually 
increases a woman's risk of genital ulcer disease is a question which remains unanswered by current 
research. 
Reports from healthcare providers treating HIV positive persons for syphilis. HSV and chancroid 
suggests that the typical course of illness and/ or treatment may be different than for HIV negative 
individuals. For example, some studies indicate that treatment failure for chancroid can be an 
important predictor of HIV seropositiviryS3• 
HSV infection is more common and recurs with more frequency in HIV positive women than in 
seronegative women54• HSV 1 and HSV 2 gene products in a laboratory test (in vicro) may increase 
the replication of HIV. Further study is needed to determine whether HSV actually accelerates the 
47 Lichtman R, Duran P, "Sexually transmitted diseases,• Gmecofogy; Well-woman Care. 1990. 
48 New Jersey Women and AIDS Network. "Me F1rst! Medical Manifestations of HIV in Women.· 
1990. (Available from NJWAN, 5 Elm Row, New Brunswick, NJ 08901.) 
49 Ibid. 
50 Mertz CJ, "Genital herpes simplex virus infections,• Medical Clinics of North America. 1990 
74(6):1443-1454. 
51 Schmid GP, "Approach to the patient with genital ulcer disease; Medical Clinics of North 
America. 1990;:'5(6):3-9. 
52 Ibid. 
53 Jessamine PG, Ronald AR, "Chancroid and the role of genital ulcer disease in the spread of 
human retroviruses, • Medical C]inics of Nonh America. 1990;74(6):1417-1431. 
S4 "Me rlfSt!_: (NJW AN). 
18G 
progression of disease in mv positive women55. 
Secondary syphilis in HIV seropositive individuals is frequently undetectable by standard testing. 
Whether mv positive women are more affected in this way is a question which should be answered, 
especi~ since research indicates that primary syphilis in women is more like~y to be undetected that 
in men . In HIV positive individuals infected with secondary syphilis, tests for syphilis have been 
negative. Failure of standard treatments for syphilis and rapid progression to neurosyphilis have been 
demonstratecf7• 
Although little research exists about the relationship between gonorrhea and mv and, in fact, what 
does exist describes gonorrhea as easily treatable in women who are mv positive, some questions 
remain. We know that the gram stain test still used in some places is useless for detecting gonorrhea 
in women. Cultures, though more accurate, must be taken from appropriate sites. Yet we also know 
that gonorrhea can show up as endocarditis, pneumonias and adult respiratory distress, unusual or 
abnormal sites for the infection (disseminated gonorrhea)58• Though these symptoms of 
disseminated gonorrhea are rare in people who are not HIV positive, women who are HIV positive 
(as well as intravenous drug users) have a high incidence of bacterial pneumonias, endocarditis and 
other respiratory diseases. Is it possible that the relationship between HIV and gonorrhea 
(undiagnosed or seemingly treatable but really not cured) is at the base of this symptom picture? 
Early and accurate diagnosis and treatment of STDs is important for all women, but especially for 
women who are HIV positive since some infections may be more difficult to treat. Additionally 
clinical evidence exists to suggest that pelvic inflammatory disease (PID) is not only more common 
among seropositive women but also more severe and refractory to treatmenr59. In fact, investigators 
Moss and Kreiss report that, • ... HIV infection itself appears to increase the severity of certain STDs 
once they are acquired60: Educational materials. clearly describing symptoms, must be developed 
since knowledge about the course of illness is an important source of information for diagnosis. 
Clinical misdiagnosis of genital ulcers occurs as often as 40% of the time. Inappropriate use of 
testing, unavailability of tests, advanced condition of ulcers, and patient self treatments can all 
contribute to making diagnosis difficult. False negative results of cultures and blood tests ~ay account 
for many of the high number of cases (25-50%) where no cause for symptoms is identified01• More 
sensitive diagnostic testing should be a research priority. 
The demographic and geographic distribution of panicular infections such as syphilis, HSV and 
chancroid, as well as the distribution of drug resistant strains, may be useful tools in diagnosing and 
treating illness. These should, however, never be used as a substitute for thorough examination, 
history taking and diagnostic testing. 
55 Moss GB, Kreiss JK. "The interrelationship between human immunodeficiency virus infection and 
other sexually transmitted diseases," Medical Clinics of North America. 1990;74(6):1647-1660. 
56 Schmid GP, "Approach to the patient with genital ulcer disease.· 
57 Ibid, 
58 Lichtman R, Duran P, Gynecoloa; WeiJ-woman Care. 
59 NIWAN, "Me Ftrst! •. :. 
60 Moss GB, Kreiss JK. Medical Clinics of North America. 1990; 74(6):647-1660. 
61 Schmid GP, Medical Oinics of North Alnerica, 1190;74(6):1559-1572. 
Generalizations about disease prevalence are subject to socioeconomic factors. For example, it may 
be that African-Americans living in urban areas in the U.S. have a higher recorded incidence of 
syphilis because many rely on public clinics for treatment where case reporting is more likely to occur 
than with private physicians62• Consequently, women suspected of having any STD should be tested 
for a full range of possible pathogens. 
Practitioners should also bear in mind that secondary infections and coinfections are always possible. 
It is imponant that clinicians understand and be able to use blood (serologic) and other diagnostic 
tests appropriately. The critical .1eed for timely diagnosis and treatment for HIV positive women 
justifies any added expense of direct testing for pathogens using the latest and most accurate 
technology. 
It is of major imponant that the practitioner be able to discuss sexual histories and practices in a 
frank, culturally sensitive and non-judgmental manner. Assuming that all women sleep with men and 
self-identify as heterosexual renders lesbians invisible and provides inaccurate information which may 
impact on treatment decisions. Clinicians must not rely on assumptions and concepts such as risk 
group categories which are impediments to assessment, treatment and patient education. 
Since there is evidence of standard therapy failure for women with some STDs (syphilis, chancroid) 
and HIV coinfection, it is imperative for there to be close follow-up after treatment. Routine initial 
culture and sensitivity testing to detect drug resistant organisms may reduce treatment failure. 
Clinicians will do well to •think• HIV coinfection when treating genital ulcer disease, especially when 
confronted with treatment failure, virulent and/or refractory PID or test results inconsistent with 
clinical evidence. 
o Improved diagnostic testing for Sexually Transmitted Diseases and access to necessary tests should 
be a priority. 
o Questions regarding the rate of false negative diagnostic tests among HIV positive women should 
be researched. 
o Research should be conducted on the course of STDs in seropositive women. These should 
include, but not be limited to syphilis, chancroid, HSV, HPV, trichomoniasis, chlamydia, gonorrhea, 
granuloma inguinale and lymphogranuloma venereum. Special attention should be paid to all 
questions regarding the spread of these infections beyond their original sites (disseminated disease). 
o Questions regarding the relationship c: HIV infection to genital ulcer disease need to be addressed. 
as do questions remaining about the increased risk of HIV transmission in the presence of genital 
ulcer disease. 
o The possible link between HSV 2 and genital cancer as well as questions about a possible 
partnership between HSV 2 and HPV in causing cancer must be researched with special attention 
paid to the potential consequences to HIV seropositive women. 
o HIV positive women should be intentionally included in all AIDS research and drug trials. 
o Researchers and practitioners must acknowledge the existence of lesbians and address the reality 
that lesbians can and do become infected with STDs and HIV through sex with one another. 
62 Lichtman R, Duran P, Gynecolou Well-woman Care. 1990. 
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It is estimated that half of the world's population is infected with the tuberculin bacilli (a rod shaped 
organism identified as causing tuberculosis). TB prevalence worldwide has doubled in the last decade; 
it is the world's major infectious killer. Half of the 6-8 million people in the world believed to be 
infected with HIV actually have TB, and TB is the most prevalent opportunistic infection to be 
reported in conjunction with HIV worldwide. 
In subSaharan Africa TB has doubled in the past 5 years; 40-70% of people with TB are HIV 
antibody positive-yet many have a negative test for TB on analysis of sputum samples63• 
From 1984 to 1986, the incidence of TB increased in the U.S. by 2%, and by 36% in New York City. 
In New York City today, active TB occurs at a rate 10 times that which was reported in 1980. When 
cases of TB increased during this period, a public health correlation with HIV should have been 
made. 
In 1987, the CDC added extrapulmonary TB to the list of AIDS-defining opportunistic infections even 
though it was only in 1988 that systematic information regarding the presence of extrapulmonary TB 
among HIV antibody positive individuals was collected. Pulmonary TB has yet to be added to the 
CDCs list of AIDS defining infections64• 
In 1989 and 1990, in the U.S., the incidence of TB rose 5% and 8% respectively. The largest 
increases were seen in children under the age of 5 (15% in 1989) and in individuals between the ages 
of 25 and 44. Since 4-5% of cases are not diagnosed until death, this would indicate approximately 10 
million people who are infected with tuberculosis without a diagnosis of infection65• . 
Prior to World Warn, TB was the major killer of all African Americans; black women were 4-5 times 
more likely to be infected than were white women. In the U.S., it is predicted that the downward 
trend in TB in whites will continue. Today, the incidence of TB in persons of color is twice that of 
whites66• 
TB occurs at a rate 30% higher in people who are institutionalized (nursing homes, prisons, shelters 
and refugee encampments) than in people in more ventilated noncongregate housing. For people 
without any housing. there is a greater danger of exposure to drug resistant strains, the prevalence of 
these strains being 300% higher than in all other populations. 
As of May, 1991, 84% of newly diagnosed cases ofTB in New York state were reported in New York 
City; with reactivation infection highest in older men and new infection highest in younger women67• 
Deaths due to TB in HIV positive women are double that reported in AIDS case surveillance, and the 
presence of HIV and TB together is almost entirely due to IV drug use, the largest transmission 
ategory for women in the U.S. (It is estimated that in IVDUs and women AIDS is underestimated 
63 Marain M, WHO Global Programme on AIDS, personal conversation. 
64 "Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special 
Focus on HIV-Related Issues,• MMWR,. 39:RR17, Dec 7, 1990. 
65McMurray D, "Micronutrients May Affect Resistance to Tuberculosis; The New York Academv of 
Sciences. press release, June 1, 1989. 
66 Marain M, WHO Global Programme on AIDS. 
67 Stoneburner RL, NYC Department of Health, personal conversation. 
by 100%.) There are virtually no repons of TB in women who are HIV antibody negative. 
TniND"issioa ud Preselltatioa ol TB 
TB is a chronic bacterial infection which usually goes unrecognized, even though some bacilli remain 
alive in the systems of individuals infected who have healthy immune systems. TB is spread from 
person to person via particles which can be airborne and which contain TB. These particles can be 
coughed or sneezed by a person with clinically active pulmonary TB. 
In immune competent individuals the TB bacillus remains dormant, contained in an envelope called a 
granuloma. In immune compromised individuals, the envelope is lost. Immune suppression increases 
the likelihood fpr dormant TB to become activated, resulting in clinical symptoms. HIV infection 
appears to be one of the highest risk factors associated with the progression from inactive to active TB 
infection; in HIV antibody positive individuals, the risk of activation of dormant TB is almost 
100%68. In addition to HIV as an agent of immune compromise, lack of proper nutrition, absence 
of specific nutrients, inadequate ventilation, incomplete health care provision and injection of immune 
suppressive drugs all contribute to decreasing immune competence. 
Pulmonary TB usually shows up in the upper portion of the lungs, however, in HIV antibody positive 
individuals, the involvement is in the middle or lower portion of the lung. TB emphysema involves 
infection throughout and around the lungs and has been misdiagnosed as lymphoma. 
Exuapulmonary and atypical TB are often not recognized as TB, and other diagnoses are fust 
reported. In the U.S., 5-10% of people with TB have both pulmonary and extrapulmonary 
manifestations. Extrapulmonary TB can involve any organ or system, including sites not observed in 
people who are HIV antibody negative. These include the gastrointestinal tract, brain, blood, genitals, 
pericardium, wrists, lymphatic and other presentations. Unrecognized TB diagnoses include oral or 
vaa;inal candidiasis. meningitis, peritonitis and lymphoma69• Central nervous system mass lesions 
caused by TB are relatively common in IVDUs with AIDS and precede other Ols by months. 
Symptoms of active TB include fever, night sweats, weight loss and sputum production-symptoms 
which are often overlooked in institutionalized and older individuals. In the absence of specific 
treatment, death occurs from chronic wasting. respiratory failure and meningitis. 
Both MAl (Mycobacterium avium intracellulare) and TB are of the same family of mycobacterial 
species. MAl is the most common species seen in persons with AIDS in general, while in IVDUs TB 
is more common. In the U.S., where greater than 50% of women with CDC-defmed AIDS are 
reported to have been infected through IVDU, ::vw shows up more frequently than in men70• 
However, TB is not being reported unless enrapulmonary in nature. Since both MAl and TB can 
present with the same clinical picture the current CDC statistics are questionable. While TB is 
infectious, it is also generally curable if treatment is begun early in the infectious process. At present 
there is no treatment for MAl and it could be the progression of untreated tuberculosis. 
TestiDc 
Initial screening for TB is based on skin test reactions. However, when someone is immune 
suppressed, these types of tests are meaningless, often nonreactive in the face of active infection. In a 
68 -rB/HIV the Connection: What Health Care Workers Should Know; CDC, July 1989. 
69 Bishburg E, Annals of Iotemal Medicine. 105:2,Aug 1986:pp210-212. 
70 Farer LS, et aL, -rB Today: Don't Count it Out, • Patient Care. November 15, 1987, ppl41-l50. 
r~ceive a dose too high to be effective as an immune modulator. Some practitioners have raised the 
concern that these high doses of naltrexone might be immunosuppressive, and should be avoided in 
drug users with HIV disease. 
The question of interactions of AZr with other drugs has been a major concern since the drug's 
approval. Drugs that share the same mechanism of elimination as AZr (hepatic ghu:uronidation) 
are likely to increase AZr toxicity, as well as to see their own toxicity increased. In addition, drug 
users tend to have abnormal hepatic functions, due to the lasting toxic effects of opioids on their 
liver. Some of the drugs that increase AZr toxicity have been identified. Non-steroidal 
anti-inflammatory drugs such as paracetemol and acetaminophen (Tylenol) have been suspected to 
increase toxic effects of AZr, i.e., to be respoosible for an increased incidence of anemia92; aspirin 
and ibuprofen do not seem to produce similar effects. 
Anti-infectious drugs such as sulfadoxine and sulfamethoxazole (a component of Bactrim/Septra) 
also compete with AZr for glucuronidation and might increase AZr toxicity. In addition, these two 
drugs, as well as pyrimethamine, gancyclovir (DHPG) and Amphotericin B, may potentiate AZr 
toxicity on the bone marrow. 
AZr has been used in individuals receiving methadone, as well as in individuals injecting opioids, 
with satisfying results93• However, opioids such as morphine or codeine compete with AZr for 
hepatic glucuronidation, and might increase AZr toxicity. 
Unofficial reports have mentioned that AZr treatment might interfere with lithium administration in 
drug use treatment. i.e., that patients taking AZr might be more likely to become addicted to 
lithium. This information has not been confirmed since. 
Probencid is a drug used to treat gout, but also to increase the duration of action of antibiotics by 
competing for glucuronidation. Proper use of probenecid with AZr could reduce the amount of 
AZr needed every day, thus dramatically cutting the cost of AZr treatment. 
The question of interaction of AZr with sexual hormones is still an open one. A 
Burroughs-Wellcome study of female mice chronically receiving large doses of AZr showed an 
increased incidence of cancers of the reproductive organs. To this date, no data collection has been 
made on the effects of chronic administration of AZr in women. Interactions of AZr with birth 
control pills and use of steroids by transsexuals have been completely ignored. Since female drug 
users often suffer from reproductive dysfunction, and hormonal cycle seems to have an influence on 
the effects of drugs on women's physiology,94 the safety of AZr and other antiretrovirals on the 
health of women with HIV who are drug users should be investigated in priority. 
AZf use in pregnant women is under studied, and there does not seem to be any incompatibility so 
far. However, more studies are needed regarding the specific toxicity of AZr in pregnant drug users 
with HIV disease. 
92 Morse GD, et al., ~Zidowdine update:l990; DICP, 1990;24:754-760. 
93 Cowan FM, et al., ~use of zidowdine for drug misusers infected with human immunodeficiency 
virus,· J. Infection. 1989;18 Suppl:59-66. 
94 Naegle M, ~substance abuse among women: prevalence, patterns, and treatment issues, • ~ 
Ment. Health Nuts., 1988; 9:127-137. 
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study done by Selwyn and coworkers, 3% of people who were not mv antibody positive were anergic 
(unable to produce a skin test reaction because of immune suppression). Z7% of mv antibody 
positive patients were anergic to multiple antigen skin testing. 
Tests used to establish a definitive diagnosis of extrapulmonary TB include collection of a variety of 
specimens for culture including respiratory secretions, bronchial washings, gastric lavage, lung tissue, 
pleural .fluid, lymph node tissue, bone marrow, blood, urine, stoo~ brain and cerebrospinal .fluid 71 . 
The current microbiological lab procedure to culture TB takes 6 weeks to grow. There is a need for 
the development of tests for the rapid diagnosis of both exttapulmonary and pulmonary TB. 
While skin tests (used to detect TB infection regardless of its site) are often uninformative, samples 
collected for diagnosis are invasive and often do not provide results. Given the incidence of 
nonreactive skin tests, there is a need for the development of more sensitive tests for both 
exttapulmonary and pulmonary TB. Less invasive tests, and research into appropriate body fluids 
from which to collect samples in .cases of exttapulmonary TB, which will yield accurate and definitive 
results must be developed. 
In New York state doctors are currently being denied Medicaid reimbursement for TB (and syphilis) 
testing. In the absence of signs or symptoms on an individual chart, payment is denied. This applies 
to screening tests of any kind, includin~ blood chemistry profiles where appropriateness of tests 
ordered must be specifically indicated . Community health physicians are being audited and some 
are being required to subject themselves to administrative hearings. According to Peter Wyer, M.D., 
there is "no precedent in the history of medicine" for this type of scrutiny in patient care 73 . 
According to the World Health Organization (WHO) people who are IDV antibody positive have an 
almost 100% risk of reactivating dormant TB. TB is one of the first Ols presenting, and once 
diagnosed is treatable74• Untreated it is fatal to HIV positive individuals. Standard treatment is 
chemotherapy over a course of 6-18 months. However, poor nutritional status, malnutrition and 
famine threaten complete healing and the stability of healed lesions. In the US., 95% of primary TB 
lesions completely heal with treatment. 
Inadequate treatment is as fatal as lack of treatment-a poorly implemented program may worsen the 
condition. Underdosing can lead to drug resistant disease. There are estimates that 25% of infected 
individuals in California and 15% in New York are drug resistant to one of the 3-5 drugs which are 
part of a treatment regimen. People who stop treatment on their own prior to the completion of a 
regimen, can also develop drug resistance. If the strain of TB was originally drug susceptible, the 
bacteria mutate and a secondary resistance is created. For people who do not respond to prescribed 
treatment, a more difficult and extended course is administered. 
If someone is resistant to TB chemotherapy, the resistant strain of TB can be spread. More than 30% 
of adults with TB at Kings County Hospital, a public hospital in Brooklyn, were resistant to at least 
71 Tuberculosis At-A-Glance. Department of Health, New York City, April, 1991. 
72 Perales CA, Commissioner, NYS Dept. of Social Services, Administrative Hearings, May 7, 1991. 
73 Wyer P, PAcr for Equal Health Services, Bronx NY. Personal Conversation. 
74 MaraiD M, WHO Global Programme on AIDS. 
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one drug75• In a study at Grady Memorial Hospital (a public hospital in Atlanta. GA.), gay men 
who were mv antibody positive had contracted drug resistant TB within the hospital setting 76• 
Isoniazid is inappropriate for people who are active alcoholics or in those with clinically significant 
liver disease. Resistance to this therapy is widespread in industrialized countries. 
If on methadone, and given rifampin, individuals may require increased methadone dosage to avoid 
withdrawal symptoms caused by the interaction between methadone and rifampin 11• While this data 
was published in 1976 and therefore certainly not a new finding, individuals continue to have these 
drugs prescribed at inappropriate levels. This results in methadone failure leading to •noncompliance" 
for the rifampia regimen. 
The Following Is a Ust Of Guidelines For Research: 
o Develop rapid, predictable diagnostic tests for the presence of TB which are unaffected by an 
individual's immune status and which include testing appropriate for infection in women. 
o Develop acute and prophylactic treatment regimens which are more efficacious and unaffected by 
compliance (which often results in the development of resistant strains). 
o Study was to boost defense mechanisms prior to infection as well as risk factors (such as living 
conditions) and their effect on TB infection. 
o Develop treatment regimens which do not contribute to immune suppression. Some examples may 
be: diet, beta blockers, air, rest and phototherapy. 
o Investigate the usefulness of vaccines which are CUITently in use in non-industrialized countries. 
o Fully investigate the clinical and pathological course of extrapulmonary TB in women. 
15 Steiner P, "Steep rise in drug-resistant cases alarms NY's doctors," The New York Post. p.4. 
76 Castro KG, Centers for Disease Contro~ Personal Conversation. 
11 Kreek MJ, et al, "Rifampin-induced methadone withdrawal, • NEJM. l976;294:ppll04-1106. 
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Standard of Care Recommendations 
o Alternative Therapies 
o Drug Detoxification 
o Prison Issues 
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A recent survey by the Physicians Association for AIDS Care found that over half of PW As use an 
"alternative• or ·complementary" therapy and feel that it is beneficial. Despite this opinion -from 
people living with HIV -the traditional medical establishment, the FDA, NIH, and health insurance 
industry (among others) are actively antagonistic towards non-traditional, non-pharmaceutical, 
nontoxic treatments for HIV infection and opportunistic infections (Ois). Physicians aiticize 
alternative and holistic treatments, the Nnl refuses to research them through its ACI'G system, the 
FDA won't license them, and the health insurance industry refuses to pay for them-even when they 
are widely used in other countries. Their resistance is aU the more outrageous when we remember 
that the distinction between "traditional" and "alternative" therapies is largely artificial. since today's 
alternative treatment may be tomorrow's conservative medical approach. After aU, where would you 
put Compound Q or NAC? Both started out in the AIDS underground and are now being 
investigated by government- and AmFAR-backed trials. 
We must demand that people with life-threatening illnesses have the freedom to make informed 
choices about the full r:tnge of treatment options. The right to choose an alternative course of 
therapy is especially needed by those segments of the AIDS-affected community to whom the 
traditional medical establishment offers the least-notably, women and people of color. We demand 
that panicipants in the health care delivery system in this country recognize and support this right 
and respond accordingly. 
The reason:-, for the exclusion of alternative and holistic AIDS treatments are many, but essentially it 
comes down to the same problems we face in other areas of AIDS policy--professional chauvinism, 
careerism, :inancial interest, racism, sexism, and xenophobia. Because of this exclusion, numerous 
barriers exist to use of iilternative treatments by the communities that need them most. Generally, 
information Jbout alternatives is available only to people who are well-educated, English-speaking, 
and motivated to seek out that information. It is not available at the agencies that provide healthcare 
services to lower-income people. Second, because of lack of research, alternative therapies are not 
approved by the FDA. Non-FDA-approved therapies are not covered by public or private health 
insurance; they are excluded from the Medicaid formally, and not available to low-income women 
who comprise a big chunk of the HIV + female population. Consequently, all cost for alternative or 
holistic therapies must be paid by the user. There is no such thing as insurance reimbursement for 
Vitamin C. 
In addi£ion to offering greater potential access, alternative treatment regimens may also offer effective 
therapies for women-specific Ols or Ols that occur with greater frequency in women. 
Anal and cervical cancer. As more becomes known about women and HIV, it is dear that various 
forms of cancer are more common in HIV + women. Research by Chinese scientists suggests that 
garlic may have an anti-tumoral effect, by killing cancerous cells and protecting against carcinogens. 
Pelvic Inflammatory Disease. A potential treatment for PID may be ozone, which many believe to 
be helpful against various bacterial and viral infections, including hepatitis-B and abscesses. Ozone 
needs more research in the United States, since it is currently available only in Germany. 
Vaginal and cervical candidiasis. This is one 01 that may be entirely treatable with natural 
therapies. One of the most effective ways of controlling many kinds of yeast infections is by altering 
one's diet. Most nutritionists tell candida-sensitive people to stay away from reftned sugar, fruit, 
dairy, and foods like beer that contain yeast. Chinese herbs, such as astragalus, have shown 
anti-candida ability in addition to inhibiting HIV and Epstein-Barr virus. Ascorbate may slow the 
growth of yeast and acidophilus may prevent areas from becoming colonized. Some physicians 
prescribe pau d'arco tea or tablets for candidiasis. Most holistic practitioners try to avoid using the 
allopathic standard-nystatin-because a long term program may be necessary. The objectives of 
treatment should be to restrain the growth of yeast long enough for sensitivities to lessen and to 
restore the ability of the immune system to suppress the yeast on its own. 
Chlamydia. This parasitic infection may be treatable by a number of natural substances. Hypericin 
(St. John's wort extract), for example, has been found to be a broad-spectrum antimicrobial. Other 
supplements, such as alkylglycerols, may increase white blood cell counts, enabling the body to defend 
itself better. 
Human papilloma virus infection. Once again, hypericin may be a possible treatment since we know 
it is effective against herpes viruses. Chinese studies of garlic showed anti-CMV, anti-herpes effect; 
it should be investigated for HPV infection, too. We could also beneftt from additional research on 
the use of bioflavinoids such as Quercitin as an antiviral. 
Pneumoeystis pneumonia. This 01 is the highest reported killer of women with AIDS; in fact, HIV + 
women generally have more pneumonias and respiratory problems than men. Garlic should be 
researched further for its anti-protozoal effect, especially since standard treatment with a 
broader-spectrum drug like Bacuim can cause yeast growth-a bad idea in a population that is 
already disproportionately affected by candidiasis. Vitamin C may also offer some promise. 
Nutritional supplements can help PWAs deal better with the side effects of traditional therapies. For 
example, metabolization of many standard HIV treatments depletes the body of nutrients necessary 
for proper immune functioning. In addition to causing anemia. AZr depletes B vitamins, and B-U 
deficiency may be responsible for some of the CFlDS symptoms associated with AIDS. ddl and ddC 
can decrease trace minerals, and vitamin therapy may reduce these side effects. Therapies like 
acupuncture and colonies may help the body to detoxify from overuse of pharmaceuticals or illegal 
drugs. Acupuncture could be part of a treatment program for injection drug users, to help them 
reduce the risk of re-infection by sharing needles. Acupuncture is covered by Medi-Cal in California 
but not by Medicaid or Medicare. Many states do not even have a mechanism for licensing 
practitioners of acupuncture. 
Strategies for tbe futnre 
In addition to overall reform of the drug development, testing, and approval process. and the current 
medical research paradigm, there are a few steps the activists can take to make the benefits of 
alternative therapies available to more women. 
Activists mUst stress the importance of enrolling women in community-based trials. These studies, 
run by physicians in their offices, constitute the only access to some non-pharmaceutical 
experimental drugs. Community-based research organizations must have community advisory boards, 
just like ACfG trials, and these boards must include women. All barriers to participation by women 
and people of color-including financial barriers-must be removed. 
Women need to contribute to the development of a master protocol for alternative and holistic 
therapies. The way that clinical trials are designed, they automatically disqualify many 
non-pharmaceutical treatments, since these therapies may have their effect through different 
mechanisms from mainstream drugs. We must design a trial model that evaluates alternative 
therapies for efficacy on their own terms. 
We need to continue to alter the power relationships between doctor and patient. Without an open, 
comfortable, and supportive relationship with her physician, many women will be hesitant to ask 
about alternatives. Without discussion, some women will choose not use many substances that could 
improve their health; others will use treatments but not tell their physician, and thereby be deprived 
of medical input on the therapy or its interactions with other medications. (For more on this topic, 
see Michelle Roland's article in AIDS Treatment News or Project Inform's Discussion Paper, "Doctor 
and Patient: Building a Cooperative Relationship). 
A long tradition of limited research on women's health issues has resulted in a lack of information 
regarding substance abuse treatment in female drug users, and especially in those infected with HIV. 
Female drug users with HIV have to deal with a double stigma. Society rejects them as persons 
addicted to alcohol or drugs, and as persons infected by HIV. Sexist attitudes stigmatize them 
further, especially as inadequate, irresponsible childbearers. Such bigotry places female drug users 
with HIV disease among the most disenfranchised populations. 
In addition, female drug users have access to far fewer resources than their male counterparts. They 
are underrepresented in treatment programs, and consequently, these programs are often not geared 
to their specific needs. Because these treatment centers do not want to take medical responsibilities, 
pregnant women are not accepted. There are only 4 or 5 centers in the United States which accept 
pregnant women; there are none in New York City. Child care is usually not offered. and children 
uuder 12 are not allowed to visit. Pre and post-natal care, training for single parents (up to 40% of 
female drug users are single parents), and women support groups are rarely providedi'8. 
Moreover, drug use is high in the lesbian community although it is rarely acknowledged nor are 
support groups provided. 
All these factors, as well as the burden associated with HIV disease, are responsible for the major 
psychological problems experienced by female drug users with HIV. To the usual low self-esteem, 
shame and guilt associated with drug use, these women grieve what they perceive as the loss of 
health. body image, sexuality and childbearing potential. They experience denial and tend to neglect 
their health. leading to anger at being incapacitated. Depression is widespread and often results in 
cocaine use. Fmally, drug users with HIV disease are often rejected by their peers, and feel 
extremely isolated. 
Although women are less likely to become dependent upon illicit drugs than men, they are more 
likely to become addicted to prescription drugs and to use them with alcohol. They also tend to 
frequently use cocaine and other psychostimulants, as a way to offset depression, to induce weight 
loss, or simply to keep going in demanding conditions. How~ver, female drug users with HIV are 
often intravenous drug users, and in addition to traditional substance abuse treatment, may be 
offered to participate in a methadone maintenance program. 
Women's health is more vulnerable to substance use. Especially with alcohol, women are more likely 
78 Kara L, ·AIDs Prevention and Chemical Dependence Treatment Needs of Women and their 
Children, • J. Psychoact. Dru~. 1989; 21:395-76/J. 
to develop cirrhosis of the liver, as well as damages to the central nervous, cardiovascular and 
reproductive systems. Drug-dependent women often have problems with menstruation., such as lack 
of periods, and a wide variety of medical problems (poor nutritional state, hypertension., hepatitis, ... ) 
that motivate them to look for medical attention., often the first step toward drug treatment. 
Issues CoDcenU.og Medical Care for Female Dnlc Ula"S 
with HIV Disease 
Little is known of the natural history of HIV disease in women, and other articles in this document 
are discussing factors that might have an influence on the way HIV disease progresses in women 
specifically. Of concern in this article is the influence of drug use on the rate of progression of the 
disease. A short discussion concerning the effects of pregnancy on disease follows, mainly as an 
introduction to the issue of drug interactions. 
Numerous studies have shown that chronic use of drugs has a deleterious effect on the immune 
system of users, whether infected by HIV or not. Intravenous drug users have abnormally low levels 
of beta-endorphin (a natural ~ain killer secreted by the body) in their blood. and their body tends 
to stop producing endorphins . It is because opioids act on the same sites as endorphins that drug 
users' brains stop producing endorphins, since they do not seem needed anymore. When users stop 
drug administration., it is the lack of endorphin production that is responsible for withdrawal 
symptoms. 
Interestingly, some white blood cells involved in immunity have receptor sites that attract endorphins. 
Thus, endorphins appear to regulate some immune functions. Persons with AIDS have low levels of 
endorphins in their blood. probably in relation to abnormally high levels of alpha-interferon (which 
might signal the brain to decrease endorphin production). Whether this decrease in endorphin levels 
plays a role in the progression cf HIV disease remains unclear. Thus, drug use and HIV infection 
act together to dramatically decrease the blood levels of a substance involved in immune regulation. 
In addition., drug users have high levels of cortisol (an hormone produced in the body to deal with 
stressful conditions) in their blood, and cortisol acts as an immunosuppressor, thus further 
diminishing the body's ability to react against HIV. Alcohol, heavy marijuana use and cocaine have 
been shown to have similar effects on the immune system80, and cocaine use has been shown to 
increase the rate of progression of HIV disease. 
In addition, it seems that the mere act of injecting a substance intravenously can be deleterious for 
CD4 lymphocytes. Reports indicate that drug users with HIV who stop injecting drugs and start 
receiving methadone experience an immediate increase in the absolute number of CD4 lymphocytes, 
even in the absence of any other treatmenc81. 
The effects of pregnancy on the progression of HIV disease have been reported in several studies in 
this country and abroad. In asymptomatic women with HIV, there is no evidence that pregnancy 
accelerates disease progression. However, pregnant female drug users with HIV are more likely to 
79 Naegle M, ·substance Abuse Among Women: Prevalence, Patterns, and Treatment Issues,·~ 
Mental Health Nursine, 1988; 9:127-137. 
80 Hubbard RL, et al., "Role of drug abuse treatment in limiting the spread of AIDS; Rev. Infect. 
~ .. 1988;10:377-384. ' 
Sl Cowan FM, et al., ·use of zidovudine for drug misusers infected with human immunodeficiency 
virus, • J.Infeqion. 1989; 18 Suppl:S9-66. 
develop bacterial pneumonia, and breech presentation is slightly more frequenr:!2 .. The effect of a 
second or third pregnancy during HIV infection have not been studied. Pregnancy, with its 
accompanying deaease in immunity, may mask non-specific symptoms of infection, and delay 
diagnosis of HIV-related symptoms. 
In female drug users, drug use often produces amenorrhea (absence of periods), and pregnancy is 
often diagnosed late, thus making difficult the assessment of fetal growth problems. 
Treatment for HIV infection in drug users relies on the same bases than for tne rest of patients. 
AZT is taken with a high compliance level, especially in methadone maintenance programs. Dosage 
is similar to the one used in non- drug using population. There is a lack of data regarding the 
pharmacokinetics of AZf in male or female drug users. Chronic drug use induces lasting damages of 
the liver, and the usual AZf dosage might be either toxic or insufficient for drug users. 
Tuberculosis is becoming inaeasingly common in drug users with HIV disease, and intradermal 
tuberculin skin testing should be done yearly. In addition, some practitioners use isoniazid as a 
chemoprophylaxis to be given daily along with methadone83• Diagnosed tuberculosis must be treated 
immediately with a multidrug combination. 
Stress reduction is part of rehabilitation programs, and is likely to have positive effectS on the 
immune system as well. 
Clinical trials of experimental drugs are often excluding female drug users with HIV disease, because 
they are designed in ways that disqualify drug users and women. Drug users have a reputation of 
bad compliance, which is not true. They often show elevated liver enzymes that exclude them from 
most trials. Exclusion from trials on the basis of elevated liver enzymes is arbitrarily imposed by 
protocols in most cases. Absence of drug treatment programs and child care at the study sites also 
excludes female drug users. 
With drug users, and especially with female drug users, the problem of drug interactions is a crucial 
one. Women with HIV in methadone programs often take AZf, as well as other HIV-related 
substances. What are the effects of these substances on the HIV-infectcd immune system, and what 
are the effectS of drugs interacting with each other? In addition, pregnant female drug users with 
HlV face the possible consequences of drug effect on their developing child. 
Metbadoae Tratmeat 
The effects of methadone on immunity seem to be extremely positive. Long-term methadone 
treatment seems to regularize the levels and release of endorphins84, by allowing the brain to 
regain progressively control of endorphin production. Individuals that have received methadone 
treatment for more than 11 years show recovered activity of their Natural-Killer lymphocytes85• 
82 Selwyn P A, et aL, "Prospective study of human immunodeficiency virus infection and pregnancy 
outcomes in intravenous drug users, • JAMA. 1989; 261;.1289-1294. 
83 Selwyn P A, et al., "Primary care for patients with human immunodeficiency virus (HIV) infection 
in a methadone maintenance treatment program; Ann. Imern. Med, 1989; 111:761-763. 
84 Cowan FM, et a1, "Use of zidovudine for drug misusers ·infected with human immunodeficiency 
virus,· J. Infegion. 1989; 18 Suppc59-66. 
85 Nathan JA., Karan LD, "Substance abuse treatment modalities in the age of HIV spectrum disease, • 
J. Psys:hoact. Druas. 1989;21:423-429. 
~rug users with HIV disease who receive methadone usually observe a lasting increase in their 
number of CD4 lymphocytes, likely to be also caused by the cessation of the deleterious effects of 
intravenous injections of opioids. Thus, it appears that methadone has a positive effect on the 
immune system through normalization of immune function. as it has been observed for the 
neuroendocrine system. 
The effects of methadone during pregnancy are extremely imponant to identify since it is often the 
case that female drug users enter a methadone program during their pregnancy, and relapse after 
giving birth. Women in methadone programs are more likely to wow :/ for prenatal visits. receive 
better prenatal care (although still not optimal), and have less anemia . Babies born from 
mothers receiving methadone have normal binh weights. 
Evidence of methadone withdrawal symptoms in babies born from women receiving methadone lead 
to a reduction in methadone dosage during the third trimester of pregnanc{7. However, such a 
reduced dosage is not sufficient to offset drug withdrawal, and women tend to use substitute drugs 
such as Valium to alleviate withdrawal. Valium abuse complicates narcotic withdrawal in newborns, 
and some practitioners recommend an increase in methadone dosage during the third trimester of 
pregnancy to avoid this type of complication88• In addition. there does not seem to be a direct 
correlation between maternal methadone dosage and the severity of withdrawal in neonates89• 
Interactions of methadone with other drugs are minimal, it does not interact with alcohol or Antabuse. 
However, rifampin, a drug used to treat tuberculosis and MAC (Mycobacterium Avium Complex), 
increases elimination of methadone by the liver, and requires an increase in the dosage of 
methadone (as well as other opioid analogs, such as morphine or codeine)90• 
Interactions of methadone with AZr have not been extensively investigated. Unofficial reports at an 
ACI'G conference stated that AZr and methadone compete for the same elimination mechanism, 
and that individuals receiving methadone should reduce their AZr dosage, possibly by half. 
However, no official guideline has ever been given. 
Naltrexone is used in drug users to stimulate the production of endorphins and, at high doses, to 
block the site of action of opioids. Recently, some researchers have tried to use naltrexone to 
regularize the immune system in people with HIV disease. Using very small doses of naltrexone, a 
study identified patients that responded positively to the treatment, and tended to develop less 
opponunistic infections91 • However, drug users wbo receive naltrexone as pan of their treatment, 
86 Edelin KC, et a1., ·Methadone maintenance in pregnancy: consequences to care and outcome,· 
Obst. Gvn., 1988; 71:399-404. 
87 Nathan JA, Karan LD, ·substance abuse treatment modalities in the age ofHIV spectrum disease; 
J. Psychoact. Drugs, 1989;21:423-429. 
88 Sutton LR, Hinderliter SA, •piazepam abuse in pregnant women on methadone maintenance. 
Implications for the neonate,· Qin. Pediat., 1990;29:108-111. 
89 Ibid. 
90 NathanJA, Karan LD, -substance abuse treatment modalities in the age ofHIV spectrum disease.· 
91 Bihari B, et al., '"Low -dose naltrexone in the treatment of AIDS, • IIIrd International Conference 
on AIDS, Washington., D.C., 1987. 
In summary, research regarding standard of care for female drug users with HIV .disease suffers from 
the same neglect that most issues regarding women and HIV. It is time for government and 
researchers you realize that drug abuse treatment is AIDS prevention, and drug users must be 
offered the same treatment options as other persons with HIV disease. Drug treatment programs 
must be expanded and made more available and acceptable to women. Admission barriers to these 
programs must be lowered, and programs must be able to offer primary care, pre- and post-natal 
care, child care during and after hospitalization, and parental training on site. In addition, increased 
support and resources services are needed for female drug users with HIV disease. 
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The number of women prisoners who are HIV infected is not known. However, in states (such as 
NY) voluntary testing among all inmates9S (male and female) has shown an approximate 20% rate 
of infection. Women specific studies in Massachusetts have shown an approximate 35% rate of 
infection in the inmate population96• Women in jail face an inequity of care as compared to their 
male counterparts, a reflection of gender bias in their "outside" society. Since the 1970's, the female 
prison population has increased steadily and at a faster rate than the male population. The number 
of women in prison was approximalely 40,000 as of 199fi"'. Most of these are drug related 
convictions. Due to the stiffer penalties for drug charges and nationwide "Drug-Free Society" fervor, 
women (and men) are receiving stiffer penalties now prior to 1970. The influx of female prisoners 
bas resulted in vastly overcrowded jail conditions. For example, at CJ.W. Frontera., 2,500 inmates 
are housed in a structure originally intended for 800 prisoners. Although CJ.W. (California Institute 
for Women) Frontera is a worst-case scenario, the problems of overcrowding and the resultant 
negligent care is a nationwide problem. Female prisoners who are HIV infected are particularly 
vulnerable to inadequate and inhumane prison conditions. The primary areas of focus to improve 
conditions for HIV infected women are as follows: 
1) Health Care 
A Lack of access to appropriate and time medical care 
1. Lack of AIDS knowledgeable medical staff 
2. Understaffmg of nurse/guards 
3. VISiting doctors rather than on-staff 
4. Transponation difficulties for access to outside hospitals 
5. Lack of state licensing for infirmaries resulting in inferior medical care 
6. Lack of state bureaucratic supervision and specific HIV I AIDS policies which lead to 
prison officials deciding these policies for themselves 
B. Lack of access to outside opinions 
C. Poor housing conditions 
D. Lack of adequate nutrition 
L Prison food 
2. Lack of access to vitamins and nutritive supplements 
E. Lack of access to clinical drug trail participation 
F. Lack of access to experimental HIV /AIDS drugs 
2) AIDS Education 
A. Lack of implementation of Safe Sex/Safe Works education for inmates and staff 
B. Lack of AIDS education for prison health care providers 
C. Lack of prisoners support and education networks inside prisons for HIV infected and 
the general population, including safe sex materials such as dental dams and condoms 
(A unique example of this is A.C.E.S. in NY) 
D. Lack of drug rehabilitation programs inside prisons ("A large percentage of women 
prisoners have histories of IV drug use, a significant source of HIV transmission for 
95 The Correctional Association of New York, Cathy Potier, Director, Prison Projects, Testimony on 
Inmate Health Services, December 12, 1989. 
96 Newsweek, "Women in Jail:Unequal Justice," June 4, 1990 pp.37-38,51. 
97 Ibid. 
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E. Lack of outside suppon systems for H1V infected female prisoners 
F. Lack of voluntary and confidential H1V antibody testing inside prison with pre and post 
test counseling 
3) Discriminatory Practices 
A. Quarantine of HIV infected inmates due to ignorance of HIV transmission routes 
B. Lack of ac..:ess to educational, job training programs and other rehabilitative programs 
for HIV infected inmates 
C. Disparity between conditions of female vs. male HIV infected inmates 
D. Lack of confidentiality for prisoners HIV status 
E. Unnecessary use of face masks, rubbers gloves, etc. for dealing with HIV infected 
prisoners (For example, in California there is a non-official policy of making HIV 
infected inmates wear face masks while being transponed to other facilities or going 
before the parole board presumably due to ignorance of HIV transmission routes.) 
F. Blatant medical neglect due to the lack of AIDS/HIV education on the part of the 
prison staff 
G. Inability to participate in overnight family visits and general discrimination in visitation 
rights 
4) Compassionate Releases 
A. Difficulty in obtaining due to the lengthy bureaucratic procedures out of sync with the 
sometime sudden and severe onset of full blown AIDS 
The situation varies according to Federal, State and local policies. However, one major concern is 
the lack of outside monitoring of prison conditions. In most state and local prisons nationwide, 
prison officials create their own policies. This lead to wide discrepancies in HIV testing, quarantine, 
medical care and discriminatory practices. 
For example, there is a law in California that inmates are not allowed to take care of other inmates 
making the implementation of a program such as A.C.E.S.99 (NY) impossible to implement. 
Additionally, the lack of AIDS education and drug rehabilitation inside prisons (for staff and 
inmates) is a primary cause of many legal and human rights violations, and a primary contnbutor to 
the spread of HIV infection among the prison population and to their families on the outside. Lack 
of access to outside medical consultation and treatment and the inability to participate in clinical 
drug trails and other experimental treatments are also blatant areas of discrimination which 
contribute to the untimely illnesses and deaths of HIV infected inmates. Overcrowding in and 
limited budgets for correctional facilities nationwide is at the root of many of the inhumane 
conditions which HIV infected women prisoners experience. Understaffed infumaries with illtrained 
and uneducated health care providers is the rule rather than the exception, nationwide. 
The most effective advocacy for H1V infected women prisoners must come from the prisoners 
themselves. A non-intrusive stance based on individual reports from prisoners and constant 
communication with them will outline specific local areas of concern and action. What type of action 
is taken on behalf of prisoners must be outlined by the prisoners themselves in order to protect 
prisoners from further violations and abuses as a result of intrusive methods. Given the violent, 
98 "Women, AIDS and Activism,• Acr UP/NY Women and AIDS Book Group, Prison Issues and 





uneducated and irrational attitudes found within the prison system on every leve~.the utmost 
sensitivity is required. The most effective method of changing prison conditions is in determining 
specific local and state policies (or lack of polici~s), working with inmates to determine actual (vs. 
officially stated) conditions, applying public pressure (letter writing, phone zaps. media focus, 
coalition with other groups. legislative advocacy) to the prison bureauaacy to change specific 
conditions, and applying pressure for massive implementation of AIDS/HIV educational campaigns 
for staff and prisoners. 
In conclusion, a 3-pronged approach is suggested at this time in advocating for: 
1) Local activism re: HIV I AIDS education in the prison system 
2) Local and State activism re: Cohesive local and state policies and outside monitoring of 
medi~ ~reatment and conditions inside the prison system 
3) Nationwide activism re: Clinical drug trial participation and access to outside medical care 
and alternative drug treatments and therapies. 
WOIDal PrisoDers Mast Haft Aa:1ess to IDV/AIDS OiaicaJ Draa ~ 'l"reatmaat INDs aad 
Compassioaate Use Dnlp 
Women have historically and systematically been left out of or underrepresented in HIV /AIDS 
clinical drug trials. They have had limited access to treatment INDs and compassionate use drugs. 
However, women prisoners (and men prisoners) have never been allowed to participate in these drug 
trials and have had no access to experimental HIV I AIDS drugs. 
The inclusion of HIV positive women prisoners is an essential pan of the "'Women's Treatment 
Agenda:: Women in prison have access to substandard medical and nutritional care. Prison doctors 
and health care workers are for the most part not knowledgeable about HIV I AIDS. In New York 
State, over 1/3 of the cases of prisoners with AIDS were diagnosed after death. Also in New York 
State, prisoners with AIDS were found to live one-half as long as IV drug users with AIDS living in 
New York City. Given the lack of understanding in the medical profession about women with AIDS, 
these figures are probably much higher for women prisoners. 
A joint report issued by the New York State AIDS Advisory Council, Ad hoc Committee on AIDS in 
Correctional Facilities, AIDS Institute and the New York State Department of Health concurred that 
it was essential that prisoners have access to clinical drug trials: 
Because of the speed and potential benefits of research, access to experimental 
produa.s could be a choice for inmates as it is for others with HIV infection. 
New drugs become approved and available through clinical trials, many of which 
have often excluded women and IV drug users. The burdens and benefits of 
testing should be shared equitably within the populations infected or at high risk 
of infection. It is extremely difficult to conduct long-term clinical trials involving 
IV drug users in the community. If the prison population can be permitted access 
to these trials, while remaining protected from coercion and abuse, not only 
individuals but also society may benefit. An altruistic motive for behavior, which 
is permitted to non-incarcerated populations and which may ennoble suffering, 
should not be denied to inmates. Of course, particular attention must be paid, in 
this instance as in all others. to the process of and protection for informed 
consent. 
Access to HIV I AIDS clinical drug trials, treatment INDs and compassionate use drugs could help 
prolong the life of women prisoners with AIDS, many of whom are poor African-American and 
Latina women. In New York City, women prisoners have an estimated seroprevalence rate of 25 
percent and in New York State, almost 19 pcrcent.100 
Women prisoners cannot rely on prison health care to treat HIV /AIDS. Federal regulations require 
that prisoners who desire to be included in clinical trials make that decision for themselves. 
Participation must be non-coerced and voluntary and only during the Phase n and m of non-placebo 
drug trials so as to avoid any abusive research or experimentation. Confidentiality of medical records 
must be respected and upheld as much as possible. All drug trials and expanded compassionate 
drug use should be conducted outside of the prison environment by the trained staff of an 
A ~S-designated hospital or the equivalent. Prison medical staff should not administer these drug 
trials. Fmally, any clinical trials in prison must be reviewed by an IRB with at least one prisoner 
representative on the paneL The active participation of AIDS activists, women's advocates and 
community-based AIDS service organizations is essential to the successful monitoring of this process. 
Women prisoners have already taken the lead in fighting this epidemic in the prisons by establishing 
peer education and counseling projects like the AIDS, Counseling and Education (ACE) program at 
Bedford Hills Correctional Facility in New York State. 
100 •Management of HIV Infection in New York State Prisons; Nancy Neveloff Dubler, et aL, 
Columbia Human Ri&flts Law Reyjew. VoL 21:363. 
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W0111m, AIDS, &Del tbe AIDS Ciaic:al Trial Groap S,SU. . 
The AIDS Clinical Trials Group (ACI'G), funded and managed by the National Institute of Allergy 
and Infectious Diseases (NIAID), was aeated in 1987. The ACI'G is the largest federally funded 
program of clinical trials to evaluate potentially effective agents for treatment . of HIV infection. 
There are 47 institutions which are funded through this system to establish research priorities, 
develop protocols and implement clinical trials. 
NIAID developed the following as goals for the ACI'G system: 
o Study the full range of HIV -related disease, including primary HIV infection, opportunistic 
infectiorb, snalignancies, and neurologic disorders, 
o Evaluate a wide array of potentially promising agents, 
o Perform both pilot/phase I innovative trials and large comparative trials. 
NIAID lists among the accomplishments of this system the development of 152 protocols and a total 
accrual of more than 11.000 patients. Their conclusion from these accomplishments is that •the 
ACI'G has contributed substantially to the current status of therapy of HIV disease. • 
An analysis of this ACI'G system of clinical trials from the perspective of women with HIV, however, 
falls dramatically short of any contributions toward the health and longevity of women with 
HIV/AIDS. 
WOIDCil Witb BlV /AIDS: Who's Afl'ected aad Who's EaroiJed 
Women account for 9.1% of the adult AIDS diagnoses in the U.S. Their numbers increased by 45% 
over the past 12 months. Of the women affected, 73% are women of color: African-American, 
Latina, Native American, and Asian c~ Pacific Islander. Most of these women are poor, most have 
children, and most have been affronted by a system of health care which has inadequately met their 
needs over the course of a lifetime. 
Although women now account for an alarmingly inaeasing number of cases, only 5% of all ACI'G 
clinical trial participants are women. Only !75 of the symptomatic women in the U.S. are in 
ACI'G-sponsored trials. Further, only 9 pregnant women have been enrolled in ACI'G trials. 
NIAID, however, continues to report inflated and inaccurate statistics for the participation of 
-women• in AIDS clinical trials. Their statistics combine into a single number-women, female 
children, and female infants. 
'111e ACI'G S)'Staa: Where are tbe Sites aad Who Raas tbe Trials 
The 47 ACI'G trial sites were selected based on the perceived ability of a particular institute to 
conduct scientifically sound research. It has long been the perception that such research can take 
place only in the context of medical school/teaching institution-affiliated hospitals-tertiary care 
centers. Institutions such as Duke University, UCLA, Johns Hopkins, Columbia University and Ohio 
State University are part of the ACI'G system. 
The reality of the lives of women affected by HIV I AIDS is reflected in the places where women seek 
health care. Primary care (when available at all) is provided at city and county hospitals or in local 
or state .!unded clinics. The linkage between these primary care settings for women and the tertiary 
centers where ACfU sites are located is poor. The result-women with HIV I AIDS either do not 
know that these trial sites exist or do not have the financial or logistical means to access them. A 
1989 National Institutes of Health SUI'\'eY of women giving birth at 46 medical centers where 
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Federally-sponsored AIDSfHIV clinical trials are underway revealed that women.do not receive 
sufficient referral either to clinical trials or to AIDS-trained physicians. 
ACfG trials are proposed and directed by a network of principal investigators (Pis) located at the .. 
various ACI"U trial sites. Of the 47 Pis, only 8 are women. None of the 47 Pis spedalize in 
gynecology, even though the reality of HIV disease in women often manifests in specific 
gynecological diseases. 
ACI"U sites are funded under contracts, called cooperative agreements, between N1AID and the 
specific site. These conttac:ts request and fund particular resources which are available at the ACI'U 
site. If an immunologist is needed, it is specified in the conttact. If the ability to perform CD4 
counts in the site's immunology laboratory is needed, it is specified in the contract. None of the 47 
cooperative agreements request, specify or fund a gynecologist or an oncologist whose specialty is 
gynecology. Under the present contracts, if gynecological assessment is to be done, it must be 
funded through a mechanism outside the ACfG system. 
Bow ACI'G Trials are Desiped to Elrdude Womea 
Before enrolling in a trial, a woman must provide evidence of adequate birth control. While the 
concept of •adequate• is subjective, the interpretations of this requirement at various trial sites are 
diverse. Most site coordinators apply rigid criteria to the interpretation of this question, even if the 
woman bas no plans to become pregnant. The requirement for birth control focuses on women as 
incubators and potential vectors of disease transmission, trades the advantage of access to 
experimental therapy in an HIV infected woman for the risks to a •theoretical" fetus and renders 
HIV infected lesbians invisible. 
Although not a requirement for entry into an ACfG trial. a large number of trial sites refuse to 
admit individuals who are injection drug users (IDUs) and are not enrolled in a drug treatment 
program. Since 52% of HIV infected women, according to Centers for Disease Control (CDC) 
statistics, have a history of injection drug use, a majority of these women are excluded. This 
philosophy presumes two things: first, that there are enough treatment programs to go around, and 
second, that IDUs are irrespoDSlble. Neither of these assumptions are true. 
Baseline levels for liver function enzymes are used as entry criteria for clinical trials. Normal 
acceptable ranges for these enzyme levels are established arbiuarily and may not be scientifically 
necessary. These baseline levels are exclusionary to IDUs, since in individuals with a history of drug 
use, liver function may be impaired (and reflected in elevated liver enzyme). 
Other serum markers such as baseline CD4 levels and p24 antigen have not been analyzed in women 
for correlation to clinical AIDS and may express at lower levels, if at all. in non-white individuals 
with HIV disease. 
Timing for blood collections during the pharmacokinetics phase of trials may be unnecessarily rigid. 
Specifications for collection increments may not reflect the reality of the half-life of a specific drug 
and may have been established simply because ·thars the way it bas always been done: Requiring a 
48 hour sample when children must be picked up from school or cared for in the hospital, often 
results in missed pharmacokinetic appointments and arbitrary removal from protocols. 
Individuals who are enrolled in the ACfG-sponsored trials are required to provide their own primary 
health care and regular physiological assessment. Women as a group are less likely to have access to 
health care for economic reasons, particularly women with HIV disease who are often poor. 
Women also make conscious decisions not to access a system which recommends invasive procedures 
such as total hysterectomies; or where coercive counselling, rather than informed choice is the 
norm. If primary health care is a requirement for enrollment in an ACfG-sponsored trial, NlAID 
must make the funds available for access to that health care. 
Since ACTG trial sites are often inaccessible to IDV-infected women., and since many mY-infected 
women are single heads of households and may have mv -infected children., it is imperative that 
NIAID fund transportation to the site and provide childcare during a woman's visit. Operating 
hours must be adjusted to reflect reality of women who work. In addition., various sites have not even 
recognized that by simply seeing pediatric patients and women at the same time and on the same day 
and time, women could have the opportuDity to take care of the healthcare needs of themselves as 
well as their children. 
Most cliuical trials which enroll women require urinary testing for controlled substances prior to 
enrollmenL This requirement arbitrarily assumes that most mv infected women are using drugs. 
More importantly, results of drug screening are not confidential and may by used by states in child 
custody decisions or in the case of child abuse (particularly for pregnant women). This requirement 
puts women in jeopardy and is not disclosed in the informed consent required for trial enrollmenL 
If cooperative agreement proposals can require institutional assets such as libraries and computers to 
receive funding, why can't they require the provision of primary care physicians. routine 
gynecological assessments, child care and transportation? These services should not only be 
provided during the time that a woman is on a study, but also during the years after the study is 
complete. 
What's Beiag Studied Vs. What Disases BJV IDiected Womea Get 
Of the 152 protocols developed under the ACTG system, 63 involve the study of zidovudine (AZT or 
ZDV). The ACTG system has not evaluated the efficacy or safety of zidovudine for AIDS and its 
related illnesses in women. 
There are 10 ACTG trials which study the effects of various treatment on Kaposi's Sarcoma, 17 
which study varous treatments on Pneumocystis Carinii Pneumonia (PCP), U which study 
cytomegalovirus (CMV) retinitis, 4 which study cryptococcus, 4 for toxoplasmosis, 1 for histoplasmosis 
and 19 trials which assess various compounds for dllc:acy and safety in treating pediatric AIDS. 
There are no trials specifically designed to evaluate the efficacy and safety of treatments for AIDS 
and related opportunistic infections in women. In addition., there are currently no trials, nor are 
trials being planned, to study treatments for AIDS manifestations specific to women -pelvic 
inflammatory disease (PID ), human papilloma virus (HPV), cervical cancer or prophylaxis for vaginal 
thrush (Candida albicans). Most of the trials for opportunistic infections (Ois) target ·end-stage• or 
lifethreatening Ois. This concept ignores the reality that women often do not live long enough to 
get these particular Ois. In addition, woman-specific Ois exist which are life-threatening and are 
currently not being studied. 
ACTG 126, a trial designed to assess impediments to initial and continued enrollment of IDUs in 
ACTG clinical trials has been deferred. 
Tbe Pl:diatric Committee ol the AcrG System: A Model ol Semm 
The Pediatric Committee of the ACTG exists as a fully operational core committee within the ACTG 
committee structure. A subcommittee of the Pediatric Committee, the OB/GYN subcommittee, is 
where NlAID officials direct inquiries regarding enrollment of HIV-infected women into the 
ACTO-sponsored trials. 
The reality of the OB/GYN subcommittee is that members are either pediatricians or obstetricians. 
None are gynecologists and none are interested in the health of women. Members of this 
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subcommittee speak openly about their interest solely in pediatric AIDS and research into 
interrupting "vertical transmission". 
Out of this committee came ACI'G 076, a protocol to assess the efficacy of escalating doses of 
zidovudine for interruption of fetal transmission. Protocol 076 targets enrollment of 700 pregnant 
women. The numbers are large to account for the fact that two-thirds of the infants born to these 
mothers will not be HIV positive. This is the largest ACI'G-sponsored trial currently being planned 
and will use an abundance of constrained financial resources. 
The trial requires that these women receive escalating doses of zidovudine, doses which may render 
them zidovudine-refractory when the course of their own disease may require zidovudine therapy. 
Maternal laboratory assessments are minimum -assessments designed solely to detect zidovudine 
toxicity so that doses may continue to be increased. 
Although a recently revised draft of the protocol for this trial incorporates a gynecological assessment 
on entry, the six week follow-up evaluation does not include a gyn exam. It is unethical to use 
women as "animal models"; i.e. vectors of transmis.aon. The protocol is an example of rampant 
sexism on the part of the investigators; there are no plans to assess the effect of zidovudine on the 
women in this trial. 
There is substantial evidence for the use of high titer neutralizing gp120 serum antibodies as a 
screening indicator for fetal outcome. Women whose serum does not contain these antibodies are 
most likely to give birth to an HIV infected child. Investigators involved in 076 refuse to include this 
marker as a criterion for enrollment. It is unethical to give AZr to fetuses not likely to be 
HIV -infected. 
In December 1989, Burroughs Wellcome Co. released data on zidovudine indicating that it may be 
carcinogenic. The ACI'G temporarily suspended its studies in pregnant HIV -infected women and 
their newborns until the carcinogenicity data could be thoroughly reviewed. In the Burroughs study 
in m~ce and rats receiving oral zidovudine, histological examination revealed vaginal carcinomas in 
10% of the animals tested. The panel which reviewed this alarming data was comprised of 
Burroughs employees and Pis involved in the 076 trial. 
The panel concluded that the potential benefits to newborns outweighed the risk to mothers. These 
results, the composition of the review panel, and their conclusions raise additional ethical questions 
regarding the safety and the health of women who enroll in ACI'G 076. 
There are numerous additional problems with the 076 trial. These were offered simply as an example 
of the ways in which ACI'G trials display a wanton disregard for the health and well being of 
women. 
Why the emphasis on continuing ACI'G 076? If any compound can be shown to interrupt fetal 
transmission of HIV, the next step will be mandatory testing for all high risk pregnant women. 
ACI'Gs: 1990 aad BeJoacl 
As a result of activist pressure, the Executive Commiuee of the ACI'G system voted at its last 
meeting in November 1990, to form a Women's Health Committee, a full core committee with in the 
ACI'G system. There is danger, however, that members of the old OB/GYN subcommittee will 
simply become the newly formed Women's Health Committee. This must not happen. 
The Women's Health Committee must: 
o Include a gynecologist, an infectious disease specialist, a GYN oncologist, an HIV positive 
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woman and a women's health activist. There is no reason to include either an obstetrician 
or a pediatrician. Individuals with this expertise can be consulted through the Pediatric 
Committee. 
o Receive full fmding commitments immediately 
o Develop standards for gynecological assessments which are routine for every ACTG 
protocol 
o Immediately write protocols to assess the efficacy of fluconazole as a treatment for vaginal 
thrush and work with the Oncology Committee to develop treatments for preventing 
HPV-related CIN and AIN. 
Core Committee appointments follow the same incestuous reasoning that is exhibited in concept sheet 
approvals and drug company consultative agreements with principal investigators. The chair of the 
newly formed Women's Health Committee has been selected by the Executive Committee, and the 
appointed chair will select the additional members. Not exactly the ideal of demoaacy, especially 
given the lack of commitment to women's lives which bas already been exJubited by members of the 
Executive Committee. 
Activists must watch carefully the implementation of ACTG recompetition scheduled for next year. 
This recompetition is supposed to correct problems of trial accrual, specifically for women and HIV 
infected people of color. However, NlAID proposals for research initiatives being submitted to 
various trial sites include the following requests for resources: 
o Support for expansions of the pediatric AIDS clinical trial effort through the establishment 
of new pediatric clinical trial units. 
o Development of reliable methods for early diagnosis of HIV infection in newborn and 
infants and establishment of timing of perinatal transmission of HIV. 
o Research into development and use of animal and in vitro models for pediatric metabolism. 
Research into the mechanisms of transplacental infection. 
o Development of strategies for preventing transmission of HIV from mother to infant. 
Where are the requests for proposals to save the lives of women? 
Other NlAID lssues/EII'orts Whida lpon BIV ill Womc:a 
The community based trial efforts of NIAID, Communir:y Programs for Clinical Research on AIDS 
(CPCRA) are following in the footsteps of the ACTG system. A major effort of CPCRA in the 
upcoming year is a community based version of ACTG 076. In addition, the committee (CPCRA 
working group) which presumably focuses on women-specific issues is the •Minorir:y; Women's and 
Children's Issues Working Group: Obviously, CPCRA operates under the same sexist principles as 
the ACTG system: women don't exist outside the context of children and their abilir:y to reproduce. 
The National Cooperative Drug Discovery Groups (NCDDG), funded by NIAID, were developed to 
encourage collaborations among scientists from academia, industry, and government on research to 
discover and develop new AIDS therapies. The NCDDG-HIV was established in 1986. The 
NCDDG-01 (Opportunistic Infections) is a part of this effort. In August, 1990, funding awards were 
given for the development of six new NCDDG-Ois. The six new awards will focus on: 
1) Mycobacterium avium 
2) Fungi- cell wall inhibitors 
3) Toxop~a 
4) Fungi- enzyme inhibitors 
5) Pneumocystis, cytomegalovirus and Toxoplasma and 
6) Cryptosporidium. 
None of the new NCDDG-OI grants were awarded for Women-specific research. 
NlAID also funds epidemiological studies. In 1983, two pr~pective cohort studies designed to follow 
the natural history of HIV infection in men were begun. The Multicenter AIDS Cohort Study 
(MACS) and the San Francisco Men's Health Study (SFMHS) continue to be funded with limited 
dollars to answer questions such as how treatment affects the natural history of the epidemic, why 
some people with high risk behavior never become infected with HIV, and how often and for how 
long HIV infection can occur before it is identified by seroeonversion. These issues are duplicative to 
efforts by the CDC in the Spectrum of Disease study. Limited resources need to be used wisely. 
Two other NIAID-funded epidemiology studies are the Heterosexual AIDS Transmission Study 
(HATS) and the Women/Infants Transmission Study (WITS). The HATS study, as a result of 
activist pressure, recently included a question which reads, "Have you ever had sex with another 
woman?" Prior to inclusion of the question, all women interviewed were presumed to be 
heterosexual. The addition of this question only serves to allow NIAID to obtain ·clean heterosexual 
·data"; it does nothing to provide information on woman-to-woman transmission. 
NlAID bas a long way to go to direct their research agenda in a way that will allow women access to 
trials and that will provide for the development of treatments which will prolong the lives of women 
with HIV. Activists will continue to watch, collect information, and demand that NIAID-funded 
research be directed in a way that will address the changing reality of those who are affected by HIV. 
Safety ud Elfic:acy: The FDA'S Role For W()lllell? 
The Food and Drug Administration (FDA) is responsible for regulating the entire process of testing 
experimental drugs in humans. It follows a drug through each phase of testing, and examines data 
submitted by the trial sponsor after completion of a trial. to determine if the drug meets standards 
legislated by Congress, and conferred by Congress onto the FDA. · 
The FDA's mission is to review data and determine that all drugs are both safe and ei1icacious 
prior to their approval for sale on the open mark.et. As a part of this effon, the FDA must also 
approve all experimental drugs trials as reasonably safe, in relation to the possible benefits of 
research and risks to trial participants. How has this mission impaded the lives and health of women 
in the U.S.? Certainly not to the substantial good. 
During the late fifties and early sixties a sleeping pill, thalidomide, was in widespread use abroad. 
Thalidomide was an efficacious sleeping pill, but it was also a drug which caused severe birth defedS 
in children born to pregnant women who bad taken it. Dr. Frances Kelsey, an FDA official, had 
serious questions about the safety of thalidomide and single handedly prevented thalidomide from 
being approved for use in the U.S. 
The thalidomide incident brought the FDA to a devastating conclusion regarding the testing, safety 
and efficacy,of drugs for women; don't test experimental drugs on women of child-bearing age. The 
one single exception to this rule, of course, is in drugs which deal with reproductive choices. 
Contraceptives have been developed, tested and released with such a frenzy that women have been 
forced to use such unsafe methods of birth control as oral contraceptives (the pill) and the Dalcon 
Shield. Unfortunately, the side affedS of these drugs and devices, and drugs such as DES are all too 
well known. 
Meanwhile, drugs which may be equally devastating for women in general, and particularly for 
women with HIV, are being released to the public with no information on their particular adverse 
affedS in women. The disregard for the differences in women's bodies, the rejection of medical 
documentation of particular opportunistic infections in women with HIV (particularly gynecological 
infections and cancers), and the focus on the importance of a fetus as opposed to a woman, have 
resulted in deadly serious consequences for women with HIV. This sexist obsession with protecting 
a fetus also ignores the fad that 22% of women with HIV are over 40, and could enroll in trials 
potentially without the risk of becoming pregnant. 
Zidovudine (ZD V), the only licensed antiretroviral therapy, was approved for widespread use despite 
evidence of its sex- and site- specific carcinogenicity in female animals, and despite alarmingly small 
numbers of women with HIV in its clinical trials. The few women who participated in the trials, 
were followed for male-defined complications associated with its use. The trials were not designed to 
assess the impad of ZDV on gynecological problems. 
ZDV is now in widespread use for the treatment of HIV in women. The risk of vaginal carcinoma 
associated with its use, coupled with the increased incidence of cervical neoplasias in women with 
HIV is alarming. There is also evidence that fatty liver associated with the use of ZDV may be 
increased in women, and that individuals who are taking methadone and ZDV may be at increased 
risk of seve. e anemia 
The FDA must require immediately that Burroughs-Wellcome institute a Phase IV post-marketing 
study to assess the safety and efficacy of RetrovirR (ZDV) in women with HIV. The study must be 
designed to assess parameters such as anemia, interactions wim ocher drugs, pharmacokinetics, and 
gynecological endpoints. Endpoints assessed must extend beyond CDC-defmed AIDS. 
Even mough women were excluded from the clinical trials of ZDV, women are now being 
e:1couraged to participate in the ACfG-sponsored trial, ACfG (176, designed to assess the efficacy 
of ZDV in interrupting perinatal transmission of HIV. This protocol, which was reviewed and 
approved by the FDA, has deadly serious consequences for women (see section on ACfG C176). 
Data being collected on a second antiretroviral (which works in a similar fashion to ZDV), ddl, 
presents a similar picture. Few women are enrolled in the NIAID-sponsored trials of ddl, and only 
4% of compassionate use ddl is in women with HIV. None of the data being collected from this use 
includes data collected from pap smears. Data aren't available to assess the impact of ddl on 
gynecological problems, yet researcher; already make statements that imply no differences in the 
adverse affects of ddl between women and men. 
The FDA has direct regulatory responsibilities to demand appropriate, gender-specific research prior 
to clinical trial development and drug approval Prior to initiating a clinical trial, a protocol must be 
developed detailing the trial's design, procedures, methods of data collection, and exclusion and 
inclusion criteria. The FDA must approve a clinical trial protocol before the trial can begin. The 
FDA must begin requiring the inclusion of HIV infected women in trials and must require that data 
be collected to assess the safety and efficacy of a drug on woman-specific endpoints which are not 
limited to CDC-defined AIDS. 
Every institution which conducts clinical trials must have an Institutional Review Board (IRB) which 
initially approves research proposals and performs periodic reviews of such research. The IRB is 
directly answerable to the FDA IRB reviews are primarily ethical, however, it is unethical for an 
IRB to approve a protocol which does not consider the safety and health of female trial participants 
or a trial which systematically and unnecessarily excludes women. Therefore, the !=DA must require 
that IRB's review trial proposals for the inclusion of women and the provision of data collection 
mechanism designed to assess the effects of such drugs on women-specific opportunistic infections. 
Fmally, informed consent documents must be developed for every research protocol. This 
information, given to trial participants prior to trial enrollment must provide accurate information on 
the risks of a particular therapy or protocol. The informed consent is approved by the IRB. r'.ll 
available information including information from literature searches must be included in the informed 
consent, and must be written in language accessible to non-medical individuals. 
In the absence of a commitment to research on the affects of HIV treatments in women, the FDA 
must initiate efforts to provide information on such treatments which allow women the availability to 
choose therapies with information which either presents what women-specific information is known, 
or clearly states that no supporting scientific information is available. 
On March 5, 1990, FDA announced in the Federal Repster the availability of a guideline entided, 
"Guideline for the Study of Drugs Likely to be Used in the Elderly". The guideline provides detailed 
advice on the evaluation of new drugs in older patients and is intended to encourage routine and 
thorough evaluation of the effects of drugs in elderly populations so that physicians will have 
sufficient information to use drugs properly in older patients. Such guidelines must be developed 
immediately for studying drugs in HIV infected women. 
The Federal Food. Drug, and Cosmetic act (Section 502(1)) states that a drug will be deemed to be 
wisbranded unless its labeling bears "adequate directions for use•. These directions are defmed in 
Section 201-5 of FDA's general labeling regulations which state "directions under which the layman 
(or woman) can use a drug safely and for the purposes for which it is intended". 
The FDA (Section 201..57) currendy requires that labeling information associated with prescription 
drugs include information on the use of drugs in pregnant women (actually in a fetus) and in the 
pediatric population. A proposed rule change by the FDA was outlined in the November 1, 1990, 
Federa1 Rezjster requiring a labeling change to include similar information in the geriatric 
population. 
The FDA must immediately draft an additional proposed rule change to include similar information 
on the use of drugs in women. All available information from the drug's sponsor relevant to its use 
in women, including results of controlled studies, other pre- and post-marketing studies or 
experience, or information obtained from a literature search must be disclosed in labeling. Included 
in this information must be reports of adverse reactions, required by law to be documented and 
reported to the FDA. 
If clinical studies do not include sufficient numbers of women, a statement to that affect must be 
included. In addition, a recommendation for starting a drug at the low end of the dosing range 
should be made. For drugs that are .known to be carcinogenic (such as ZDV) or are .known to 
increase the risk of gynecological infections (such as certain antibiotic agents) a statement should be 
included. This is particularly important for women with HIV. Cautionary statements must not be 
limited to risks associated with CDC-defined AIDS symptoms/infections. 
The FDA must ensure the safety and efficacy of drugs for all populations. Their concern for "special 
populations• has, to date, excluded women. This practice must stop. The FDA must immediately 
address the regulatory issues which will ensure that women have access to information which enables 




ZDV For W01111m: A Doable :SW.d Gamble or Risks VL Beaefits 
The ZDV years, the years when this drug was the treatment of choice for people with HIV, were a 
time of hope for people with HIV and a time of fierce activist pressure to release a treatment that 
could save the lives of millions. The politics of expeditious release of ZDV, the intense and 
incestuous commitment of NlA1D to the development of this drug with Burroughs-Wellcome, the 
subsequent information indicating that ZDV would not be the •cure for AIDS; and the economic 
devastation associated with the cost of this therapy have been the subject of demonstrations, writings 
and congression;'.i investigations. The unique and life-threatening problems of ZDV therapy in women 
with HIV, however, are only beginning to be addressed. 
Clinical trials supporting licensure of ZDV included an alarmingly low number of women. The 
reasons for this exclusion included: 
1) a refusal to test experimental therapies in women of child-bearing age, 
2) the rejection of the reality that women with HIV exhibit different symptoms than men, and 
3) the refusal of NIAID to put into place AcrG trial sites which were both physically and 
economically accessible to women with HIV. 
It is a testament to the willingness of researchers and regulatory authorities to change the rules 
according to their latest research interests, that each of these three exclusions has in some way been 
either rejected or ignored in subsequent research on ZDV, or in recommendations for routine ZDV 
therapy for women with HIV. 
The refusal of researchers to test ZD V in women was a result of concerns for a theoretical fetus (see 
section on FDA). This information was confirmed at a recent conference on women with HIV by a 
Burroughs-Wellcome spokesperson. Women who enrolled in any of the original trials of ZDV had to 
document either •appropriate• methods of birth control or commit to abstinence during the duration 
of the trial. Women's ·compliance" with these unnecessary rigid demands were conf.umed with 
routine, periodic pregnancy tests during trials enrollment. 
AcrG (176, a trials in which ZDV will be given to HIV infected pregnant women has incorporated a 
mechanism to circumvent this requirement. Pregnant women enrolled in this trial will be given 
ZDV during the second and third trimester of pregnancy, since organogenesis (the developme::t of 
f~tal body organs) is complete after the f1rst trimester. It seems that when research interests focus on 
the theoretical benefits to a fetus, the •ruJes• no longer apply. Willingness to acknowledge the safety 
of experimental therapies in this cohort of women should abrogate the arbitrary exclusion of 
pregnant women or women of child-bearing age in future experimental protocols. 
What are the clinical manifestations of HIV in women? Researchers and activists know that both the 
early indicators of immune dysfunction, as well as the ongoing and end-stage manifestations include 
gynecological infections and cancers. Refractory vaginal thrush, pelvic inflammatory disease (PID ), 
treatment-resistant human papillomavirus (HPV), and cervical cancers are well-documented in the 
literature, despite the Centers for Disease Control's (CDC) denial of their existence. However, the 
small number of wor ::1 included in the ZD V trials supporting product licensure, ignored these 
symptoms both from <.. .;:andpoint of assessing ZDV in interrupting or exacerbating their 
progression. No gynecological assessments were incorporated into these trials; women were 
evaluated using male-defmed endpoints. 
Results of studies in female animals given ZDV reveal an increased incidence of carcinogei:Jcty 
among these animals. In the Burrougbs-Wellcome study, oral ZDV was administered to m1ce and 
rats for 18-20 months. Enminations revealed vaginal carcinomas in five female mice. Three female 
mice had benign vaginal tumors. Literature searches reveal three other compounds which induce 
vaginal tumors: DES (diethylstilbestrol) a synthetic estrogen, and two naturally-derived estrogen 
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compounds. The devastating effects of DES are well-known. The increased incidence of vaginal 
carcinomas in women with mv, coupled with the information provided in these animal studies, raise 
serious questions about the long term effects of ZDV in women. Should ZDV be prescribed for 
mv-infected women? The answer lies in a post-marketing study to assess the long-term 
gynecological effects of ZDV in women. Given the available information, the FDA must require that 
Burroughs-Wellcome fund and conduct just such a study, and until such information is available, 
these questions should be discussed in the package inserts supplied to pharmacists and physicians 
with Retrovir. 
Additional concerns regarding the effects of ZDV in women include: 
1) the increased incidence of fatty livers in women on ZDV therapy, 
2) the interaction between ZDV and other concomitant therapies (ie. methadone), and 
3) the effects of ZDV on CD4 counts in mv-infected women (both symptomatic and 
asymptomatic). The Burroughs post-marketing study must be designed to address these 
issues as well. 
Now that the interest in ZD V research lies in the investigations surrounding fetuses and newborns, 
uial sites have been selected to target geographic locations with dense populations of women with 
HIV. Although the intent of ACI'G (]76 is in no way designed to assess the impact of ZDV on any 
relevant parameters in women, these very same researchers who rejected women, particularly 
pregnant women, in the original ZDV uials, are actively seeking women, specifically pregnant 
women, as an entre' to the study of the •innocent victims.· Indeed a woman can participate in this 
study at centers other than NlAID trial sites; Harlem Hospital, for example, will enroll women since 
Mount Sinai Medical Center has no access to qualified study subjects. 
Where were the same concened efforts to seek out, enroll, and assess the effects of ZDV on women 
in the original studies of this drug? If ACI'G (]76 targets the accrual of 748 pregnant mv-infected 
women for this trial. why can't they seek out equally large numbers of women for trials of other 
antiretrovirals and prophylactic therapies? 
There is some data from the original ZDV studies which should be retrievable to begin to answer 
some questions regarding the risks vs. benefits of ZDV therapy in women. NIAID must instruct the 
researchers and data analysts to compile and analyze that data immediately. In addition, further 
work must be done to assess ZDV's effect on women-specific parameters. The risks are too great and 
the benefits too questionable to require any less. 
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There are two pieces that make up the puzzle of women's lack of perceived risk. The first part has 
to do with the way in which public health education campaigns have failed in this epidemic to do 
little but scapegoat gay men. Most women can feel or have felt a false sense of security in knowing 
that they are not gay men. In fact, the confusion of "risk groups• with routes of transmission has 
practically guaranteed the spread of HIV to women. Every time a woman has sex with a man and 
does not use a condom or has sex with a woman and does not use a latex barrier clearly denotes the 
CDCs failure to adequately educate the public. As early as 1981, (this comes from the 
epidemiological article in AIDS: The Burdens of History) cases of women with AIDS were known to 
this agency. As we see with their refusal to change the definition of AIDS to include gyn-HIV 
infection, fear of alarm in the white middle class has been at the forefront of the creation of policy 
in this epidemic. 
The second piece of the puzzle, fitting perfectly with the first has to do with practitioners of all 
varieties not seeing women as posstbly HIV -infected. The lack of awareness that women can, do and 
are becoming HIV -infected prevents them from receiving appropriate medical treatment. 
Misdiagnosis of AIDS-related diseases in women occurs too often. For example, PCP is the number 
one documented cause of death in women with AIDS. Interestingly, Chris Norwood in Ms. 
Magazine in 1988 noted that the number of women in NYC dying of bacterial and other pneumonias 
increased dramatically over time. Whether or not these women were HIV infected is unknown, but 
most likely many of them were. Anecdotal reports from HIV positive women 
chronicle events such as their being sent home from hospital emergency rooms with a prescription for 
penicillin in hand only to get sicker. As women, they were not seen as possibly HIV-infected and 
hence in need of particular medical treatment, Fmally, a woman need not know her HIV-starus in 
order for her practitioner to begin to think "AIDS". 
Fmally, a third element which secures the further HIV infection of women is the artificial deflation of 
numbers in this epidemic. The recent fi:."'W'es are the only way in which people can, short of 
knowing individuals infected with the virus, feel any proximity to their possible infection. 
Unfonunately, reading that women account for only 9.1% of adult AIDS diagnoses reinforces the 
notion of women's safety from infection. The manner in which these numbers are kept low run the 
gamut from misdiagnosis and underd.iagnosis to a medically inappropriate definition of AIDS for 
women to women's poverty and resultant lack of access to health care. It is sobering to remember 
that the increase in AID diagnoses in women skyrocketed when this disease's definitions was 
changed in 1987. One can only imagine how those numbers in women would again soar if cervical 
cancer, pelvic inflammatory disease, endocarditis and pulmonary tuberculosis were to be included in 
definition of AIDS. Of course, this is the most morbid of ways to make sure that people feel some 
proximity to and take some precautions against becoming HIV -infected. It would be altogether 
easier and less murderous to create safer-sex and safer-drug campaigns that work. In this epidemic, 
the great educator has been either personal loss of a loved one or feeling overwhelmed at the 
numbers of "your kind" that are infected. For many gay men, these two factor have been quite 
persuasive. What does the CDC have in store for women? 
CODdoms, Lesbians & Tbe Bat Study 
Many people have been given the opportunity to feel liltle fear of HIV or AIDS while other people 
(namely gay men and IVDU's) have had to shoulder the burden of being perceived as the absolute 
embodiment of risk. This has far reaching implications for infection control as has been previously 
discussed. However, it is worthwhile to take note of three ideas that predominate in a discussion of 
women's perceived lack of risk. 
"When the media refer to heterosexual AIDS as a myth, they seem to suggest that "heterosexual• 
must not include women, because AIDS for heterosexual women is not only a myth, but is what, in 
some cities, is most likely to kill them: (Women, AIDS and Activism, p. 187) 
Condom use has failed because women have been targeted to •get• men to wear these prophylactics. 
This idea comes from a very uninformed point of view about the real lack of power women have in 
heterosexual sex. That the CDC has focused very little attention on encouraging condom use among 
straight men has aeated a false sense of safety among heterosexuals Necessary to preventing further 
infection in women, public art campaigns need to be aeated that address straight men and make 
condoms appealing to them. For many women who have sex with men, the fear of becoming HlV 
infected is insignificant in comparison to the fear of reprisal involved in even suggesting to their 
lovers that they use condoms. (IBID, p. 188) 
Heterosexual women are vulnerable to this virus through a lack of power in sex. Simply knowing 
what prevents transmission is not a guarantee of behavior change in the least. However, not 
knowing what prevents transmission of this disease places lesbians in a rather precarious position. 
Of all the women who have a perceived lack of risk, lesbian's lack of information and overall denial 
that they are at risk is overwhelming. This problem could be somewhat remedied if the CDC would 
study the ways in which people become infected, and not who's infected them. Indeed, if this were 
to take place, by necessity cunnilingus would come to be considered a risk behavior and all people, 
including lesbians, could realistically assess their risk of infection by this and other modes of 
transmission. 
Bow tbe Gcm!namaat uad tbe Media Blallle Womea for the AIDS Crisis 
"Vector Discussions• 
The normal discourse about women in the HIV pandemic has focused on our. role as vectors of 
transmission. The intent of this discussion, of course, is to continue the long and sexist tradition of 
sending messages of guilt to women. On an examination of the science, however, the fact is that 
women infrequently transmit HIV. Women are twelve times more likely to b .x:ome infected during 
vaginal intercourse with a male sexual partner than the other way around. And, the incidence of 
perinatal transmiuion has been estimated as approximately 33%. The occurrence of perinatal 
transmission is rel'Qrted to be as low as 15% when women receive adequate prenatal health care. 
Several factors may exacerbate the alarming rate of male to female transmission of HIV. Most of 
these relate to circumstances causing erosions of the surface of the cervix or vagina. Note: It has 
been postulated that the increased incidence of cervical carcinoma associated with ZDV therapy is 
also a result of vaginal/cervical sloughing, resulting in increased contact of ZDV urinary by-products 
with the vaginal/cervical subepithelium. 
Cervical infections and genital ulcers -caused particularly by syphilis, gonorrhea, Herpes simplex-2, 
trichomoniasis, and chlamydia! infection may increase HIV transmission by disrupting the integrity of 
the cervical mucosa. An association has also been found between HIV transmission and the use of 
oral contraceptives. When cervical erosion occurs, the columnar epithelial cells lining the cervical 
canal extend to an area of the cervix ordinarily protected by squamous epithelium, appearing as a 
friable, reddened area. 
As cervical erosion is a natural consequence of puberty, this may account for the increased incidence 
of young women of reproductive age who become HIV infected (as compared to older women). 
Sexual activity during menses may be an additional risk factor. 
V agina1 tightening agents and vaginal herbal medicines may increase the risk of female HIV 
transmission. In addition, semen with increased numbers of lymphocytes may pose an additional 
risk. Intercourse with men who have not been circumcised or who have penile ulcers have also been 
implicated in increased transmission. 
The lack of research into modes of transmission leaves the above questions unanswered. It is 
imperative, however, that women be informed of these possible risk factors when making decisions 
about their relative risks of infection. 
Almost every current and available barrier to HIV transmission is fraught with problems, particularly 
from the perspective of women. Relying on women to control the use of condoms with male sexual 
partners is ridiculous. 
Recent studies of spermicides as virucides raise serious concerns. A recent srudy by Joan Kreiss 
(University of Washington), found that nonoxynol-9, on a vaginal sponge or as a suppository, was not 
protective against HIV. Further, in the case of the vaginal sponge, it may have acrually been 
associated with increased rates of trans~ion. 
Lade of specific transmission research has led to a variety of ·home remedy" viral barriers. Fmger 
cots (latex gloves and tips used on the fmger during vaginal and anal insertion) are used by some. 
Research into the incidence of transmission via digital to oral/ anal insertion may show that this type 
of protection is unnecessary. 
Dental dams or rubber barriers have been used for protection during oral/anal and oral/vaginal sex. 
Tile Caters ror Diseale Coatrol's Policies 
Until the Center's for Disease Control changes the definition of AIDS to include gynecological 
infections, there is no reason to believe that NIAID will sponsor clinical trials to study HIV -related 
gynecological infections. Government agencies have a responsibility to each other and to the public. 
Scientists must use their authority to assert needed pressure on other government institutions when 
they stand in the way of life-saving scientific and medical research. Clearly this is what is need to 
stem the already overflowiDg epidemic of AIDS in women. 
Womm.. The AIDS Crisis, aad the Ceaters for Disease Control 
Basic to the prevention and spread of any disease, as well as to the care of people who are ill, is the 
knowledge of its symptoms and routes of transmission. This information may eventUally lead to 
understanding the cause of a disease but the most important part of epidemiological research is that 
the information gathered can reduce the impact of a disease even before its exact nature is 
understood. 
Accurate information about symptoms and transmission routes is necessary, first and foremost, so 
that people , themselves, can take preventative measures to avoid infection, can determine if they 
might be infected, and can seek appropriate care (if it exists) and avoid further transmission. 
Accurate information about symptoms and transmission routes is also important for health providers, 
although they usually see people after they are already ill. However, if they know what symptoms to 
look for they can be alert for signs of illness in people who may not know they are ill. 
Accurate infonr. . ..-on about syr;. ?toms and transmission routes is necessary to provide the basis for 
focusing scientific research on appropriate treatments and for providing standards of care for people 
who are ill. 
Fmally in an epidemic.. accurate information about symptoms forms the basis for establishing the 
extent of the epidemic. This information about symptoms is necessary in order to obtain an 
adeqUate level of funding from Federal, State and Local governments. Without adeqUate funding for 
education, prevention, social services, research aad treatment we cannot end this epidemic and 
people will continue to die needlessly. 
The Centers for Disease Control, which is part of the Public Health Service, is the agency charged 
with doing the appropriate epidemiological research, with developing prevention and educatio::.. J 
programs and with setting standards of care. Yet, wbea it comes to the AIDS crisis, the CDC is not 
doing aa adequate job ill any or these respects. After 10 1/2 years into this epidemic.. the 
information they have collected (and are still collecting) is minimal and misleading. It includes no 
women-specific symptoms. The CDC knows very little about transmission routes for people and 
their method of defining AIDS which excludes the symptoms women are getting keeps the extent of 
this epidemic artifici.ally low and becomes a barrier to obtaining the funding necessary to end this 
crisis. They have published few standards of care and the research they are now doing is inadequate 
and will not provide useful information for several years. 
Instead of collecting and disseminating aceurate information and doing appropriate research in an 
efficient manner, the CDC has focused most of its energies and funding on mandatory and 
confidential, rather than anonymous testing and is seeking to institute undemoaatic and unnecessary 
control procedures -contact tracing. partner notification and •routine testing", espcci.ally for pregnant 
women. These strategies bave been sbOWD not to work for sexually transmitted diseases or for TB. 
They act to make people avoid seeking medical care, especially those people who have had a history 
of negative treatment by the health system, including people of color, women, poor people, 
ont: 
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intravenous drug users and lesbians and gay men. These measures substitute ~ false sense of control 
for effective programs and practices of prevention, education and treatment which would really save 
lives. 
In this section of our Women's Treatment and Research Agenda we will address: 
o the background and history of the current AIDS Surveillance definition; 
o the data currently being collected -what is missing and what is wrong; 
o why the CDC surveillanc.; definition is important; 
o other problems with CDC research and policy, especially in relation to women; and 
o what we believe the CDC must do to save lives. 
B.c:qromad ud History ol tbe Clllftllt CDC Slll'ftillaDce Defiajtioa ol AIDS 
AIDS is not a single disease -it is a syndrome -Acquired Immune Deficiency Syndrome. A syndrome 
is medically defmed as a set of symptoms and diseases. This set changes and, therefore, the basis 
for a diagnosis changes. It is not fixed like, for example, TB. The definition of a syndrome must be 
continually changed as new symptoms are identified. In addition, not everyone gets symptoms. Some 
symptoms will be unique to specific groups because of anatomical differences. For example, women 
have vaginas, uteruses, fallopian tubes and ovaries. Men do not have these organs and opportunistic 
infections associated with AIDS cannot affect them in these sites. Some other differences which 
could produce different symptoms and severity of symptoms in different people might be their 
general state of health, the mode of HIV transmission, endocrine differences, age, geographic 
location, and so on. 
There are at least three different systems the CDC refers to in relation to AIDS/HIV: 
1) The CDC has a classification system ror HIV disease. This 
divides people, all of whom have tested positive for HIV, into groups starting with HIV, 
asymptomatic. It is supposedly based on clinical manifestation of HIV ~~ 
although not one I)'Decological symptom is listed in any category. This means that a 
woman who has tested positive for HIV would be considered asymptomatic even is she 
had any number of gynecological symptoms known to be associated with HIV. This 
system is supposedly not hierarchical in terms of severity, but it does range from 
asymptomatic to a listing of conditions. It is not used for surveillance purposes. 
2) There is also an international classification system (MMWR, 
36, No 7), in which a person doing the reporting codes "associated conditions• under 
categories of -wjth HIV-, "due to HIV", "with an AIDS-like disease•, ·due to an 
AIDS-like disease•, "with AIDS" and "due to AIDS". AIDS, in this system, is defined 
according to the CDC surveillance defmition. Although there are over 50 categories of 
"associated conditions• on this list (and a larger number of specific infections), not one 
I)'Decological symptom is Usted in any category. 
3) The CDC has a sumillanc;e definition or AIDS. The 
surveillance defmition of AIDS is the only one used for U.S. national reporting. It is 
the most limited set of symptoms compared to the other two; it includes cases which 
are diagnosed "presumptively", that is people who show cenain symptoms but whose 
lab tests have not been done; it also includes people who have no laboratory evidence of 
HIV but who show specific diseases/symptoms and for whom causes other than HIV 
have been ruled ouL This classification system does not include any I)'Decological 
symptoms. The figures from this system are the only ones used for determining the 
extent of the epidemic and on which budget requests are based. For example, this was 
the data used to determine the choice of sites for the CARE Bill Funds as well as for 
the allocation of these funds aaoss sites. 
The CDC surveillance definition was originally published iD 1982, based on a sm~ number of cases 
among predominantly white gay men. The conditions then considered to constitute an AIDS ~e for 
national reporting were limited (PCP, KS, cryptococcal meningitis, and certain lymphomas). This was 
;>efore HIV was discovered. No research bad been done. 
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Here is what officials at the Centers for Disease Control said about aeating that definition: 
•y es, we asked clinicians.· 
-yes, we went around the country looking for more cases -surveillance data 
-opportunistic infections -it wasn't clear that is was an epidemic at first -an 
epidemic of Kaposi's Sarcoma, an epidemic of pneumoc:ystis pneumonia -so 
we looked for everything ... what we found got included in the definition.· 
AIDS was so associated with gay men at that time that, initially, it was called GRID (Gay-Related 
Immune Deficiency). That AIDS was associated with a •gay-male life style" can be viewed both 
positively and negatively. Epidemiologically speaking, on the positive side, the fact that it was 
discovered "Post-Stonewall" (after the Gay Liberation movement) meant that some gay men were out 
enough to self-identify. Therefore, the reporting of PCP, even in a small number of cases (5) who 
all self-identified as gay might be the only thing that led to its discovery at all. (It bas since become 
clear that there were earlier cases, notably among intravenous drug users, which bad never been 
identified). And, since the CDC bad just been involved with the Hepatitis B studies in the gay 
community, they were familiar enough with gay male sexual behavior to look for posstble clues to 
transmission. However, the negative pan was the immediate connection between a gay "life-style" 
(including the use of "poppers") and the illness -a homophobic direction -which we have never 
recovered from and which not only still affects the gay community but affects. everyone else as well. 
Between 1983 and 1985, HIV was discovered (first by the French and called 
Lymphadenopathy-Associated Vuus, lA V; then by the Americans and called Human T-cell 
Lymphottopic Vuus m, HTI.. V-m; and finally, after an international panel arbitrated the issue, it 
became known as the Human Immunodeficiency Vuus, HIV). It is considered to be the cause of 
AIDS (although there is still disagreement as to whether it is the sole cause of AIDS and, for some 
people, whether it is the cause of AIDS at all). 
NIAID (The National Institute for Allergy and Infectious Diseases), Ia 1983, instituted its only major 
epidemiological study to date -The Multicenter AIDS Cohort Study (MACS). IDitial evaluations were 
completed in April, 1985. 4.955 gay men were involved in this study; 1,835 were seropositive on 
entry, the remainder were noL This is a natural history study. Every six months the men have 
physical exams, answer questions, and provide lab specimens. According to NIAID, this study 
identified unprotected "anal-receptive" intercourse as the primary route of transmission and also 
showed the linlc between T -cell suppression and seropositivity. As it progressed it also provided 
information for expanding the CDC surveillance defmition. 
In 1985 the CDC made its first substantive revision of their surveillance definition. Some diseases 
were added to their lisL The defmition made a distinction between opportunistic diseases present 
with an HJV + finding and those present with such a ftndlDg. Even so. the CDC estimated that its 
1985 mjsions resulted in the m;lassificatlon of less thaq one pm;mt of pm;ously Rvoned qses 
and added only 3-4% new cases. At this point there bad been 428 female AIDS cases reported and 
101 These quotes and others are from a meeting which took place at the CDC. Atlanta, Nov. 19, 1990. 
Present were members of Acr UP and Lifeforce (a peer education project for HIV + women) and Gary 
Noble, Ruth Berkelman, May Guinan, Jacob Gayle, Bert Petersen, Peter Drotman and Bill Para, all of 
the CDC. 
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1,785 intravenous drug users -1,511 male, 224 female -compared to 5,413 homose~/bisexual 
males). 
In 1987, the CDC once again revised its surveillance definition with changes in both adult and 
pediatric definitions. In desaibing the process they used to change the pediatric definition, the CDC 
stated that they gathered together clinicians and other experts who had been seeing cases of 
pediatric AIDS (although the number was quite small at that time) and used their information on 
which to defme Pediatric AIDS symptoms. For adults, additions included HIV encephalopathy 
(dementia), PIV wasting syndrome and certain lymphomas. Fmally, the CDC added diagnosis made 
presumptively (without having to do with laboratory tests) as long as a person was HIV+. In our 
opinion the diseases which were added in 1987 were probably found because the gay men being 
followed were staning to live longer due to medications for opportunistic infections including PCP 
prophylaxis. As some diseases in this group started becoming less prevalent, others began to appear 
at a more advanced state of illness (HIV Wasting Syndrome or HIV Dementia). This revision had 
a significant impact on reported cases or AIDS: 
a) Prior to the revision, of cases meeting the CDC defmition, 67% were homosexual/bisexual 
men and 23% were intravenous drug users. In the fJrSt year following the revision, the 
percent who were intravenous drug users, both homosexual and heterosexual. increased to 
43%, Blacks increased from 24o/o-36%, Hispanics from 13%-16%, and women from 
2.6%-3.6%. 
b) As of 1989, nationally, approximately 30% of new cases fit only the 1987 defmition. In the 
latest New York City Surveillance report, all cases diagnosed since January 1990, 30% of all 
cases fit only the 1987 revision. Furthermore, 38% of IVDU cases fit only the 1987 definition 
and 26% of heterosexual transmission cases fit only the 1987 definition. 
c) In the August 1990 CDC National Surveillance Report, of reported cases fitting only the 
1987 definition, approximately 56% were presumptively diagnosed and about 30% were people 
diagnosed with HIV encephalopathy or HIV wasting syndrome. 
d) According to the CDC itself, ·compared with patients who meet the pre-1987 definition, a 
higher proportion of patients who meet only the 1987 definitiot~ were female, Black or 
Hispanic or were intravenous drug users.· (HIV I AIDS Surveillance Report, August 1990). 
Both locally in NYC and nationally these categories overlap. For e.g., nationally, 58% of 
reported AIDS cases among Black females were listed under IVDU {August 1990). 
Why was it that adding these few, new advanced diseases/symptoms and, especially presumptive 
diagnoses, resulted in so many new cases among women, Blacks, Latino/as, and intravenous drug 
users? This is the way we have pieced the story together: 
o The majority of people who were not (and still are not) being counted are people who are 
poor, have little access to health care (including drug rehabilitation), and do not have primary care 
physicians or access to expensive testing. Some gay men who were not being counted had access to 
private physicians who did not report them until they had to enter the hospital system -at a more 
advanced· stage of the disease. 
o Due to institutionalized racism and sexism in this country, both economic and otherwise, a 
disproportionate number of women, Blacks and Latino/as are poor. They do not have access to 
private health care and have to use public health care systems when necessary (and if they are 
available). Women tend to come more into contact with these systems in their roles as caretakers of 
others and because childbirth has been moved outside the home and into the hospitals. Many poor 
people do not go for health care in these settings until they are very ill; women often go to emergency 
rooms when they are about to give birth. In both cases this is due to the way poor people have been 
treated, personally and medic:a.lly, in such systems. Even when it comes to intravenous drug use, it is 
poor people who enter the public system since wealthier people can go to private physicians and avoid 
becoming part of published statistics. 
o There began to be enough cases reported in other than gay males so that health care 
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providers could be alert to the possibility that AIDS was a poss1ble diagnosis. . 
o The earlier opportUnistic infections, in women especially, but also in intravenous drug users 
(many of whom are women) are not listed in the CDC definition. 
o The infections/symptoms which were added in 1987 occur later on in illness and these 
people were probably diagnosed when they were close to death; many were not diagnosed until after 
death. Fmally, presumptive diagnosis would allow low-funded public health care systems to diagnose 
people without having to do expensive diagnostic testing. 
Yet, despite these additional cases, recent studies indicate that 35-40% of the serious HIV related 
disease treated in hospital in-patient settings do not fit the CDC definition of AIDS. (New York 
City Department of Health Case Projections, 1989-1993). And, in one CDC study of the death 
certificates for women which listed HIV J AIDS, 48% died from conditions not listed in the CDC 
definition. 102 
And, the CDC admits that "Diagnosed AIDS cases do not represent all cases of severe morbidity 
associated with HIV infection. Many HIV + persons suffer from illnesses that are not reportable as 
AIDS even under the current definition and some persons may not have access to medical or 
diagnostic care. The number of persons with serve HIV related morbidity exceeds the number of 
diagnosed AIDS cases:103 
When somebody already fits the CDC definition, the health provider is supposed to report the case to 
the CDC (or to their local surveillance unit). The CDC keeps these statistics by case number 
(although the names exist). Other data include age, race, sex of the person, their geographic 
location (by zip codes), the mode of transmission (ac:tually a •fisk group• in the way it is done) and 
the •life-threatening illness• at the time of the AIDS diagnosis. The CDC collects no other 
information about the use until the person dies. This is what the CDC has been collecting and 
publishing for 10 years. They don't even know what diseases someone dies from (you don't •die from 
AIDS•; a person dies from an AIDS-related cause). Many people become part of the CDC data only 
after death when an autopsy reveals HIV. 
Getting counted is a catch-22. You have to already have an identified disease in order to be counted 
and they only identify that disease. How can a new disease be added as they should in the case of a 
syndrome? They haven't been added since 1987. Those diseases now in the defmition come from a 
very selected sample of people, predominantly gay men. 
Much research now exists which shows and association between HIV and specific opportUnistic 
infections or indicator diseases which have atypical outcomes in immunocompromised people (not 
responsive to conventional therapies, much more rapid progression, and so on). These aa infections 
or diseases which are showing up primarily in wgmen and intravenous drug uun. The aa 
severe. disabling conditions which are life-thrptening. Why aren't they being included in the CDC 
sui"'Veillanc;e definition? 
When we met with officials from the CDC on November 19th, they could not provide a satisfactory 
answer to this question. Here are some of the answers they gave (Although in quotes, the answers 
are paraphrases of longer answers): 
102 Chu S, et aL, "'mpact of the Human Immunodeficiency VU'US Epidemic on Mortality in Women 
of Reproductive Age, United States,• JAMA July ll, 1990, 254(4):225-229. 
103 MMWR Supplement, S/12/89. AIDS and Human Immunodeficiency VU'US ID.fection in the 
United States, l988 update. 
"Some women who are HIV + show some of these symptoms while others don't• 
(This is also true for the symptoms in the current CDC definition; some HIV + 
men get them and others don't. In fact, this is the nature of a syndrome; it does not 
have the same pattern in all people). 
"So many women get these infections that we can't be sure they are caused by HIV". 
(In fact, the CDC definition now in existence lists infections which gay men had 
before the AIDS epidemic. One is Herpes Simplex VU"US. However, there is a 
condition attached to its use as a definer of AIDS: •causing a mucocutaneous ulcer 
that persists longer than one month•. Isn't it possible to do the same thing with 
symptoms women show? 
"So many women have pelvic inflammatory disease and vaginal thrush that it would 
throw them into a panic if they believed they might be HIV + or have AIDS: 
(Since the CDC wants to push "routine testing", their strategy would seen to raise 
more panic since such testing would not be based on the appearance of symptoms 
at all). 
·How could a doctor tell the difference between severe, chronic pelvic inflammatory 
disease that is not AIDS related and a case that is?" (The current international 
classification system asks health care providers to do just that with over 50 
diseases). Dr. Harold Minlcoff, at the National Conference on Women and HIV 
Infection. December 1990, stated that clinically one could tell the difference 
between PID in a severely immunocompromised woman and PID in a woman 
without severe immunocompromise. · 
"The bottom line is immunosuppression -we look for immunosuppression as the 
cause of the disease. • (There is research showing a relationship between 
immunosuppression, HPV and Cervical Cancer -see section on opportunistic diseases 
in women. PCP occurs in cases of imm~osuppression other than HIV). 
"When you talk about less severe diseases they really aren't AIDS -they are not 
life-threatening. • (People who have a bout of pneumocystis pneumonia -which is in 
the current definition -can live for years. Cenainly cervical carcinoma is not less 
severe than some diseases already listed in the CDC definition). 
-we would be laughed out of the country for inflating the epidemic curve and simply 
trying to bring more money into AIDS research: (This is not a reason for giving 
up scientific integrity and for saaificing women's lives. We need more money for 
AIDS research.) 
-we need more research to show a casual relationship between the conditions 
women get and HIV before we can include them in the defmition: (All the 
surveillance defmitions so far have been based on clinical evidence and not on large 
scale research srudies showing causality beyond a shadow of a doubt. There are 
many doctors seeing hundreds of HIV + women and who know which symptoms 
they are getting. There is also more research now in terms of relating cenain 
symptoms to HIV in women than there ever was on which to base earlier 
defmitions. The CDC is using a double standard for women.) 
Given their stated concern with research and the lack of major epidemiological srudies of women, 
one would thi.nk that the CDC would focus on that area. Yet, last year, the CDC instituted studies 
designed, according to them, to finally get information on the spectrum of diseases shown by a 
broader range of people with HIV infection (that is, people other than gay men). The SPECTRUM 
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OF DISEASE STUDIES have been underway for about one year. The sites chosen were Atlant~. 
Dallas, Seattle and Denver. (They did not choose Newark, Brooklyn, Miami, San Juan or other. oues 
with the largest numbers of reported cases for women or intravenous drug users). How was this 
study done and what type of information is being collected about whom? 
o Each site was allowed to design their own study. In Atlanta, 
representatives from ACf UP have panicipated in designing the study. We were told that 
Atlanta will account for 60% of the data because they were the only location which used 
multiple sites to gather cases. In the other locations. oae hospital or provider has been 
selected as the source of information. 
o In our meeting at the CDC we confirmed our earlier 
information that although a total of 4,000 people are now involved in these studies onlv 7':'9 
are womep. We were also told that there are few people of color and few intravenous 
drug users. Is this another study of gay men? H the CDC so desperately needs a research 
base for their changes in defmition, how could they design yet another study which excludes 
women? 
o We found out that when the Atlanta site presented their list of 
opportunistic infections/indicator diseases for approval by the CDC they were told they 
should not collect data on vaginal thrush because lots of women get it. Therefore, when 
we wanted to access this data it had not been entered into the computer and we were told 
that perhaps it we went through each form by hand it might be listed under "other 
conditions.· CDC officials did not seem to know about this at all. 
Clearly, the CDC is unwilling to change their surveillance definition to include infections/indicator 
diseases specific to women, diseases which have been documented clinically and in scientific research 
papers. The CDC is requiring a different procedure for adding these infections compared to the 
procedures used for earlier revisions. The CDC is requiring a level and type of research it did not 
require for earlier revisions. research will take years and years to complete. Their own research. 
supposedly designed to include women, has only 7% women among 4,000 people after one year. 
The CDCs willful use of such a doubl\! standard and their inadequate monitoring of their own 
research (or willful concern for its adequacy) has no scientific justification, is unethical and will be 
respoDSible for the deaths of thousands of women. 
Wby tbe CDC SanaJiaace Ddlaitioa is haportut 
Many social service benefits as well as access to experimental drug trials are based on having CDC 
defmed AIDS. Obviously, these agencies do not have to use the CDC defmition. For example. the 
HHS has an independent responsibility to decide what constitutes a disabling condition. Yet. while 
the CDC does not have a legal responsibility in this regard, they do have a .ll!!l!Jll responsibility. 
They are the government agency charged with defining such diseases. Social services agencies, 
whether on the federal, state or local levels may not have the capabilities to do such epidemiological 
research. nor could other smaller agencies. Obviously, the CDC should be playing a leadership role 
in this area. By refusing to include the opportunistic infections women are getting into their 
definition, the CDC is ultimately respoDSible for the denial of these benefits and the exclusion of 
women from experimental drug trials, their denial of housing and so on. 
The lack of acknowledgement of women specific opportunistic infections also has repercussions for 
women's ability to monitor their own health and to determine they are ill as well as for health 
providers abilities to be alert to and diagnose AIDS in women before they are so sick that they die 
quickly. Educational material published by the CDC does not specify these infections. making it 
impossible for women to know they may be ill. Instead, the CDC pushed "routine testing", 
confidential testing, and mandatory testing, partner notification and contact tracing. These strategies 
will not work. Instead of bringing women towards the health care system they will push them away 
from it. 
One suggestion made is that the CDC should add some of these infections to their classification 
system but leave their surveillance defln.ition untouched. However, we should not be willing to 
accept changes only at this level While adding some new opportunistic infections to this system 
would help alert some health care providers to look for new symptoms, and might catch some cases 
earlier, this is not enough! Wby? 
The Cu~nt CDC surveillance definition is actively keeping the number or cases or AIDS artificially 
lowered. 
The CDC admits that, even using their current definition they undercount cases by 40%. They admit 
there are people who are HIV + who are severely ill but whose symptoms are not in the current 
defmition. We know that there are no women-specific symptoms included in the definition. 
Right now. the people who are being excluded are overwhelmingly women and intravenous drug 
users, who are poor and disproportionately people of color due to institutionalized racism in this 
country. 
The CDCs unwillingness to change their surveillance definition will also affect gay men, even those 
with access to health care. Over the last year there have been articles claiming that the rate of new 
AIDS cases is dropping among gay men. This doesn't mean there are no new cases, just that the 
number being added each month is lower than in earlier years and the total number is rising more 
slowly. In these articles several explanations are offered. One is that gay men are practicing safer 
sex. Another is that they are using prophylaxis and treatments so that they are not yet showing up 
as AIDS cases, according to CDC definition. 
This last point relates directly to the surveillance definition. PCP has been the major presumptive 
and definitive opportunistic infection at diagnosis for AIDS in the U.S. (TB is the major one 
worldwide but is not in the CDC definition). In New York, PCP accounts for 16,629 out of 26,205 
cases. Since many gay men have access to PCP prophylaxis and will not have PCP as their first OI, 
they will not be counted as having AIDS until they have a more "severe" condition, one that occurs 
later in illness. KS is the second most frequently reported diagnosis in N.Y. (4,038), although it is 
substantially lower in number. However, KS is also declining, perhaps because it is an opportunistic 
infection that is linked to other co-factors. (We have been given hardly any information at all by the 
CDC as to whether specific opportunistic infections are associated with different modes of 
transmission). The safer sex explanation for lowered cases is beginning to be countered bv papers 
presented at the VIth International on "relapse" behavior in relation to safer sex practices.104 
Given this information, refusing to change the current defmition bas three outcomes: 
1) It keeps the overall scope of the epidemic lower than it is. 
2) It keeps the number of cases of other than gay men lower than they should be and it 
keeps the number of cases of women extremely low. 
3) It keeps the rate of inaease for gay men lower than it is. 
This combination of effects is a perfect rationale for overall lowered funding for this epidemic. The 
fate of the Care Bill is a prime example.- It avoids the issue of the need for national health care. It 
can divide one community against the other in flghting for the funding that does not exist. It still 
keeps AIDS an overwhelmingly "gay disease• and current studies of "relapse" behavior can be the 
104 When we raised this point during our meeting at the CDC we were told that the rate among gay 
men was llQ1 deaea.sing; that there was a "trend toward a deaease in urban areas with large numbers of 
eases but that elsewhere in the country the rates were increasing". When asked why they had not 
countered newspaper repons about the deaease, they finally admitted that they should have but did not. 
basis for another homophobic attaclc in the future. 
In order to get the type or funding needed for health care, re.searc:h and treatment and education It 
is essential that the true scope of this epidemic be recorded. This can only happen if the 
opportunistic infections/indicator diseases affecting..il! people be represent~d in the CDC surveillance 
definition of AIDS. 
Other Problems with CDC Research and Policy 
a. The CDC is not collecting data on the progression of HIV disease, 
that ~ its natural history in all people affected. Nor is it collecting data on the entire spectrUm 
of dise~ after diagnoses. Progression stUdies do not require the abandonment of anonymous 
testing. We can find ways to gather this data. 
b. Without data on disease progression and Ols after diagnosis we: 
L do not really know how HIV is being transmitted and bow 
transmission routes relate to opportUnistic infections/indicator diseases and cannot focus 
the development of preventative treatments and protocols where they are needed 
2. cannot develop standards of care because we don't know why some 
people are living while others are dying. Of particular ·1terest here is research showing 
that women with HIV who receive primary health care iive longer than those who don't. 
regardless of specific medical treatment. 
3. cannot effectively educate people, both people with HIV who 
don't know it and health care providers who don't recognize it. A woman reading the 
usual pamphlet describing symptoms of HIV disease will not recognize herself unless she 
is desperately ill. (An exception here that I know of is a pamphlet put out by the New 
Jersey Women and AIDS Network which lists likely opportunistic infections in women). A 
doctor reading the CDC classification system (let alone the AIDS Surveillance definition) 
will no.: recognize a woman who is HIV positive. 
c. Instead of doing the type of epidemiological research and massive 
education they should be doing, the CDC is instead focusing on ·routine" testing of pregnant 
women, and moving towards confidential, rather than anonymous., testing, partner notification 
and contact tracing. These are not preventative strategies that work. 
d. Furthermore, the CDC is still focusing on women as "fetus carriers• 
and seem more concerned about the fetus than the woman. In addition to the spectrum of 
diseases studies discussed earlier, the CDC bas two other major studies now: 
1) a study to assess behavior in "high-risk" women in decisionsabout contraceptive and 
pregnancy choices; and 
2) a study of biological markers of pregnant women that correlate with the outcome of the 
fetus (U.S. and Africa). We were told that only if they get more funding this year will they look 
at "non-pregnant" women. In reality they are not looking at the woman at all-they are looking 
at the fetus. 
e. The CDC epidemiology still relies on "risk groups" and does not 
explicidy describe modes of transmission. If you look at their tables you see a ctegory for 
"homosexual/bisexual sexual contact". Is this meant to imply "anal intercourse without a 
condom"? 
f. Women are listed as the sex partners of men (sex partner of an 
IVDU, for example). Men are presumed to be their sex partners since none of the studies or 
2 nn . "'" _,,.., 
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questionnaires ask explicit questions about woman to woman sexual behavior, Yet. 
o From ·1981 to 1984 there were 101 reported cases of AIDS in 
which the women self-identified as lesbians or bisexuaL The CDC decided not to collect 
this information any longer because there "weren't enough cases." 
o While many cases of lesbians with AIDS are among lesbians who 
are also or were intravenous drug users, there have been documented cases of 
woman-to-woman sexual transmission (Rlbble, D. HIV Infection in Lesbians. Poster 
presented at the 5th International AIDS Conference, Montreal, 1989; Cohen, J.B., Hauer, 
LB. and Wofsy, C.B.: Women and IV Drugs: Parenteral and Heterosexual Transmission 
of Human Immuno-Deficiency VJ.rUS: The Jourpal of Drui Issues. 1989, 19:39-56; Marmor, 
M., Weiss, L.R., Lyden, M., Weiss, S.H., Saxinger, W.C., Spira, TJ., and Feorino, P.M. 
POSSible female-to-female transmission of Human Immunodeficiency Virus (letter): Annals 
of Internal Medicine: 105: 969; Mondanaro, J .: Treating Chemically Dependent Women. 
Lexington Books, 1988. 
o The percent of •undetermined risk• cases for women nationally 
is twice that of men: 7% vs. 3% in New York: 10% vs. 5%. The CDC recendy 
acknowledged that this is where woman-to-woman cases would be listed. 
o Cunnilingus is not listed as a poSSible mode of transmission 
(female-to-female or male-female) even though there was a letter last year in one of the 
major medical journals documenting a case of a man who apparently became HIV + and 
had only cunnilinguaJ sex with a woman for 13 years. 
o Without detailing all possible ways that a woman might 
transmit HIV to another woman sexually, the most obvious way is through oral-vaginal 
unprotected sex during menstruation. Somehow no one puts menstrual blood in the same 
category as ·blood •. 
o Even now, NIAID is beginning what they call a ·heterosexual· 
transmission study in women. When we confronted Dan Hoth about his inability to say 
these women were definitively heterosexual because no one is asking questions about 
woman-to-woman sexual behavior, he finally replied that they would add a question asking 
•Have you ever had sex with a woman?·. This may allow him to separate the two groups 
but it will provide no information about what type of woman-to-woman sexual behavior 
occurred. It's goal is to keep their sample ·clean· and not to provide transmission 
information about aU women. 
g. The CDC Surveillance definition places people hierarchically. For 
example, if a woman has ever used drugs she will be placed in the IVDU category even if she 
has also had unprotected vaginal intercourse with a man who was mv positive, or who fits 
some other ·suspect• group. Surveillance reports list overlaps between categories, although 
the only one which forms its own separate category is homosexual/bisexuallVDU. 
o Of 18,469 cases for which they list overlapping categories in 
August 1990, 13,201 are counted in their main surveillance statistics as homosexual/bisexual 
contact (men), of whom 8.714 were also IVDUs; 1,7'..6 bad heterosexual contact in addition 
to homosexual contact and are listed under homosexual/bisexual (these must be men 
because no women are listed under bisexual). Of 6,572 cases of heterosexual contact 
which overlap, 3,499 also were IVDUs but are listed in the main surveillance report under 
IVDU (the report does not divide these overlapping categories by sex). 
o Given that the CDC often relies on local reporting and given the 
sloppiness of its own categories, how do we know what the real story of transmission is, 
especially for women? 
Obviously the CDC deOnitlon or AIDS as ~II as its epidemiology are bad science and are political 
I! well 15 medical issues. 
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What the CDC Must do in Order to Save Lives 
November 25, 1990 
Memorandum 
TO: Gary Noble, M.D., Centers for Disease Control 
FROM: Maxine Wolfe for the ACI' UP Network 
RE: Demands for Changes in the CDC Epidemiology and AIDS Policies 
1. We demand that the CDC's surveillance definition of AIDS 
immediately be revised so that opportunistic infections and/ or indicator diseases with atypical 
outcomes in immunocompromised people, presendy being diagnosed, be added. These include 
but are not limited to: chronic pelvic inflammatory disease unresponsive to conventional 
therapy, including but not limited to repeated episodes of endometritis, salpingitis, tuboovarian 
abscesses leading to multiple pelvic adhesions and chronic pelvic pain; chronic refractory 
vag:in.a1 thrush (candidiasis); chanaoid., unresponsive to conventional therapy; anal, vulvar or 
vag:in.a1 condylomas (caused by Human Papillomavirus), unresponsive to con"Yentional therapy; 
genital ulcers of undetermined etiology which last for more than 4 weeks and which are 
unresponsi"Ye to empiric therapy; vulvar, vaginal, cervical and anal squamous cell neoplasias of 
the lower genital track; chronic, refractory urinary tract infections unresponsive to conventional 
therapies; neurosyphilis, with laboratory evidence of HIV, or definitively diagnosed reactivation 
of syphilis; renal failure with laboratory evidence of HIV and with exclusion of other causes; 
pulmonary tuberculosis with laboratory evidence of HIV; endocarditis' unresponsive to 
conventional treatment; neutropenia (non-AZT related); bacterial and atypical pneumonias 
unresponsive to conventional therapy; chronic or fulminant hepatitis; thrombocytopenia. 
2. We demand that the CDC immediately institute a mechanism for 
regular periodic review and revision of its surveillance definition on a quarterly basis to include 
newly discovered or developing opportunistic diseases in all affected people. Representatives 
from all communities must be included in this process of review and revision. 
3. We demand that the CDC immediately revise its system of 
collecting and publishing AIDS statistics: 
o The CDC must abandon its system of collecting and publishing 
statistics by "risk group· and, instead, collect and disseminate statistics based explicitly 
described modes or transmission. For example, "anal-intercourse -no condom" should be a 
mode of transmission which can occur for both men and women. 
o The CDC must collect and publish statistics on modes of 
transmission which do not now appear in their surveillance reports, for example, • cun.nilingus 
-no latex barrier", and this data should be collected for both female-female and male-female 
sexual partners. 
o The CDC must stop listing women according to the behavior of 
their presumed male sex partner and, instead, list both men and women according to specific 
modes of transmission. 
4. We demand that the CDC abandon their misguided strategies and 
intentions for "routine• and mandatory testing, partner notification and contact tracing, as well as 
their policy of counseling women with HIV disease to delay pregnancies. These strategies and 
policies protect no one. Instead, 
'I 
o The CDC must direct its resources towards developing and 
widely disseminating educational materials which include explicit descriptions of all 
transmission routs and poss1ble opportunistic infections/symptoms, especially those affecting 
women and intravenous drug users. These would include but not be l,imited to repeated 
chronic and severe urinary tract infections, refractory pelvic inflammation, genital warts, 
chronic refractory vaginal yeast infections, syphilis or venereal ulcers (chancroid), frequent 
herpes outbreaks, abnormal pap smears, chronic fatigue and loss of appetite 
o The CDC must instruct counselors and health providers to give 
womea accurate information on which they can base their decisions about pregnancy. 
o The CDC must audit grants given to State and local governments 
for educational purposes to insure that they are being used in a timely and appropriate 
fashion. The CDC should publicly report State or local governments which leave such funds 
unspent and reallocate them to agencies who will use them appropriately. 
5. We demand that the CDC malce opportunistic infection diagnosis and prevention a priority: 
o The CDC must research and collect statistics on the types of 
opportunistic infections people with HIV have from diagnosis through their course of illness 
and collect statistics on the causes of death of all persons with HIV disease. All of this must 
be done in a manner which protects the anonymity of people and the CDC must include 
substantial numbers of women, intravenous drug users and people of color in this research. 
o The CDC must provide, free of charge, the most up-to-date 
immune system monitoring along with appropriate counseling and referral services at all HIV 
testing sites. 
o The CDC must publish, on a timely basis, standards of care for 
the prevention and treatment of all opportunistic infections and/or indicator diseases with 
atypical outcomes in immunocompromised people or associated with HIV disease. These 
standards should include but not be limited to: a minimum of two pap smears annually for 
detection of possible cervical cancers; on site or rapid referrals for colposcopic examination 
and definitive therapy for all abnormal paps; testing for chlamydia at every gynecological 
screening; accurate testing for syphilis; viratyping for genital and anal warts; and health 
maintenance appropriate to age including but not limited to mammography. 
o The CDC must advocate, within HHS, to Congress. and to State 
and local governments and health departments for the provision of programs and funding to 
make preventative treatments available to all persons with HIV disease. 
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STATE HEALTH DIRECTOR 
ANNOUNCES FINAL RESULTS OF STUDY OF 
HIV INFECTION AMONG CHILD-BEARING WOMEN 
Sta~e Health Direc-:or Kenne~~ W. Kizer, M.D., M.P.H, today 
anr.c~r.ced t~e release cf final results frcm a California 
Depar-:~ent cf Eealth Services study of Human Immunodeficiency 
Vir-.:.s (HIV) i::.fection among California women who gave birt!'l i:l 
1989. 
After anonymously tes~ing bleed speci~ens from 144,284 live 
bir~~s among California women during July, August and September 
of 1989, depart=ental researc~ers found the HIV infection rat:e 
statewide to be 6.4 per 10,000, or one in every 1,568 women who 
gave birth in the study period. However, there was significant 
variability among the rates based on race and geographic 
loca"t:ion. 
For example, among the 10,802 black mothers, 32 tested positive, 
for a rate of 29.6 per 10,000 women. The rate for the 58,667 
whii:e women who gave birth i::. the study period was 3.9 per 
10,000. Thus, the rate for black women was more than seven i:imes 
-MORE-
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that for white women. The rates for Hispanic, Asian and women of 
other racial/ethnic groups did not differ significantly from that 
for whites. "These results underscore the seriousness of the 
epidemic in California's African-American community," Kizer said. 
Twenty-one of California's 58 counties had at least one HIV 
positive birt~ during the study period. The remaining, typically 
smaller coun~~es, had no HIV positive birt~s. Compared to the 
rate for the rest of the State (3.8 per 10,000), the six-coun~y 
San Francisco Bay Area rate (11.8 per 10,000) was thr~e times 
higher, and the Los Angeles county rate (7.9 per 10,000) was 
twice as high. However, high rates are not limited to these two 
densely populated, urban areas. Other counties with rates higher 
.than six per ten thousand were Merced, Sacramento, San Luis 
Obispo, santa Barbara, santa cruz and Sonoma Counties. "HIV 
infection is by no means limited to California's largest urban 
centers," Director Kizer remarked. 
Women under 20 at the time that they gave birth were slightly 
less likely to be HIV infected, as were those 35 years of aqe and 
over. However, these differences are relatively small and they 
are not consistent throughout the State. The Department's Office 
of AIDS is engaged in further exploration of the relationship 
between mother's age and HIV infection. "All childbearing women, 
-MORE-
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regardless of age, need to avoid high-risk behaviors such as 
unsafe sex and intravenous drug use, if they are to protec~ 
themselves and their children from this deadly disease, " Kizer 
advised. 
T~e 1989 rate was essentially unchanged from 1988: 7.4 per 10,000 
in 1988 compared to 6.4 per 10,000 childbearing women in 1989. 
''T~e lack of a significant change in this measure of the 
in:ec~icn ra~e is encouraging. It indicates that California is 
holding the li~e on the spread of HIV infection in childbearing 
women and their infants. We are encouraged, and importan~ly, we 
believe tha~ California's prevention programs are working," added 
Kizer. 
The study used blood samples routinely taken from infants shortly 
after bir~h for the purpose of screening for several genetic 
diseases that is required by law. Infants acquire HIV antibodies 
from their mothers. Thus, a positive HIV test for a newborn 
infant means that the mother has HIV infection. Not all of the 
infants will develop the disease themselves. currently, experts 
predict that about one-third of the infants born to HIV infected 
women will eventually develop HIV infection themselves. In order 
to protect the mothers' and infants' rights to privacy, the H!V 
test results were not linked to any individual baby or mother. 
~ou- ryi~ 
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However, using standard "unlinked survey" techniques, the 
researchers were able to link the mother's age group, 
racejethnicity, and area of residence to their HIV status, maki~g 
these analyses possible. 
-ooo-
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San Francisco Bay Area includes Alameda, Contra Costa, Marin, San 
Francisco, San Mateo and Santa Clara counties. 
All HIV positive tests were confirmed by Western blot. Excludes 
cases for which the blood specimen was either not available or 
inadequate for HIV testing. Only one result included for 
multiple births. Excludes mothers who were not residents of 
California and those for whom residence was not known. 
California Department of Health Services 
Office of AIDS 
November 1990 
HIV Test Results for Mothers of Newborn Californians 























Area of Residence and RacejEthnicity 
Percent 



























































































































San Francisco Bay Area includes Alameda, Contra Costa, Marin, San 
Francisco, san Mateo and Santa Clara counties. 
All HIV positive tests were confirmed by Western blot. Excludes 
cases for which the blood specimen was either not available or 
inadequate for HIV testing. Only one result included for 
multiple births. Excludes mothers who were not residents of 
California and those for whom residence was not known. 
California Department of Health Services 
Office of AIDS 
November 1990 
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HIV Test Results for Mothers of Newborn Californians 
Third Quarter 1989 
Area of Residence, Age Group, Racejethnicity 
95% Confidence 
Percent Interval 
Positive Negative Positive Lower U:g:ger 
Area of 
Residence 
Total 92 144192 0.064 0.052 0.079 
S.F. Bay Area 25 21192 0.118 0.078 0.177 
L.A. County 39 49315 0.079 0.057 0.109 
Rest of Calif. 28 73685 0.038 0.026 0.056 
Age Grou:g 
Total 92 144192 0.064 0.052 0.079 
under 20 8 15883 0.050 0.023 0.1.03 
20-24 30 35742 0.084 0.058 0.121 
25-29 22 42383 0.052 0.033 0.080 
30-34 22 29779 0.074 0.047 0.11.4 
35 and over 8 14533 0.055 0.026 0.1.13 
Unknown 2 5872 0.034 0.006 0.1.37 
Racelethnicit:::t 
Total 92 144192 0.064 0.052 0.079 
Asian 1 9178 0.011. 0.001. 0.071 
Black 32 10770 0.296 0.206 0.423 
Hispanic 29 55847 0.052 0.035 0.076 
Others 6 8312 0.072 0.029 0.165 
Unknown 1 1441 0.069 0.004 0.449 






















San Francisco Bay Area includes Alameda, Contra Costa, Marin, San 
Francisco, San Mateo and Santa Clara counties. 
All HIV positive tests were confirmed by Western blot. Excludes 
cases for which the blood specimen was either not available or 
inadequate for HIV testing. Only one result included for 
multiple births. Excludes mothers who were not residents of 
California and those for whom residence was not known. 
California Department of Health Services 
Office of AIDS 
November 1.990 
HIV Test Results for Mothers of Newborn californians 
Third Quarter 1989 
Odds Ratios for: 
Area of Residence, Age Group, RacejEtbnicity 
Percent 
Positive Negative Positive 
Area of 
Residence 
S.F. Bay Area 
L.A. County 





























































































Costa, Marin, Sari 
* Signifies reference groups for computing odds ratios. The odds 
ratio is a measure of how much more likely a particular group is 
to be HIV infected as compared to the reference group. "n.a." 
means that odds ratio and confidence intervals were not computed· 
as the expected number of positive tests for one cell was less 
than 5. Odds ratios were computed by the computer program "Epi 
Info, Version 5," using Cornfeld's approximation, as described by 
Joseph Fleiss, Statistical Methods for Rates and Proportions. 
New York: John Wiley & Sons, 1981, pp. 71-75. 
All HIV positive tests were confirmed by Western blot. Excludes 
cases for which the blood specimen was either not available or 
inadequate for HIV testing. Only one result included for 
multiple births. Excludes mothers who were not residents of 
California and those for whom residence was not known. 
California Department of Health Services 
Office of AIDS 
November 1990 
HIV Test Results for Newborn Californians 
Third Quarter 1989 
Area and County of Residence 
(page 1 of 2) 
95% Confidence 
Percent Interval 1 in 
Positive Neaative Positive Lower Upper Every 
:tatewi.de 92 144192 0.064 0.052 0.079 1568 
:.F. Bay 'I'ota1 25 21192 0.118 0.078 0.177 849 
,lameda 10 5380 0.186 0.094 0.353 539 
:antra Costa 9 3252 0.276 0.135 0.544 362 
[arin 0 725 0.000 ----- -----
ian Francisco 4 2543 0.157 0.050 0.431 637 
ian Mateo 1 2425 0.041 0.002 0.267 2426 
ianta Clara 1 6867 0.015 0.001 0.094 6868 
~os Angeles County 39 49315 0.079 0.057 0.109 1265 
>ther Counties 25 68973 0.036 0.024 0.054 2760 
3utte 0 689 0.000 ----- -----
n Dorado 0 429 0.000 ----- -----
~resno 1 3701 0.027 0.002 0.175 3702 
iumboldt 0 421 0.000 ----- -----
r:mperial 0 771 0.000 ----- -----
:<ern 1 2983 0.034 0.002 0.217 2984 
:<ings 0 491 o.ooo ----- -----
'1adera 0 475 0.000 ----- -----
wterced 1 970 0.103 0.006 0.666 971 
~apa 0 393 0.000 ----- -----
)range 2 11995 0.017 0.003 0.067 5999 
Riverside 2 5807 0.034 0.006 0.139 2905 
Sacramento 3 4383 0.068 0.018 0.218 1462 
San Bernadino 3 7508 0.040 0.010 0.127 2504 
San Diego 6 11375 0.053 0.021 0.121 1897 
San Joaquin 1 2463 0.041 0.002 0.263 2464 
San Luis Obispo 1 708 0.141 0.008 0.910 709 
Santa Barbara 2 1528 0.131 0.023 0.526 765 
Santa Cruz 1 1076 0.093 0.005 0.600 1077 
Shasta 0 590 o.ooo ----- -----
Solano 0 1370 0.000 ----- -----
Sonoma 1 1545 0.065 0.004 0.419 1546 
Stanislaus 0 1817 0.000 ----- -----
Tulare 0 1779 0.000 ----- -----
Ventura 0 3147 0.000 ----- -----
Yolo 0 559 0.000 ----- -----
- - - - ------- - - - -
California Department of Health Services 
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HIV Test Results for Newborn Californians 
Third Quarter 1989 
Area and County of Residence 
(page 2 of 2) 
95% Confidence 
Percent Interval 1 in 
Positive Negative Positive Lower Upper Every 








Reqion 2 counties 2 1691 0.118 0.021 0.475 847 
Monterey 
San Benito 




Reqion 4 counties 1 515 0.194 0.011 1.248 516 
Lake 
Mendocino 
Reqion 5 counties 0 790 o.ooo ----- -----
Nevada 
Placer 
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All HIV positive tests were confirmed by Western blot. Excludes cases for 
which the blood specimen was either not available or inadequate for HIV 
testing. Only one result included for multiple births. Excludes mothers wh< 
were not residents of California and those for whom residence was not known. 
California Department of Health Services 
Office of AIDS 
November 1990 
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SAC~N'I'O - ~~~ne .:.n every 1,420 child.l:aar.!.!'lg woman test H!V 
:: :::sl. -:::;e ac:~rci::q -:.o ~ California De;>ar-::men-: of Health services 
s~udy on s~atewide HIV prevalence in child~aaring woman conduc~ea 
d.-:.;.r:.::q :..990." sa~d Sta~e Heal~"l Di.re.c-:or Molly .Joel coye, M.D., 
X. :?.H. 
CRS raeearc~ers ~es~ea anonymous blood specimens f~om lS0,494 
~~fan~s born ~o California women durL~q July, Auqus~ and Septam=ar 
:: 1990. one-hundred and six tasted positive, !or a stataw~de HIV 
~~evalence rate o! seven per 10,000, or one in ever; 1,420 women 
~ho gave bi=-:~ dur:::q the study pericd. 
Fi!~y-seven of the ll, 703 Atr!::a:n-Amer!:an mot±ers .:.n the 
sample ~ested posi~ive for HIV infection, !or a ra~e of 48.7 per 
:o,ooo ~others. For white mothers, the rate was 3.4 per lO,OOO or 
~o H!V .:.~fec~ad mo~hers out of ~9,189. Thus the rata tor African-
Amerl.can ~o~hers was 14 ti~es higher than that !or white mc~ars. 
::1 adai":!on, t.he i::!ec-:ion rata is hiqher for .Afri::an-American 
~ethers in every age qroup studied. This shows that the high ::ate 
:or At::~can-Ame=ican mothers is not a ret!ac-:icn or di!!arences in 
~~e ages of wo:an gi~ir.g birth. 
"'!'he .consi.stent!y higher rata ot HIV .!.ntec-:.1o:n !or Afr!can-
A.merican mothers gives us qreat concern," !:)r. Coya said.. "!ut the 
:::.sk of HIV intec~icn is widespread: no rac:.al/ethn.:i.c group is 
:.::t:nune ~~om tha~ r!.sk ... 
"At l.aast:. one ::~o~her ~asted posit!.ve tor HIV i.nfactl.on :..n :!6 
of Cali!ornia's 58 counties," said Mary Jess Wilson, ~.o., !i.?.H. 
?u~lic Healt.~ Medical ot:icer with tha state Ot!!.ce of AIDS. •'RIV 
in!ect:ion was more prevalent in the State • s ~._.o larqes~ urt=an areas 
-- the San Francisco Bay Area and Los Angeles County -- ~han it ~as 
.::..~the =est of the St~te." _ .... -
-2-
However, tha c:cun-eies in those areas d.it:ered great'.! y i:'l 
~~:fac~ion ra~e among t~amselvas. In Alameda Coun~y, one out'. of 
eva~i SlO ~as in!ec~ed, q~vinq ~ham the highest'. rata ot infac~!on. 
7ha next highest rates were in San Joaquin County with one out'. o! 
~ve:y 777 ana contra Costa county with one out ot every Bll. 
''Mos~ cf t!la HIV infected mothers were ::-om the larqer, more 
~==~n counties, ~ut mot~ers ::-om smaller ana leas ur=an coun~ies 
~re ::o~ immune t=om in:fec'Cion," or. ccye remarltec1. 
~he =ate !or 1990 was slightly niqher than that'. :or 1989 and 
s~i;ht~y lower than i~ was in 1988. OHS researchers concluded that 
~~ese di!!e:ences were net :arqe encuqh to sugqest any siqni!~cant 
=::.anqa in the prevalence ot HIV infection amonq :ali!ol:"'nia 's 
=nildbeari~g women. 
"While tha absence of an increasing t::-enc:l is welccma,. we 
:annot oe sure of the reasons !or it," Or. Coye c:aut1cned. 
''Although HIV intec-eion amonc; Ca.li:ornia women ot ch1lc1l;:)aarinq aqe 
:ay ~ct be increasinq, it could mean that mora in~ac-eed women may 
:e chcosinq no~ ~= have children. Thia could make the rate appear 
-:.o be s~eady, while t.~e act'Ual =ate amonq all woman ot child,J:,aarinc::r 
age could oe inc::-easing." · 
Finally, since the projee~ beqan in l988, ~· rata has bean 
~iqhe: :or Afr~can•Amarican mothers in the San Francisco Bay Area, 
:.os Anc;eles county and all ot.~ar counties, th.e three areas the 
3 ~a ::e was broken in~o to cond.uc-: the s-eudy. on the other hanc:l, the 
:ates amonc; Lat~~a, Asian, Pac~!ic Islander, and mothers ot other 
:acial;e~hnic oackqrcunQs did not'. di!:ar siqni!icantly from that'. 
:or ·..;hitas. 
':'ha s~ud.y uaeci :Cleoci samples :cu~inely taken !::'om in~ants 
sho~:y attar birth to screen tor seve::"al qene~ic diseases. 
3ecause infants acquire H:IV antibodies from their mothers , a 
:ositive HIV tast tor a newborn intant means that the mother is 
lnfected. To protect'. each mot'.her•s and intant•s r1qht to pr~vacy, 
':he HIV test results ware not linkaa to any identified mother or 
:::aJ:2v. For the same reason, aqe and. race/ eth.nici ty ware qrouped and 
s~ailer counties combined. 
Not all t."1e intan-ea whc tea-cad posit'.:!.va wll~ d.avelop Hr; 
disease themselves. currently, expe~ predict that about one-
!!!~~ to one-thi=c:l of the in!an-es born eo Hrv in~actad mcthara will 
beco~e ill themselves. Separa~e stuc:lies are bainq ccnducted to 
1 denti!y the staqes of HIV disea~e in Chil~an under tha aqe of 13. 
I") ... t. 
4_,,),1 
HIV seroprevalence among California Childbearing Women 
Third Quarter 1990 
Office of AIDS 
California Depar~men~ of Health Services 
Sep~ember 1991 
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95\ Cont. :nt. 



























































HIV ::os.:.t:ive t:est:s were con:fi::ned by West:ern Blot:. Cases wit:h r:u.ssing or i.:'laciecuat:e ;:;.:..cc 
s~ec~mens were omitted. Only one result is present:ed for ~ult:.:.ple oirt:hs. ~xci~ces 
.. ._ ..... _ ..... -1"'-'\~~,.....o...,,-o •J.::~c:: 11nknnwn. r"\"''~ 
HIV Seroprevalence among California Childbearing Women 
Third Quar~er 1990 
Office of AIDS 




HIV ?ositive ~5\ Conf. :~t. l in 
~ Pet. :ower ' Uc~er ' Eve~r 
Statewide 150494 
Area of State and Aqe Group 





35 and over 
Unknown 





35 and over 
Unknown 




























Area of State and RacefEthnicity 














Rest of California 
















































































































































































































san Francisco Bay Area includes Alameda, Contra Costa, Marin, San Francisco, San Matec 
c;anta Clara Counties. t) ··Q ..... h, 
HIV Sercprevalence among California Childbear~ng Women 
Third Quarter 1990 
Office of AIDS 
California Depar~men~ of Health Services 
Septemeer 1991 
Statewide 
Area of State 
San Franc~sco Bay Area 
Los Angeles County 
~est: of California• 












35 and ever• 
Unknown 



















HIV Positive 95\ Conf. :::1t. 
!!2..:.. Pc~. Lower ~ Uooer i: 
106 0.0704 0.0579 0.0855 
23 0.1075 0.0698 0.1640 
52 0.0997 0.0752 0.1318 
31 0.0403 0.0279 0.0580 
1 0.0121 0.0007 0.0786 
57 0.4871 0.3724 0.6353 
27 0.0419 0.0281 0.0618 
20 0.0338 0.0212 0.0532 
0 0.0000 . 0.0596 0.0034 0.3859 -
10 0.0575 0.0292 0.1096 
19 0.0493 0.0305 0.0785 
47 0.1069 0.0794 0.1434 
18 0.0563 0.0344 0.0910 
8 0.0506 0.0236 0.1040 

























. . . -·- ... 
0.97 
2 ~·~ . --
~ .. _ ........ 
2.79 
HIV ocsitive tests were confi~ed by Western Slot. Cases with miss4ng or ~~adequate o~cc 
soeclmens were omitted. Only one result is presented for multiple oir~hs. ~xcluaes 
mot:hers who were not res~dents of Califcrn4a or whose residence was unknown. 
• Designates the reference group for computing relative risks. 
•• Indicates that the rela~ive risk for the group is significantly larger (or smal:er: 
than 1 at the 95' confidence interval, using the Tayler Series as programmed ~n ·~?~ 
,. ... ,., ... _,."" .. "'ion 5. in the ·sTATCALC• module. ry-:c-l 
TEL No. MaY 7.3! 13:58 P.03 
IPl~IMIO~CQICAt OVI~VIIW 
In Hay of 1985;. the Loe Angelee County Sheri!'!·~ Depart:=ent 
began maintainin& statistical information on inmates with H!V 
Dieease. A that time, it wae the beet "qu~ee"t.imate" that 'the 
&eroprevalance rate for HlV infection in the nalione pri5on~ and 
jails wpe anywhere between 8 ana 30~ and the gener~l publi:'e 
perception was that the virus would be spreading rapidly by 
sexual activity in our correclional in~titutione. 
Since that ~i~e. we have gained invaluable insigh~ into ~he 
epidt;;miolo&Y of .. HlV D!f;eace behind bare", prioaril~· thru the 
four annual eurveye done by Dr. Ted Hammett, euppo~~ed by the 
National Institute ~f Jus~ice and the John Hopkine/CtC Sero-
Prevalance Study in 10 correctional facilities aero~e the Ur.!ted 
State&. 
Eased on theee, ae well as other ef!orts, we know that: 
o The Seropervalance Rates amonc new 
entrante in~o U.S. correctional 
fac1li~!ee ran1es from 0.17% to 20%. 
0 The annual rate ot increaee in the 
~· 
number of caaes of AIDS in 
correctional faeil1t1ee for 1990 
waa 29%. 
77 
.,., ...... r ....... ,,~ . 
I 
TEL No. Ma~ 7,31 l3:5S P.)J 
-2-
The annual r~tc of increase in the 
United Statea, in the free eommunity, 
·.for 1990 was 38". 
o 0! the tranemieeion that i~ cceurrin& 
in our jails and prieone. es~ is reported 
to be related to Intravenous Drug 
Oe~/Sharing of Needle worke. 
In t~rme o! our Los Angel~& County Jail Sys~ems, ~he 






'The signi!icc:.uct: c-! our seroprevalanc~ ra"te is that on any 
day we r~ay ht:~ve ae many as 5~0+ !.:lmates who are 
The cummulative HIV statietice for 
cur e~rvice (May 5, 198~ thru February 26. 1991 are attached .~:-­...... 





SHERIFF•s D&PARTM~NT MEDICAL SERVICES 
•. 
• 
AIDS CASELOAD STATISTICS* 
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• Males......... 506 
Females....... 15 
Number of AIDS Related Dea~hs••• .••••••••.•••••••••.•••• 
Number o! Employee/Possible HIV Exposure InJury Repo~: .• 
Ethnicity of the Confirmed Cases: 
a) Cauea!:ian •••••. .••.•••••••••..••... ·• 
b ) B la-c 1:. •••••••••••••••••••••••••••••• • • 
e) Hispanic .•.................•.•..•.... 
d) Other •••••••.•••..••••..••.••.••••••• 
e) Unknown • •••••••••••••..•••••••••••••• 
Risk Group Districutlon ot Confirmed Cases: 
a) Gay Males •...••..•..•••••.•......•..•. 
b) Lesbians ••.••••••••••.•.•..• ••••••.•• 
c) I.V. Drug User.l!i •••••••••••••••••••••• 
o) elooo T~ansfUSlOns .•••.•••.••.•••.... 
e) Ot-her • ••••••••••••••• • •••••••••••••••• 
Averag~ Daily Census c! PWA (Mcn~h ot Novemoer, l9i0) ••• 
Average Daily Census o! known HIV Positive Inmates •••••• 
Sercprevalence raLe in New Entrants··~·················· 
Number of HIV Teat done in Month of January, 1991 ••..••• 
Number o! HI V Te.s t do.ne in Month of December, 1990 •••••• 
Number of HIV Teat done in Montn of Novemoer, 1g9o •.•••• 
Number of HlV Test done in Month of October, 1990 •••.••• 
Number of HIV Test done in Month of September, 1990 ••••. 
Nuwber of HIV Ttst done in Mon~h of August, 1990 ••••.... 
~umber of Positive Test !or Month of January, 1991 ••••• 
Number of Positive !est for Month of Oecember, l990 ••••• 
Number of Positive Test for Month of November. 1990 ••••• 
Number ot Positlve Test for Month of October, 1990 •••••• 
Number of Positive Test for Month of September. l990 ••.• 
Number of Posi~ive Test fer Month of August, 1990 ••••••• 
*Aa of ~anuary 3l, l99l 
••cumulative from May 2, 1985 
**•Includes LCMC Jail Ward 
















































TEL ~·lo . MaY 7.31 14:0~ P.Cl 
SHERIFF'S D&PARTM~NT MEDICAL SERVICES 
AIDS CASELOAD STATISTICS* 
Number of Confirmed Cases of AIDS (Includes ARC)*• .••••• 
• Males •••.•..•• Sll 
Females....... lS 
Number of AIDS Related Deaths••• •••••••••••••••••••••••• 
Number of Employee/Possible HIV Exposure Injury Report •• 
Ethnicity of the con!irmed Cases: 
a) Caucasian •••••••••••••••••••••••••••• 
b) Black ...•.•...•.....•.•...•.•••..••.• 
c ) H is pan i c . . . • • . . . . . . . • . . . . . . . . . . . . . . . . 
d) Other .••....•..•.••••••••.••••••••••• 
e) Unknown ••••••••••••••••••.•.••••••••• 
Risk Group Distribution of Confirmed Cases: 
a) Gay Males ••••••••• •••••••.••••••••••• 
b) Lesbian!' .•.••••••.•.•••••.•••.•••••••• 
e) I.V. Oru9 Users •••••••••••••••••••••• 
d) Bloo~ Transfusions ••••••••••••••••••• 
e) Other .•••••••••••••• ~ •••••••••••••••• 
Average Daily Census of PWA (Month of November, 1990) ••• 
Average naily Census of known HIV Positive Inmates •.•••• 
Sercprevolence rate in New Entrants•••• ••••••••••••••••• 
Number of HIV Tes~ done in Month of February, 1991 •••••. 
Number of HlV Tes~ done in Month of January, 1991 ••••••• 
Number of HlV Test done in Month ot December, 1990 •••••• 
Number of HIV Test done in Month of November, 1990 •••••• 
Number of HlV Test ~one in Month of October, 1990 ••••••• 
NYmber of HIV Teat ~one in Month of September, 1990 ••••• 
Number of Positive Test !or Month of February, 1991 •••• 
Number of Positive Test for Month of January, 1991~····· 
Number of Positive Test for Month of December, 1990 ••••• 
Number of Positive Test for Month of November, 1990 ••••• 
Number of Positive Tast for Month of October, 1990 •••••• 
Number of ·positive Test for Month of Sep~ember~ 1990 •••• 
*As of February 28, 1991 
**Cumulative from May 2, 198~ 
***Includes LCMC Jail Ward 

































Acquired Immunodeficiency Syndrome (AIDS) ll 
Monthly Surveillance Summary· October 31, 1991 
I ., 
(; 






1991 1990 90 to 91 
,, 
Los Angeles County 
I New cases reported in October 232 301 -23% 
i New cases reported year-to-date 2.450 2.180 +12% 
I 
I 
l Cumulative cases 13.647
1 10.7562 +27% 
Cumulative deaths 9,5341 7,3222 +30% 




\I Cumulative cases 38.0183 30.422" +25% 
tl 
Cumulative deaths 25,98<Y 19,89~ +31% 






Cumulative cases 195.718s 152.1266 +29% I, 
ii Cumulative deaths 126.1!igs 93,7i56 +35% 
II 
Cumulative case-fatality rate 64% 62% 
I 
I 1 Includes all cases reponed to the AIDS Epidemiology Procram 81 or October 31. 1991. 2 Includes all cases reponed to the AIDS Epidemiology Progn~m 81 or October 31. 1990. 
I 3 California Office of AIDS. California AIDS Update. October 31. 1991. 
4 California Office of AIDS. California AIDS Update. October 31. 1990. 
s Centers for Disease Control. HIV/AIDS Surveillance Repon. October 1991:1-18. 
6 Centers ror Disease Control. HIV/AIDS Surveillance Repon. October 1990:1·16. 
AIDS SURVEILLANCE REPORT 
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Acquired Immunodeficiency Syndrome (AIDS) 
Monthly Surveillance Report • October 31, 1991 
Los Angeles County AIDS EpidemioloaY Proaram • Surveillance Unit 
REPORTED AIDS CASES AND D£4THS BY DIS£4SE C4.TEGORY 
Disease Adult Pediatricl Total 
Cateaory1 Cases Deaths1 Cases Deaths Cases Deaths 
No. ( %) No. (CFR4) No. ( %) No. (CFR4) No. ( %) No. (CFR4) 
PCP W/0 KS 6499 (48) 4579 (70) 47 (43 ) 31 (66 ) 6546 (48) 4610 (70) 
KS w/o PCP 2037 (15 ) 1431 (70) 1 (01 ) 1 (100) 2038 (15 ) 1432 (70) 
KS and PCP 975 (07) 803 (82) 1 (01 ) 1 (100) 976 (07) 804 (82) 
Other 01 4026 (30) 2653 (66) 61 (SS) 35 (57) 4087 (30) 2688 (66) 
Total 13537 9466 110 61 13647 9534 
[%of Total] (99] (01 ] [100) 
REPORTED AIDS CASES BY AGE AND RACE!ETHNIC11l' 
Age at Diagnosis White Black Hispanic Asian5 Total' 
No. ( %) No. ( %) No. ( %) No. ( %) No. ( %) 
less than 13 30(00) 37 (02) 39 (01 ) 4 (02) 110 (01 ) 
13- 19 10 (00) 9 (00) 12 (00) 0 (00) 31 (00) 
20-29 1229 (15) 461 (21) 612 (23) 28 (14) 2356 (17 ) 
30-39 3745 (44) 1018 (46) 1189 (44) 71 (36) 61}67 (44) 
40-49 2244 (27) 457 (21) 556 (21) 68 (35) 3353 (25 ) 
so- 59 877 (10) 174 (08) 2D7 (08) 19 (10) 1283 (09) 
Greater than 60 325 (04) S6 (03) 57 (02) 7 (04) 447 (03) 
Total 3460 llll 1611 197 13647 
[%of Total) (62] [16} [20 1 (01 ] [100} 









History of Intravenous Drua Use 
No Yes Unknowu 
No. ( %) No. ( %) No. C %) 
4298 (73) 731 (46) 4937 (81 ) 
953 (16) 216 (14) 638 (10) 
326 (06) 253 (16) 123 (02) 
82 (01 ) 257 (16) 260 (04) 
199 (03) 131 (08) 133 (02) 
5851 1511 6091 










1 ~ cafe&Oria are onlered ~n:aically; KS•ICapoai'surcoaa. PCP•Pn~umOCYStis c:arinii paeuaoaia. Ol•opponni&lic: ia(ec:tiotl. 
1 Reportia' of dca!M il '--pletc. 
3 IKJadel all palieall • dlaa 13 at tile tiae of diapoai&. 
4 CfRac.e.fa&ality rate. 
S IKJadel 1 Buna-=. 3 Caabocliaa, 23 Cilia-. 60 filipiao, 3 lDdoaesiaa, 37 Japaa-. 7 K.orua, 3 Mayalaa. 11 Pacifac: blaaclen., 4 
Taiwaa-. 13 'Illai. aad 11 Vietuaae; :Zt are of uDkllowa etllaicity. 
' Total iadadel 16 ~~~ ladiaDIIAlauu NatiYes, aDd 90 ~ wbolc raceletluaicity iiUDkDowa. 2GG 
4. 
s. 
REPORTED AIDS CASES BY EXPOSURE CATEGORY AND GENDER 
Exposure Cateaory7 Male Female Total 
Adult/Adolescent No. ( %) No. ( %) No. ( %} 
Homosexual/bisexual male contact 10826 (83) 0 (00) 10826 (80) 
Intravenous drug use (IVDU) 510 (04) 131 (28) 641 (OS ) 
Homosexual or bisexuaiiVDU 947 (07) 0 (00) 947 (07) 
Hemophilia or coagulation disorder 59 (00) 5 (01 ) 64 (00) 
Heterosexual contact 87 (01 ) 152 (33 ) 239 (02) 
Transfusion recipient 142 (01 ) 105 (23) 247 (02) 
Undetermined 503 (04) 70 (15 ) 573 (04) 
Adult Subtotal 13074 463 13537 
[% of Adult Subtotal] [97 I {03 I [100] 
Pediatric 
Hemophilia or coagulation disorder 4 (06) 1 (02) 5 (05) 
Parent with or at risk: of AIDS8 26 (41 ) 33 (72) 59 (54) 
Transfusion recipient 33 (52) 11 (24) 44 (40) 
Undetennined 1 (02) 1 (02) 2 (02) 
PedUllric Subtotal 64 46 110 
[% of Pediarric Subtotal} [58 I [42 1 [100/ 
Total 13138 509 13647 
[%of Total] [96) [04) [100] 
REPORTED AIDS CASES BY EXPOSURE CATEGORY AND RACE/ETHNICI7l' 
Exposure Cateaory7 White Black Hispanic: Other 
Adu It/Adolescent No. ( %) No. ( %) No. ( %) No. ( %) 
Homosexual/bisexual male contact 7233 (86) 1425 (66) 1930 (73) 238 (80) 
Intravenous drug use (IVDU) 217 (03) 254 (12) 160 (06) 10 (03) 
Homosexual or bisexualiVDU 572 (07) 213 (10) 154 (06) 8 (03) 
Hemophilia or coagulation disorder 38(00) 10 (00) 9 (00) 7 (02) 
Heterosexual contact 81 (01 ) 81 (04) 67 (03) 4 (01 ) 
Transfusion recipient 137 (02) 34 (02) 58 (02) 18 (06) 
Undetennined 152 (02) 152 (07) 255 (10) 14 (OS) 
Adult Subtotal 8430 2175 2633 299 
[% of Adult Subtotal] [62 I [16 1 [19 1 102 I 
Pediatric 
Hemophilia or coagulation disorder 2 (07) 0 (00) 2 (OS) 1 (25) 
Parent with or at risk: of AIDS8 12 (40) 25 (68) 22 (56) 0 (00) 
Transfusion recipient 16 (53) 10 (27) 15 (38) 3 {15) 
Undetennined 0 (00) 2 (OS) 0 (00) 0 (00) 
PedUllric Subtotal 30 37 39 4 
[%of Pediarric Subtotal} [27 I [34 1 [35 1 /04 I 
Total 8460 llll l67l 303 
[%of Total) [62] [16] [20] [02] 
7 Ellpolare c:atqoriel are ordered laienn:~cally. Ell:ept (or Ole coabiulioll lialed. - widt aalliple risk W:ton are aabulaled ia dte catecory listed 
fin&. 
8 ladadel oae c:aae ua ... illed by breul ailk. 
6. REPORTED AIDS CASES BY EXPOSURE C4TEGORY AND YEAR OF DIAGNOSIS 
Before 
Exposure Cateaory' 1987 1987 1988 1989 1990 1991" 
Adult/Adolescent No. ( %) No. ( %) No. ( %) No. ( %) No. ( %) No. C %) 
Homosexual/bisexual male contact 2707 (83) 1600 (81 ) 1749 (80) 1901 (79) 1860 (77) 1009 (76) 
lntraYenous drug use (IVDU) 80(02) 79 (04) 122 (06) 126 (OS ) 151 (06 ) 83 (06) 
Homosexual or bisexual IVDU 262 (08) 147 (07) 164 (07) 165 (07) 138 (06) 71 (OS ) 
Hemophilia or coagulation disorder 22 (01 ) 4 (00) 14 (01 ) 3 (00) 10 (00) 11 (01 ) 
Heterosexual contact 35 (01 ) 34 (02) 40 (02) 43 (02) 53 (02) 34 (03 ) 
Transfusion recipient 65 (02) 48 (02) 42 (02) 32 (01 ) 42 (02) 18 (01 ) 
Undetermined 71 (02) 52 (03) 65 (03) 122 (OS) 166 (07) 97 (07) 
Adull Subtotal 3242 1964 2196 2392 2420 1323 
[% of AduJJ SubtottJll [24 I [15 J [16 I [18 J [18 I [10 J 
Pediatric 
Hemophilia or coagulation disorder 0 (00) 2 (17 ) 2 (14) 0 (00) 0 (00) 1 (07) 
Parent with or at risk of AIDS11 12 (38) 6 (50) 6 (43) 19 (79) 8 (57) 8 (57) 
Transfusion recipient 20 (63) 4 (33) 6 (43) 4 {17) 6 (43) 4 (29) 
Undetermined 0 (00) 0 (00) 0 (00) 1 (04) 0 (00) 1 (07) 
Pedialric Subtotal 32 12 14 24 14 14 
I% of Pediatric SubtottJJ I [29 J [II I [13 J [22 J [13 I [13 J 
Total 3274 1976 2210 2416 2434 1337 
(%of Total) [24] (14 1 [16 1 [18] (18) (10] 
1. REPORTED AIDS CASES BY RACE/ETHNICJTY AND YEAR OF DIAGNOSIS 
Race/Ethoicity 
White, not Hispanic 








No. C %) 
2287 (70) 
464 (14) 
482 (15 ) 





No. ( %) No. ( %) 
1328 (67 ) 1322 (60) 
290 (15 ) 412 (19) 
319 {16) 439 (20) 
23 (01 ) 27 (01 ) 
16 (01 ) 10 (00) 
1976 2210 
[14] [16 1 
1989 1990 1991l' 
No. ( %) No. ( %} No. ( %} 
1433 (59) 1356 (56) 734 (55 ) 
389 (16) 427 (18) 230 (17 ) 
535 (22) 564 (23) 333 (25 ) 
46 (02) 52 (02) 19 (01 ) 
13 (01 ) 35 (01 ) 21 (02) 
2416 2434 1337 
(18] (18] (10 1 
9 &ponre cale~Griea are ordered ILieran:llically. E:rl:ept for tile combiutioo listed. tuea witll more tbao oae risk factor are tabulated ia tbe catqory listed firsL 
10 Cues di.apoled tlli.a year aod reported to the AIDS EpidemioiOC)' Pro&ram aa of tbe date of this report; tllese data are provisioaal 
11 lodudea oae cue rrauairted by breaat milk. 
2GS 
• 










85 85 86 86 87 87 88 88 89 89 90 90 91 91 .• 
Half-Year of D1agnos1s 
Case-Fatality 
Half-Year of Diagaosis Deatbs Rate 
Before 1985 851 788 93% 
1985 January • June 425 400 94% 
July· December 513 474 92% 
1986 January • June 689 640 93% 
July - December 796 740 93% 
1987 January - June 991 881 89% 
July - December 985 821 83% 
1988 January- June 1080 852 79% 
July - December 1130 863 76% 
1989 January· June 1266 874 69% 
July- December 1150 7'1/J 63% 
1990 January - June 1323 674 51% 
July • December 1111 472 42% 
1991 January - June 988 294 30% 
July - December12 349 41 12% 
Total 13647 70,. 
12 Cua diapOMd tllis year aad reported 10 die AIDS Epideaiolo&Y Procraa u of die date of tllis report; t.11ae dau are prcMaloul < u" 




REPORTED AIDS CASES BY MONTH AND lE4R OF DIAGNOSIS 
Before 
Moath 1986 1986 1987 1988 1989 1990 
January 112 106 178 174 197 231 
February 102 98 157 170 174 189 
March 128 116 141 184 232 223 
April 117 113 168 190 208 234 
May 145 125 174 189 202 215 
June 167 131 173 173 253 231 
July 154 133 157 200 190 201 
August 183 121 146 213 194 218 
September 162 152 183 186 212 184 
October 168 131 192 172 199 167 
November 149 106 130 178 194 169 
December 202 153 177 181 161 172 
Total 1789 1485 1976 1110 1416 1434 
10. REPORTED AIDS CASES BY HEALTH DISTRICT OF RESIDENCE AT ONSET 
Rate per 
Healtb District No. ( '> 1oo,ooo'• 
Alhambra 193 (01 ) 60 
Bellflower 138 (01 ) 43 
Central 1329 (10) 448 
Compton 201 (01 ) 74 
East Los Angeles 153 (01 ) 80 
East Valley 804 (06) 248 
El Monte 169 {01) 44 
Foothill 138 (01) 52 
Glendale 576 (04) 168 
HarbOr 99 {01) 56 
Hollywood-Wilshire 3700 (27) 821 
Inglewood 369 (03) 86 
Long Beach 1136 {08) 295 
Nonheast 377 (03) 151 
Pasadena 143 {01 ) 114 
Pomona 230 (02) 56 
San Antonio 163 (01) 47 
San Fernando 205 (02) 54 
South 160 (01) 120 
Southeast 158 (01) 130 
Southwest 547 (04) 174 
Torrance 190 (01 ) 58 
West 853 (06) 163 
West Valley 642 (05) 99 
Whittier 129 (01 ) 47 
Unknown 845 (06) NA15 
Total 13647 170 
13 C.. diaplOIMid IU year aad reported to tlw AIDS l:.pide•ioloa,y Prop-a• aa of t1w date of tlaia report; t1aae datA are proviaioaal. 
14 19&5 poptialioa estiaa• baed oa 1980 Ceaaua. 















11. ANNUAL ADULT/ADOLESCENT AIDS C4SES AND RATES11 PER 100,000 BY RACE!ETHNICJTY AND GENDER 
Year or Diagnosis White Black Hispanic: Other Totall7 
~ No . .B,rus No. Rate No . .B,rus ~Rate ~~ 
1984 349 22 61 19 56 7 1 0 469 16 
1985 637 41 121 38 129 16 13 4 900 30 
1986 991 64 196 62 225 26 17 5 1433 47 
1987 1295 84 268 84 297 34 21 6 1897 61 
1988 1286 85 380 119 414 45 27 7 2114 67 
1989 1396 93 355 111 511 54 46 11 2317 73 
1990 1323 89 388 122 523 53 51 12 2315 72 
199118 712 48 208 65 313 32 17 4 1269 39 
~ No . .B,rus No . .B,rus ~Rate ~.B.rus ~~ 
1984 4 0 5 1 1 0 0 0 10 0 
1985 18 1 3 1 4 0 0 0 25 1 
1986 15 1 16 4 10 1 1 0 42 1 
1987 30 2 19 5 16 2 2 1 67 2 
1988 35 2 26 7 19 2 2 0 82 2 
1989 31 2 23 6 18 2 3 1 75 2 
1990 28 2 35 9 36 4 4 1 105 3 
199118 17 1 16 4 17 2 3 1 54 2 
12. REPORTED AIDS-INDICATOR CONDITIONS 
Condition" 
Bacterial infections, multiple or recurrent20 
Candidiasis of bronchi, trachea, or lungs 
Candidiasis of esophagus 
Coccidioidomycosis, disseminated or extrapulmonary 
Cryptococ:cosis, extrapulmonary 
Cryptosporidiosis, chronic intestinal 
Cytomegalovirus disease other than retinitis 
Cytomegalovirus retinitis 
HIV encephalopathy 
Herpes simplex: chronic ulcers, pneumonitis or esophagitis 
Histoplasmosis, disseminated or cxtrapulmonary 
lsosporiasis, chronic intestinal 
Kaposi's sarcoma 
Lymphoid interstitial pneumonitis20 
Lymphoma, Burkitt's 
Lymphoma, immunoblasti<: 
Lymphoma, primary in brain 
Mycobacterium avium or M. kansasii, disseminated 
M. tuberculosis, disseminated or extrapulmonary 
Mycobacterium, other or unidentified species 
Pneumocy$tis carinii pneumonia 
Progressive multifocal leukoencephalopathy 
Salmonella septicemia, recurrent 
Toxoplasmosis of the brain 
Wasting syndrome 
16 Aa .. al popwlatiotl •tiaatcs baaed oa 1980 Ceasua. 
17 Tocal iad*"- penou wllole rac:elethai(il)' ia ualul-.. 
No. ( ~) 
35 (0.3 ) 




499 (3.7 ) 
791 (5.8) 
514 (3.8 ) 
619 (4.5 ) 
409 (3) 
85 (0.6) 
94 (0.7 ) 
3014 (22.1) 







7522 (55.1 ) 




11 C.U. diapoeed IU year aad ~poned to the AIDS Epidoliolo(y f'rova• aa oliM date or Ibis report; lbele data •~ pi'O'Iisioaal. 
19 Palinll aay Uw - thaa oae cotlditioa. 
lD Palintal- tllaa 13 II Ole ti- or diapoaia. 2';'1 





OUtside Los Angeles/Unk 
Total 
AIDS • LOS ANGELES COUNTY 
SURVEILLANCE SUMMARY 
DEATHS DURING SEPTEMBER 1991* 
AS OF 10/31/91 







*These data are provisional due to delays in mortality reporting. 
LOS ANGELES COUNTY STD CONTROL PROGRAM 
Gonorrhea Data 
(Annual Report 1/1/89 - 12/30/89 And Third Quarter 1990) 
Reported by Public/Private Sector/Military/Other Jurisdictions 
Gonorrhea Los Angeles County 1/1/89 - 12/30/89 
















Gonorrhea South Area 1/1/89 - 12/30/89 
Tota1 Reported Cases= 8,047 (31% of County Wide Total) 
B 1 acl\ Hispanic Wh1te 
Maie 3,813 562 as 
Female 2' 176 283 1 2 1 
TOTAL: 5,989 (74%) 845 ( 11 ~) 209 (3~) 
Gonorrhea Los Angeles County Third Quarter 1990 (7/1/90- 9/29/90) 
















Gonorrhea Metro South Area Third Quarter 1990 (7/1/90 - 9/29/90) 













153 ( 8%) 
'~'"''10 




50 ( 3%) 
LOS ANGELES COUNTY STD CONTROL PROGRAM 
Syphilis Data 
(Annual Report 1/1/89- 12/30/89 And Third Quarter 1990) 
Reported by Public/Private Sector/Military/Other Jurisdictions 
Syphilis Los Angeies County 




















Total Reported Cases = 9 ':''7 ... f (33% of County Wide Total) 
Black Hispanic White 
Maie 397 125 18 
Female 307 50 15 
TOTAL: 704 (75%) 175 {19%) 33 (4~) 
Syphilis Los Angeles County Third Quarter 1990 (7/1/90 - 9/23/90) 
Total Reported Cases = 466 
Black Hispanic White 
Male 142 94 3"" .:.
Female 115 ·-: ., ...... 15 
TOTAL: 257 (55~) 127 (27%) 48 (10%) 
Syphilis Metro South Area Third Quarter 1990 (7/1/90- 9/29/90) 
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Table 1.1. Demographic characteristics 
of STDs In Los Angeles County during 
1986. 
Demographic 
0\aracter 1st lc 
Sex 



















Of the cases reported by publfc sources 11 percent were froa custOdial 
facilities. The nuaber of positive cultures fro• these facilities fs 
preseni'ed 1 n Table 1.2. 
Table 1.2. Positive gonorrhea cultures froa custodial facilities fn Los 
Angeles County during 1986. 
Fee lllty 
Men 
Los Padrlnos Juvenile Hall 
Men's Central Jail 
Hall of Justice Jail 
Central Juvenile Hall 
Wanen 
Sybil Brand Institute 
Central Juvenile Hall 
Los Padrlnos Juvenile Hall 
Number of 
Cultures 
17,585 ,,, .. 
1,239 
54 275 
Number of Positive 
Cultures (percent) 
•• ( 8.9) 
139 (31.2) 
• ( 7.1) 
0 ( 0.0) 
1,989 (11,4) 
139 ( •••• , 
137 ( 17.6) 
Tlble 1.3. Annual rate of gonorrhea Jn Los Angeles 
County during 1986, by health district. 
Heelth District Num&»er Annual Rate 
of Cases Ccases/100,000) .. 
South A,828 3,631 .:s. 
Southe••t A,36• 3,593.1 
SouthwesT 8,452 2,686. 7 
Ccalpton ,,730 2,102.0 
lnglhood 6,889 1,610.7 
Central 3,109 1,041.1 
Hoi I ywood-W II shIre 3,770 136.2 
East Los Angeles 725 379.1 
NorthNst 915 367.3 
HaM> or 6A7 363.5 
El Monte t ,351 351.1 
foothill 879 329.4 
East Valley 1,255 326.0. 
San Antonio f ,063 305.1 - West 1,593 303.9 
Torrance 821 2A9.9 
Pceona 967 234.2 
Be I If I ower 696 211.9 
West Val ley 1,39' 214.9 
San fernando 1AO tt•.a 
Whltff.,.. 41. 176.0 
Alhl&lbra "' 129.5 Glendale •ta 122.0 
55 
·-
Race-specific rates Indicate that Slacks not only had the •lghest 




WotTE  a...c< ~.,..tO 
Race 
Figure 1.2. Annual rate of gonorrhea In Los Angeles County during 1986, 
by race. 
The age-specific Incidence Is presented In Figure 1~. Persons betw .. n 
the ages of 15 and 29 accounted for 73., percent of all reported cases. 
~Fo..~~~~~.~~------------------------~ 
COCIO.,._ _ _ _ ...__ _ _ 
Figure 1~. Annual rate of gonorrhea In Los Angeles County during 1986, 
by age. 
• 
The apparent decrease In gonorrhea Is In contrast with an rnorease 
during 1986 In the rate ot penfcllllnas ... produclng NIISSICI' gonocrb•• 
(PPM;). The rata of gonorrl'tea lftay have decreased a110ng W"te 
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LOS ANGELES COUNTY DIPA~TMIMT or IIALTR II~VIC&I 
IIXOALLt TRAMSMITTID DISIAII PAC~ SRI&T 
IPO~,.KC JIIOliiD%1'! Tl&.DI 
nit.ed Stat•• 
a11tora1a 









MPIC~%00S SYPHILIS (Priaary & Secondary) 
nit.ed St.at.ea · 
al1tora1a 
08 Aa9elea COUilt.y 
!PIUI.%1 (All St.a9ea) 
att.ed Stat•• 
alitornia 
































OMPLICA,.IOMS • LOS ANGELES COON1'T S1'A1'ISTICS • ILAIORATIOM 
~~COCCAL PILVIC INFLAMMATORY DIS!A§~_(G/PID) 
1982 1,176 reported ca••• 
1983 1,161 reported ca••• 
















REPORTED CHILD SIXOAL AIOSE 
(STDa in g.,, year oldal_ 
•EWICILLIMASE-PRODOCIMG NEISSERIA GONORRROEAI CPPWGl 
1982 69 reported 
1982 139 reported ca••• 1983 93 • 
1983 169 reported ca••• 1984 107 • 
198 .. 286 reported ca••• 1985 124 • 
1985 489 reported ca••• 1986 80 • 
1986 942 reported c•••• 
:OWGEWITAL SYPHILIS (Aaon! childrell leaa than 1 year of •!e) 
1912 10 reported caaea 
1913 8 reported caaea 
1984 5 reported caaea 
1985 10 reported caaea 
1986 31 reported c•••• 
•Aat.oaated record keepin9 ayatea introduced in Loa An9elea Coull~ ill 1982. 
••aat£aated/pro•1a1onal data tor 1986. • 
!Or 4£a:aae illforaatioa or clillica tor dia9aoa1a aad treat.aeat call 
~b• •~o Botlille. Monday - Tburaday 8 a.a. to 6 P••• alld Friday I •·•· 
tbl'oa•b 5 P••• 
279 "g 
caaer 
7he M1nor1tv AIDS Conso~t1um was establ1shea 1n ~ebruarv l3b9. 7~e 
ou n:;ose of the Censor~ 1 um 1 s ~o oromo~e ana ;nnance ri I,;,: A IDS 
acucat1cn. creven~1on and 1n~ervent1on oroqrams ~n e~hnlc m1nor1~v 
commut11t1es tt1rouohout L.OS ~rtcales Cour1t·,.. . ne ·,:or-;scr-tlurn·:.:; 
membersn1o 1s ccmor1sed of aqenc1es and ~na1v1duais irom ~he cuol1c 
.:ina :.;r-lvat.e sect:.ot-s ..;no ar-e ot-cvldH1Q serv1ces to ct1e i-ii'·.f/AIDS 
-;ryfected ano,.or- aTfacted ccmmun1~·l. Add1t1onail·,., .nanv ;nemoer-s 
;.:;er·ve as aavoca~es =or- HI·w· :nt'ected/affec~ea ··nOlvlcuais. Uie-.r-
,-·amli1es a.na the .::;cmmunl~·.--a-c-iar-qe. The Ccnscr--c.ium·;::. c •. n-r-ent. 
r;iernoer-sn;o cor..a;s ~ft1r;:,v-s1x. 1na1v1auais r-eor-eserit,1no c.•vecat,-,.-c~ ... o 
t .:.~; commurtl I.-,-Caseo or-oar-i 1 za·c; or1s.. t'tt~e 1 \;e ._ j..;. 1 ;:;ubi -i c se~ ~~r­
·.:ioenc1es ana,-or- ..:.r-oqrams; Cecar--c.ment oT Heaiti-; Ser--.-,ce:;; t...o:;; ;:..nqe 16-S 
Count.v. Deoar~menc of Heaith Serv1ces Lonq Seacn. 0CLA. Cai1torn1a 
Stat.e Unlver-sltv i..os Anqeles. :alifor-nla State i..;nlvers·;t.v i...cno 
3eacn a.na two 12; ~avoerscns. 
riemoer aqenc1es of the Consor~1um have worKed col iaborat.lvelv on 
1umerous cccas1ons to cromote and suooort. riiV/AICS-reiat.eo 
cr-oorammlnq be1no 1molementea throuqhout i..os Anqles Count-;. :n 
add1t1on. the Consor-t1um ouolishes and d1ssem1nat.es a auartet-1·; 
ca1endar of HIVIAIDS-related events and orcqrams to 1ts membersn1o 
as weil as over two hundred 1200l aqenc1es and 1na1v1auals from the 
cubl1c and cr1vate sectors 1n i..os Anqeles Ccuntv. 
For the cast e1qhteen months. member aqenc1es nave oeen act1ve1v 
1 nvo I ved 1 n t.he deve I cement. of the AIDS Req 1 ona 1 Soard of ~.-..:.s 
~noeies Count.v to ensure that the unmet ~IV/AICS-related sarv1ca 
needs of ethn1c m1nor1tv commun1~1es are aaeauatelv addressee. 
MINORITY AIDS CONSORTIUM ROSTER 
Community Based Organizations 
Ms. Collette Jacques 
Executive Director 
S.O.A.P. 
945 S. Prairie, Ste. #103 
Inglewood, CA 90301 
(213) 671-1185 
Mr. Phill Wilson 
Community Development Dept. 
215 W. Sixth Street, 6th Floor 
Los Angeles, CA 90014 
(213) 485-6320 
Mr. Alvin Ransom, Coordinator 
ATTN: Mr. Johnnie Johnson 
AIDS Program Office 
600 S. Commonwealth, 6th Floor 
Los Angeles, CA 90005 
(213) 351-8076 
Dr. Perry Brown, Director 
Population Studies 
ATTN: Lisa Clements 
1621 E. 120th Street 
Los Angeles, CA 90059 
(213) 563-5843 
Mr. Michael Puentes 
Health Educator 
Cara A Cara 
Latino AIDS Project 
3324 Sunset Blvd. 
Los Angeles, CA 90026 
(213) 661-6752 
(213) 660-1408 FAX 
Mr. Andre Cunningham 
Director 
ATTN: Msadiki Gray 
Blanca Hernandez 
Southern California Youth and 
Family Center 
101 N. LaBrea Ave, Ste. #100 




HIV/AIDS Outreach Targeting 
the Caribbean Community: 
Referrals 
Directs the City of Los 
Angeles Education and 
Prevention Programs targeting 
city employees and L.A. City 
residents. 
Coordination of services and 
technical assistance to 
community-based 
organizations. 
HIV/AIDS related planning, 
coordination, development and 
research: epidemiology and 
prevention. 
Education and prevention 
programs targeting the Latino 
community. 
Teen pregnancy prevention and 
HIV/AIDS education targeting 
school age, out-of-school 
youth and the general 
community. 
281 
Ms. Ramona Hall 
The Gathering Place 
3536 W. Slauson Avenue 
Los Angeles, CA 90043 
(213) 295-2687 
Ms. Nola Thomas 
T.H.E. Clinic for Women 
3860 W. Martin Luther King 
Blvd. 





AIDS Project Los Angeles 
6721 Romaine Street 
Los Angeles, CA 90038 
(213) 962-1600 
Ms. Yealanda Charles 
Metro South HIV Program 
Florence Firestone Health 
Center 
8019 S. Compton Avenue 
Los Angeles, CA 90001 
(213) 586-6588 
Rev. Carl Bean, Director 
Minority AIDS Project 
ATTN: Mr. Paul Davis 
5149 W. Jefferson Blvd. 
Los Angeles, CA 90016 
(213) 936-4949 
Ms. Rochelle Jefferson 
P.O.Box 4763 
Diamond Bar, CA 91765-0763 
2 
Services targeting HIV 
infected individuals and 
their families: emotional and 
spiritual support groups: 
massage therapy; AIDS 
referral: library. Lunch is 
served and a safe environment 
to "hand out" is provided. 
OB/GYN clinic: health care 
for women and children: 
pregnancy testing; prenatal 
care: pediatric services: 




Assists people affected by 
AIDS through advocacy and 
providing vital human 
services like food, 
counseling, support groups, 
referrals, dentistry and 
transportation: helps reduce 
the incidence of HIV 
infection through educational 
programs. 
Confidential and anonymous 
HIV testing; pre and post HIV 
counseling; referrals, 
community outreach. 
Assists with rent, food, 
utilities and transportation: 
give anonymous HIV antibody 
testing; early intervention: 
case management: in-home 
nursing care. Dignity House 
and housing referrals: 
outreach to Black gay men and 
Black and Latino women: 
psycho-social support. 
Community layperson 
interested in HIV/AIDS 
advocacy. 
Ms. Cynthia Davis 
Drew University/NOBCO AIDS 
Information & Education 
Projects 
1631 E. 120th Street, Bldg. C 
Los Angeles, CA 90059 
(213) 567-7799 
Mr. Milton Ortega 
Comprehensive AIDS Resource 
Education (C.A.R.E.) 
St. Mary Medical Center 
1050 Linden Avenue 
Long Beach, CA 90813 
(213) 491-9050 
Dr. Betty Jackson, Director 
AIDS Education and Prevention 
Center 
3737 Martin Luther King Blvd. 
Lynwood, CA 90262 
(213) 638-0460 
Mr. Robert Ming 
Cal State University, Long 
Beach AIDS Research & 
Education Project 
Psychology Dept. 
Community Site:1229 Cedar Ave. 
Long Beach, CA 90813 
(213) 985-7508 




741 S. Atlantic Blvd. 




prevention and control 
programs targeting youth, 
women of reproductive age; 
incarcerated individuals and 
the general community; 
material development; 
training programs: community 
outreach and referrals. 
Program has national and 
local funds. 
Services to the South Bay 
community; comprehensive case 
management; services to 
people with HIV, ARC and AIDS 
for ambulatory health status 
clients; support groups. 
HIV/AIDS education and 
executive prevention program 
targeting the Black, Latino 
and Haitian community. 
Health and family services 
for women; referrals; HIV 
testing and counseling; 
research targeting female sex 
partners of injection drug 
users: has component for 
outreach to Black churches, 
community groups within the 
greater Long Beach area, to 
do presentations. 
Crisis Intervention; Case 
Management; Support Groups; 
Education and Prevention; 
Consultation. 
2R~ 
Ms. Ruth Slaughter 
Prototypes/WARN 
5601 W. Slauson Ave. 
Suite #200 
Culver City, CA 90230 
(213) 641-7795 
Ms. Janet Rochester 
Clinic Manager 
Family Planning AIDS Education 
and Prevention Project, UCLA 
22-222 CHS 
10833 LeConte Avenue 
Los Angeles, CA 90024 
(213) 825-2753 
Mr. Levi Kingston 
Community Consortium 
3109 1/4 s. Western Avenue 
Suite B · 
Los Angeles, CA 90018 
(213) 731-9227 
(213) 591-1261 
Ms. Melvina Luke 
Minority Council on AIDS 
1133 Rhea Street 
Long Beach, CA 90806 
(213) 591-3381 (office) 
(213) 591-8334 (home) 
Ms. Laurie Aronoff 
Hospice/AIDS Project 
L.A. Bar Association 
617 S. Olive Street 
Los Angeles, CA 90014 
(213) 896-6436 
4 
Outreach and education 
program that assesses women's 
needs holistically; gives 
referral: counseling and 
information. 
Education and Prevention 
program for Latino and other 
women of childbearing age. 
Provides basic AIDS 
information: sex negotiation 
workshops: referrals to 
testing sites: anonymous and 
confidential testing; 
provides info for pregnant 
women with AIDS; community 
programs, including some 
presentations. 
HIV/AIDS education targeting 
the Black/Hispanic community. 
HIV/AIDS education targeting 
the Black/Hispanic community. 
Free legal referrals to 




Rev. Carl Bean, Director 
Minority AIDS Project 
ATTN: Mr. Paul Davis 
5149 W. Jefferson 
Los Angeles, CA 90016 
(213) 936-4949 
Connie M. Wynn 
People Who Care Youth Center 
1504 W. Slauson Avenue 
Los Angeles, CA 90047 
(213) 778-8905 
Ms. Mbete Kiarnbe 
10636 Woodley Ave.,Suite #81 
Granada Hills, CA 91344 
Ms. Pamela Coleman 
10215 S. Dixon Ave., #1 
Inglewood, CA 90303 
Cleante Stain 
Watts Health Foundation 
4116 E. Compton Blvd. 
Compton, CA 90221 
{213) 639-3068 
Ms. Carolyn Williams 
11107 Lamaida, Suite #107 
North Hollywood, CA 91601 
5 
Assists with rent, food, 
utilities and transportation: 
gives anonymous HIV antibody 
testing; early intervention: 
case management: in-horne 
nursing care. Dignity House 
and housing referrals: 
outreach to Black gay men and 
Black and Latino women: 
psycho-social support. 
Graffiti Abatement Program: 
AIDS outreach to Black and 
Hispanic youth aged 18-21; 
Youth Advocacy Senior 
Citizens checking and sharing 
program: parenting education 
and Black parenting 
education. 
Community layperson 
interested in HIV/AIDS 
advocacy. 
Community layperson 
interested in HIV/AIDS 
advocacy. 
The South Los Angeles AIDS 
Community AIDS Program 
(SLACAP) Drug Abuse AIDS 
Outeach Services: Case 
Management Referral Services. 
Community layperson 





Tobacco Control Program 
12012 s. Compton Avenue 
I&R Bldg., Room #211, MP. 31 
Los Angeles, CA 90059 
(213) 603-3558 or 3559 & 3561 
Mr. John Morant 
Health Center 
Cal State University, L.A. 
5151 State University Drive 
Los Angeles, CA 90032 
(213) 343-3346 
Mr. Howard Eley, Director 
Institute of Alternate 
Attitudes 
Substance and Chemical Abuse 
Consultants 
856 South St. Andrews Place 
Los Angeles, CA 90005 
(213) 385-1847 
Mr. Mike Sims 
Early Intervention Project 
Hospital Social Services 
Martin Luther King Jr Hospital 
12021 s. Wilmington Avenue 
Los Angeles, CA 90059 
(213) 603-4218 or 603-3467 
6 
Hospital clinic-based tobacco 
prevention and cessation 
educational program. The 
target populations include 
current smokers, parents of 
children 6 years/younger and 
nurses. 
AIDS Education and Prevention 
Program; provide limited 
medical services. College-age 
18 years and older. 
Substance and chemical 
abuse/use counseling for 
adults: multicultural. 
Services for people who are 
HIV infected. 
Ms. Fay Nugent 
Hubert Humphrey Comprehensive 
Health Center, Room #2030 
5850 So. Main Street 
Los Angeles, CA 90003 
(213) 235-7401 
Dr. Wilbert Jordan, Director 
Graduate Medical Education 
Augustus Hawkins Bldg. MP. 56A 
Martin Luther King Jr Hospital 
1720 East 120th Street 
Los Angeles, CA 90059 
(213) 603-8166 
Barbara Walker 
YWCA of Los Angeles Executive 
Offices 
1125 W. 6th Street, #400 
Los Angeles, CA 90017 
(213) 482-3470 
Rue Thais Williams 
Rue's House 
P.O. Box 37036 
Los Angeles, CA 90037 
(213) 295-9575 (Office) 
(213) 734-2467 (Fax) 
Mike Neeley, Director 
Homeless Outreach Project 
846 E. 6th Street 
Los Angeles, CA 90021 
(213) 683-8304 
Stephanie Farrington 
6238 Haas Avenue 
Los Angeles, CA 90047 
(213) 751-3030 
Cornelia Owens 
3707 Coliseum Street 
Los Angeles, CA 90016 
(213) 298-5526 
Marcus Kuilard 
Community Outreach Worker 
c/o JWCH Institute 
2829 S. Grand Avenue 
Los Angeles, CA 90007 
(213) 744-3916 
7 
Free HIV testing, T-cell 
count, Psychosocial 
counseling, physician 
evaluation and referral 
services. 
Testing, counseling, social 
support, and clinical services 
for HIV+ persons. 
AIDS Information and Education 
Provides residential housing 
to HIV+ women and their 
children. 
Provides HIV testing, 
counseling and referral to 
homeless individuals in the 
City of Los Angeles. Also, 
provides drug abuse counseling 
and referral. 
HIV/AIDS Consultant. 
Los Angeles Unified School 
District staff implementing 
AIDS Education, Risk Reduction 
Program targeting students and 
teachers. 
Operate women's clinic on skid 
row; provide medical outreach 
to the homeless; referrals; 
HIV/AIDS community outreach to 
the community. 
Ray Johnson 
Long Beach Comprehensive 
Health Center 
1333 Chesnut Avenue 
Long Beach, CA 90813 
(213) 599-8711 
Calvin Williams 
Public Policy Department 
APLA 
6430 Sunset Blvd, Suite 421 
Los Angeles, CA 90028 
(213) 962-1600 ext. 505 
Sue Crumpton 
Executive Director 
L.A. Shanti Foundation 
6855 Santa Monica Blvd. 
Los Angeles, CA 90038 
(213) 962-8197 
8 
The clinic provides the full 
range of services to the HIV 
positive client, including 
early intervention care, 
management of infections or 
complications related to HIV, 
ongoing follow-up, and 
referral as needed, for 
further evaluation or 
management. 
Assists people affected by 
AIDS through advocacy and 
providing vital human services 
like food, counseling, support 
groups, referrals, dentistry 
and transportation: helps 
reduce the incidence of HIV 
infection through educational 
programs. 
Services targeting HIV 
infected men and women and 
their families; one on one 
volunteers and emotional 
support groups. A speakers 
bureau on Education and 
Prevention; 7-week 
Education/Support Group; and 
positive Living for Us 
seminars for those recently 
tested or testing for HIV 
positive. 
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Percent of fenles 15-19 pregnant tn: 
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TESTIMONY 
"FUNDING AIDS PROGRAMS• 
HEARING OF THE SENATE COMMITTEE ON HEALTH AND HUMAN SERVICES 
OF THE CALIFORNIA STATE LEGISLATURE 
DECEMBER 17, 1991 
WAYNE E. SAUSEDA, CHIEF 
OFFICE OF AIDS, DEPARTMENT OF HEALTH SERVICES 
MADAM CHAIRWOMAN, MEMBERS OF THE COMMITTEE, DR. TATE, ON BEHALF 
OF THE DEPARTMENT OF HEALTH SERVICES, THANK YOU FOR YOUR 
INVITATION TO DISCUSS THE STATE'S AIDS PROGRAM. DURING MY 
TESTIMONY, I WILL OVERVIEW: (1) PROGRAMS ADMINISTERED BY THE STATE 
OFFICE OF AIDS; (2) EPIDEMIOLOGIC TRENDS; AND (3) STATE FUNDING FOR 
EDUCATION AND PREVENTION, TESTING, CARE AND TREATMENT AND 
RESEARCH. 
OVERVIEW OF STATE OFFICE OF AIDS 
THE OBJECTIVE OF THE OFFICE OF AIDS IS TO PROVIDE INFORMATION AND 
EDUCATION, TESTING, EPIDEMIOLOGICAL INVESTIGATION AND SURVEILLANCE, 
RESEARCH, AND TREATMENT TO ADDRESS THE PUBUC HEALTH PROBLEMS 
RESULTING FROM ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). 
THE OFFICE OF AIDS PROVIDES A COMPLETE AND TIMELY REGISTRY OF AIDS 
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CASES, EDUCATIONAL INFORMATION FOR HIGH-RISK GROUPS, HEALTH 
PROFESSIONALS, AND THE PUBUC AND POUCY DIRECTION AND 
DEVELOPMENT OF PILOT PROJECTS FOR THE CARE OF PEOPLE WITH AIDS 
AND EARLY INTERVENTION PROJECTS TO PROVIDE SERVICES TO 
HIV-INFECTED PERSONS. ADDITIONALLY, THE OFFICE CONDUCTS 
SURVEILLANCE ACTIVITIES TO IDENTIFY RISK GROUPS AND PATTERNS OF 
TRANSMISSION, AND EPIDEMIOLOGY FOR SELECTED CASES. THE OFFICE 
ALSO ADMINISTERS A PROGRAM WHICH TESTS FOR THE ANTIBODY TO THE 
AIDS VIRUS AT OVER 100 ALTERNATIVE TEST SITES, WHICH ARE FREE AND 
ANONYMOUS. LOCAL ASSISTANCE BLOCK GRANTS ARE PROVIDED TO LOCAL 
AGENCIES FOR AIDS EPIDEMIOLOGICAL INVESTIGATION AND SURVEILLANCE. 
THIS PAST YEAR, FIVE SIGNIFICANT LEGISLATIVE MEASURES WERE PASSED 
BY THE CALIFORNIA STATE LEGISLATURE AND SIGNED BY GOVERNOR 
WILSON. THESE MEASURES REFLECT THE GOVERNOR'S COMMITMENT TO 
PREVENTION, PATIENTS' RIGHTS, INTEGRATION OF SERVICES, AND EXPANDED 
ACCESS TO HEALTH CARE. 
AS 11 (HUGHES) • AIDS IN.SCHOOL EDUCAnON • COMMENCING WITH THE 
1992-93 SCHOOL YEAR, INSTRUCTION FOR THE PREVENTION OF AIDS WILL 
BE PROVIDED BY ADEQUATELY TRAINED TEACHERS TO STUDENTS IN GRADES 
7·12, AT LEAST ONCE IN JUNIOR HIGH OR MIDDLE SCHOOL AND ONCE IN 
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HIGH SCHOOL AB 11 FITS INTO THE CURRENT CAUFORNIA DEPARTMENT OF 
EDUCATION HEALTHY KIDS/HEALTHY CALIFORNIA PROJECT WHICH IS FUNDED 
BY THE OFFICE OF AIDS TO PROVIDE TRAINING TO TEACHERS AND SCHOOL 
ADMINISTRATORS ON PROVIDING INSTRUCTION ON HIV TRANSMISSION TO 
STUDENTS IN THE 7TH AND 8TH GRADES, AS WELL AS HIGH SCHOOLS. 
STUDIES ON YOUTH SHOW INCREASES IN DRUG USE AND SEXUALLY 
TRANSMITTED DISEASES, WHICH ARE MAJOR CO-FACTORS FOR HIV 
INFECTION. SURVEYS ON YOUTH OUT OF MAINSTREAM SCHOOLS INDICATE 
THAT NEARLY ALL OF THEIR HEALTH AND HIV/AIDS RELATED KNOWLEDGE 
WAS OBTAINED FROM THEIR SCHOOL EXPERIENCES. 
SB 1070 (THOMPSON) - PATIENT PROTEcnON ACT OF 1991 • THIS BILL 
REQUIRES THE DEPARTMENT OF HEALTH SERVICES TO DEVELOP WRITTEN 
GUIDELINES AND REGULATIONS AS NECESSARY TO MINIMIZE THE RISK OF 
TRANSMISSION OF BLOOD-BORNE INFECTIOUS DISEASES FROM HEALTH CARE 
WORKER TO PATIENT, FROM PATIENT TO PATIENT, AND FROM PATIENT TO 
HEALTH CARE WORKER. SB 1070 REINFORCES THE DEPARTMENT OF HEALTH 
SERVICES' LEADERSHIP ROLE IN ESTABUSHING CONSENSUS-BASED 
RECOMMENDATIONS FOR THE PREVENTION OF TRANSMISSION OF HIV AND 
HEPATITIS B VIRUS BETWEEN HEALTH CARE WORKERS ANI) PATIENTS. 
AB 305 (FRIEDMAN) - DEFINITION OF AIDS • REDEFINES THE TERM CHRONIC, 
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LIFE-THREATENING ILLNESS TO MEAN HIV DISEASE OR AIDS. AB 305 ALSO 
PROVIDES THAT THE DEPARTMENT OF HEALTH SERVICES MAY PROVIDE 
SUPPLEMENTAL FUNDING TO RESIDENTIAL AIDS SHELTERS AND TO 
RESIDENTIAL CARE FACILITIES. 
AB 1281 (RLANTE)- HIV ANTIBODY TESTS/INSURANCE· UPDATES CURRENT 
lAW WHICH PROHIBITS THE USE OF HIV ANTIBODY BLOOD TESTS AS A 
PREREQUISITE FOR DETERMINING EUGIBIUTY FOR HEALTH INSURANCE. 
AB 1281 REDEFINES HIV TESTING AND DISCLOSURE STATUTES TO BE MORE 
REFLECTIVE OF CURRENT MEDICAL TECHNOLOGY, THEREBY SERVING TO 
PROTECT THOSE PEOPLE AT RISK FOR HIV INFECTION FROM BEING DENIED 
HEALTH OR DISABILITY INSURANCE BASED ON OTHER •LEGAL• HIV 
LABORATORY TESTS. 
AB 1287 (VASCONCEU.OS) • HIV TEST DISCLOSURE- INSURES THAT HIV/AIDS 
VACCINE CLINICAL TRIAL VOLUNTEERS WHO TEST HIV ANTIBODY POSITIVE OR 
NEGATIVE AS A RESULT OF THEIR PARTICIPATION IN HIV/AIDS CUNICAL 
TRIALS WILL NOT BE DENIED HEALTH CARE, DISABIUTY, WELFARE, OR UFE 
INSURANCE COVERAGE. 
EPIDEMIOLOGY 
TO PLACE MY TESTIMONY INTO PERSPECTIVE, I WOULD UKE TO GIVE YOU 
SOME FACTS AND FIGURES ABOUT THE SCOPE AND COURSE OF THE AIDS 
EPIDEMIC IN THE STATE AND LOS ANGELES COUNTY. 
AS OF NOVEMBER 30, 1991, 38,660 CUMULATIVE CASES OF AIDS AND 26,369 
AIDS-RELATED DEATHS HAVE BEEN REPORTED IN CAUFORNIA. AS OF THIS 
DATE, 13,672 CASES AND 9,576 DEATHS HAVE BEEN REPORTED IN 
LOS ANGELES COUNTY. 7,683 NEW CASES WERE DIAGNOSED AND 
6,036 DEATHS WERE REPORTED DURING THE MOST RECENT 12·MONTH 
PERIOD. DURING THIS TIME PERIOD, AN AVERAGE OF 640 NEW AIDS CASES 
WERE DIAGNOSED AND 503 AIDS-RELATED DEATHS WERE REPORTED TO THE 
OFFICE OF AIDS, AIDS CASE REGISTRY EACH MONTH. 
AS THE EPIDEMIC IN CALIFORNIA CONTINUES TO GROW, THE REGIONS OF 
THE STATE WHERE CASES ARE REPORTED FROM CONTINUES TO CHANGE. 
CUMULATIVELY, LOS ANGELES COUNTY HAS ACCOUNTED FOR 35 PERCENT 
OF ALL AIDS CASES REPORTED IN THE STATE. SAN FRANCISCO HAS 
ACCOUNTED FOR 27 PERCENT; OTHER BAY AREA COUNTIES 13 PERCENT; 
SOUTHERN METROPOLITAN COUNTIES (ORANGE, RIVERSIDE, 
SAN BERNARDINO, AND SAN DIEGO) 16 PERCENT; AND THE REST OF 
CALIFORNIA 9 PERCENT. THE PROPORTION OF NEW AIDS CASES BEING 
DIAGNOSED OUTSIDE SAN FRANCISCO AND LOS ANGELES COUNTIES 
CONTINUES TO INCREASE. DURING 1986, SAN FRANCISCO AND LOS ANGELES 
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COLLECTIVELY ACCOUNTED FOR 68 PERCENT OF ALL CASES DIAGNOSED IN 
THE STATE. FOR THE YEAR ENDING JUNE 30, 1991, lOS ANGELES 
ACCOUNTED FOR 38 PERCENT OF All NEW CASES REPORTED IN THE STATE. 
THE SOUTHERN METROPOLITAN COUNTIES ACCOUNTED FOR 12 PERCENT OF 
ALL AIDS CASES REPORTED IN CALIFORNIA DURING 1986. BY THE END OF 
NOVEMBER 1991, THEY WERE REPORTING 24 PERCENT OF All NEW CASES. 
AN ESTIMATED 12,500 CALIFORNIANS WERE LIVING WITH AIDS AT THE END 
OF 1990. AT THE END OF 1993, THERE Will BE AN ESTIMATED 16,200 PEOPLE 
ALIVE WITH AIDS. 
THE INCIDENCE OF AIDS CONTINUES TO INCREASE IN All ETHNIC AND 
RACIAL GROUPS WITHIN THE STATE. OF THE CUMULATIVE TOTAL AIDS 
CASES REPORTED IN CALIFORNIA THROUGH JUNE 1991, WHITES HAVE 
ACCOUNTED FOR 71 PERCENT OF THE TOTAL; AFRICAN AMERICANS 
13 PERCENT; LATINOS 14 PERCENT; AND ASIANS/PACIFIC ISLANDERS 
2 PERCENT. IN CONTRAST TO STATEWIDE RACIAUETHNIC DISTRIBUTIONS, 
62 PERCENT OF AIDS CASES REPORTED IN LOS ANGELES COUN1Y HAVE 
BEEN AMONG WHITES; 16 PERCENT AMONG AFRICAN AMERICANS; 
19 PERCENT AMONG LATINOS; AND 1 PERCENT AMONG ASIAN/PACIFIC 
ISLANDERS. BETWEEN 1986 AND 1991, THE PROPORTION OF NEW AIDS 
CASES REPORTED AMONG WHITES IN CALIFORNIA DECREASED FROM 
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77 PERCENT TO 65 PERCENT. CONVERSELY, AMONG AFRICAN AMERICANS 
THE PERCENTAGE OF NEW CASES INCREASED FROM 10 PERCENT IN 1988 TO 
14 PERCENT IN 1991. LATINOS ACCOUNTED FOR 11 PERCENT OF NEW CASES 
REPORTED IN 1986 AND 18 PERCENT IN 1991. THE PERCENTAGE OF NEW 
CASES REPORTED AMONG ASIAN/PACIFIC ISLANDERS INCREASED FROM 
1 PERCENT IN 1986 TO 2 PERCENT IN 1991 (SEE ATTACHMENTS I AND II). 
THE PROPORTION OF NEW AIDS CASES AMONG DIFFERENT TRANSMISSION 
CATEGORIES HAS REMAINED RELATIVELY STABLE OVER TIME. THE MAJOR11Y 
OF NEW AIDS CASES CONTINUE TO BE REPORTED AMONG GAY AND 
BISEXUAL MALES. APPROXIMATELY 83 PERCENT OF CAUFORNIA AIDS CASES 
DIAGNOSED IN 1991 WERE AMONG THIS GROUP. CUMULATIVELY, NEARLY 
NINE OUT OF EVERY TEN CALIFORNIA AIDS CASES HAVE BEEN DIAGNOSED 
AMONG GAY AND BISEXUAL MEN. 
THE NUMBER OF CASES ATTRIBUTABLE TO HETEROSEXUAL INJECTION DRUG 
USE CONTINUES TO INCREASE. NEARLY 1,250 OF THE 2,211 CASES IN THIS 
TRANSMISSION CATEGORY HAVE BEEN REPORTED IN THE LAST TWO YEARS. 
NOTABLY, AFRICAN AMERICANS ACCOUNT FOR 12 PERCENT OF ALL AIDS 
CASES, BUT 40 PERCENT OF CASES AMONG INJECTION DRUG USERS. 
THE NUMBER OF NEW CASES ATTRIBUTABLE TO HETEROSEXUAL CONTACT 
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WITH AN INFECTED PERSON ALSO CONTINUES TO INCREASE. AS OF 
NOVEMBER 30, 1991, A TOTAL OF 702 AIDS CASES HAVE BEEN REPORTED 
AMONG PERSONS WHO CITE HETEROSEXUAL CONTACT AS THEIR PRIMARY 
RISK FOR INFECTION. MORE THAN HALF OF REPORTED CASES HAVE BEEN 
DIAGNOSED IN THE PAST TWO YEARS. TO DATE, 204 CASES OF AIDS HAVE 
BEEN DIAGNOSED AMONG HEMOPHILIACS. 802 CASES HAVE BEEN 
DIAGNOSED AMONG TRANSFUSION RECIPIENTS. 
A TOTAL OF 258 AIDS CASES HAVE BEEN DIAGNOSED AMONG CHILDREN IN 
CALIFORNIA. CASES HAVE BEEN ALMOST EVENLY DISTRIBUTED AMONG 
WHITE (34 PERCENT), AFRICAN AMERICAN (29 PERCENT), AND HISPANIC 
(33 PERCENT) CHILDREN. BECAUSE OF UNDER-REPORTING AND 
MIS-DIAGNOSIS, THE ACTUAL NUMBER OF CHILDREN WITH AIDS MAY BE AS 
MUCH AS 50 PERCENT HIGHER (SEE ATTACHMENTS Ill AND IV). 
IT IS ESTIMATED THAT THERE WERE ABOUT 146,000 CAUFORNIANS UVING 
WITH HIV INFECTION IN 1990. AN ESTIMATED 83 PERCENT OF THE PEOPLE 
WITH HIV INFECTION ARE GAY OR BISEXUAL MEN; 9 PERCENT ARE 
HETEROSEXUAL INJECTION DRUG USERS; 2 PERCENT ARE WOMEN INFECTED 
THROUGH HETEROSEXUAL TRANSMISSION; AND 6 PERCENT TRANSFUSION 
RECIPIENTS, HEMOPHILIACS, MEN INFECTED THROUGH HETEROSEXUAL 
TRANSMISSION, OR INFANTS INFECTED PERINATAL 
3n.~ I(J 
THE CENTERS FOR DISEASE CONTROL (CDC) ESTIMATES THAT THERE ARE AT 
LEAST 40,000 NEW HIV INFECTIONS OCCURRING PER YEAR NATIONALLY; THIS 
COULD IMPLY THAT AS MANY AS 8,000 NEW HIV INFECTIONS WERE 
OCCURRING ANNUALLY IN CALIFORNIA, ASSUMING THE PROPORTION OF 
RECENT AIDS IN THE UNITED STATES FROM CAUFORNIA IS THE SAME AS 
THAT FOR HIV INFECTIONS. AN ESTIMATED 100.150 NEW INFECTIONS 
OCCURRED ANNUALLY IN NEWBORNS AS THE RESULT OF PERINATAL HIV 
TRANSMISSION IN 1988 AND 1989. 
THE CDC ESTIMATES THAT ABOUT 60 PERCENT OF THE 1 MIWON 
HIV-INFECTED PERSONS IN THE UNITED STATES MAY HAVE T-HELPER 
LYMPHOCYTE (CD4+ CELL) COUNTS BELOW 500 CUBIC MIWMETERS OF 
BLOOD AND MAY BENEFIT FROM EARLY TREATMENT WITH AZT. IN 
CALIFORNIA IT IS LIKELY THAT AT LEAST 60 PERCENT OF THE ESTIMATED 
146,000 HIV-INFECTED PERSONS WOULD BENEFIT FROM EARLY AZT 
TREATMENT SINCE THE HIV EPIDEMIC BEGAN EARLIER IN SAN FRANCISCO 
AND LOS ANGELES COMPARED TO THE REST OF THE UNITED STATES. 
THE NUMBER OF AIDS CASES REPORTED IN CAUFORNIA WILL CONTINUE TO 
INCREASE THROUGH 1993, WITH PROJECTIONS OF 8,600 CASES TO BE 
DIAGNOSED IN 1990; 9,200 IN 1991; 9,500 IN 1992; AND 9,700 IN 1993. BY 1993, 
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THE CUMULATIVE NUMBER OF AIDS CASES DIAGNOSED IN CALIFORNIA IS 
EXPECTED TO REACH 68,000. THESE PROJECTIONS ARE BASED ON THE 
METHOD OF BACK-CALCULATION, WHICH USES THE DISTRIBUTION OF TIME 
FROM HIV INFECTION TO AIDS TO ESTIMATE THE NUMBER OF PAST HIV 
INFECTIONS MOST CONSISTENT WITH OBSERVED AIDS INCIDENCE. THESE 
PROJECTIONS ARE ADJUSTED UPWARDS TO ACCOUNT FOR AN ESnMATED 
15 PERCENT UNDER-REPORTING OF AIDS CASES AND ALLOWS A MORE 
ACCURATE REFLECTION OF THE EXTENT OF SEVERE HIV DISEASE. 
AIDS CASE PROJECTIONS ARE INFLUENCED BY THE SLOWING OF THE RAPID 
UPWARD TREND IN AIDS INCIDENCE THAT OCCURRED IN 1987 AMONG 
HOMOSEXUAUBISEXUAL MEN IN SAN FRANCISCO AND LOS ANGELES. THiS 
SLOWING HAS ALSO OCCURRED TO A LESSER EXTENT AMONG WHITE 
HOMOSEXUAUBISEXUAL MEN IN THE COUNTIES SURROUNDING 
SAN FRANCISCO AND LOS ANGELES. INCIDENCE AMONG INTRAVENOUS 
DRUG USERS AND HETEROSEXUAL CONTACT CASES IS STILL INCREASING 
STEADILY. 
POSSIBLE EXPLANATIONS FOR THE SLOWING OF INCIDENCE IN CERTAIN 
POPULATIONS INCLUDE ADVANCES IN MEDICAL THERAPY, A DECUNE IN 
INCIDENCE OF NEW HIV INFECTIONS AMONG HOMOSEXUAUBISEXUAL MEN IN 
THE EARLY 1980'S, AND DECREASED TIMEUNESS AND COMPLETENESS OF 
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AIDS CASE REPORTING. THE RELATIVE CONTRIBUTIONS OF THESE FACTORS 
REQUIRE FURTHER INVESTIGATION. 
STATE AIDS FUNDING 
OVERALL, FUNDING FOR AIDS PROGRAMS ADMINISTERED BY THE STATE 
TOTAL $124,626,000. OF THIS AMOUNT, $76,595,000 IS STATE FUNDS AND 
$48,031,000 IS FEDERAL FUNDS AS REFLECTED IN ATTACHMENTS V AND VI. 
FUNDING FOR EDUCATION AND PREVENTION PROJECTS BEGAN DURING 
FY 1983-84. AT THAT TIME, A TOTAL OF $450,000 WAS AVAILABLE FOR 
EDUCATION AND PREVENTION PROJECTS. SINCE THEN, THE EDUCATION AND 
PREVENTION BUDGET HAS GROWN TO $16 MIWON FOR FY 1991·92. WHILE 
THE SPECIFIC NUMBERS OF CLIENTS SERVED ARE UNAVAILABLE, THE 
NUMBERS OF EDUCATION AND PREVENTION CONTRACTORS HAVE INCREASED 
FROM 15 IN FY 1983-84 TO 137 IN FY 1991-92. 
THE OFFICE OF AIDS BEGAN DISTINGUISHING BETWEEN EDUCATION AND 
PREVENTION SERVICES TO MINORITIES AND OTHER GROUPS DURING 
FY 1988-89. DURING THAT FISCAL YEAR, THE TOTAL EDUCATION AND 
PREVENTION BUDGET WAS $16 MILUON, OF WHICH 38 PERCENT WAS 
TARGETED FOR MINORITY PROJECTS. IN FY 1991·92, THE AMOUNT AVAILABLE 
AGAIN IS $16 MILLION. OF THE 137 CONTRACTORS FUNDED, 52 PERCENT ARE 
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MINORITY OWNED AND/OR SERVE MORE THAN 50 PERCENT MINORITY 
POPULATIONS. 
STATE-FUNDED HIV ANTIBODY TESTING IS PROVIDED THROUGH VARIOUS 
SOURCES IN THE STATE. FREE AND ANONYMOUS TESTING IS PROVIDED 
THROUGH THE ALTERNATIVE TEST SITE (ATS) PROGRAM. ADDITIONALLY, 
CONFIDENTIAL HIV TESTING IS PROVIDED THROUGH VARIOUS COUNTY 
PRIMARY CARE CLINICS AND OTHER FREE STANDING COMMUNITY PRIMARY 
CARE CUNICS, SUCH AS FAMILY PLANNING AND RURAL COMMUNITY CUNICS. 
OF ALL TESTING AND COUNSELING SERVICES PROVIDED DURING 
JANUARY-DECEMBER 1990, 25 PERCENT WERE RECEIVED BY LATINOS AND 
13 PERCENT WERE RECEIVED BY AFRICAN AMERICANS. THE TESTING 
PROGRAM IS ALSO CONDUCTING AN OUTREACH CAMPAIGN TO PROVIDE 
INFORMATION ON TESTING AND THE SERVICES AVAILABLE TO THE PUBUC. 
OF THE $300,000 EARMARKED FOR THE CAMPAIGN, ONE-THIRD IS BEING USED 
IN THE LATINO COMMUNITY AND ONE-THIRD IS BEING USED IN THE AFRICAN 
AMERICAN COMMUNITY. 
THE EARLY INTERVENTION PROGRAM PROVIDES BEHAVIOR CHANGE 
INTERVENTIONS, PSYCHOSOCIAL SUPPORT, HEALTH EDUCATION, CASE 
MANAGEMENT SERVICES, AND EARLY MEDICAL ASSESSMENT AND TREATMENT 
TO HIV-INFECTED PERSONS. THE GOAL OF THE PROGRAM IS TO PROLONG 
-12-
THE HEALTHY AND PRODUCTIVE LIVES OF THOSE INFECTED WITH HIV. 
STATEWIDE, 22 PERCENT OF EARLY INTERVENTION PROGRAM CUENTS ARE 
LATINO AND 11 PERCENT ARE AFRICAN AMERICAN. THESE PERCENTAGES 
ARE EVEN HIGHER AT SOME LOCATIONS SUCH AS THE EARLY INTERVENTION 
PROGRAM IN SAN FRANCISCO WHERE 52 PERCENT OF THE CUENTS ARE 
LATINO AND SOUTH/SOUTH-CENTRAL LOS ANGELES WHERE 49 PERCENT ARE 
AFRICAN AMERICAN. THE TOTAL 1990-91 STATE FUNDING OF THE EARLY 
INTERVENTION PROGRAM IS $2.6 MILUON. 
FUNDING FOR PILOT HOME AND COMMUNITY-BASED CARE PROJECTS BEGAN 
IN FY 1985-86. AT THAT TIME, THE PILOT CARE PROJECT BUDGET WAS 
$1.6 MILLION. SINCE THEN, THE BUDGET HAS GROWN TO $6.6 MIWON FOR 
FY 1991-92. PILOT CARE PROJECTS HAVE OFFICIALLY TARGETED 25 PERCENT 
OF THEIR FUNDS FOR SERVICES TO MINORITIES; HOWEVER, THE ACTUAL 
PERCENTAGE HAS BEEN OVER 35 PERCENT SINCE FY 1988-89 (SEE 
ATTACHMENT VII FOR PILOT CARE CLIENT SERVICES BY RACE/ETHNICITY). 
THE OFFICE OF AIDS FUNDS A VARIETY OF MINORITY PROJECTS 
THROUGHOUT THE STATE WHICH ADDRESS ETHNIC MINORITY GROUPS 
INCLUDING LATINOS, AFRICAN AMERICANS, ASIAN/PACIFIC ISLANDERS, AND 
AMERICAN INDIANS. ALL MINORITY-BASED PROJECTS PROVIDE EDUCATION 
AND MATERIALS IN THE TARGET GROUPS' NATIVE LANGUAGE WITH A SPECIAL 
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EMPHASIS ON CULTURAL VALUES. SOME EXAMPLES OF OFFICE OF 
AIDS-FUNDED MINORI1Y PROJECTS ARE: 
• MINORI1Y AIDS PROJECT- OPERATES HOME AND COMMUNITY-BASED 
CARE PILOT PROJECT. APPROXIMATELY TWO-THIRDS OF THE 
POPULATION SERVED ARE AFRICAN AMERICAN. MINORITY AIDS 
PROJECT ALSO OPERATES A RESIDENTIAL AIDS SHELTER, DIGNITY 
HOUSE, WHICH SERVES PRIMARILY AFRICAN AMERICANS AND LATINOS. 
SERVICES INCLUDE: COMMUNI1Y OUTREACH, HEALTH EDUCATION, 
BIUNGUAL SERVICES, SERVICES FOR THE HOMELESS, MENTAL HEALTH 
(PSYCHOLOGY AND PSYCHIATRY), WOMEN-SPECIFIC SERVICES, AND 
SUPPORT GROUP SERVICES FOR SIGNIFICANT OTHERS. 
• ASIAN AIDS PROJECT· PROVIDES OUTREACH EDUCATION TO GROUPS 
OF HARD-TO-REACH GAY MEN IN SAN FRANCISCO CLUBS. THIS 
PROJECT ALSO PROVIDES GENERAL EDUCATION TO COMMUNITY 
LEADERS IN AN EFFORT TO REDUCE FEAR AND OVERCOME THE MANY 
BARRIERS OF DISCUSSING SEXUAUTY AND DRUG USE. 
• LA FAMILIA COUNSELING SERVICES· PROVIDES SPECIAUZED BIUNGUAL 
(ENGLISH AND SPANISH) AIDS EDUCATION AND PREVENTION TRAINING 
TO •peeR• YOUTH EDUCATORS TO ASSURE EFFECTIVE COMMUNICATION 
-14-
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WITH THE TARGET AUDIENCE. THE PEER AIDS EDUCATORS PROVIDE 
OUTREACH EDUCATIONAL ACTIVITIES TO SELECTED COMMUNITY YOUTH 
GROUPS IN THE HAYWARD AND SAN LEANDRO AREA. 
YWCA. OAKLAND • TRAINS PEER EDUCATORS (PRIMARILY AFRICAN 
AMERICAN). THIS PROGRAM DEVELOPED THE FIRST PEER EDUCATION 
TRAINING MODULE (WHICH INCLUDES A VIDEO AND LESSON PLAN) FOR 
AFRICAN AMERICAN YOUTH. 
FAME· SERVES AFRICAN AMERICANS IN THE SOUTH CENTRAL AREA OF 
LOS ANGELES PROVIDING EDUCATIONAL ACTIVITIES TO MEN WHO HAVE 
SEX WITH MEN, YOUTHS, JAILS, AND SUBSTANCE ABUSERS VIA 
COMMUNITY CENTERS, DETENTION CENTERS, CHURCHES, AND 
NEIGHBORHOOD YOUTH CENTERS. A YOUTH RAP CONTEST IS ALSO 
SPONSORED. 
• AVANCE HUMAN SERVICES. INC. • PROVIDES HIV EDUCATION AND 
REFERRAL SERVICES THROUGH THE SOUTHERN CAUFORNIA HIV/AIDS 
SPANISH HOTLINE. 
• SALUD PARA LA GENTE/PROYECTO ALARMA SIDA <PAS) PROJECT • 
SPECIALIZES IN PROVIDING AIDS EDUCATION AND PREVENTION 
·15-
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INFORMATION TO MONOLINGUAL SPANISH-SPEAKING FARM WORKERS, 
YOUTH, INJECTION DRUG USERS, AND WOMEN OF CHILDBEARING AGE 
IN THE PAJARO VALLEY AREA (SOUTHERN SANTA CRUZ COUNTY). 
• NIPOMO FAMILY HEALTH CENTER. NIPOMO. SAN LUIS OBISPO COUN1Y • 
THIS PROJECT HAS DEVELOPED AN AIDS EDUCATION, PREVENTION, AND 
INFORMATION CAMPAIGN SPECIFICALLY TARGETING MONOUNGUAL 
SPANISH-SPEAKING MIGRANT FARM WORKERS AT THEIR WORK PLACE 
(FIELDS, MIGRANT WORK CAMPS, AND CANNERIES). 
• CENTRAL VALLEY INDIAN HEALTH PROJECT • PROVIDES HIV/AIDS 
EDUCATION AND PREVENTION ACTIVITIES TO AMERICAN INDIAN YOUTH, 
INJECTION DRUG USERS AND OTHER SUBSTANCE ABUSERS, WOMEN~ 
AND HOMOSEXUAUBISEXUAL MALES. THESE SERVICES ARE PROVIDED 
IN FRESNO, MADERA, AND KINGS COUNTIES. 
• SOUTH LOS ANGELES COMMUNI1Y AIDS PROGRAM (WATTS HEALTH 
FOUNDATION) • PROVIDES HOME AND COMMUNI1Y·BASED SERVICES TO 
PREDOMINANTLY AFRICAN AMERICAN AND LATINO PERSONS WITH AIDS 
IN THE SOUTH-CENTRAL LOS ANGELES AREA. ADDITIONALLY, THE 
STAFF DEVELOPS AND IMPLEMENTS WRITTEN HEALTH PLANS DESIGNED 
TO REACH WOMEN AND SUBSTANCE ABUSERS IN TREATMENT. THE 
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PRIMARY GOAL IS TO INFLUENCE BEHAVIOR THROUGH THE 
IDENTIFICATION OF KNOWLEDGE, ATTITUDES, AND BEUEFS ABOUT 
HIGH-RISK BEHAVIORS AND HOW IT RELATES TO HIV. 
- OTHER OFFICE OF AIDS SIGNIFICANT ETHNIC MINORITY ACHIEVEMENTS 
INCLUDE: 
THE OFFICE OF AIDS BEGAN WORKING LAST FAU.. TO DEVELOP A 
COMPREHENSIVE PLAN IN RESPONSE TO THE RYAN WHITE 
COMPREHENSIVE AIDS RESOURCES EMERGENCY <CAREl ACT OF 1990. 
EVERY EFFORT WAS MADE TO ADDRESS THE NEEDS OF ETHNIC 
MINORITIES. A 41-MEMBER WORKING GROUP, REPRESENTING A BROAD 
DIVERSITY OF PERSPECTIVES WAS APPOINTED TO HELP DEVELOP THE 
RESPONSE. LATINO, AFRICAN AMERICAN, ASIAN/PACIFIC ISLANDER, 
FILIPINO, AND NATIVE AMERICAN REPRESENTATIVES WERE APPOINTED 
TO AND MADE UP 50 PERCENT OF THE WORKING GROUP. IN 
CONSIDERING AN EQUITABLE DISTRIBUTION OF THESE FUNDS 
THROUGHOUT THE STATE, A FORMULA WAS DEVELOPED THAT TOOK 
INTO ACCOUNT EPIDEMIOLOGICAL DATA, IMPACT TO HIGH INCIDENT 
AREAS, RURAL AREAS, AND COMMUNITIES OF COLOR. SPECIFICAU..Y, 
A •NON-WHITE• INDEX FACTOR WAS ADOPTED AND WEIGHTED AT 
20 PERCENT. 
-17-
3 .- t:t jf'W 
• THE MINORITY AIDS RESOURCE CENTER PROVIDES INFORMATION, 
TRAINING, AND TECHNICAL ASSISTANCE TO OFFICE OF AIDS EDUCATION 
AND PREVENTION CONTRACTORS. THE INFORMATION CENTER 
INCLUDES A LIBRARY, COMPUTER DATABASE, BULK LITERATURE, ANp 
A RESOURCE GUIDE. THE TRAINING CURRICULUM INCLUDES A BASIC 
AIDS INFORMATION CLASS, ORGANIZATIONAL DEVELOPMEN.T, 
COMMUNITY DEVELOPMENT, GRANT WRITING, AND LEADERSHIP 
TRAINING. TECHNICAL ASSISTANCE IS AVAILABLE TO ALL 
CONTRACTORS. THE FOCUS OF THE ASSISTANCE IS TO HELP 
CONTRACTORS TO OVERCOME CULTURAL BARRIERS THAT PREVENT 
DELIVERY OF QUALITY EDUCATION AND PREVENTION SERVICES TO 
ETHNIC MINORITY COMMUNITIES. 
• THE OFFICE OF AIDS PROVIDED FUNDING TO THE MULTICULTURAL 
TRAINING RESOURCE CENTER (MTRC) TO SPONSOR MULTICULTURAL 
AIDS CONSENSUS AND COLLABORATION WORKSHOPS. THE 
PARTICIPANTS ARE OFFICE OF AIDS CONTRACTORS PRESENTLY 
PROVIDING DIRECT EDUCATION AND PREVENTION CLIENT SERVICES. 
THE PURPOSE OF THE WORKSHOPS IS TO DISCUSS BARRIERS AND FIND 
SOLUTIONS TO PROVIDING QUALITY AIDS EDUCATION AND PREVENTION 
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BARRIERS AS THEY PERTAIN TO RURAL, URBAN, COMMUNITY-BASED 
ORGANIZATIONS, AND HEALTH DEPARTMENT ISSUES. 
THE OFFICE OF AIDS PROVIDED FUNDING FOR A STATEWIDE •peOPLE 
OF COLOR• CONFERENCE IN THE SUMMER OF 1991 WITH THE GOAL OF 
IMPROVING THE "SURVIVABILITY- OF SERVICE PROVIDERS IN 
MINORITY-BASED COMMUNITIES AND FOCUSING ON STRATEGIES TO 
IMPROVE OUTREACH AND PREVENTION ACTIVITIES TO ETHNIC MINORITY 
POPULATIONS. AT THE CONFERENCE, THE GROUP ELECTED 
REPRESENTATIVES TO SERVE ON THE NEWLY FORMED OFFICE OF AIDS 
MULTICULTURAL LIAISON BOARD. THIS ELECTED GROUP WILL SERVE 
AS AN EFFECTIVE AND IMPORTANT LIAISON BETWEEN THE OFFICE OF 
AIDS AND MULTICULTURAL PROVIDERS/COMMUNITIES. 
CONCLUSION 
IN CLOSING, THE OFFICE OF AIDS IS COMMITTED TO STOPPING THE AIDS 
EPIDEMIC IN COMMUNITIES OF COLOR. WE RECOGNIZE THAT THIS MUST BE 
DONE NOT IN ISOLATION, BUT IN CONCERT WITH A COMPREHENSIVE 
APPROACH TO OVERALL HEALTH CARE ACCESS. THANK YOU FOR THIS 
OPPORTUNITY TO APPEAR BEFORE YOU TODAY. I AM AVAILABLE TO ANSWER 
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ATTACHMENT III 
Annual Incidence of California AIDS Cases and Deaths 1981-1991 
by Year of Diagnosis and RacejEthnidty 
Format: Cases /Deaths 
\.lhi te I Black I Hispanic I 
Asian \ Native I Unknown 
I I Amer1can _ Total 
7/5 I 2/1 2/2 I 0!0 I 0!0 I 0/0 11/8 I 
4!./41 I 7!7 9/7 I 0!0 ! o;o I 0!0 60/55 I 
180!165 ! 23/22 I 15!14 i 1!1 I 0!0 I 0/0 219/202 I I 
I 
I ! I I 565!529 68/63 I 62/59 i 2/2 i 0!0 1!1 698/654 I I 
1118/1058 1i2/102 i 131!118 I 8/8 I 0/0 Z/2 1371/1288 
I 
1941 !1837 233/223 I 287/259 I 37/37 I 5/5 I I 1!1 2504/2362 
3027/2811 ' <'.06/370 I 453/411 I 53/47 I 10/10 I 9/7 3958/3656 
4058/3528 I 626/533 642/553 I 83/72 I 7!7 I 22/17 5438/4710 
4388/3411 ! 
I 
847/642 I 882/680 I 77!67 I 12/8 I 11/7 6217/4815 
4722/3115 I 914/573 I 1041/678 I 130/91 I 18!13 I 17/6 6842/4476 I 
4502/2077 I 957/461 1097/513 I 121/54 I 21/10 I 41/8 6739/3123 I I 
3034/662 i 651!137 807/200 I 76/17 i 10/4 i 25/0 4603/1020 I I I 
27586/192391 4846/3134 I 5428/3494 1 538/396 I 83/57 I 129/49 38660/26369 I 
71.4 12.5 I 14.0 I 1.5 
I 0.2 I 0.3 100.0 I I 
69.7 64.7 i 64.4 I 67.3 : 6S.7 3a.o 68.2 
I i I I 
TOTAL C~5ES: 3~660/26367 


















Annual Incidence of Los Angeles County AIDS Cases and Deaths 1981-1991 




Hispanic Asian Native Unknown Percent 
American Total of Total 
Before 1981 3/1 0/0 1/1 0/0 0!0 0!0 4/2 0.0 
1981 13/11 I 5/5 I 2/1 0/0 0/0 0/0 20/17 I 0.1 
12/12 
I 
8/8 0/0 79/71 0.6 1982 59/51 I 0/0 0!0 I 
l 39/39 I 35/34 1983 200/183 ! 1/1 0/0 0/0 27S/257 2.0 I 
~984 355/335 I 69/64 ' 60/52 1/1 I 0/0 2/2 487/454 I 3.6 ' i 
1985 662/618 i 128/122 I i41/127 15/15 I 0/0 0/0 946!882 I 6.9 
1986 1018/954 217/198 I 240/219 13!12 5/5 I 4/3 1497/1391 I 10.9 I 
1987 1338/1143 292/263 320/274 23/19 0/0 16/12 1989!1711 14.5 
1988 1328/1029 417/323 I l.42/343 27!24 3/2 7/4 2224!1n5 16.3 
1989 1431/948 389/264 537/347 46/31 4/3 9/1 2416/1594 17.7 
1990 1352/622 424/213 563/276 52/26 I 3/1 32/4 2426/1142 17.7 
1991 • 710/176 I 228/59 I 333/90 18/5 1/0 I 19/0 1309/330 I 9.6 I 
Total 8469/6071 I 2220!1562 2682!1m 196/134 16/11 89/26 136nt9576 100.0 
~ of Total 61.9 I 16.2 I 19.6 1.4 I 0.1 0.7 100.0 
~Mortality 71.7 70.4 I 66.1 68.4 I 68.8 I 29.2 70.0 I I I I I I 
TOTAL CASES: 136nt9576 
Source: California Oept. of Health Services, Office of AIOS, December 1991 
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S'"f A'"fE 01? CALIFORNIA 
FISCAL YEAR 1991-92 AIDS FUNDING 
COUNSELING AND TESTING $15,514 (12.5%) 
EDUCATION AND PREVENTION 
$15,633 (12.5%) 
AIDS DRUG PROGRAM 
$14~00 (11.5%) 
DEPT. ALCOHOL AND DRUG J>ROGRAI\IS 
$20,885 (16.8%) 
(In Thousands of Dollars) 
CARE AND TREATMENT $29,649 (23.8%) 
RESEARCH $12,438 (10%) 
PROGRAM SUPPORT $7,060 (5.7%) 
BLOCK GRANT $5,298 H.2%) 
DISEASE ~IONITORING $3,789 (3.0%) 
Source: California Department of Health Services, Office of AIDS 









ILOT CAHE MID TREI\THEil'f SERVICES SEC'l'lOil, 011!1/0A 
GGREGATE TOTALS OF PROJECTS FUNDED IN LOS 1\IIGELE:; t:OUII'I'Y 
ENDER AND RACE/ETIUIICITY 
Ml\LE \ FEMALE · \ WIII'l'E 't. BLACK \ IIISPAIHC \ ASIAII \ AMIIHJ \ 
OTJIEH 
UNKNOWN \ TOTAIJ \ 
••a•a•-a••••====•===aaa•••=••========•••••=======a=•=========a••••=•===•==========~========================================= 
:IP (1) 154 86.0 24 14.0 31 17.0 88 49.0 53 30.0 1 1.0 J 2.0 2 1.0 178 100.0 
:He (2) 482 91.0 47 9.0 245 46.0 116 22.0 153 29.0 5 1.0 6 1.0 4 1.0 529 100.0 
LAS (3) 82 93.0 6 7.0 41 47.0 25 28.0 22 25.0 0 0.0 0 0.0 0 0.0 88 100.0 
lAIVER(4) 79 99.0 1 1.0 48 60.0 18 23.0 11 14.0 2 2.0 1 1.0 0 o.o 80 100.0 
•••••••••••••••=••••aa••=••••••••••ccaac==•=•==:•=====•===~=a=======••===========~============================================ 
'OTAL 797 91.0 78 9.0 365 91.0 247 91.0 239 91.0 
1) Data for EIP is for a seven month period - Jan 91 thru July 91. 
2) Data for CHC is for FY90/91. 
3) Data for RAS is for the 1st QTR FY91/92 - Jul-Sep 91. 
4) Data for Medi-Cal Waiver is for the a ten month period - Jan 91 thru oct 91. 






















SENATE HEALTH AND HUMAN SERVICES COMMITTEE 
December 17, 1991 
Good morning. I am Dr. Jim Kooler, Deputy Director of the Division of Alcohol and Drug 
Prevention at the California Department of Alcohol and Drug Programs. Senator Watson, thank 
you for inviting me to participate in today's hearing regarding HIV I AIDS. With me today is 
Eddie Yamamoto, Program Analyst for the Department's HIV/AIDS Counselor Program. 
The Department's formal mission statement is based upon the principle that in order for alcohol 
and drug-related problems to be eliminated in Ca1ifornia, a comprehensive, statewide effort must 
be made in partnership with county governments, private and public agencies, organizations, 
groups and individuals. The cornerstone of our efforts is the California Master Plan to Reduce 
Drug and Alcohol Abuse. The objective of the Master Plan is to foster the involvement of the 
community in the determination of local service policies. This emphasis reflects an awareness 
that effective policies require the commitment and involvement of local communities in 
determining their own priorities. It recognizes that the needs of one part of California may 
differ considerably from those of another, necessitating that governmental policies be tailored 
to appropriately and effectively address those local needs. Curr~ntly, 55 counties are 
participating in the Master Plan process, including Los Angeles County, which is a phase six 
county (Master Plan due in June 1992). Thirty one counties are in phases one and two; one-
third of them have identified HIV/IVDU populations as a priority for their county. 
In regards to HIV I AIDS, the Department first formally addressed this issue in December 1986 
when emergency regulations were passed authorizing exceptions to existing methadone program 
eligibility requirements for clients in response to the AIDS crisis. These exceptions improved 
treatment services by allowing programs to: 
o exceed licensed capacity by ten percent when the need is documented; 
o upon the Department's approval, waive the requirement that the client provide 
documented history of at least two years of narcotic addiction; and, 
o also with the Department's approval, waive the requirement that the client provide 
documented history of two or more unsuccessful attempts in withdrawal treatment 
with subsequent relapse to regular narcotic use. 
By the following year, the Department began allocating to counties federal Alcohol and Drug 
Abuse and Mental Health Services (ADMS) Block Grant funds, specifically to target 
intravenous drug users (IVDUs). These federal dollars are allocated by the Department via the 
county subvention process. This process reflects a state/county partnership in the field of 
alcohol and drug abuse services. The counties are given maximum flexibility in determining 
2 
their program priorities as long as federal requirements are met. In this manner, alcohol and 
drug abuse services are relevant to the needs of each community. During 1987-88, a total of 
five million dollars was allocated to the counties, of which, Los Angeles County received nearly 
two million dollars. Currently, 35% of the Department's total ADMS Block Grant Award is 
dedicated to drug programs, and half of that is· "set-aside" for treatment programs for 
intravenous drug abuse as prescribed in the federal Public Health Service Act. For 1991-92, 
IVDU set-aside monies available to counties totaled over $23,000,000, a 360% increase from 
just four years prior. Of this, Los Angeles County will receive over $8,000,000, a 300% 
increase since 1987-88. 
In addition to IVDU set-aside, other funds targeting IVDUs have become available to the 
Department over the past few years and are as follows. 
o Augmentation of the Budget Act of 1988: Since 1988, general funds have been 
allocated to counties with the highest number of AIDS cases with a history of 
intravenous drug use. This increased treatment for IVDUs at risk of contracting 
and spreading HIV. Currently, over 1.2 million dollars is allocated to counties, 
of which, Los Angeles County receives nearly $400,000. 
o HIV/AIDS Counselor Program: In late 1988, the federal Centers for Disease 
Control offered funding to state health departments to coordinate with state drug 
abuse authorities in establishing HIV counseling and testing services in drug 
3 
treatment programs. In response to this initiative, the Department of Health 
Services, Office of AIDS and the Department of Alcohol and Drug Programs 
collaborated to establish the HIV I AIDS Counselor Program. Approximately 1. 8 
million dollars was subvened to 20 counties throughout the state during 1991-92. 
Los Angeles County receives funds directly from the federal Centers for Disease 
Control to administer their own HIV I AIDS Counselor Program. 
o Statewide AIDS, Alcohol and Drug Abuse Training: In September 1990, the 
Department convened a forum to develop a statewide AIDS, alcohol and drug 
abuse training system for program providers, administrators and staff. The 
primary purpose of the training is to ensure that HIV I AIDS training is available 
to all alcohol and drug service providers to minimize the risk of HIV infection 
among California's alcohol and drug using populations. County alcohol and drug 
program administrators, recovery and treatment providers and key experts on 
AIDS, substance abuse and training as well as recognized experts from other state 
agencies were in attendance. As a result, California was divided into twelve 
regions and local representatives were utilized to develop their own training 
curriculum based on their local needs. The Department used ADMS Block Grant 
funds to contract with Valley Community Counseling Services to coordinate and 
facilitate the training in each of the regions. The contract was in the amount of 
$100,000, expiring December 31, 1991. The Department is preparing a Request 
for Proposals to continue the training for the next three years. 
4 
o Continuation Waiting List Reduction Grant Programs: The intent of this grant 
program is to rapidly expand drug abuse treatment capacity in California. 
Expanding drug abuse treatment was one of the recommendations put forth by the 
National Commission on AIDS earlier this year. Approximately $13,000,000 in 
continuation funding is available for the Waiting List Reduction Grant Program 
for 1991-92, of which, $2,000,000 must be targeted to serve IVDUs. For 1991-
92, Los Angeles County received 3.7 million dollars of continuation funding, of 
which, nearly $750,000 must be targeted to IVDUs. 
In closing, the Department funds over $28,000,000 in programs targeting IVDUs throughout the 
state. Los Angeles County receives over $9,000,000 of this total. The state total represents a 
significant increase (460%) in resources dedicated to IVDUs since 1987-88 when $5,000,000 
was committed. At this time, The Department looks forward to not only continue its existing 
efforts, but explore areas of potential collaboration with the State Department of Health Services 
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Test~ony of Alan Barris: PBS AIDS Regional Coordinator 
California Senate Committee on Health & Welfare 
Inter~ Bearing on AIDS Funding in Ethnic Minority Communities 
Los Angeles: December 17, 1991 
I want to thank Senator Watson and her staff for the invitation to 
share with the Committee preliminary Public Health Service (PBS) 
Fiscal Year (FY) 1991 AIDS financial data for California recipient 
organizations. This information should be of some interest as the 
State government, local governments and local AIDS planning 
agencies prepare their budgets for 1992. 
Based on preliminary data, for Federal FY 1991 (10/1/90 - 9/30/91) 
the PBS awarded nearly $191M to support AIDS program activities in 
348 CA organizations. CA received slightly more than 10% of the 
$1.8858 FY' 91 national PBS AIDS appropriation. PBS support 
includes new financial and direct (personnel, equipment, supplies) 
assistance for a prospective 12 month budget to support AIDS/BIV 
and related activity. Assistance was provided through grants, 
cooperative agreements and contracts. In some cases, particularly 
for some research projects, the financial assistance includes 
program funding from appropriations' other than AIDS. In all cases, 
the financial assistance does not include previously awarded and 
unused funds which PBS generally reauthorizes to support subsequent 
years of a 3 to 5 multi-year project. 
I have prepared two exhibits that describe the preliminary PBS 
FY'91 CA AIDS funding: 
* One exhibit indicates the PBS funding agency and general 
purpose; 
* The other exhibit compares fuaaiag levels ia PBS AIDS 
funding levels in CA for FY 1989, 1990 and 1991. 
For the Committee, I am presenting copies of PBS computer printouts 
which detail all of the CA recipient organizations and their 
preliminary funding levels (Grants and Cooperative Agreements; 
Contracts) • I am also sharing a separate printout of PBS AIDS 
grants and cooperative agreements awarded in Los Angeles County. 
Of the three FY '89-'91 total $550M inCA PBS AIDS funding, $261M 
was awarded by the Rational Institutes of Health (RIB) in support 
of a wide range of biomedical and clinical AIDS research projects. 
Given the focus of the Committee's hearings today, I want to share 
the demographic statistics of the 3, 466 adult and adolescent 
volunteers who have enrolled cumulatively in California's 5 AIDS 
Clinical Trials Groups (ACTG) and the 182 children who have 
enrolled cumulatively in California's Pediatric AIDS Clinical 
Trials Groups. 
AIDS Clinical Trials Groups are University Medical School organized 
networks of hospitals and clinics whose participating physicians 
accept patient volunteers to enroll in clinical trials of 
328 
experimental therapies for BIV disease and opportunistic 
infections. Specific clinical trials of AIDS and BIV exper~ental 
therapies are sponsored and supported by the National Institute of 
Allergy and Infectious Disease, a major component of the NIB. 
These statistics reflect that adult/adolescent volunteers enrolled 
in CA' s 5 ACTGs were generally representative of California's 
cumulative AIDS cases with two exceptions: women at 2% vs. 3.5% and 
Blacks at 7% vs. 12% were underrepresented. California's total 
ACTG cumulative adult/adolescent enrollment represented 23% of 
nationwide ACTG enrollment. The children who were enrolled in 
California's 3 Pediatric ACTGs were fairly representative of the 
sex and racial composition of California's cumulative pediatric 
AIDS cases. These children represented 16% of the nationwide 
Pediatric ACTG enrollment. 
I hope this information has been interesting and helpful. I look 
forward to answering any questions you may have now or later. 

TESTIMONY TO THE CALIFORNIA SENATE 
COMMITTEE ON HEALTH AND HOMAN SERVICES 
Tuesday, December 17, 1991 
Mr. Robert E. Frangenberg 
Director, County of Los Angeles AIDS Program Office 
"HIV/AIDS FONDING IN LOS ANGELES COUNTY 
AND HIV/AIDS IN COMMUNITIES OF COLOR" 
INTRODUCTION 
I am pleased to have the opportunity to address the Senate 
Health and Human services Committee on the subjects of 
governmental funding for HIV/AIDS services in Los Angeles 
County and particularly in communities of color. 
Los Angeles county is the second-ranking metropolitan area 
in the United States in terms of.both its present and 
cumulative AIDS caseloads. 
As of October 31, 1991, there were approximately 4,000 
living individuals in the county with confirmed cases of 
AIDS and an estimated additional 36,000 HIV-infected. our 
cumulative AIDS caseload was 13,647. Given these 
statistics, the County is facing enormous challenges on a 
variety of fronts. 
1 
THE STATUS OP HIV[AIDS IN LOS ANGELES COUNTY 
CURRENT HIV/AIDS FUNDING 
The County Department of Health Services has two mechanisms 
through which funds are expended for HIV/AIDS-related public 
services: the AIDS Program Office and the Department's 
medical facilities. 
The AIDS Program Office is responsible for policy and 
program development for prevention and treatment services. 
The Department's medical facilities provide direct patient 
care to persons with HIV/AIDS. The majority of funding for 
these services falls under the budget of each individual 
facility; however, some funds for dedicated outpatient 
services are provided to certain facilities through the AIDS 
Program Office. 
Projected expenditures in Fiscal Year 1991-92 for AIDS 
Programs total $38 million. Of this, $14 million (37 
percent ) are County funds, $18 million (47 percent) are 
federal funds, and $6 million (16 percent) are State funds. 
2 
County funds expended through the AIDS Program Office are 
spent in the following service categories: 
• HIV/AIDS education and prevention, 
• community-based outpatient clinical services and 
case management, 
• home health care, 
• residential care, 
• drug abuse treatment for persons with HIV, 
• day care, dental care, and 
The $18 million in federal funds will be spent in two broad 
programmatic categories: 
• $10 million in Centers for Disease Control funds 
have been allocated for HIV prevention and 
surveillance programs, and 
• nearly $8 million awarded through Title I of the 
Comprehensive AIDS Resources Emergency (CARE) Act 
of 1990 is supporting patient medical and support 
services. 
Seventy-one percent of the CARE Act funds is being expended 
on patient services through contracts with community-based 
organizations. Twenty-four percent is supporting HIV/AIDS 
medical services at County facilities, while the remaining 
five percent has been allocated for administrative oversight 
of the grant and the related contracts. 
3 
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We already know that our 1992 CARE Act Formula grant will 
increase from $3.9 million to $5.4 million. Our CARE Act 
budget will be augmented when the second-year CARE Act 
grants are awarded. 
The State Office of AIDS allocations to the County are being 
spent on the following activities: 
• $737,000 supports anonymous HIV testing and 
counseling at seven locations, 
• the AIDS drug program for low income persons in 
need of AZT and other HIV/AIDS drugs will receive 
approximately $4 million, 
• Martin Luther King/Drew Medical Center has been 
allocated $287,000 for primary care, and 
• the HIV/AIDS Block Grant of $1,123,000 will 
support epidemiological investigation of AIDS 
cases, counseling and HIV testing at juvenile 
halls, an HIV/AIDS prevention center at the Gay 
and Lesbian Community Services Center, and an 
outreach program for injection drug users operated 
by the Los Angeles Center for Alcohol and Drug 
Abuse. 
4 
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HIV/AIDS-related expenditures for inpatient and outpatient 
care at the County's medical facilities are supported by 
several revenue sources. The primary revenue supporting 
care is Medi-Cal, with smaller amounts coming from Medicare, 
patient revenues and insurance. During Fiscal Year 1990-91, 
the medical facilities spent a total of $34 million on 
HIV/AIDS-related care, with $9 million spent on inpatient 
care and $25 million spent on outpatient care. $16.0 
million of the total expenditures were made at county cost. 
It is important to note that a trend toward greater reliance 
on outpatient medical services, rather than inpatient 
services, has been taking place in the County. This should 
inherently provide a more effective and efficient use of our 
financial resources, even though it provides lower 
reimbursement from MediCal. 
HXV/AXDS XH COMMUHXTXES OP COLOR 
Thirty-seven percent of the cumulative adult AIDS caseload 
in Los Angeles county is comprised of people of color. By 
racejethnicity, this breaks down into 16% African-American, 
20% Hispanic, and 2% "other peoples of color", which 
includes Asians, Pacific Islanders, and Native Americans. 
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Compared with the 1990 u.s. Census data for the County, the 
















The behaviors which put adults and adolescents at risk in 
Los Angeles County are as follows for all racesjethnicities 
combined: 
Male to male sexual contact 80% 
Male to male sex and injection drug use 7% 
Injection drug use 5% 
Transfusion recipient 2% 
Male to female sexual contact 2% 
Hemophilia or coagulation disorder <1% 
Los Angeles is significantly different from East Coast 
cities and somewhat different from other cities in 
California in the lower percentage of cases which are 
related to injection drug behaviors. 
6 
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Even when the behavior categories are examined within each 
racial/ethnic group, gay and bisexual men comprise the 
predominant group affected by the HIV/AIDS epidemic and at 
risk for HIV infection. For example, 66 percent of African-
American adult/adolescent cases, 73 percent of Hispanic 
cases, and 80 percent of cases among other persons of color 
are attributable to male to male sex. An additional 10 
percent of African-American cases, 6 percent of Hispanic 
cases and 3 percent of cases among other persons of color is 
attributable to the combined behaviors of male to male sex 
and injection drug use. 
These statistics are useful in targeting our prevention 
efforts. Particularly important are the trends in 
statistics over time. Although very slowly, the 
distribution of AIDS cases in the County by behavior 
category has been shifting as the epidemic has progressed. 
Prior to 1987, 83% of the adult caseload for all races were 
attributable to male homosexual or bisexual contact. This 
figure dropped to 77% in 1990. 
Conversely, the percentage of cases linked to injection drug 
use rose from 2% prior to 1987 to 6% in 1991. 
7 
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Over the same period, cases linked to injection drug use in 
combination with homosexual or bisexual contact dropped from 
8% to 6%. The cases attributable to heterosexual contact 
rose from 1% of the total caseload prior to 1987 to 2% in 
1990. 
Thus, though homosexual and bisexual contact may be viewed 
as the riskiest behavior for HIV transmission, injection 
drug use and heterosexual contact have increased in risk in 
recent years. 
The racial/ethnic distribution of new cases has also changed 
over time. Prior to 1987, 70% of new AIDS cases in the 
County were Caucasian cases. In 1990, only 56% of the new 
cases were diagnosed in Caucasians. 
These statistics for African-Americans are 14% prior to 198 · 
and 18% of new cases in 1990. For Hispanics they are 15% 
prior to 1987 and 23% in 1990. 
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Another way of looking at these trends is by incidence (the 
number of cases each year per 100,000 population). 
• The male caucasian incidence in 1984 was 22/100,000. 
This figure rose to 89/100,000 in 1990; 
• For male African-Americans these statistics were 
19/100,000 in 1984 and 122/100,000 in 1990; 
• The Hispanic figures are 7/100,000 in 1984 and 
53/100,000 in 1990; 
• The "other" category incidence rates have changed 
from 0/100,000 in 1984 to 12/100,000 in 1990. 
The 1990 incidence rates for women in Los Angeles County 
were as follows: 
• 2/100,000 for Caucasian women, 
• 9/100,000 for African-American women, 
• 4/100,000 for Hispanic women, and 
• 1/100,000 for "other" women. 
Primary behaviors which put women at risk are heterosexual 
contact (33 percent of cases) and injection drug use (28 
percent). Transfusion recipients constitute 23 percent of 
female cases, most for transfusions occurring prior to 
testing of the blood supply. 
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As the local face of HIV/AIDS has changed, so has our 
approach to HIV/AIDS prevention and HIV/AIDS-related medical 
services. For instance, community-based organizations 
serving people of color and women now constitute the 
majority of our contractors for our HIV/AIDS education and 
risk reduction programs. 
We firmly believe that our preventive impact on high-risk 
persons of color will be maximized through the expertise of 
community-based organizations. These organizations have 
vast experience in targeting programs to their communities 
and in providing effective outreach in a culturally adept 
context. 
FUNDING FOR COMMUNITIES OF COLOR IN FISCAL YEAR 1991-92 
HIV/AIDS PREVENTION AND EDUCATIONAL OUTREACH PROGRAMS 
The County has contracts with the following community-based 
organizations for HIV/AIDS education and prevention programs 
for specified target groups: 
•AIDS Healthcare Foundation/Gay Men of Color Consortium -
Gay Men of Color - $255,286 
•American Indian Free Clinic - Native Americans - $30,000 
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•Asian Pacific Lesbians & Gays - Asian and Pacific Island 
Lesbians and Gays - $28,500 
•Avance Human Services Spanish Hotline - Hispanic 
Americans - $150,000 
•The CORE Program Drop In Center - Hispanic Americans -
$60,000 
•The CORE Program Latino Gay Bar Project - Gay Latino Men -
$50,000 
•Drew University of Medicine and Science - Women of Color -
$166,800 
•El Centro Del Pueblo- Hispanic Americans -·$104,186 
•El Proyecto Del Barrio Latino Street Outreach - Hispanic 
Americans - $129,978 
•Gay and Lesbian Latinos Unidos - Gay and Lesbian Latinos -
$86,226 
•Minority AIDS Project Men of Color Project - Gay Men of 
Color - $83,531 
•Minority AIDS Project say Sister Program - Women of Color -
$100,000 
•Southern California Youth and Family Center - Adolescent 
Women of Color - $100,000 
•Special Service For Groups Youth and Men's Program -
Asians and Pacific Islanders - $75,000 
•Special Services For Groups Asian Community Outreach -
Asians and Pacific Islanders - $144,706 
11 
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We also have contracts for programs which do not 
specifically target communities of color that do serve 
people of color, such as programs targeting high-risk 
adolescents. 
A total of approximately $1.5 million of HIV/AIDS education 
and prevention funding has been allocated specifically for 
communities of color. This is 65% of our total education 
and prevention budget ($2.3 million). 
ANONYMOUS HIV COUNSELING AND TESTING 
The County provides anonymous HIV counseling and testing to 
its residents at these following locations: 
• The Edelman Health Center of the Gay and Lesbian 
Community Services Center in Hollywood, 
• The Roybal Health Center in Los Angeles, 
• The Valley community Clinic in North Hollywood, 
• The South Bay Free Clinic in both Manhattan Beach 
and Gardena, 
• The East Valley Community Health center, and 
• The Minority AIDS Project in Los Angeles. 
12 
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Data from the month of october 1991 provide a picture of the 
racial distribution of anonymous testing and counseling 
services for all locations combined: 
• 67% of those receiving services were caucasian, 
• 6% were African-American, 
• 20% were Hispanic, 
• 4% were Asians and Pacific Islanders, 
• 2% were Native Americans, and 
• 1% were classified as "other" or "unknown". 
AIDS DRUG PROGRAM FOR LOW INCOME INDIVIDUALS 
HIV/AIDS Drugs are dispensed to qualifying persons with 
HIV/AIDS at seven locations in the County. Available data 
pertaining to AZT distribution for October and November 1991 
demonstrate the following racial distributions of clientele 
by facility: 
• Los Angeles County + USC Medical Center 
- 35% of the doses were dispensed to Caucasians, 
- 47% were dispensed to African-Americans, 
- 12% were dispensed to Hispanics, 
- 1% were dispensed to Asians, and 




• Hudson Comprehensive Health Center 
- 60% were Caucasian, 
- 10% were African-American, 
- 27% were Hispanic, and 
- 3% were Asian. 
• West Hollywood Clinic 
- 59% were Caucasian, 
- 7% were African-American, 
- 33% were Hispanic, and 
- 2% were Asian. 
• Harbor/UCLA Medical Center 
- 37% were Caucasian, 
- 19% were African-American, 
- 40% were Hispanic, 
- 1% were Asian, 
- 1% were Native American, and 
- 2% were "other." 
our allocation of CARE Act funds for outpatient services 
attempted to achieve an appropriate geographic balance of 
funding. CARE Act funding should thus have an impact on the 
racial distribution of outpatient services. Unfortunately, 




Similarly, our unmet needs projections for Fiscal Year 
1992-93 account for needs in specific geographic areas, and 
hence by racejethnicity. 
PROJECTED UNMET NEEDS FOR FISCAL YEAR 1992-93 
The County Department of Health Services is facing Fiscal 
Year 1992-93 with projected unmet needs for HIV/AIDS-related 
services of approximately $29 million, at a minimum. 
This figure includes: 
• $3 million for HIV/AIDS educational outreach and 
prevention programs targeting high priority 
audiences, 
• $23 million for outpatient and inpatient medical 
services, 
• $2 million for HIV testing and counseling, 
• $900,000 for residential care for persons with 
HIV/AIDS, 
• $800,000 for dental care services, and 
15 
We have stratified our projected unmet needs for HIV/AIDS 
educational outreach and prevention programs into priority 
groups. These groups are as follows: 
• Adolescents, 
• Women, 
• Substance Abusers, 
• Gay Men of Color, and 
• Gay White Men. 
These priority rankings were established through 
consideration of the current behaviors driving the HIV/AIDS 
epidemic in the County combination with the volume of 
HIV/AIDS education and prevention services each already 
allocated for each group. 
our primary considerations in setting priorities are the 
behaviors which put persons at risk. Secondary 
considerations are the epidemiological data which associate 
certain demographic characteristics with the riskiest 
behaviors. 
The County's unmet needs for HIV testing and counseling may 
very well be approaching a critical status. The demand for 
anonymous HIV testing has been steadily rising during the 
past year. 
This can be attributed, to some extent, to a promotional 
campaign for HIV testing which was implemented locally by 
the State Department of Health Services. 
The demand for testing will surely rise during the upcoming 
year as well. CARE Act-funded contracts for programs 
promoting HIV testing are in the initial stages of 
implementation. We expect that these programs will cause 
more individuals to seek HIV testing. 
Furthermore, the public disclosure by Magic Johnson of his 
HIV-positive status is expected to have a increased impact 
on our HIV testing programs. 
The demand for publicly-funded HIV/AIDS outpatient and 
inpatient medical services has grown as this epidemic has 
progressed. studies published in academic and professional 
journals have demonstrated that public health care programs 
serving the poverty-stricken are assuming an ever-increasing 
burden in the financing of AIDS care. 
Given this, the County's projected unmet needs figure of $23 
million for outpatient and inpatient HIV/AIDS-related care 
is not surprising. It must be remembered that this figure 
is in addition to the current expenditure level in these 
service categories. 
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Although we have made considerable progress in Los Angeles 
County in recent years both in terms of prevention and 
treatment for HIV/AIDS, particularly in communities of 
color, there are still extensive unmet needs for additional 
resources. 
Thank you for this opportunity to update you on these 
aspects of HIV/AIDS in the County of Los Angeles. I will be 





PUBLIC HEALTH SERVICE AIDS/BIV GRANTS, CONTRACTS & COOPERATIVE 


























Risk Assessment Medical Product 
Research & Prevention care Safety 
33,830,998 -0- -0- -0- 33,830,998 
1,694,615 -0- -0- -0- 1,694,615 
-0- -0- -0- -0- o.oo 
-0- 47,995,619 -0- -0- 47,995,619 
-0- -0- -0- 41,045 41,045 
-0- -0- 44,900,948 -0- 44,900,948 
-0- -0- 13,701 -0- 13,701 
62,093,314 -0- -0- -0- 62,093,314 
-0- 351,576 -0- -0- 351,576 
97,618,927 48,347,195 44,914,649 41,045 190,921,816 
Notes: (1) Humber of projects are in parenthesis. 
(2) $ reflects total PBS financial and direct assistance 
to identified AIDS/BIV projects. For some projects, 
total PBS support exceeds AIDS/B:IV appropriations. 
Sources:· PBS Grants Management Information System: 
Report I GMS~8A' File I IPF91339. 
PBS Contract Information System: Report I CISDISP4 
Prepared by: Alan Barris' PBS Regional AIDS Coordinator, 12-9-91 
PUBLIC HEALTH SERVICE AIDS/HIV GRANTS, CONTRACTS & COOPERATIVE AGREEMENTS 
AWARDED TO CALIFORNIA ORGANIZATIONS 
FY'89,'90, &'91 COMPARISON 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 
PHS AWARDING FY 1989 FY 1990 FY 1991: PRELIMINARY 
AGENCY 
ADAMHA $18,415,692 $29,115,371 $33,830,998 
(46) (70) (72) 
CDC 36,118,425 41 ,219,839 47,995,619 
(52) (72) (82) 
FDA 381,735 515,256 41,045 
(2) (4) (2) 
HRSA 11,405,456 18,132,239 44,900,948 
(13) (22) (35) 
NIH 92,041,359 106 t 773 t 161 62,093,314 
(241) (241) (148) 
IHS N/A 439,941 13,701 
(2) (1) 
OASH 225,493 270,389 351,576 
(5) (5) (6) 
AHCPR 2,067,953 2,402,099 1 ,694,615 
(6) (6) (2) 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
TOTALS: CA $160,656,103 $198,868,295 $190,921 ,816 
(365) (417) (348) 
us $1,301,012,000 $1,589,756,000 $1,885,000,000 
CA 'I of US 12.3'1 12.5'1 10.1'1 
Notes: (1) Numbers of projects are in parenthesis. 
(2) $ represent total PHS financial and direct assistance to 
AIDS/HIV projects. For some projects, this may exceed the 
AIDS appropriated funding. 
sources: FY'89: PHS/DHHS FY'92 Budget Justification to OMB 
FY'90 & '91: PHS Grants Management Information System; 
PHS Contract Information System 
prepared by Alan Harris: PHS Regional AIDS Coordinator: 12~10~91 
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COUNTY OF f..OS ANGELES • DEPARTMENT OF HEALTH SERVICES 
AIDS PROGRAMS 
600 SOUTH COMMONWEALTH AVENUE. SIXTH FLOOR -LOS ANGELES. CALIFORNIA 90005 
(213) 351-8000 
August 8, 1991 
TO: CARE Act HIV Planning Council 
FROM: Robert E. Frangenberg f(' 
SUBJECT: ESTIMATE OF UNSPENT CARE ACT FUNDS 
At the last meeting of the CARE Act HIV Planning Council, AIDS Programs was 
requested to prepare an estimate of funds which will be unspent in the CARE Act 
Formula and Supplemental grants this year. This is the response to that request. 
When all of the contracts which are being developed are approved by the Board of 
Supervisors, all of the CARE Act Formula and Supplemental grant funds will be 
encumbered. Funds are encumbered in one of three ways: contracts, purchase 
orders, and County departmental service orders. Funds which are encumbered by 
the end of the budget period {January 31, 1992 and April 3, 1992 for the Formula and 
Supplemental grants respectively) are considered as 11Spent" by the Health Resources 
and Services Administration, even though actual expenditures under the contract 
continue into the second budget year. Therefore, if each contractor or program 
spends 1 00 percent of its contract budget, there will be no unspent funds. 
However, since many contract agencies are starting new programs and may not have 
full staff on the payroll from the beginning of the contract, potential savings will be 
generated in some contracts. At this time it is too early to calculate savings based on 
actual cost reports from the contractors. Therefore, we have estimated these savings 
by using 15 percent of contracts, with several exceptions. Savings were not projected 
in currently operating outpatient clinics and hospitals, dental, residential, and 
detoxification programs, and administration. 
Attached is a schedule of projected savings by category and contract. Until we have 
a longer history of experience with each contractor, it will be difficult to determine a 
more reliable estimate. Specific savings must be demonstrated before we can 
contract for these savings. The earliest date by which we will have reliable 
expenditure data to demonstrate savings is October. 
·3··~ 
l. 'Jf<W 
CARE Act Planning Council 
August 8, 1991 
Page2 
We will continue to monitor CARE spending and as soon as savings are 
demonstrated, we will propose contract modifications in accordance with the Planning 
Council's priorities. Augmentation of existing contracts using savings will be expedited 
by a new contract provision which authorizes the Director of Health Services to 
augment contracts by 1 0 percent without going back to the Board for a contract 
amendment. 





PRIORITIZING FOR UNSPENT FUNDS 
Analysis of Supplemental Funding 
APPL! CAT I ON ACTUAL PERCENTAGE 
CATEGORY ALLOCATION ALLOCATION DIFFERENCE FUNDED 
-------------·----·-------------------- .................. .. ..................... .. ... .. .. .. .. .. . .. .. . .................. 
Early Intervention & Outpatient Medical 
South Central S1DO,OOO S75,000 S25,000 75X 
Hollywood, ~H. WLA $400,000 $344,000 S56,000 861 
Long Beach, South Bay $100,000 $175,000 ($75. 000) 175X 
San Fernando Valley S200,000 $150,000 $50,000 751 
East Los Angeles S250,000 $215,000 $35,000 861 
Central LA 0 S315,000 ($315,000) 
Special Pooulations 
Outpatient $700,000 $415,949 S284,051 5~ 
Support Serv1ces $100,000 S86,000 $14,000 861 
Mental Health (RFP) $100,000 S75,000 S25,000 751 
Promotion of Services (RFP) $100,000 S75,000 S25 ,000 751 
4ccess to Alternative TheraPies S250,000 0 
Orug Abuse Treatment 
Res1aential Detox $300,000 S258,000 S42,000 361 
Outpatant Oetox $150,000 $129,000 S21,000 861 
o:>rimary Care to Substance Abusers S150,000 $129,000 S21,000 861 
:ase Management $450,000 S337,500 S112,SOO 75X 
wental Health/Psychosocial Support $500,000 S375,000 $125,000 75X 
=iesidentlal Care $500,000 S375,000 $125,000 75X 
~ecruitment/Retention $100,000 $86,000 $14,000 86% 
T ransoortat ion S50,000 S37,500 S12,500 7'SX 
Outreacn for Testing $100,000 S7'5, 000 S25,000 75X 
Ac:lninistration $242,105 $196,208 S45,897 81X 
........................ . .................... 
S4,842, 105 S3,924, 157 
~ote: Central LA monies derived from Special Populations ($200,000) and Access to Alternative Therapies ($115,000). 
Long Beacn received additional S100,000 from Access to Alternative Therap1es. 
n ~· t: 
,_). )'1c. 
COUNTY OF LOS ANGELES • AIDS PROGRAMS 
ESTIMATE OF UNSPENT CARE ACT FUNDS · PROJECT BUDGET YEAR ONE 





Outpatient/South Central :King/Drew 765,000 114,7'50 
Outpatient/San Gabriel :Pasadena AIDS Coord.: 239,000 35,850 
Outpatient/San Fernando V:Northeast Valley 189,000 28,350 
:Olive View 50,000 0 
Outpatient/Long Beach :Long Beach Comp. Ctr: 382,000 57,300 
CBO CARE to Relieve 5P21 :AIDS Healthcare Foun: 287,000 0 
:Alta·Med 287,000 43,050 
Case Management :Various CBOs 382,000 57,300 
Mental Health :Various CBOs 191,000 28,650 
Dental Care :APLA 96,000 0 
Residential/Emerg. Relief:Various CBOs 239,000 0 
Cross-Training :Various CBOs 191,000 28,650 
Transportation :Various 143,000 21,450 
Outreach/Promotion :Various CBOs 191,000 28,650 
Regional Consortia :AIDS Regional Board 96,000 0 
Aaninistration :AIDS Programs 196,157 0 
-------------------------:··-----------------·:··-----------:-------------: 
TOTAL FORMULA GRANT 3,924,157 444,000 
SUPPLEMENTAL GRANT 
Outpatient/South Central :King/Drew 7'5,000 11,250 
Outpatient/West :AIDS Healthcare Foun: 219,000 0 
:Gay & Lesbian CSC 7'5,000 0 
:UCLA 50,000 0 
Outpatient/Long B, So.Bay:Harbor/UCLA 17'5,000 0 
Outpatient/San Fernando V:Nortneast Valley 150,000 22,500 
Outpatient/East L.A. :AltaMed 215;000 32,250 
Outpatient/Central :Hudson Comp. Ctr. 315,000 47,250 
Special Pop. 
Outpatient :Various CBOs 415,949 62,392 
S~rt Svcs. :Various CBOs 86,000 12,900 
Promotion of Svcs. :Various CBOs 7'5,000 11,250 
Mental Health :Various CBOs 7'5,000 11,250 
Mental Health :Various CBOs 37'5,000 56,250 
Outreach for Testing :Various CBOs 75,000 , ,250 
Case Management :Various CBOs 337,500 50,625 
Residential :Various CBOs 37'5,000 0 
Recruitment/Retention :Various 86,000 12,900 
Transportation :Various 37,500 5,625 
Residential Oatox :Tarzana Treat. Ctr. 258,000 0 
Outpatient Oatox. :BAART 129,000 0 
HIV Primary Care/Subst. :El Proyecto del Barr: 129,000 19,350 
Administration :AIDS Programs 196,208 0 
--------------·----------:--------------------:-------------:-··········--: 
TOTAL SUPPLEMENTAL GRANT 3,924,157 367,042 
TOTAL BOTH GRANTS 7,848,314 811,042 unspfund.wk1/rev. 8/5/91 
LOS ANGELES COUNIY- DEPARTMENT OF MENTAL HEALTII 
IDV MENTAL HEALTii NEEDS 
IN EniNIC MINORIIY COMMUNTilES 
Testimony Presented to the 
State Senate Committee on Health and Human Resources 
by Elsie Go Lu, Ph. D. 
Deputy Director 
I. Lack of funding for: 
A. HIV mental health services 
1. State Depamnent of Mental Health - $476,000 
2. L.A. County Depamnent of Health Services - $100,000 
B. Services for ethnic minority communities 
II. Special HIV mental health needs of ethnic minority communities 
A. Geographic accessibility 
B. Providers familiar to the community (e.g. established agencies) 
C. Providers familiar with the community (e.g. acculturated/culturally 
sensitive) 
D. Stigma associated with mental health treatment 
E. Sensitivity to cultural nonns re: sexuality and drug use 
F. Child care 
III. Ethnicity of HIV mental health consumers 
A Program H.O.P.E. 
B. AIDS Project Los Angeles 

LOS ANGELES COUNTY 
HIV STRATEGIC PLAN 
Fiscal Years 1990/91 - 1992/93 
Prepared by 
The County-Community HIV Planning Council 
and the 
County of Los Angeles· 
Department of Health Services AIDS Programs 
March 1990 
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Mental Health services 
Mental health services for HIV impacted persons are a 
critical need throughout the continuum of the illness, from 
immediately after testing seropositive to the most advanced 
stages of AIDS. They may also be required by those who are HIV 
negative, including significant others, families, and the 
"worried well." Early psychological evaluation and intervention 
are of the utmost importance in order to deal with the many 
emotional, physical, behavioral, and psychological impacts of HIV 
disease. currently, community-based organizations are providing 
the majority of mental health services. These agencies are able 
to reach and effectively serve the community via a non-
threatening environment. 
Agencies handle clients with a perplexing range of emotional 
and psychosocial issues associated with HIV, including: denial, 
depression, stress, anxiety, the impact of discrimination, and 
suicidal ideation. Persons not infected with the virus, but 
still impacted by the disease, may share some of these same 
issues. HIV brain disease, in varying degrees and often more 
severe in the latter stages of the illness, also affects many 
HIV+ individuals. 
This section of the plan will discuss the general mental 
health needs of the HIV impacted population as well as the unique 
needs of special populations. The services currently being 
offered are outlined, and the barriers to receiving these 
services are described. The Mental Health section also defines 
specific needs and offers recommendations for a comprehensive 
system of HIV-related mental health care. Lastly, projections of 
service utilization and capacity are presented. These 
projections demonstrate that additional funding and resources are 
necessary if we are to provide psychosocial support to all those 
who require it. 
Dtsgription of attegte4 pqpulatiop 
Those infected with HIV are by no means a homogeneou~. 
population. They may be anywhere along the HIV continuum, ·from 
asymptomatic to full-blown AIDS. Different stages of the disease 
present varying needs and may require different modes of 
treatment or assistance. In addition to the dimension of illness 
severity, the personal history and background of the individual 
must be taken into account. As discussed in the Prevention 
section of the plan, service providers must recognize the needs 
of individuals with diverse ethnic/racial backgrounds, cultural 
values, sexual orientation, etc. 
For mental health planning purposes, HIV affected 
populations may be categorized in the following manner: 
o individuals with severe psychiatric complications as a 
result of the disease, i.e., advanced HIV brain disease 
(commonly referred to as HIV dementia complex): 
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o those with pre-existing psychiatric conditions, i.e., the 
chronically mentally ill; 
o persons with multiple diagnoses, i.e., persons with several 
primary problems, such as addictive behaviors and a 
psychiatric complication; and 
o persons with the significant emotional reactions to severe 
stressors, such as a diagnosis with a chronic, life-
threatening illness or the illness or death of a loved one. 
Advanced HIV Brain Disease 
HIV brain disease is a direct result of infection of the 
brain by HIV. The complex is characterized by a host of 
cognitive, motor, and behavioral symptomatology. The impact of 
dementia ranges from the functional impairment of early cognitive 
loss to the profound effects of its severe form in which patients 
are rendered nearly vegetative and require full-time 
institutional care. Neuropsychological impairments appear to 
affect those with AIDS, particularly those at an advanced stage 
of the disease (Tross, et al., 1988). The prevalence of HIV 
brain disease in otherwise asymptomatic HIV+ persons is very low. 
Clinical experience indicates that HIV brain disease is 
common and imposes significant morbidity in the late stages of 
HIV infection. At least two-thirds of patients eventually 
develop dementia before the terminal phase of the disease, and 
additional numbers exhibit subclinical evidence of neurological 
dysfunction (Price and Brew, 1988). 
Chronically Mentally Ill 
The severely/chronically mentally ill are especially 
difficult to reach in terms of HIV services. Education and 
behavior change can be especially difficult for this population. 
Mental illness may interfere with their ability to hear, process, 
and integrate information. Lack of ability to control behavior 
or delay gratification may prevent safer behaviors, even if 
educational material is understood or remembered. 
Whether the mentally ill population can be mainstrea~ into 
the HIV health care system or not depends on the severity of 
their mental illness. If their physical ailments are too severe, 
the psychiatric wards, concerned about infection control and the 
ability to provide needed medical services, will not admit them. 
Special protocols and close communication must be developed 
between the mental health and HIV health care systems to avoid · 
"bouncing" the patient back and forth between facilities. 
Persons with Multiple Diaqno••• 
Persons with multiple diagnoses are dealing with many of the 
same issues as the chronically mentally ill. Mental health 
professionals find working with this population especially 
difficult. They may have character disorders and drug abuse 
problems that adversely affect attempts at behavioral change. 
Unfortunately, HIV service agencies are seeing a high number of 
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individuals in this category. 
Persons with Siqnitieant Reactions to Stressors 
The persons in the last category do not fall into the other 
three. They have no pre-existing mental health conditions and 
are not experiencing advanced HIV brain disease, but they are 
seeking psychosocial support in order to cope with their illness. 
Upon learning of their seropositive status, many individuals may 
seek short-term counseling in the form of crisis intervention. 
Later, they may attend group therapy and remain with this 
modality for the long term. Others seek individual psychotherapy 
and/or therapy involving loved ones. 
Oniyersal Mental Health Needs 
The impact of HIV often results in similar or universal 
reactions among all populations. General psychosocial issues are 
presented to mental health and other professionals by those 
affected by HIV. These issues become important when an 
individual learns that he/she or a loved one is seropositive, and 
cannot wait to be addressed until symptoms appear or an AIDS 
diagnosis is made. 
These psychosocial issues include: an increase in suicidal 
ideation; inadequate social supports; lack of resources; social 
isolation; stigmatization; anxiety; depression; negotiations 
surrounding implementation of safe behaviors; and factors 
concerning the grief and loss process. This list is by no means 
an exhaustive one, but it does present several of the common 
problems that HIV affected persons face. 
Suicidal ideation is an especially common presentation among 
persons with HIV. Recent data have revealed that the relative 
risk of suicide in men with AIDS ages 20 to 59 years was 36.3 
times that of men without the diagnosis, and 66.15 times that of 
the general population (Marzuk, et al., 1988). Health 
professionals who serve such clients must be constantly alert to 
the risk of suicide. 
K1ntal 11alth 111d1 of Splcial Populations 
The needs of special populations, often overlooked o~.unmet, 
are important to recognize in the continuum of HIV-related·· 
services. Special populations include, among others: gays and 
bisexuals, women, intravenous drug users, ethnic;racial 
minorities, adolescents, and the incarcerated. The unique needs 
of these populations have been discussed extensively in the 
Prevention section under "Guiding Principles and Selection of 
Target Groups" and "Health Education/Risk Reduction Programs." 
In addition to the items discussed under these sections (e.g., 
cultural norms, unique needs, specialized interventions, etc.), 
providers must recognize that mental health services for these 
groups may require a specialized approach. In all cases, 
providers must be sensitive to the needs of these special 
populations. Language, culture, social support, and sexual 
orientation are some of the variables that must be taken into 
account in the.provision of HIV-related mental health care. 
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Access tor special populations is an especially crucial 
issue. These communities are often unwilling or unable to access 
any health services, let alone mental health services. Some 
populations may see a stigma associated with accessing mental 
health care, e.g., a service only for "crazy people." Often 
cultural values do not encourage the focus on self that mental 
health care traditionally requires. They may be helped more by 
group support than traditional individual psychotherapy. 
one confounding factor in attempting to service the HIV 
impacted population is the number of individuals who live by 
themselves and/or do not have close family or other support 
networks. Populations engaging in high risk behavior, such as 
IVDUs, prostitutes, street youth, and undocumented persons, are 
often those without the stable support network or help-seeking 
skills needed to attempt behavior change. Most of these 
individuals experience feelings of isolation and abandonment, but 
may not have the knowledge, skills, or financial ability to seek 
out mental health care. 
Minority populations are most often comfortable receiving 
care from a member of their own community, someone who is seen as 
sensitive to their needs. The level of trust that must be 
developed between therapist and client is often more intense in 
these communities than in the mainstream population. Without 
that trust and sense of caring, the individual may not continue 
to utilize the needed services. Consequently, mental health 
professionals may need to adapt traditional techniques to make 
them effective with special groups. 
The following outline is a brief synopsis of some of the 
unique needs of special populations: 
o Gays/Bisexuals: This population is often facing issues of 
homophobia and the "coming out" process. The nature of HIV 
disease may also lead to feelings, originating !rom 
themselves and/or others, of blame or responsibility for the 
epidemic. They are also facing multiple losses of friends 
and loved ones. Those who have tested negative may 
experience the trauma of "survivor's quilt." When acqessing 
services, this population encounters social service • ;. 
providers who are often not accepting of gays and bisexuals 
because of their sexual orientation. 
o women: Issues surrounding pregnancy and/or children are 
common among women facing HIV disease. Parents must face 
how their children will be cared for during illness and 
after death. They may be losing their support system at a 
time when they need it the most. The risky behaviors of a 
spouse or significant other may be at the forefront for the 
first time. Many issues, including financial dependence 
upon a man, contribute to the woman's fear of changing 
behaviors. She may also require assertiveness training and 
psychosocial support to handle negotiations around safe sex. 
Few programs exist that are designed specifically for women, 
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many of whom are uncomfortable with male-dominated settings. 
o IVDOs: The issues faced by drug abusers are only 
exacerbated by the presence of the virus. These persons, if 
they are in recovery, may relapse upon learning of a 
seropositive status. Their sense of isolation may increase 
as they are shunned from their drug culture. The number one 
priority may be to take care of their drug habit, and the 
motivation to change behaviors is often low. The IVDUs' 
reactions to the disease are quite dependent on their 
initial psychosocial standing, i.e., the less stable before 
the positive test result, the more intensive assistance they 
will need in facing the disease. Matters are further 
complicated by the fact that some residential drug treatment 
programs still will not accept HIV+ persons, especially if 
they are symptomatic. 
o Bthnic/Racial communities: As discussed throughout this 
plan, the needs of people of color may differ according to 
language, culture, and religion. Bicultural and bilingual 
providers are necessary to deal with clients• deeper social 
isolation, rejection, and fear. Many Asians, for example, 
feel shame and experience a loss of status for themselves 
and their entire families. The risk of suicide may be even 
greater than in other populations. Differing approaches may 
have to be taken with immigrants versus native-born persons. 
Undocumented persons face a host of complications 
surrounding their immigration status, including fear of 
accessing public systems of care. In some cases, Blacks and 
other racial/ethnic minorities are in denial regarding how 
they acquired the virus, and are internalizing feelings of 
homophobia. 
o Adolescents: Young adults at high risk (homeless/runaway) 
may be resistant to accessing health services: many come 
from homes which are dysfunctional and abusive. The 
behavior that is appropriate for their age group may be in 
conflict with the demands of adult decisions necessitated by 
HIV. Alcohol and drug usa are especially prevalent. 
Adolescents are a particularly difficult population to 
educate and produce behavior change because of their 
impulsivity, experimentation with their emerging sexuality, 
and a belief in their own immortality. 
o Incarceratedl Those in the jail and prison systems may fear 
the consequences of their HIV diagnosis. They may have 
well-entrenched character disorders that, similarly to the 
severely chronically mentally ill, interfere with the 
ability to integrate information and change behaviors. 
Severe and chronic mental illness may also be a factor in 
their HIV-related care. Also, the prison system lacks the 
resources to provide comprehensive mental health care for 
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HIV-related issues. Once the inmate is released, networking 
or "discharge planning" among the prison system and other 
agencies rarely exists. 
Bange of Stryices 
Mental health services may be discussed via several 
categories. These categories include inpatient care, residential 
care, day treatment, and outpatient services. The following 
outline of these services provides a useful understanding of the 
mental health care needs of HIV-affected persons in Los Angeles 
County. 
Inpatient cart 
o 24-hour acute hospital care: This care is defined as 
hospital beds for: (1) HIV+ mentally ill patients, (2) HIV 
brain disease patients with or without medical 
complications, and (3) patients experiencing psychiatric 
crises in response to the severe stressors attendant with 
HIV. current facilities are already completely overwhelmed 
and very few beds exist in the private sector. 
o Sub-acute cart: This category of mental health care refers 
to locked/unlocked skilled nursing facilities with increased 
nursing components, rehabilitative staffing, and mental 
health services. Sub-acute care is a high priority because 
of current and expected future demand from HIV impacted 
patients. Currently, no such facilities accept HIV-infected 
clients. 
Residential cart 
o Board and cart facility: A residential site of this type 
offers structure and access to mental health services while 
allowing clients to remain in the community. Medications 
are distributed by staff. Frequently, a family and ~everal 
staff members are administrators for a small number o.f beds. 
o Residential psychiatric facility: While similar to board 
and care facilities in terms of programmatic structure, 
residential psychiatric facilities are larger with perhaps 
one hundred or more beds. 
o "Our Bouse" aodtl: The AIDS Project Los Angeles• our House 
is an important and unique model of a residential facility 
for the multiply diagnosed. The 14-bed facility is designed 
to accommodate ambulatory HIV+ clients who have a pre-
existing mental illness, HIV brain disease, and/or a history 




o Day treatment proqrams: This program involves a structured 
environment that is an avenue for providing mental health 
treatment and socialization for clients, as well as respite 
for caregivers. This alternative is more cost-effective 
than an inpatient situation or homecare for all affected 
individuals. A program in this category should provide 
integrated services that are responsive to the psychosocial 
and spiritual needs of the client. Life skills improvement, 
which gives structure to daily living, and compensatory 
strategy development, which helps clients cope with memory 
loss, are important components of the program. 
outpatient Care 
o Professional services: This category encompasses a wide 
range of programs and modalities, including: crisis 
intervention; early counseling; support groups; individual, 
couple, and family psychotherapy; case management: and 
psychiatric medication evaluation. Providers must be able to 
treat and refer multiply diaqnosed clients in a sensitive 
and competent manner. They must understand both the medical 
and psychological aspects of HIV disease, to satisfy client 
needs. 
Crisis intervention may be provided for such crises as a 
clients• deteriorating medical condition, loss of loved 
ones, and others• reaction to the client's illness (i.e., 
rejection, discrimination). 
Early counseling is delivered as soon as possible following 
post-test counseling. This period is a crucial time to 
educate, offer support, initiate behavior change, provide 
information and referral, initiate/support secondary 
prevention efforts and, support positive coping strategies. 
Support groups (on-going and drop-in) provide peer emotional 
support on both an as-needed, flexible basis without regular 
attendance requirements and on a more structured, weekly 
basis. 
case management provided by mental health professionals 
involves referrals to needed resources, psychosocial 
assessments, and, often, some form of crisis intervention. 
Psychiatric medication evaluations are crucial and a high 
priority. The evaluations are designed to determine whether 
the client needs to be placed on psychotropic drugs. 
Evaluation may reduce the need for inpatient care as the 
clients• needs are mora clearly defined. 
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o Paraprofessional/Volunteer Programs (mental health 
specific): These programs include the successful "buddy" 
programs and peer counseling. Programs may be provided to 
individuals, couples, and/or families. Providers must deal 
with the training of volunteers, matching volunteers and 
clients, and burnout. 
Training and Professional support 
o Training, Consultation, and Education: These programs are 
targeted to specific disciplines or providers, e.g., board 
and care operators, psychiatrists, and students/interns in 
different mental health disciplines. Providers cannot be 
equipped to handle HIV-related clients without HIV-specific 
training. The HIV+ patient presents issues that differ from 
the providers' traditional clients. Emphasis on culturally/ 
linguistically appropriate client needs is necessary. 
o Emotional support services to BIV service Providers: 
Support groups and burnout prevention workshops provide 
emotional support to HIV service providers. Providers are 
often coping with the deaths of clients and loved ones, and 
may feel a sense of isolation from their colleagues. 
Barriers to Meetipq Needs 
The single greatest barrier to meeting the mental health 
needs of the HIV-impacted population is, of course, financial. 
Patients often do not have the personal funds to access care, 
thus placing the onus on the public sector to provide care. The 
existing public mental health system is so limited and so 
underfunded that the Department of Mental Health cannot serve 
populations beyond one target population, the chronically 
mentally ill. 
Unfortunately, HIV mental health care is multiply 
stigmatized--not only does the public associate a stigma with 
mental health, but also with HIV disease. consequently, mental 
health services, especially for HIV-related issues, are no~ seen 
as a priority by the public or public funding sources. Neither 
the funding nor the pressure to acquire the funding are 
sufficient to meet the current demand for services. 
Another significant limitation involves staff resources. 
The staff fear the possibility of themselves becoming infected. 
Emotional burnout among. HIV service providers is prevalent, and 
retaining staff can be difficult. The demands of working 
exclusively with severely ill and dying patients are quite high. 
This burnout is also due, in part, to the inability to find 
support from colleagues who do not see HIV impacted clients. 
Also, the environment of long hours, high caseloads, and low pay 
makes retaining and recruiting staff especially difficult. 
The lack of HIV-related training and information provided to 
mental health professionals and the inadequate reimbursement 
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rates for the care are the major reasons for inadequate numbers 
of appropriately trained staff. Providers are often resistant to 
receiving this education because of their reluctance to care for 
HIV impacted persons. They are not well-compensated financially 
and may not be able to deliver the ethnic and culturally 
specificity required. Space in which to provide services is also 
an issue. Community organizations do not have the space or rent 
to hold all the support groups and offer the peer counseling that 
is required. 
Access to and development of resources is also hindered by 
the discrimination that exists against those who require 
services. Potential clients are stigmatized because of their 
mental illness, seropositive status, sexual orientation, and/or 
substance abusing history. This tendency to "blame the victim" 
creates a difficult environment in which to design, develop, and 
support HIV-related mental health services. 
A serious lack of coordination also exists. Networking is 
necessary among and within County departments and between these 
departments and the community. Effective referral and case 
management cannot take place without formal mechanisms to link 
inpatient facilities, CBOs, and other sites. Agencies recognize 
this deficiency and many are attempting to correct it through 
more open communication, but much work remains to be done. 
Naa4s au4 Recogmen4ations 
Particularly crucial categories that require expansion are: 
medical-psychiatric hospital beds for acute care, sub-acute care 
facilities, residential facilities, and day care mental health 
programs. Further funding for outpatient services is also 
urgently needed to meet both current and projected needs. 
Training and education to professionals and paraprofessionals is 
necessary in all programs. 
Other needs arise from the fragmentation of the health care 
system among the various organizations, including the Department 
of Mental Health, the Department of Health Services (e.g. AIDS 
Programs, Alcohol and Drug Programs), and community-based 
organizations, which especially adversely affects the treatment 
of the multiply diagnosed patient. Coordination between t~~se 
systems must be a priority if clients are to be effectively 
served. For example, attempts at early counseling will not work 
if improved connections are not made between post-test counseling 
and other follow-up services. 
Multi-laval ~acilitys Sub-acute, aasi4antial, an4 Day care 
Ideally, sub-acute care should be offered in a single, 
multi-level facility. The best situation provides for sensitive 
staff in one location to meet the demanding needs of the mentally 
ill client. The facility could provide a continuum of mental 
health care through the combination of a locked ward with a 
skilled nursing component, residential care, transportation, and 
day treatment at both the intensive (crisis resolution) and 
habilitative (maintenance) levels. If a single facility is not 
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established, strong and formal ties must be made with the several 
sites providing these services. A patch funding program is 
needed to pay sub-acute care facilities for extra services 
provided to HIV mental health patients. 
case management coordination between mental health and 
community-based providers becomes critical when placement of an 
HIV-positive chronically and severely mentally ill person in a 
community residential setting is necessary. Few facility 
operations (from board and care homes to SNFs) are willing to or 
comfortable with caring for an HIV-positivejchronically mentally 
ill individual who could place other residents at risk of 
exposure to HIV. Additionally, residential facility operators 
must be educated to deal with issues related to HIV/AIDS. 
Acute care 
Too often inpatient facilities are not accepting HIV+ 
patients in direct violation of anti-discrimination ordinances of 
the Cities of Los Angeles and West Hollywood and the County of 
Los Angeles. These violations should be reported and appropriate 
action taken. This situation highlights the need for training 
and education to decrease fear and sensitize providers to the 
psychosocial need of HIV patients. 
Professional services 
Professional services such as cr1s1s intervention, 
counseling, and support groups require further staff training and 
expanded availability. Greater geographic distribution of 
programs and services provided in languages other than English 
are needed. Development of new models that are culturally 
appropriate, based upon what people perceive they want and need, 
is necessary. New and innovative models should outreach to 
clients and educate them on the benefits of mental health 
services. services should also incorporate the provision of 
· messages to prevent transmission of the virus and the development 
of acute mental health conditions. 
A major priority includes the need to increase the 
availability of case managers. Increased communication is 
necessary between DMH, CBOs, and DHS (e.g. , AIDS Programs,·· .Drug 
Abuse Program Office, Alcohol Programs) to decrease overlapping 
services and multiple case managers. Some mental health 
professionals believe that creative and culturally sensitive 
mental health counseling may be provided by mental health 
professional case managers, rather than through a more 
traditional, formal setting. Clients may feel more comfortable 
with this one-on-one relationship in which they have already 
developed a level of trust and security. 
Medication EValuations 
Medication evaluations are an integral part of mental health 
care. Unfortunately, very few private providers agree to do 
evaluations on a long-term basis or at low cost. Monitoring and 
follow-up are important, but most psychiatrists are unwilling or 
unable to devote the intensity of effort required. Resources 
should be developed in this area through active recruitment and 
education. 
Psychosocial support for Providers 
The need to develop more support groups and burnout 
prevention workshops for mental health providers is acute. 
Bereavement intervention is also a very real need. These 
services should be part of an overall resource development 
program that seeks to recruit and retain HIV providers throughout 
the various delivery systems. 
Pro1ectiopa 
The projections of psychosocial services needed by HIV+ 
adults (Table 18) are made with the use of the estimates 
described below. All estimates are derived from the experiences 
of the County Department of Mental Health and community-based 
organizations providing HIV care. 
By definition, the chronically mentally ill and persons with 
multiple diagnoses (categories 2 and 3) are not mutually 
exclusive. However, the overlap between the two categories is 
insignificant given the uncertainty of the seroprevalence 
estimate. All numbers have been rounded to the nearest fifty. 
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Tllble 18 
Mlntal .._lth Service ProjectiON 
1990/91 - 1992.193 
Cttmrx 
Persons ~ith HIV brain disease 
needing mental health intervention (1) 
Chronically mentally ill <2> 
Persons ~ith .ultiple diagnoses C3) 






sHking mental health intervention (4) 22,400 22,400 






(1) It is estimated that 66 percent of patients develop significant symptomatology related to HIV brain 
disease before the terminal stages of the disease. HOMever, approximately half of these individuals 
C33 percent> ~ill need mental health intervention. The esti .. tes use AIDS eases per year plus 10 
percent to capture the severely symptOMatic. 90/91: (8,845)(.33) • 2,918; 91/92: (10,678)(.33> • 
3,523; 92/93: (12,293)(.33) • 4,056 
<2> It is estimated that one and one·half percent of the general population is chronically mentally ill. 
Those ~ith a chronically mentally ill diagnosis prior to HIV infection are estimated as 1.5 percent 
of the 112,000 infected. <112,000)(.015) • 1,680 
<3> This estimate is the number of HIV infected persons Who are also diagnosed ~ith. several primary 
problema, such as a payehiatric complication and addictive behaviors. The total number of infected 
persons is ~~a~l tipl ied by 15 percent (the estimated proportion of infected who are IVDUs) and by 
another 15 percent to estimate the total nu~Cer of HIV+ IVDUs with a psychiatric disorder. 
(112,000)(.15)(.15). 2,520 
(4) This estimate is baed on the APLA figure of 66 percent of """ clients receiving counseling and 
group therapy services. The number is reduced to 58 percent when categories 1, 2, and 3 are 
excluded. Approximately one·third of these indivic11als Who •ight need mental health intervention 
actually seek the care. The bulk of this care is group ther~. Therefore, 20 percent of the HIV· 
infected were placed in category 4. (112,000)(.20> • 22,400 
Acute Hospital Care 
.. 
Approximately five percent of mentally ill patients 
(categories 1-3) need acute inpatient care, according to 
Department of Mental Health statistics. This figure may be 
applied to the HIV+ population to determine the number of 
hospital psychiatric beds needed for their care. Five percent of 
categories 1-3, and 5 percent of half of category 4 (they are not 
considered mentally ill, but half may be suicidal) require such 
care each year. Average length of stay is two weeks. 
Sub-acute care 
In order to determine the number of beds in a locked mental 
health skilled nursing facility (SNF) that are required by HIV+ 







those entering an acute hospital setting will be 
into sub-acute care. Five percent of persons from 
l-3 will enter the locked SNF directly from the 
Average length of stay is two months. 
Residential Care 
Board and care facilities experience a six-month length of 
stay for their patients. Only categories 1 and 2 are considered. 
Eighty percent of those entering a sub-acute care setting will be 
discharged into board and care. Five percent of persons from 
categories l-3 will enter from other sources. 
category 3 utilizes the "Our House" model of care. 
Individuals with multiple diagnoses remain at our House about six 
months before being discharged into hospice or other care. It is 
estimated that 8 percent of persons with multiple diagnoses 
require an our House facility. That is, 200 HIV+ persons per 
year need 100 "Our House" beds. This figure reflects seven times 
as many beds as currently exist. 
Day Treatment 
Individuals with HIV brain disease and those who are 
chronically mentally ill are the most appropriate clients for a 
day treatment program. Approximately 15 percent of categories l 
and 2 require such care. Five percent of those with multiple 
diagnoses would benefit from day treatment. currently, DMH's 
Program H.O.P.E. can handle a case load of twenty-five, 
significantly less than what is needed. 
outpatient care 
For outpatient care, projections are made for four 
professional services: individual therapy, group therapy, case 
management, and medication evaluation. The percentages described 
below are estimates provided by a working group comprised of Los 
Angeles county mental health professionals. 
HIV-infected persons require individual therapy at the 
following percentages: 7 percent of category 1; 66 percent of 
category 2; 60 percent of category 3; and 33 percent of category 
4. The chronically mentally ill utilize long term individual 
psychotherapy while persons with multiple diagnoses are more 
likely to seek intervention intermittently, during times of 
crisis. 
Group therapy is the most utilized mental health 
intervention, especially by persons in category 4. However, 
chronically mentally ill patients are not placed in group therapy 
settings. Persons with multiple diagnoses are often disruptive 
in group settings, but they will seek such care on a drop-in 
basis for crisis resolution. Approximately 7 percent of category 
1, 25 percent of category 3, and 66 percent of category 4 seek 
these services. 
Case management projections consider those individuals who 
need this service within the mental health system. The Case 
Management section of the Plan captures the HIV+ population 
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receiving non-mental health specific case management in 
community-based agencies. One hundred percent of the chronically 
mentally ill and 25 percent of those with multiple diagnoses 
should receive case management in the mental health sector. 
Medication evaluation for psychotropic drugs is required by 
a large number of individuals in our categories. One-hundred 
percent of the chronically mentally ill patients, 50 percent of 
persons with multiple diagnoses, and 6 percent of category 4 





Mntal ._lttt servtc. C:.t Projec:tiana 
1990191 
'ISIIRtx if 11rv;;1 ~s needed Tgttl Costs 
Acute Hospital Care 35 psych bedS I 6,591,900 
Sub· acute care 86 SNF bedS I 2,511,200 
R .. identlal care 240 board and care bedS I 1 '752,000 
100 "'ur House" bedS I 1,785,714 
Day Treat-.nt 815 HIV+ individuals/year 110,866,664 
OUtpet I ent Care 
Individual cCU~Sel ino 10,200 HIV+ Individuals/year 114,203,800 
Group ccuwelino 15,600 HIV+ individuals/year 128,315,!32 
case ..,.....nt 2,325 HIV+ individuals/year I 1,453,000 
Medication evaluation 4,300 HIV+ individuals/year I 378.400 
TOTAL: 167,858,510 
1991/92 
~ISIIRtx gf 11rvi51 ~s needed Total Coati 
Acute Hospital Care 36 psych bedS I 6,826,680 
Sub· acute care 93 SIIF bedS I 2,715,600 
R .. ldential care 261 board and care beca I 1,956,400 
100 IIQur Hous.- beca I 1 '785, 714 
Day Treat-.nt 905 HIV+ Individuals/year 112,066,664 
outpetient care 
Individual ccuwel ino 10,260 MIV+ individuals/year 114,400,360 
Group ccuwelino 15,654 MIV+ individuals/year 128,442,504 
c ... Jlllnllg-.nt 2,325 HIV+ Individuals/year I 1,453,000 
Medication evaluation 4,300 HIV+ individuela/year ' 3ZJ.400 
TOTAL: 170,025,322 
1992/9S 
~ISIIRtx Rt ltrvisl Mru!S I'IHded Tosat c91sa 
Acute Hoapltal Care 37 plych bedl I 7,043,916 . . 
Sub· acute care 100 SIIF becla I 2,920,000 
a .. tdentlal care '1!17 board and care beca I 2, 168,100 
100 IIQur Houa.- beds I 1,785,714 
Day T reet-.nt 9tl MIV+ lndivlduala/year 113,166,338 
OUtpetient care 
Individual courwel ino 10,297 MIV+ lndividuala/year 114,582,880 
Group ccuwel I no 15,693 HIV+ individuals/year 128,560,128 
c ... ..,.._,t 2,325 HIV+ indlviduala/year I 1,453,000 
Medication evaluation 4,300 HIV+ lndivlduela/year ' 3ZJ.400 
TOTAL: 172,058,476 
G-52 
1991 CARE/CDC REQUESTS FOR PROPOSALS FACT SHEET 
TOTAL NUMBER OF PROPOSALS RECEIVED: 47 
RFP MENTAL HEALTH & PSYCHOSOCIAL SUPPORT SERVICES (191-003) 
RECOMMENDED FOR FUNDING: 
AIDS PROJECT LOS ANGELES 
EAST VALLEY COMMUNITY HEALTH CENTER 
PACIFIC CENTER FOR COUNSELING 
MINORITY AIDS PROJECT 
HOLLYWOOD-SUNSET COMMUNITY CLINIC 
*GAY AND LESBIAN COMMUNITY SERVICES CENTER 




NUMBER OF AGENCIES RESPONDING: 20 








RFP HIV OUTREACH AND PROMOTION OF SERVICES (f91-004) 
RECOMMENDED FOR FUNDING: 
JWCH INSTITUTE, INC. 
THE LOS ANGELES FREE CLINIC 
CITY OF LONG BEACH DEPT. OF HEALTH 
CALIFORNIA DRUG CONSULTANTS, INC. 
*AIDS HEALTHCARE FOUNDATION/ 
GAY MEN OF COLOR CONSORTIUM 
NUMBER OF AGENCIES RESPONDING: 18 
TOTAL AMOUNT OF FUNDING REQUESTED: $1,845,610 









RFP TRAINING & CROSS-TRAINING (191-005) 
RECOMMENDED FOR FUNDING: 
*PROTOTYPES/W.A.R.N. 
LOS ANGELES HOMELESS HEALTH CARE PROJECT 
*AIDS HEALTHCARE FOUNDATION/ 
GAY MEN OF COLOR CONSORTIUM 
NUMBER OF AGENCIES RESPONDING: 9 
TOTAL AMOUNT OF FUNDING REQUESTED: $1,046,087 







* Represents group/consortium proposals 
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i" ax \ ~ ' ~ i :i c ; - : ; :; o 
t-he -.~ ....... ;·,iy name 
i-iI'-.·/ A I CS 
i s C y n -r,h i a 
educat-ion, 
~avis and 
pre ·.Jerlt ~ or'1 ana reaucLion programs being 
imp i emenLed under- t-he aus::n c~s of t-he .:.en~e r f c r Ccmmurn t.,. and 
Preventive Medicine of the Charles R. Drew university of Meaicine 
and Science, the National Organization of o1aCK Count.y 0fficia1s. 
Inc. :NOBCC~ and the Canters for ~isease Cont.rc1; The purpose of 
the projec0s are cwofoid: 
1) to develop a model HIV/AIDS r1s~ reduct1on orogram t-argeting 
school-age, out-of-schoo1 and college-age )outh which can be 
repi icat.ed in t:.he Afncan American communiLl .;;n a nat.ior.ai 
basis and 
to increase the HIYiAICS-reiaLed ~now~edge ana awareness or 
alack elected and appointed cour.Ly officia1s so cna~ Lhey can 
more effectively advocate for increased ana/or .anhance 
HIV/AIDS-related services targeting the "'fr-ican American 
communit-y on a national basis. 
I have been involved in developing, 1mpiementing and 
evaluating family life education (FLE) and HIY/AIDS education 
and r1sk reduction programs targeting e~nnic maJori~y youth 
and young adults in Los Angeles County since 1984. 
My testimony will focus on the overall HIV/AIDS-reiated educational 
needs of African American youth on a national as wei i as local 
ievel. 
BACKGROUND 
As of uc~ober 1991, on a national level ~here have been 
approximateiy 758 cases of AIDS among 13-19 year olds reported to 
the Centers for Disease Control (CDC). vf these 7Sa cases, 42~ are 
White (322), 37% are Black (280) and 19~ are Hispanic (142). 
Gf ~nose cases repor~ed among Black you~h. 53~ are male (166~ and 
41;;, are fema 1 e ( 114). ihe exposw-e ca~egor 1 es tha~ ilave been 
reccn:.ed for ail you~h aged 1.::.-19, ~ 11respec~ive of race. ind1ca~e 
that ~6~ were infec~ed due to homosexual/bisexual con~act . .:;c~ were 
infectea cue to hemophilia/coagu1atlon disorders: 14% due to 
he-c.ercsexua i ccntac~, 12% due to :::vuu, 7 ~ due to rece i ct. of 
contaminated biood products; for /:it. their exposure ca~egory is 
unknown and 4~ due to the multiple ris~ factor of 
homosexuai/bisexuai contact and IYDU. 
Gut. of a cumulative total of 139,405 cases reported to date. the 
numcer of 13-13 year aids recor-c.ed w1-c.h AIDS accoun~s for less -c.han 
~~ i • .::.6:it.) of the to~ai cases. ~owever, this fac~ shcuid not give 
In ~-~s ~nge i ~s c~~:-,-cy, :.c cate ( ~ePLember 1 S~ 1 i cnare nave baer-i a 
cc-c.a i of .:;c ;..:;::cs cases naoor~ed among 1 outh aged i 3- i 9; 3 among 
Siaci"s (30:it.;, 11 among riisoanics ,.:;7.ib) and 1C among whi~es. (3.::.;;:.1 
Whi~a adolescents (age 13-13~ account for less than i.ib of the to-c.a1 
numcer of ,.:..rr;s cases. bo~h nat. i ana i 1 y and i oca i i y, ~0% of a i 1 
repcr~ed AIDS cases are among persons 20-29 years of age. ~ivan the 
eAt.ended 1atency period from the time of initial infection wi~h ~IV 
un~ii manifes-c.ation of s;mptcms which result in an AIDS diagnosis, 
usually from one to ten years. it can be concluded tha~ most or -c.ne 
ind1viduals in the ~0-29 age category were infected with riiY during 
the1r teen age years. 
For far -c.oo long i'"'iiY infection and AIDS has been • ;awed as a 
ga:u:::i1sexuai white male disease". !his my-c.h s-c.iii pre·..;aiis .... n 
iieu of the fact tha~ -c.he incidence and prevaience of rii; infec~ion 
ana ~IDS 1s relatively 1ow among the adolescent. ooou1aticn. 
aaoiescen~s are a-c. serious risk for riiV 1nfecticns. 
lhe number of reported cases of AICS among adolescents aces no~ 
accurately reflect the risk that this dead1y virus cases ~o you~h 
in ~his nation. iO understand the full impact of AIDS among 
adolescents we must lock beyond these seeming1y iow statistics to 
ctner sources wn1cn suggest tha~ adolescents are a-c. h1gn risk for 
contracting HIY because of their behaviors. 
WHY ARE .;.OUTri AT RISK FOR ril'-/ INFECT:ON·? 
Adolescents and young adu~ts are at increased risk for HIV 
infection due to numerous factors. These factors include: 
1 i increased sexuai experimentation {heterosexual. as we11 as 
homosexual~ among youth, 
' . ._ I ji'OUth•s 
drugs, 
increased experimenta~ion with ~ic1t and/or - ~ . ' -, : i 1 c 1 t, 
~) youth engaging in casua i sex or sa;<. r~ i th more t..i1an one 
par~ner, and 
4) youth 
' 1 • e. 
faiiing to utiiize 
iatex condoms) 
me~hcds ,-,"T'" '-"I 
According to the 1930 Census, t..here are iO.S m1iiion Si.:;,.c~-_ youth 
under the age of 19 in the 0.5. with nearly ~ mi11ion aged 15-;S 
and ~ mi 1 i ion aged 20-24. This under 24 age group comonses 
accrcxima~eiy ou% of the to~al U.S. Slack co;:;uia~ion. Thus. we have 
a whoie generation at increased risk for HI~ infec~ion. 
SiacKs and riisoanics currently account.. for approxima~aiy 44~ of a;' 
ca~ient..s diagnosed wi~h AICS. 7~~ of women. anc 76~ of ali ohi1dren 
w1t..h cenna~ai acquired infection. Ti-.e -.:;·.-er-wneiming ma.}or1t'f OT 
minor1t..~es who have con~ract..ad ~ICS are 1nner =~t..y ras;dant..s of ~ow 
socioeconom1c status. 
;·~umercus hea i th 
hea i th and we 11 be illg of 
SOCiai problems 
numoers of Slac~ and o~her 
acuits across t..ne u.S. The 
overview of the seriousness 
e~hnic minori~y adoiescents and young 
fo11owing statistics present a general 
of the problems: 
Nationaiiy, 
LOW 
> ..,. ___ • -·. 
i....i.lt:ii .... l..f 1981, 15.4ib of Siaci-_ 10u~h aged ;6-24 were high 
school dropouts: anot..her survey es~ima~ea that over 
20% of Slack males aged 12-17 couid not.. read a~ a 
fourth grade reading levei. 
In 198~, 4.3. ~;;, of 3 i ack yout..h agee i 6- i;;, ••er-e 
unempioyed. more than twica the 21.6~ ;·a~e for all 
teens. 
INCARCERATED - In 1973, 15% of ail Black ;outh (456,636~ .:;,.ged 15-
19 had an arrest record. :n aadition, .:;;::.:. of aii 
juvenile offenders in pub1ic or pri~a~e rasiden~ia~ 
facilities were alack. 
DRUG USC: 
AND ABUSE In 1979, a National Institute on ~rug Abuse (NIDA) 
survey indicated that non-white youth aged 18-25 
have nigher or equal rates of drug abuse than white 
youth in every major drug category except for 
inhalants and hallucinogens. ~hereas a decreasing 
trend in marijuana use has been noted among white 
youth aged 12-17 and iS-25. this trend 1s not 
paralleled by a decreasing trend among minority 
youth in the same age ca~egories. Another NIDA s~udy 





Hispanic youth through 1995 because they constitute 
the fastest growing segment of the J.S. popu~ation 
and because of t.hei r drug use patterns. A 
conservative estimate is that. :oo.ooo adolescents 
have used drugs 1ntravenously. 
Over one million teenage gir1s become pregnant 
annually in the U.S. The rates of teenage pregnancy 
for Black and Hispanic teens in Los Ange1es County 
are 2-4 times greater than for White teens. A 19a1 
report of the Population Counci~ inaicated that 62% 
of babies bor-n to 51aci\ teens were born our--of-
wedlock, compared r.o 22% born r.o nhite teens. 
C:~PE~IMENTATION -5y age 15, ;6~ of boys and 5~ of g1r;s ~n the u.~. 
have engaged in sexual intercourse at ~ease once. 
5y age 17, these rates are almost three times nigher 
for boys and five times higher for g1r:s. 1ne rates 
of sexual activity for Black youth ~iving in urban. 
inner cities are est i matad to be higher than for 
white youth and st~dies indicate that Black youth 
begin en9a.g i ng in sexua i intercourse at ear 1 i er ages 
than ~hite youth. 
SE~<uAi...L.( 
TRAt-JSHITTED 
DISEASES -Sexually transmitted diseases (STi::s1 have reachea 
epidemic proportions in the U.S. In 19S5. the 
Centers for Disease Controi (CDC) reported that 25~ 
of a:: individuals infected with gonorrhea or 
syphiiis were agea 10-19 ana 27tt. or ;na1viduais 
infected were aged 20-24. The rates of STus for non-
whites in Los Angeies County have been at epidemic 
proportions for several years. 
On a local levei, Cai ifornia ieads the nation in the number of 
teenage pregnancies. In 1981, there were a total of 143,730 teen 
pregnancies of 15 to 19 ·year olds in the State, for a rate of 145 
births per 1,000 teenagers age 15-19. In Los Angeles County this 
rate was 148 birth per 1, 000 teenaged gi r i age 15-1 9 or 4 7, 091 
pregnancies. 
In 1988 in California, there were 284 births to Black giris less 
than 15 year olds; 3,504 births to Blacf" girls aged 15-17, and 
5.832 for Black girls aged 18-13. Los Angeles County had. a tota~ 
of 6.659 births for ail ethnic groups who were ies's than 20 years 
old and who were unwed teens. 
4 
These high r-ates of teenage pregnancy and .=.res indica1:.e that 
preadolescent. adolescents and young adults are not using barrier 
methods of birth control when engaging in sexual intercourse. It's 
obvious that many teens and young adults are having sex: bu~ unsafe 
sex. 
CURRENT STATUS OF HIV/AICS ~DUCATION IN THE AFRICAN A~ERICAN CO~NT~· 
IN LOS ANGELES COUNTY 
Los Angeles Unified Schooi uis-.rict (LAUSD) .,.,1-;ich 1s ~he second 
1argest schoo~ dis't.rict in 1:.he nation with o~er 600.CJO s-.uden't.s 
[-,as been involved in HI'l/AICS education since 1S2.4. -:-;-,a dis-.:-ict.. 
r-eceived iimi-r,aa fur;Cing fi-Cfn ~he puolic atld pr1-.;at-e S8Ct,Or fCi-
Famliy Life ~ducation which included ~I~/AIC.=o eauca-.ion beginning 
na't.ionaiiy to rece1v·a CDC f: .. mding expand and ennanca :.he1r 
i-ii"'i/AIDS educat..ion programs for teacher training ana cur-,-icuium 
deveiopmen't.. 
Currently, -.he Cls't.rict.. implements a comprehensive haa~~h education 
curriculum which includes a component on STDs/HI~. Th1s curricu1um 
is targeted to the upper elementary (5th-6th) graces and secondary 
grades (7-12). Beginning in 5th and 6th grades stl.iden-. :-ecei·.;e 
Family Life Education and ril'-•'/AIDS education within the 
comprehens1ve neaith education curricl.iium. STus/AI:JS covet-s a-10 
~esson and can be implemented over a ~-6 week ceriod depenaing uocn 
the needs of class. 
Parental consent is reouirad for both -.ha e1amen~ary and secondary 
school stuaents. 
LAUSD is Cl.irran't.iy upaating .ts STi:Js;A~uQ Cl.irrlcu~um. 7ha ~ist..r1c~ 
for the pas-. several years has been 1ooking a-. changes in know1edge 
and at..titudes concerning HIV/AIDS: and not beha~iors. 
For gay identified youth there are specia1 peer counseling programs 
offered by ~he district's psychological services departmen~ at. each 
school. And at Fairfax riigh, Project. 10, a progr-am for gay 
identified youth has been implemented for approximate~y 10 years. 
rcu't.h can be r-eferred to this program from ether schcois. The 
district is currently developing a Senior ~xit program for 17-18 
year oids. Prior to graduation, they wiii receive additional 
HIV/AIDS related information. 
This past fiscal year over 1 ,662 secondary teachers were trained 
to use the STu/HIV curriculum. A staff of three persons ccordina't.es 
the program and the· program is in its 5th year of :J years of 
funa1ng. The district also works with 1oca1 CBOs to crain their 
staff in the use of its HIV/AIDS curriculum. (Urban ~eague, Asia 
Pacific Project, AVANCE, and WARN Project) 
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!here are severai local C80's target-:ng schooi-age ana out-of-
scnool population in South Centra1 Los Angeles: 
' 
N08CO AIDS Information and Education ?reject 
Drew University Information and Education ProJect 
Watts Health Foundation 
"(outh and Family Center of Inglewood 
Feop i e ·~-4ho Care 
FAME Project 
Minority AICS ?reject 
Func1ng for these proJects 1s primari1y from tne r-.• '.-•• - .-.....,u...., I ...... private 
sec~cr (LACDHS-AFU. ~ta~e Cffice cf AIW~ and CCC) 
r.I\' /AIDS-rei a ted ..;: • I .. -, ,-I ..; lr\ ,"""\ I \,o,lf\..A 1a1~ targe"Ling Afr-~can ,-\meri.::~n women, 
a.nd ,.oung a.du 1 ts has oeen nomi r-,a l . 
LOS Angeles County AIDS Program Office lS90-~1 
Frevention/Educat1cn Contracts 
El Centro da1 Pueblo - Central/Echo Par~. 
:1275.651 
Siivari.:l.ke 
El Froyecto del Barrio- Northeast San Fernando ~alley 
AIDS Awareness Campaign - Countywide 
,.outh 
Gay ~ Lesbian Community Service Center - ~~u~ AIDS Project 
Valley Community Clinic 
Health Education/~isk ~eduction 
~APO contract with ioca1 C8Cs; 
CORE Program -·.:utreacn .;ay/bisexuai mates 
Children's hospital -Hollla i ass/Runaway iOUth riiV /AIDS 
A VANCE -Spanish ~anguage ~ot1ine 
Minority Initiative $96,700 
(Targeted Education/Prevention) 
Asian, Latino and Black Comm~nity Outreach 
Los Angeles City AIDS Coordinators Office funding for education, 
prevention and risk reduction totals $70,000: $17,500 of these 
doiiars are targeted for South Central Los Angeles. 
Incarcerated Populations (Juvenile Court Health Services) 
Individuals who traditionally have been underserved are homeless, 
incarcerated and street youth. 
Approximately 20-25,000 minors are in some form of custody in the 
Juvenile Halls and Camps in Los Angeles County annua~iy. A majority 
of these youth are Hispanics and Blacks. 
5 379 
During 1990, approximately 1,754 minors .-eceived n.;..:,· ant.ibody 
testing and pre/posttest counseling for ~IV. Of the 1.754 tested. 
2. were HIV "~"· 
DHSJCHS provides HIV/AIDS education Tr-..r I VI ~hesa ;·out:.h: 
State AIDS ?rogram - 1987 
CDC HIV detection program - 1989 
CDC/State AIDS Video Project - 1989 
A survey of risk behaviors of these youth det.erm1nad that.: 
97~ are sexually active (1S~ use ccndoms frequent:.1y; 
7~.S~ use drugs (6~ usa IV drugs~ 
o o:;o get. d runi-;. .. 
Since ;386, ~cHS has nad 21 cases of n~~ T m1nors. 
Of the 250 females tasted, 21 were pregnant. upon admi~s1~n: SO had 
a prev1ous pregnancy; ~0 had children and 34 haa report:.ea history 
of -... -~iUS. 
Of the 1 504 rna 1 es tested. i 20 had a partner who was pregnant.. ..:. t;.; 
had a part.ner with a previous pregnancy; 221 had children and 268 
had a hist.cry of STDs. 
Of the 1,754 surveyed. 
American: 7~ were White: 
.22.% Nat.ive American and 
51~ were r.ispanic: 
.33:{. r..;ultiethnic: ; .5~ 
.05~ Undetermined. 
~5~ ~ere ~frican 
As 1 an: l • s;;, Other-: 
Of the l .754 minors tested, ~1 females and ~So ma~es report.ed zip 
codes in Sout.h Cent.ra1 ~os Angeles as we11 as ot.ner areas of the 
city/counr..y copulated by ethnic majority populat1ons. 
EFFECTIVE STRATE~IES 
The key issues we have had to address in developing effect.ive and 
cuituraily relevant and sensitive programs include the foilowing: 
1) Developing culturally relevant programs; 2) gaining widespread 
community involvement and acceptance: 3) target group 
accessibility; 4) developing program 1egitimacy: and 5) having 
adeauate resources. On another level, we still have to deal with 
a great. deal of fear, denial, ignorance and apathy 1n cur 
ccmmun1r..:;·. Early on, in our educational our..:-each effcr-r..s. women 
adolescents and young adults verbalized that they were immune t.o 
AIDS and HIV infection. They repeatedly stated, "It can't happen 
to me". : don~t know anyone with AIDS'', and "0n1y prostitutes and 
drug users have AIDS." Many of them believed that AIDS was only a 
"gay/bisexuai White male disease." However, after repeatediy 
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exposing commun1ty residents to accura~e informa~ion on ~IDS and 
~I~ infection, as well as· focusing on the fac~ &haL i~'s no~ r1sK 
groups but one's behavior Lha~ places one at increa~ed r1sk for nLv 
infec~1on, many individuals overcame ~heir iniLia1 den1al. fear ana 
apachy. 
One cannot over i ook the impact of poverty, i i 1• teracy, i aci\ of 
access to medica i /soc i a i hea 1 th care, and a genera i sense of 
hopeless, powerlessness and lowered seif-esteem and self-worth tha~ 
comes into play when considering people's knowledge levels 
concerning AIDS and HIV, as wail as their a~tit.LJdes. beliefs and 
values concern1ng maintenance oT good hea~t.h and mental ana 
sp1ritual wellbe1ng in general. In addition, communiLy norms. mores 
.:;.nd values play a key r-oie 1n ~-.ha~ is commoni y "accec~able" ·..-ersus 
··non-accep~ab1e" benavior. ir1Us, educating -indi•1dua~s ana Lne 
communiLy-at-iarge aione 1s not enougn and ~11~ never be enougn. 
iher-e has to be a concer-ted effort to -:.nanga the ;;.oc~ai norms. 
values and mores of a commun1~y if we are co have a 1as~ing effecc 
in (educing r-lsk taking behaviors for AIDS and rii··.:, as weii as 
reducing ~he· incidence and prevalence of adolescen~ pregnancy, STi:, 
I~ drug use. aicohoi and cocaine abuse, and a hosL of other healLh 
and socially related problems that have for genera~ions plagued our 
communities. 
---T""". ---··"'*'-.::ilr<Ait:\.l.lt:,j 
It has only been wi~h1n the iast four years Lha~ there has been a 
na~ional and iocai effort LO educate e~nnic m1nor1~y commun1~1es 
about HIV and how to stop its spread. Los Angeies :oun~y as wei: 
as the res~ of the na~ion is 6-6 years behind Lhe gay community in 
developing and implementing effecLive and successful educa~ion ana 
risk reduc~ion campaigns. ~e need to learn from Lhe gay communi~1·s 
success 1 n reducing the inc i dance of HI '-.1 i nf action among 
gay/bisexual men. However, models developed in the gay communiti 
may no~ be replicable in minority communities. Jn~i1 recently, ~he 
vas~ majority of educa~ionai programs being deveioped and 
implemented were not targeting ethnic minority communities nor were 
they culturally relevant or sensitive in their approach. 
We have found, to insure greater efficacy, it is incumbent tha~ 
HIV/AIDS educationaiiinformational campa1gns focus on community 
development. Effective programs are comprehensive and 
multidisciplinary in their approach and focus on prevention, are 
skills and values based, are peer mediated and work towards 
community empowerment. 
tJe have been very successfu i in using the mode i of community 
development. In the area of program development, utiiizing this 
model, the following steps should be taken: 
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1) formation of a broad-based community advisory counci~ which 
wi11 provide ongoing input concer-ning the plann1ng, 
implementation and evaluation of the projecL. 
2) developing models that 
of social competency 
ski11s. 
include skills buiid1ng, anhancemenL 
and deveiopmenL of problem-solving 
3) administration of a comprehensive communiLy needs assessmenL 
survey of Lne target groups, as we 1 i as the i oca 1 serv 1 ce 
providers, in order Lo i denL i fy unmet needs, b r "i dge gaps • n 
services and avoid duplication of services. 
4} deveiopmenL of a process for eva1uaL10n ;:.haL ~nc1udes ·.l 
formaLive, as wei~ as summative evaluaLion of the program. 
5) incorporation of ~IV/AI~S educaLian inLo e~1sL1ng family ~if6 
educaLion and/or sex educaLion programs wn1cn are school or 
communlty-based. 
01 working in concert and collaboration with publi~ and privaLe 
sector organizations such as schools, youth service agencies, 
probation departmenLs, children~s serv1ces, county health and 
social service departments, county drug abuse programs, 
colleges, civic and business organizations, ~he mec1a, 
religious institutions, the gay/bisexual communiLY and parenL 
groups. 
RECOMMENDATIONS 
These recommendations are based upon the Women and ~IV/AIDS ~ublic 
Hearlng held on February .:a. 1991 aL exPOSition ~an;. ln i...os 
Angeles, California. ~hat held true ten monLhs ago, SLl l i holds 
true today. 
~IV/AIDS affecLed women, youth and young adults are in dire need 
of the following services and programs in Los Angeles CounLy and 
in Metro South Health Area (South Central) in particular. 
1 .. 
-.... 
Comprehensive and multidisciplinary Eariy Intervention 
Programs (EIP) which provide culturally spec1r1c, gender 
sensitive and linguistically appropriate services including 
case management, mental health, social support, respite, child 
care and public benefits counseling and advocacy. These 
services are needed immediately. 
5pec i a 1 i zed ·women ' s C 1 i n i cs based on the \-fes L rio 11 y wood moae 1 , 
need to be deve 1 oped. These c 1 in i cs wou 1 d provide care rom 
initial diagnosis to full blown AIDS. Further deve;opment of 
the adolescent clinic in the Oasis program at MarLin Luther 
King Jr. Hospital. This clinic provides medical services to 







A well coordinated and integrated residential and shelter 
program for HIV infected women and ~ne1r cn1 :oren is needed 
immediate1y. The type of housing needed includes: emergency 
she 1 ~er. and 1 ong -cerm res 1 aen~1 a 1 programs. A 11 of these 
programs should be geared -co promote independent liv1ng for 
the women and their children. Child care and respite serv1ces 
need to be incorporated into all of these programs. 
Women and youth with dual diagnoses, HIV infection and having 
mental health and/or addiction problems, have unique special 
needs. These women, :;ou~n and their chi i dren and fami 1 i es 
require specialized case management services to insure ~hat. 
~hey receive the full range of EIF, mental health, substance 
abuse and rehabi1ita~ive services. 
Many women ana adolescen~s at. risk for M~~ 1nfec-cion can be 
charact-erized as be1ng of low 1ncome. low 5ES. 1ow educationa1 
attainmen~. iilitera~e and single heads of households. These 
women and adoiescen~s are generally in deep dania~ concerning 
their risk for HIV infection. A client advoca~e (ombudsman) 
needs t.o be integrated into the existing system of care. 
He/She would play a key role in advocating for the personal 
and 1ega1 rights of HIV infected and affected woman. 
Existing HIV/AIDS resources throughout L.A. County are 
i nadeoua~e and do no~ fu 11 y address the neat t.n ( men~<l1. 
physical and spiritua~) of HIV affected women, ;out.h and their 
children and families. A standardized and comprehensive 
communi ~Y needs assessment t.o identify unme~ service and 
clien~ needs must be developed and admin1stered on an ongoing 
basis. 
HIV positive women and you~h recen~ly released from an 
incarcerated setting and gay/bisexual women and youth need to 
receive targeted outreach in order to educate -chem about their 
risk for infection as wei1 as the benefits of EI? programs. 
Primary prevention programs need to be developed and expanded 
to reach pre-adolescent, adolescent and aduit women in order 
to stop the spread of HIV infection among women of 
childbearing age and their sexual partners. According to the 
most recent data from the State Office of AIDS, in Los Angeles 
Count}1 , in a recent HIV seropreve 1 ance study of women of 
childbearing age (14-44) 1 in 174 African American women of 
childbearing age in the study was found to be infected with 
HIV (N=5,403). 
A comprehensive educational campaign targeting local African 
American churches, radio stations, social organiza~ions, the 
business community and elected officials needs to be 
implemented and maintained to ensure tha~ t.ne public 3nd 
private sectors are aware of the problem and can work 
1 0. 
co11aboratively to develop solutions ~o 
of HIV infection in the African American 
of HIV/AIDS and women/youth needs to 
addressed in the form of public hearings 
on an ongoing basis. 
solving ~he problem 
communi~y. The issue 
be a oriori~y and 
and communi~y forums 
Continued lobbying at the state and federai 
HIV/AIDS education in grades k-12 and for 





There are no simple solutions for comba~ing the spread of ~IJ 1n 
muitiethnic communities national~y or 1oca1~y. Combating the spread 
of HIV will reouire complex multidisciplinary approaches and 
s~rategies, as weil as greater coliaboraticn be~ween pubiic and 
priva~e sector organizat1ons throughout ~he na~1on. AIDS and ~IV 
have to be looked at in ~arms of the in~erconnec~ing ~inks be~ween 
one's 010IOg1ca1, social and psychological envii-onmen~. It can'~ 
.:>e ~ooi\ed upon in isolation and in a vacuum. In i ieu cf r.ne fac~ 
that present 1 y, the majon ty of cases are concen~ra~ed among 
homosexual and bisexual men and IV drug ~sers, AI~S and HIV 
infect1on are related to behavior, not risk groups, and we in the 
alack community currently have an entire community of men, Nomen, 
children and adolescents a~ increased risk for infection . 
• 
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DATE: November 9, 1991 
LOCATION: UCLA Faculty Center 
PRESENTER: Cynthia C. Davis, MPH, CHES 
Program Director 
NOBCO AIDS Education Projects 
1631 E. 120th Street, Bldg. "C" 
Los Angeles, CA 90059 
(213) 567-7799; Fax: (213) 567-7796 
"HIV/AIDS-Related Service Needs of HIV Affected and Infected 
Women in Los Angeles County. 
In February of 1991, the first public hearing in Los Angeles 
County on Women and HIV/AIDS was held at Exposition Park under the 
sponsorship of the Los Angeles Commission on the Status of Women, 
former Los Angeles City Councilman Robert Farrell, and numerous 
community-based organizations which serve and advocate on behalf of 
HIV affected and infected women, children and adolescents who are 
the most medically unclerserved and under represented constituencies 
in Los Angeles County, the state and nation. A summary report of 
the public hearing was presented to the Los Angeles City Council in 
June of 1991 outlining the numerous gaps in services and the need 
for immediate resources for women. To date, nine months after the 
·public hearing there has. been no response from city government to 
address the crisis situation that HIV infected and affected women, 
children and adolescents have to deal with. There has been token 
response from local County government, vis-a-vis the nominal 
allocation of Ryan White Care Act funds to enhance and/or develop 
specialized services for women. As we begin to assess the need for 
comprehensive services for women, we must also look to the unmet 
needs of the preadolescent and adolescent females (aged 13-19) who 
are at just as great a risk for HIV infection, if not more, than 
their adult female counterparts. And lastly, we cannot overlook 
the infants and children that are apart of the lives of most women 
in this society, whether they be married or single, straight or 
gay, young or old, of childbearing age or post menopausal, drug 
free or drug addicted. 
The purpose of this presentation is to focus on existing 
HIV/AIDS-related services being provided by community-based 
organizations throughout Los Angeles County. Los Angeles County is 
a very large county covering over square 4,000 miles and with a 
total population over 9 million. Currently, there are over 300 
HIV/AIDS-related service providers in Los Angeles County. These 
providers make available a full spectrum of services ranging from 
primary prevention (education) services, testing, counseling, 
direct medical/clinical services, social support, mental health, 
extended care, residential, hospice, transportation, food, 
clothing, and legal. 3R5 
Because one of the primary the purposes of this conference was 
to target HIV infected women, I' 11 be highlighting those few 
agencies having specialized services for women. 
In looking at the "health" needs of HIV infected women, I feel 
it is imperative that we define their health in a wholist manner -
with health being one's physical, mental and spiritual well being, 
not merely the absence of disease or infirmity. Thus, we must 
begin to look at addressing the overall health care needs of HIV 
infected women in a comprehensive fashion and it must encompass a 
full range of services. 
At a minimum, HIV infected women's physical health service 
needs would include: 
. direct medical/clinical care (inpatient and outpatient) 
. ongoing education regarding risk reduction 
. fulfilling necessities of life needs (i.e. food, clothing 
and shelter) 
. residential care (long term and short term; in home or free 
standing) 
. emergency shelter; drop-in center; crash houses, 
transitional housing, permanent housing 
• hospice care (6 months or less to live); transportation 
• drug treatment and rehabilitation 
Mental Health service needs would encompass: 
direct medical/clinical services (counseling/treatment -
individual and family) 
• support care for: HIV symptomatic and HIV asymptomatic women 
and their affected families, and care givers; and counseling 
to couples, individuals and the community . 
. comprehensive case management; vocational; legal; respite; 
buddy/support programs; volunteers; stress reduction; 
counseling referral; financial/benefits counseling; 
self-employment programs; and having cultural competent 
staff and 
multilingual staff 
Spiritual Health service needs would include: 
• bereavement counseling; spiritual counseling; education 
concerning alternative/wholist treatment modalities; burial 
counseling; grief resolution 
Having a well coordinated and integrated system of care 
encompassing all of the aforementioned services will go a long way 
towards adequately addressing the needs of HIV infected women. 
There are numerous agencies which provide a full range of 
services to all individuals impacted by HIV. No agency can legally 
discriminate solely on the basis of one's sexual preference or 
one's gender. Thus, for the HIV infected woman, there are numerous 
agencies throughout the County which could provide a wide range of 
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services as well as make appropriate referral for services. 
Geographically these agencies are located as follows: 
Westside APLA Pacific Ctr Tuesday's Child 
AHF Being Alive Project Angle Food 
GLCSC Act-up LA/Women's Caucus 
LAPAN 
JWCH Institute 
Hollywood/Sunset Ctr. (Cara-a Cara) 
Caring for Babies with AIDS 
Eastside ADVANCE 
Milagros AIDS Project 
Altamed/Buenacare 
El Project del Barro 
Calif State University Los Angeles 
Downtown HOP 
Weingant Center 
L.A. Bar Association-Hospice Project 
Salvation Army 
Chris Brownlie Hospice 
Northside/Valley All Saints AIDS Service Center 
Northeast Valley Health Center 
Tarzana Treatment Center 
Foothill AIDS Project 
Southside MAP Youth & Family Center 
WARN Project 
WHF 
King/Drew Medical Center 
THE Clinic 
NOBCO/Drew I & E Projects 
Drew Women's Outreach Project/LA Southwest College 
Southbay/Lonq Beach Southbay Free Clinic 
Long Beach Minority AIDS Project 
Calif State University Long Beach 
Los Angeles County Comprehensive Health Centers. 
Los Angeles County. Hospitals 
UCL:A/Harbor 
MLK 
County/USC (SP21 and the outpatient clinic)/Maternal/Child 





St. Francis Medical Center 
St. Mary's Medical Center 
Euchemenical Agencies 
FAME Church 
St. !rigid's Catholic Church 








Search Alliance (Community-based trials) 
Residential Facilities 
Rue's House 
St. Francis House 
Group One 
Dignity House 
Hospices (6 months or less to live) 
Chris Bronlie (AHF) 
City of Angles 
West Hollywood (AHF) 
Our House (APLA) 
Its only been within the last year that there bas been a 
"popular" interest in the impact that the HIV epidemic is having 
among women. As a result of this interest and the rising number of 
women (adult and adolescent females) becoming infected, there bas 
been greater lobbying to involve women in clinical trails as well 
as changing the CDC case definition to reflect manifestations 
commonly found among women, as well as, the demand for more 
specialized services for women. 
The Women's Caucus of Act-Up (National chapters & LA Chapter) 
have been instrumented in advocating for more comprehensive and 
gender specific services for women. As a direct outcome of their 
advocacy role, women serving in the HIV/AIDS arena have mobilized 
to lobby and advocate on a local, statewide and national basis to 
insure that comprehensive HIV related services targeted for women 
are developed and/or enhanced. All of these advocates for women 
who are affected/infected by HIV are to be commended. 
Currently, in Los Angeles County there are a few programs 
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which have or are developing gender specific programs for women. 
One joint project is being developed in collaboration with the 
Women's Caucus of the Los Angeles AIDS Regional Board and THE 
Clinic for Women. 
A full time OB-GYN and a mid-level Nurse Practitioner are 
being identified to provide Level I & II treatment to symptomatic 
and asymptomatic women, using a conmuni ty-based model. 'l'wo 
satellite clinics where the Staff will rotate to on a weekly basis 
have been identified (Polanco Clinic & Altamed/Buenacare). 'l'hese 
women will receive a baseline assessment of their HIV status and be 
case managed to insure that they receive adequate follow-up care 
and treatment. Another program is the AHP's Palanco Clinic. '!'his 
Clinic which provides EIP services and medical treatment to HIV 
positive individuals recently developed a specialized program to 
treat women. '!'hey have a case load of over 60 women that they have 
been treating and following for the pass several months. At County 
USC there is a program for women who deliver at USC and test 
positive to receive ongoing treatment and care by staff at the 
Maternal and Child HIV Research Project. 'l'hese women and their 
families receive comprehensive care and support services. 
Concerning the extended care needs of women, there are women's 
support groups being implemented at AC'l'-Up Women's Caucus, WARN 
Project, Gathering Place, APLA and the GLCSC. Plans are in the 
making to develop a women's support group at Minority AIDS Project 
and the new Oasis Project at Martin Luther King Hospital will be 
having a specialized clinic for women and a specialized clinic for 
transvestites. 
Search Alliance which is involved in community-based clinical 
trials is currently recruiting women to participate in those 
trials. 
Tarzana Treatment Center which is headquartered in the valley 
has two residential detox programs. One program is not specialized 
for women, but does take women clients. It is a 6-9 month 
residential drug detoxification program which is comprehensive in 
its scope (case management, education, therapy/support groups) and 
then a non-residential detoxification program provides the same 
services as well as nursing and home health care and case 
management. Tarzana's residential treatment center in Long Beach 
primarily targets women and their children. '!'his program can take 
up to 85 women, not including their children. It is a long term 
residential program for drug addicted women. '!'hey will take 
pregnant women and their children up to 3 years of age. The 
program includes parenting classes, a cooperative nursery; AIDS 
education on site, HIV testing and counseling, a back to school 
program and vocational programs. The ultimate goal is to help the 
women to develop the skills to live independently in a supportive 
environment. '!'he women are court referred, physician and self-
referred. They don't have to have insurance to become enrolled; 
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they only have to pay a $100.00 admission fee. This program also 
has two transitional houses that their clients can graduate to and 
they have bilingual and bicultural staff. 
Rue's House is the only residential AIDS Shelter program 
targeting only women located in the Black community. 
These agencies are reflective of the need to develop and 
identify more resources for HIV affected and infected women. 
The remainder of my presentation will focus on filling in the 
gaps in services. 
Follow-up Recommendations: 
These recommendations are based upon the Women and HIV/AIDS 
Public Hearing held on February 28, 1991 at Exposition Park in 
Los Angeles, California. What held true nine months ago, still 
holds true today. 
HIV /AIDS affected women are in dire need of the following 






Comprehensive and multidisciplinary Early Intervention 
Programs (EIP} which provide culturally specific gender 
sensitive and linguistically appropriate services including 
case management, mental health, social support, respite, chi 1 d 
care and public benefits counseling and advocacy. These 
services are needed immediately. 
Specialized Women's Clinics based on the West Boll ywood model, 
need to be developed. These clinics would provide care from 
initial diagnosis to full blown AIDS. 
A well coordinated and integrated residential and shelter 
program for HIV infected women and their children is needed 
immediately. The type of housing needed includes: emergency 
shelter, and long term residential programs. All of these 
programs should be geared to promote independent living for 
the women and their children. Child care and respite services 
need to be incorporated into all of these programs. 
Women with dual diagnoses, HIV infection and having mental 
health and/or addiction problems, have unique special needs. 
These women and their children and families require 
specialized case management services to insure that they 
receive the full range of EIP, mental health, substance abuse 
and rehabilitative services. 
Many women and adolescents at risk for HIV infection can be 
characterized as being of low income, low SES, low educational 
attainment, illiterate and single heads of households. These 
women and adolescents are generally in deep denial concerning 
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their risk for HIV infection. A client advocate (ombudsman) 
needs to be integrated into the existing system of care. 
He/She would play a key role in advocating for the personal 
and legal rights of the HIV infected and affected woman. 
6. Existing HIV/AIDS resources throughout L.A. County are 
inadequate and do not fully address the health (mental, 
physical and spiritual) of HIV affected women and their 
children and families. A standardized and comprehensive 
community needs assessment to identify unmet service and 
client needs must be developed and administered on an ongoing 
basis. 
7. HIV positive women recently released from an incarcerated 
setting and gay/bisexual women need to receive targeted 
outreach in order to educate them about their risk for 
infection as well as the benefits of EIP programs. 
8. Primary prevention programs need to be developed and expanded 
to reach pre-adolescent, adolescent and adult women in order 
to stop the spread of HIV infection among women of 
childbearing age and their sexual partners. According to the 
most recent data from the State Office of AIDS, in Los Angeles 
County, 1 in 300 African-American women of childbearing age 
(14- 44) is projected to be infected with HIV. 
9. A comprehensive educational campaign targeting local African 
American churches, radio stations, social organizations, the 
business community and elected officials needs to be 
implemented and maintained to ensure that the public and 
private sectors are aware of the problem and can work 
collaborati vely to develop solutions to solving the problem of 
HIV infection in the African American community. The issue of 
HIV /AIDS and Women needs to a priority and in the form of 
public hearings and community forums on an ongoing basis. 
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AIDS Rea1onal Board Title II Publ1c Hear1nas 
Hubert Humohrey Comorehens1ve Health Center 
Auaust 21. 1991 1-3 P.m. 
PUBLIC TESTIMONY 
Mv name 1 s Cynthia Dav 1 s and I worf'- for the Char 1 es R. Drew 
UrnversltY of Medicine and Sc1ence. I have been extensl\tely 
1nvolved in HIV/AIDS-related education and prevention orograms 
target1nq the Black communitv on a local level since 1984 and on 
a nat1ona1 level since 1987. I currently cha1r the Minor1ty AIDS 
Consort1um wh1ch was establ1shed 1n Februarv of 1989 to address the 
HIV/AIDS-related needs of med1cally undeserved communit1es 
throuahout ~os hngeles County and 1n the South Health Area (South 
Central Los Angeles) in oart1cuiar. 
The South Heaith Area of Los Anaeles CountY cont1nues to lag beh1nd 
other Health Areas of the County 1n terms of health. suoport and 
ex~ended care services for 1nd1v1auals w1th HIV d1sease and the1r 
fam1l1es and s1gn1ficant others. Several months ago the membershlo 
of the Consort1um 1dent1f1ed several or1or1ty taraet oooulat1ons 
for orogram development and/or enhancement. These target 
ooou lat1ons were identif1ed as women. adolescents and ch1ldren. 
aav men of color. the homeless and undocumented. 
The consensus of the Consort1um was to develop orograms that would 
comolement and/or augment the ex1st1nq orograms being operated by 
the AIDS Cl1nic at Martin Luther King Hoso1tal. The Consortium 
clans to work 1n collaborat1on w1th Mart1n Luther K1ng Hoso1tal to 
ensure that an infrastructure of needed outoat1 ent and suooort 
serv1ces for HIV oosit1ve 1na1v1duals and their fam1l1es 1s 
deve 1 ooed 1 n the South He a 1 th Area. The Consort i urn sees these 
services as be1ng comorehens1ve 1n their scooe. These serv1ces 
include: 
-Early Intervent1on Programs 
-Mental Health Services and Services for the Dual Diagnosed 
-Res1dent1al Care Programs (Emergency and Lonq Term) 
-Case Management and Referral Services 
-Suoport/Advocacy Serv1ces 
-Transportat1on Services 
Level I. II and III serv1ces are orovided by the EIP and AIDS 
Clin1c at Martin Luther Kina Hoso1tal. There is a need to provide 
EIP serv1ces at local CBO's wh1ch have a track record for orov1ding 
serv1ces to HIV infected indiv1duals. Currently, M1nor1ty AIDS 
Pro1ect is the only local CBO in the reqion provid1nq a full 
comolement of EIP and CAse Management services to HIV infected 
ind1viduals in the area. Peoole who test pos1t1ve for HIV need 
serv1ces such as: benefits counseling. legal aid. suooort services. 
case management. menta 1 hea 1 th <drug counse 1 i ng. resoi te care. 
residential care (emergency and long term). transportation. 
clothing and food banks and rental ass1stance. 
Title II fund1nq will allow several local CBO's with1n the req1on 
to excand and enhance the1r ex1st1nq HIV/AIDS related serv1ces. For 
examcle: 
-THE Clinic for women which currently operates a CTS 1s 
crooos1nq to exoand its serv1ces to include early 1ntervent1on 
serv1ces tarqet1nq women of color aqed 14-44. 
-The Gather1nq Place which cur-rently orov1des supoort and 
reso 1 te care is crooos ltiCI to become an ATS as we 11 as to 
exoand 1ts benefits counsel1no and outreach and cromo~1on of 
EIPs. 
-The ~.YARN Fro.1ect 1s orooos1no to orov1de transoortat1on t.:l 
the HIV 1nfacted women ~hev work w1th. 
-The M1nor1tv AIDS ProJec~ is oropos1ng to develop a 
res1dent1al oroqram for dual diaqnosed ind1v1duals. 
-The Watts Health Foundat1on 1s orooos1ng to augmen~ 1ts case 
management serv1ces w1th an EIP. 
-The Drew Un1vers1tv I&E Project is orooosin~ to provide food 
baskets to HIV infected 1nd1v1duals during the holidays (i.e. 
Thanksq1v1ng, Christmas and Easteri. 
All of the aforemention serv1ces are needed and currentlY are no~ 
be1ng orovidad by CBOs in South Central Los Angeles. There w1ll 
be no duol1cat1on or over lao of services because ali of the 
orov1ders are qeoqraohlcally d1soersed throuqhout the region ana 
enhanc1nq serv1ce 1n one req1on will create greater access1bility 
to serv1ces throughout the entire region. 
Lonq range orooram clans of some of the orov1ders of the thirty-
seven member Consort1um 1nclude: 
-develooment of a mob1le unit target1ng adolescents for 
outreach and promotion of EIP services. 
-increase 1n the number of res1dential hous1nq sites for HIV 
1nfected women and their children. 
-targeted case manaoement at qeoqraphicallv d1spersed s1tas 
(i.e. Watts Health Foundat1on, M1nor1ty AIDS ProJect. T.H.E. 
Clinic. Gather1ng Place) throughout the region. 
-develooment of additional ATS 1n the reg1on. 
-develoPment of a req1ona1 transportat1on network to serve 
HIV+ ind1viduals and their families 
Allocation of Title II funds to local CBOs 1n the South Health Area 
of Los Anqeles County will go a long wav toward ameliorating not 
only the serious gaps in HIV/AIDS outpatient and support services 
for the tarqeted populations, but for the community-at-large. 
I have attached copies of addit1onal public testimony presented to 
the Ryan Wh1te Care Council (Title I} as well as other relevant 
documentation concerninq the need for HIV/AIDS-related serv1ces in 
the Metro South Health Distr1ct of Los Anqe1es County. 
Thank vou. 
senate Health and Human Services committee 
Diane E. Watson 
Chairperson 
statewide Interim Hearing 
December 17, 1991 
"HIV/AIDS in Ethnic Minority communities" 
Presented by: suzi Rodriquez 
Director, Drug Abuse Programming 
AltaMed Health services corporation 
First and foremost, I would like to thank the committee for 
inviting me here to present before you today. on behalf of AltaMed 
Health Services Corporation, we welcome the opportunity to share 
what we have learned, thus far, in our attempt to provide HIV/AIDS 
services to the predominantly Latino population of East Los 
Angeles. 
Background: 
AltaMed Health Services Corporation began providing primary health 
care services in the East Los Angeles Community over twenty years 
ago. We were originally known as the "East Los Angeles Barrio Free 
Clinic". We are a community based, multi-service organization with 
diverse programming. currently, we operate Four Primary Health 
·care sites, a Teen Pregnancy Program (which provides case 
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management to over 150 pregnant andjor parenting teens), an Adult 
Day Health care Center (which evolved from a National Model we 
developed that targets specifically Latino Elderly), a Methadone 
Maintenance and Detoxification program, and a community-based HIV 
Early Intervention program that includes pre and post test 
counseling, HIV Testing, T-Cell Testing, Case Management, and 
access to appropriate therapies for HIV+ clients. 
our funding sources. for our Drug Treatment and HIV/AIDS Services 
come from the Los Angeles County Drug Abuse Program Office, the 
Federal Office for Treatment Improvement, the Federal Bureau of 
Health Care Delivery and Assistance, and the Federal Ryan White 
CARE Act. 
The focus of AltaMed has, historically, been on providing access 
to quality health care to Latino populations who have 
systematically been disenfranchised from access to these types of 
services. When publicity regarding the AIDS epidemic and its 
impact on the Latino populations of New York hit the local press 
back in the early 80s, AltaMed decided we had an obligation to take 
a proactive position in regards to this disease within our own 
community. 
Because the initial reports linked HIV positivity with IV Drug Use 
within the Latino population, we agreed to accept a sole source 
contract with the County of Los Angeles to provide methadone 
maintenance and detoxification services to injecting drug users in 
the East Los Angeles Community. Although we do not see methadone 
as the panacea to all drug abuse problems, we did see its 
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connection to the HIV epidemic and believed that it would provide 
us with an avenue by which to reach and educate this very at-risk 
population (the community of East Los Angeles has more injecting 
drug users than anywhere else in the County ... conservative 
estimates place the number at well over 10,000). 
Our initial efforts were met with resistance on the part of the 
Community. We fell victims to the "NIMBY (Not In My BackYard) 
Syndrome" and were forced to abandon two different identified sites 
before, with the help and support of councilman Edmund Edelman, we 
were finally able to open our program on the grounds of the County 
USC Medical Center. The availability of additional resources, 
through the aforementioned Federal entities, allowed us to pursue 
the development of HIV specific programming. 
Although fairly new to this arena on the direct service delivery 
side, we have learned some lessons we feel may be of value to 
others who have a desire to provide like-services. 
What we have learned: 
Although we have operated our program for a short time, we can 
discern some pattern in our population: 
* Most of our patients are of Mexican origin. 
* Most are undocumented. 
* They have a relatively low level of formal 
education/schooling. 
* They are alone in the United States. 
* All were infected by sharing needles or by having sex with 
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an infected man. 
* There is a definite gap in culturally appropriate services 
for gay and bisexual Latinos, especially those with drug 
problems/treatment needs. 
* Clinic staff must be culturally appropriate to the 
population they are serving. 
Recommendations: 
Given our experience, we feel the following steps should be taken: 
* Linkages must be made with historically Gay HIV/AIDS 
programs in order to provide appropriate staffing, 
training, and service provision for Gay and bisexual 
clients. 
* There must be continuous and on-going education forjto the 
Community. 
* The Church must be accessed. 
* Intensive training in pre and post test counseling should 
be required for all case managers. 
* Clinic personnel should be reflective of the population 
they are serving. 
* HIV testing should be encouraged to all program 
participants. 
* A system of comprehensive care should be instituted that 
includes: 
- Pre-test Counseling 
- HIV Testing 
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Post test counseling when delivering any results. 
If positive, there should be an expeditious way to 
admit patient into a medically managed program where 
one case manager will follow the patient during the 
course of the disease. 
* Increased outreach must be done to the injecting drug 
using population (we believe the sero-positivity rates 
remain low for this population only because the data being 
gathered is reflective only of those IDUs who are accessing 
treatment. Additionally, consideration should be given to 
the legalization of needle-exchange programs tied directly 
to increased treatment availability). 
* Staffing should include a financial analyst to assist 
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Good afternoon Senator Watson, Ladies and Gentlemen, I am 
very pleased to be able to present testimony on the 
subject of AIDS and the impacts on the homeless community. 
I am sure that your have heard much testimony on the HIV 
Virus and the AIDS epidemic therefore I would like to 
focus my testimony on the unique problem of AIDS and the 
homeless community. By definition a homeless individual 
has no resources except public resources., however the 
majority of the public health resources have gone to 
communities which are not poor, are not undereducated or 
are not underrepresented. We must reverse the trend 
because society will pay a much greaater price in the long 
run. 
In Los Angeles county the Central Health District (which 
contains the highest concentration of homeless people in 
the county) has the second highest rate of infection in 
the entire county, however we do not receive monies 
proportionate to the severit of our problem. We also do 
not receive any consideration for the complexity of the 
problem. You have probably heard how AIDS is considered a 
chronic disorder that is not true in the homeless 
community. We have found tht homeless people generally 
have 18-24 months life expectancy from diagnosis to 
demise. The present county system is overloaded with 
individuals who would not normally be in that system and 
leaves no room for homeless people who have no other 
health system. 
A person infected by the HIV virus who is homeless is 
practically without care in the state of California. The 
current care system is not designed to deal with the 
mul~iplicity of problems a homeless person presents. The 
current system is designed to either take care of the 
persons medical problem or to deal with the persons 
survival needs generally not both. In a system of this 
nature conflicts orise and the person who suffers is the 
one we say we are helping an example is a person goes to 
the clinic and receives medication, he/she then returns to 
a shelter the shelter takes the medication and gives it to 
the personas their schedule or time permits. The person 
has night sweats and cannot sleep the next morning the 
person is tired however shelter rules say everyone must be 
out of bed by seven O'clock therefore that person must get 
up. the person takes his/her medication but experiences 
side effects there is nothing for that person. The person 
makes a decision not to take his/her medication because it 
makes life too difficult. I have tried to portray this 
scenario as realistically as possible and not to portray 
any party as wrong because no one is wrong we merely have 
a system not able to deal with the problem. 
We no longer have the luxury of hoping that AIDS will 
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somehow go away, we must recognize the clear and present 
danger among us. We must also expand our vision of the 
problem for the minority community. We must also 
recognize that the majority of the homeless community are 
minority. I realize tht this is difficult to believe, 
because in most cases when you see someone advocating on 
behalf of the homeless they are mostly white and mostly 
middle class, believe me that although they may speak for 
the homeless they do not represent the homeless community, 
because unless you share a common bond with your 
constituency it is difficult to represent them. We need 
special consideraion because more than any group you may 
have heard from today we have the least and have the most 
to have to overcome. We do not have the money to lobby 
you, we do not have the political sophistication to defeat 
candidates, We do not have the ability to impact the 
planning process, however we do have the ability ot impact 
negatively on our entire society. We want to make 
contributions but we do not have the opportunity. We want 
some help in changing our destinies that is what we are 
denied. Our needs are very simple, we need the type of 
assistance that other communities currently receive but we 
need them designed for homeless people specifically. We 
need specialized treatment programs, we need peer-based 
counseling, we need specialized housing , we need a strong 
political advocate to make changes in public benefits on 
federal , state and county levels to force the bureaucrats 
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to declare an individual who is homeless and HIV positive 
as an emergency case and afford them certain 
considerations. 
Finally, I am personally a strong advocate of categorical 
£unding to solve problesm that are unique or so 
longstanding that special efforts are needed to protect 
the common good. Homeless persons with AIDS are a problem 
which has serious impacts on all of us. 
In order to understand the need for categorical funding we 
need to analyze L.A. county's allocation of C.A.R.E. ACT 
formula and supplement grants. The county received $7.8 
million in total allocation for year one. ( See 
attachment one) Total monies allocated for homeless 
persons is $127,238, this represents less than 2% of the 
county funds, and of that amount 2/3 of the money goes 
into cross-training of staff. (See Attachment II) 
Further, no monies were allocated for early 
interviention/Outpatient care. (see Attachment III) The 
only clinics which provide early intervention/outpatient 
care are not located where there are concentrations of 
homeless persons. 
Ladies and gentlemen this is the reason why a homeless 
person is 100 times more likely to contract HIV than a 
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homed person. The rate of infection in the homeless 
community is about 1 in 5. This is an emergency of the 
greatest magnitude. I have spotlighted Los Angeles county 
but in my travels around the state I have found similar 
situations in other large urban counties. 




COUNTY OF LOS ANGELES • AIDS PROGRAMS 
ESTIMATE OF UNSPENT CARE ACT FUNDS - PROJECT BUDGET YEAR ONE 
Service Provider : Allocation 
FORMULA GRANT 
Outpa~ ient/South Central :King/Drew 765,000 
OUtpa~ ient/San Gabriel :Pasadena AIDS Coord.: 239,000 
Outpa~ ient/San Fernando V:Northeast valley 189,000 
:Olive View 50,000 
OUtpa~ ient/Long Beach :Long Beach Comp. Ctr: 382,000 
CBO CARE to Relieve 5P21 :AIDS Healthcare foun: 287,000 
:Alta·Med 287,000 
Case Management :Various CBOs 382,000 
Mental Health :Various CBOs 191,000 
Dental Care :APLA 96,000 
Resident i a l/Ernerg _ Rel ief:Various CBOs 239,000 
Cross-Training :Various CBOs 191,000 
Transportation :Various 143,000 
OUtreach/Promotion :Various CBOs 191,000 
Regi~l Consortia :AIDS Reg1onal Board 96,000 




















TOTAL FORMULA GRANT 
SUPPLEMENTAL GRANT 
OUtpatient/South Central :King/Drew 
OUtpatient /\Jest :AIDS llealthcare Foun: 
:Gay & Lesbian CSC 
:UCLA 
OUtpatient/Long B, So.Bay:Harbor/UCLA 
OUtpatient/San fernando V:Northeast valley 





Promotion of Svcs. 
Mental Health 
Mental Health 






OUt pet tent Detox. 
HIV Primary Care/Subst. 
Administration 











:Tarzana Treat. Ctr. 
:BAART 

















































TOTAL SUPPLEMENTAL GRANT 3,924,157: 367,042 
TOTAl BOTH GRANTS 811,042 







ALLOCATION OF C~E ACT FUNDS BY MODE OF SERVICE & TARGET POPULATION 
! ~~ .' ~\ ~t • J l 
Prewntion and 
EcU:ation' 
Adolescents/,...,. ..Wlts I -ring 
... ired 
Cay """ of Color Pediatrics Peq>l e of Col or Stbotance Abo.a:urs H.-less w._. 












L.A. Free Clinic S40,ooo' 
($) 
CA Drug Consul tents 
142,000 ($) 




City of long &edch 
S3S,OOO (f) 
tarzana Treatment 
Center S258,000 (S) 
JWCH, Inc. S42,538 
(S) 
-!------+-----+----~ 
BAART S129,000 ($) 
I Total= S129,000 II 1--.. -- l-'--------+-------+--------11 
I I L.A. Peoiatr•c AIDS Early lnte,._,tiOfl/ OUtpatient tare 11 Childrens Hospital S212,000 ($} 










"""Ul Ileal th/ 
Ps-,dlosoc:ial 
$<.4lpaf't 
Total • Sob41,000 
S96,000 allocated t> all 
11 populations 
$46,000 allocated ll all 
populations 
S138,SOO allocated to 
all populations. 
S719, 500 allocated to 
all poplllt ions. 
I ___ r 
Gay Men of Color 
Cons or""" Sl06, 300 
(f) 
Minority AIDS ProjeCt 
1111,000 (S) 
East valley COOft. 
Kl th. Ctr. S7'.i,OOO 
(f) 
Mol\ ywood Sunset 
conn •. Ct 1n1c SU,OOO 
(f) 
Network St-6, ~00 (5) . 
El Proyecto del 
Barno S129, 000 {5) 
HIV Program for 
women S138, 000 IS l 
_I I 




GLCSC Sb¢. SOO 
PacifiC Cr.tr. for 
C0<1>sel1ng S55, 000 
(f!S) 
APLA S46, SGO ( S J 
1 ar zane 1 reetment 
Center $108,000 (S) 
APL A S46, 500 ( S l 





// "-./1 p I I r. -! (, t-f c' "I T 1-
. 
AdDiesc: .... ta/- .... u. -ing C.Oy """ of COl or Pediatrics People of Color St..Ds t ance Abusers Hc:J~Meless -I~ ired I 
So4>Port Services AIDS Education Cay Htn of Color Asian Pacific AIDS 
for the Deaf Consorti,. $36,000 Ecsucat ton Project 
Total = S86 000 125 000 ($) ($) • S25 000 (S) 
Residontial care 1613,969 allocated to 
(CUf 'lAS) all population~. 
TOTAL: 1294,000 S25,000 157'5, 762 166,000 1228,000 1624,000 ,.S127,238 1251,000 
• NOTE: CARE Act flllds cannot be tltilir:ed for prevention and testi"9 services. The agencies plctced wHhtn thiS taot~ tnclude only those programs specifically charged wtth serv1ng <l parttcular target 
populatlon(a) and does no: Include progr- that aarve all c-.nitias. Thia table adclresaes only the special populations as defined t>y the CARE Act Plaming Council. Th1s does not e.clude the 
fact that all other orotr:- not I is ted are responsible for serving all populations. 
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COMPREHENSIVE AIDS RESOURCES EMERGENCY (CARE) ACT 
BIV HEALTH SERVICES PLANNING COUNCIL 
600 S. Commonwealth Ave., 6th Floor, Los Angeles, CA 90005 
December 9, 1991 
TO: 
FROM: 
CARE Act Interim HIV Health Services Planning Council Members 
Suzi Rodriguez, Co-Chair 
Pb.ill Wilson, Co-Chair 
SUBJECT: MEETING DATE 
DATE: 
LOCATION: 
Thursday, December 19, 1991 
1:00 p.m. - 4:00 p.m. 
American Red Cross 
Fredrick G. Larldu Board Room 
Mezzanine 2 
2700 Wikbire Blvd. 
Las ADgelfs 
The building is located at the comer of Wilshire Blvd. and Rampart Blvd. 
Parking is limited. If the Red Cross lot is full, park on the street or at the Sheraton 
Town House Automate lot at 6th and Commonwealth. 
If you have any questions or need additional information, please contact Cherie 
Orilonise at (213) 351-8130. 
·109 
COMPREHENSIVE AIDS RESOURCES EMERGENCY (CARE) ACT 







600 S. Commonwealth Ave., 6th Floor, Los ADgeles, CA 90005 
AGENDA 
December 19, 1991 
1:00 p.m. -4:00p.m. 
American Red Cross 
Fredrick G. Larkin Board Room 
Mezzanine 2 
2700 Wilshire Blvd. 
Review of Handouts and Pre-meeting (15 min.) 
Opening and Roll Call (5 min.) 
*Approval of Agenda & Minutes (5 min.) 
*Priorities for Unspent County Funds (60 min.) 













NEXT MEETING: January 8, 1992 
Orthopaedic Hospital 
1:00- 4:00p.m. 
Crowe Seminar Room 
·! i 0 
PRIORITIES POR UNSPENT CARB ACT TITLB I PUHDS 
Total = $1 1 000,000 
NOTE: This document reflects changes agreed upon at the 







If actual unspent funds total less than $500,000, then 
APO will perform budget modifications, budget 
augmentations, and contract extensions. 
If actual unspent funds exceed $1 million, 50% of the amount 
over $1 million will go to priorities which received zero 
funding on this sheet (#5-10). The remaining 50% over $1 
million will be divided proportionally among priorities on 
this list which have been allocated unspent funds (#1-4). 
If unspent funds exceed $2 million, the Council will meet 
again to allocate those funds over $2 million. 
Level III HIV Outpatient Care / Specialty Consults 
• Level III care is required by HIV infected patients who have 
reached a level leas than 200 CD4+ cells 2£ who have 
developed HIV related symptoms, and who may receive medical 
and/or psycholoqical services in non hospital basad 
outpatient clinics. 
AIDS Drugs 
• CUrrently, the State has allocated $12 million state-wide 
this year for AIOS druqa. APO is billinq the State at a 
rata of 300,000 per month. With the CARE Act, additional 
centers will be billinq to the State AIOS druq proqram 




NOTE: Due to the increase in State dollars for AIDS drugs, 
should this category remain #2 on this list? 
Residential Detox Slots $300,000 
• L.A. county has an estimated 190,000 IDUs and 35 residential detox 
slots. With an estimated aeroprevalence rata of as much as 10,, 
19,000 HIV+ IOUa need druq treatment. The Council allocated 
$258,000 to Tarzana Treatment, which only pay• for 3.5 beds or 90-
100 parsons par year (10-day averaqe stay). 50' of this money 
will qo to Residential Detox, with the other 50' qoinq to 
rehabilitation facilities. 
Primary HIV care for Undocumented $100,000 
• Of the oriqinally prioritized populations, the undocumented is the 
only qroup not directly receivinq funds. Providers can no lonqar 
rely on the IRCA/SLIAG fundinq. 
Primary HIV care to Special Populations $ 0 
• Special populations include women, pediatrics, and adolescents. 






counseling/Testing in County STD and TB Clinics 
• The need to make testing available to all persons entering 
county STD and TB clinics has long bean a priority. 
Individuals being treated at STD clinics have already placed 
themselves at high risk. Experience in TB clinics shows 
that a high proportion are HIV-infected. Currently, 
resources do not allow this service to be universally 
available. 
outreach/Promotion of Services to Gay Men of Color 
$ 0 
$ 0 
• The HIV Strategic Plan names this group as a priority for outreach 
services. Gay men of color are not always reached in effective or 
culturally specific ways. More than three-quarters of AIDS cases 
among man of color are tr~nsmitted through gay/bisexual contact. 
Residential Care 
• The Planning Council passed a motion on May 15 to consider 
residential care a priority for unexpended funds. 
Adult Day Health Care -- City of West Hollywood 
$ 0 
$ 0 
• The City of Wast Hollywood requested funds from the Planning 
Council for an adult day health care program for parsons with 
AIDS. It is scheduled to open January of 1992 at the L.A. Free 
Clinic. 
Case Management $ 0 
• If unspent funds are available, the Case Management Consortium will meet 
and recommend allocations. 
· mprior .una 
November 19, 1991 
........ ~ 
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LOS ANGELES COUNTY CARE ACT PLANNING COUNCIL 
PRIORITIES 
Priorities for Planpinq Council Fupdinq Decisions 
• Programs and services must focus on underserved and indigent 
populations with little access to health care. 
• Program and service staff must be linguistically competent 
and culturally sensitive to ethnic populations, gay and 
bisexual communities, and other special populations. 
• Consortia are encouraged and given priority in funding 
allocation decisions. 
• Programs and services must be provided by indigenous 
community-based organizations whenever possible prior to the 
County providing such programs and services. 
• Programs, services, and agencies with existing 
infrastructure(s) must be given preference. 
Priorities for the Coptractors in tbe Provision of care 
• Programs must have advisory committees comprised of clients, 
providers, and persons with HIV. 
• Providers and programs must have internal HIV workplace 
policies for staff and volunteers. 
• For those contractors providing training on human sexuality, 
the training will attempt to present human sexuality as a 
normal, positive aspect of the human experience. 
• Contractors must rely on paid professional staff for program 
administration, direction and guidance, and services; 
trained volunteers may be used to supplement services 
provided by paid staff. 
• Programs and services must meet the community standard of 
care provided to HIV-infected individuals. 
Priorities for the Planning Council and the Contractors 
• Programmatic, service, and staffing information on the needs 
of women and how they will be met must be detailed in each 
program and service recommended, unless women are not an 
appropriate target group for the contractor or if women are 
not included in the specific target population(s) under the 
Agreement. ~~ ".3 
• Programs and services must have specific linkages to other 
service sectors, i.e., homeless and substance abuse 
services, with cross-training of staff. 
• Contractors must coordinate services with other service 
providers of the same service(s) and other providers of any 
AIDS/HIV services located in the same geographic region, and 





PRIORITIES FOR UNSPENT NET COUNTY COST FUNDS 
Total = $2,000.,000 
Based on approved decisions at the December 4, 1991 
meeting, dollars were allocated to 1 and 3 which 
totaled $750,000. Decisions are pending for 2 and 4 
through 10. The total available is $1,250,000. 
Previous Formula: If actual unspent funds exceed $1 
million, 50% of the amount over $1 million will go to 
priorities which previously received zero funding (#5-
10). The remaining SO% over $1 million will be divided 
proportionally among priorities on this list which have 
been allocated unspent funds (#1-4). 
$450,000 1) Level III HIV Outpatient care/Specialty Consults 
2) Primary HIV care for Homeless/Skid Row Area 
$300,000 3) Residential Detox and Residential Rehabilitation 
Slots (funds split 50-50 between these slots) 
snunspen.ncc 
12-9-91 
4) Primary HIV care for Undocumented Persons 
5) Primary HIV Care for Special Populations (women, 
pediatrics, adolescents) 
6) counseling/Testing in county STD and TB Clinics 
7) outreach/Promotion of Services to Gay Men of Color 
8) Residential Care 
9) Adult Day Health Care (City of West HollywoodfL.A. 
Free Clinic) 
10) case Management 
·' ·s '1:j 
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Arttur B. Bla:kwell 
f'egla1a Dteda. Nort/l- Ml 
George 0. Dardtll 
F/egtala t:Xector. t~t - NY 
.lell'fHenderscn 
Flegtala Drector. SaJt> - AL 
Mdeel Hrjltawef 
Pr()f!CI Vee Prest»JI - G4 
Wlte Kenredy 
Flec;tala Drecror. West- CA 
Proi«t Voce Preroent- .:~ 
Robert WallY. - NC 
Cra'ldal C J(t)(:C 
Exi!C!ANe Drectt• 
CtriStal A MJ•ra~ 
4{jnnfSira~ **'5/!Tit 
Headquarters: 440 First Street, NW • Suite 500 • Washington, DC 20001 • (202) 347-6953 • Fax: i202) 39~-0096 
February 16 ~ 1990 
Th1s project is part of a national grant from CDC. Its purpnse is to 
Increase the availability of HIV/AIDS education and informatioit tc 
Black and minority youth in urban and rural communities. It is 1 
nat1onal project, and it will be managed out of our office in Washir1gton, 
D.C. Project technical focus will be provided at the Charles R. D~ew 
University of Medicine and Science located at the King/Or~~ Meciical 
Center in Los Angeles County, Los Angeles California. 
NOBCO PROJECT OPERATIONS GROUP 
Webster J. Guillory - Chairman of the Board, NOBCO Office of the Ora11gc 
County Assessor 
(714) 834-2734 
Crandall Jones - Executive Director, NOBCO 
(202) 347-6953 
Westley Sholes - Western Regional Director, NOBCO, Project Coordinatcr/ 
Department of Health Services, Los Angeles County 
(213) 974-8136 
Mary Ashley - Technical Assistance, Charles R. Drew University of 
Medicine and Science 
(213) 603-4755 
Cynthia Callahan Davis - Program Director, NOBCO AIDS Education Pro1e:t 
(213) 567-7799 
~ATIONAL AIDS TASK FORCE 
Commissioner .John Stroger - Cook County, IL 
Commissioner Mary McAllister - Cumberland County, NC 
Ralph Mitchell, Director Health Services - Fulton County, GA 
Paul Simms, Deputy Director Physical Health Services, San Diego 
County, CA 
Supervisor Doris Ward - San Francisco County, CA 
Commissioner Bernard Kilpatrick - Wayne County, MI 
Commissioner J.W. Scarborough - Natchitoches Parish, LA 
David N. Dinkins, Mayor, New York, ~ew York 
Caswell Evans, D.D.S., Asst. Dir. Programs Dept. of Health Services, 
Los Angeles County, CA 
Commissioner El Franco Lee - Harris County, Texas 
Commissioner Virgil Brown - Cuyahoga County, Ohio 
NATIONAL LIAISON TEAM* 
National Medical Association (NMA) 
National Conference of Black Mayors (NCBM) 
National Forum ior Black Public Administrators tNFBPA) 
National Black Caucus of State Legislators (NBCSL) 
National Black Caucus of Local Elected Officials (NBC-LEO) 
*Partial Listing 
Corinne Tanon, M.S.H., C.A., tiea.Lcn .c..uucctLuL 
9500 Artesia Blvd., Bellflower, CA 90706 
~xE1J:»x4~i.x-xx~~M.~Jtx~~~~~~~ 
P;hone (21:3) :i:~QS:: 920-7227 
A. Agency Background 
1. Briefly describe the scope of services your agency provides. 
The American Indian ClinLc is located in Compton, California, in 
a buildin~ that once was a motel. The American Indian Clinic. Inc. 
was founded in 1969 to serve the health and social needs of 
American Indians in ehe Los Angeles area. It has provided continuous 
care t::- the community for over n;ency years and is the oldest American 
Indian. service agency in the Los Angeles area. The clinic department 
are medical. dental, ~IC. ~amily planning, pre-natal, outreach, 
health education. two alcohol ~ecover~ programs and a food box program. 
~. Communit·: Demographics 
According to 1980 census. California has the largest Indian population. 
There are approximately 225.000 American Indians from 200 different 
tribal affiliations. In Los Angeles County alone there are over 90.000 
Urban -~'11erican Indians. And is the largest Urban Indian community 
in the nation. The American Indian communit:: is ·.;ell dispersed and 54,000 
of the A~eric3n Indians ~ive below povertv leve~. ~etropolitan 
Los Angeles :ndian unemplo:~ent is ~5~. 
The Indian peculation is a youn~ population. ~ationwide the average age 
is 20.~. The average age 0f Indians in Los Angeels is l7.J. Sixt~-se~en 
oercent ~i the Indian popuiat~on are 2S ~ears o~d or youn~er. Ina1ans are 
3 times ~ore likely to die young (between ages :- and ~0) than non Indians. 
Average life expectancy for Indians is ~~ (this :s lower than the aver~ge 
life excecrancy for migrant farm workers). 
Accordi~g to the Los Angeles Unified School Dist=ict. Indian Hi~h School 
drop out rate is 23:. This figure increases when you include those ~~at 
never enrolled in high school. Average age of Indians living in 
Los Angeles is 17.3 vs 20.~ for Indians nationwide. Sixty seven percent 
of Urban Indian adolescents drink or use drugs moderately to heav?; 
whereas the non-Indian urban adolescent rate is :J:. 
t ~ .... 
·~ .l ( 
Health Issues 
Indian suicide rate is 7 times that of the national rate. Indians have 
the hi~hest rate of heart disease and diabetes. 20-25 percent of all 
American Indian children suffer from mental illness. Adjusted alcoholism 
mortality rate for Indians is 41.3 deaths/100,000 vs 17.4 deaths/100,000 
for Afro- Americans and 6.4 deaths/100,000 for Whites or 2.3 times that of 
Black ?Opulation and 6.5 times that of White population. 
Gaps in Health Care 
Health care is expensive to nearly all segments of the community but especially 
to many Indian people. They may not be able to afford health care due to lack 
of insurance or other needs that are more pressing. They will go to a health 
care facility only when the need is acute. Therefore, they might hear the 
message about AIDS, Diabetes, Hypertension prevention at a health facility. 
There is a pressing need for outreach at those places where they may congregate; 
community functions, pow wows, sports events. 
:>tzU·t: c ~ (1-+f, 17-
With the high rates of sexually transmitted ~isases and alcohol and IV drug use 
among .\merican Indians, ilopefully, hid:· H11a_ic l!hrviee may understand the 
importance of • a:r&iRued funding as a preventative T.easure. 
We are the only peoples who have a treaty, or trust ~elationship with the 
United States Government. That is, we have a contractual agreement whereby 
the Government is to provide free and "Adequate" health care as ratified by the 
Snyder ~ct of 1921 to Indian people regardless of location-this is not being done! 
Since the Indian Health Service (IHS) cannot be counted on to provide 
3dequat~ health services we must continually seek out other funding sources. 
The source of continued funding is always contingent upon the outcome of 
census, demographics, and socioeconomic and political strategies. 
Becaus~ we are a small population of 90,000 American Indians in Los Angeles 
County, t"e are sometimes mistaken for hispanics, filipino, white, and Afro American. 
Tl1e communitv is well dispersed and this may contribute to the political 
under~epresentation and social misrepresentation in the communities. We are 
poorlv represented in every segment of society. I can only speak for myself-we 
have no political clout, and our voices aren't being heard. This theme is 
reflected in the decision making of our city fathers and government. 
Source: Kathy Grandstaff, American Indian Counseling Center 
0 
PO. Box 4068 • 1330 South Long Beach Blvd. • Comoton. Calif. 90221 
Phone: (213) 537-0103 
According to the HIV-AIDS and American Indians handbook for Tribal Leaders 
stated the following: 
"Since September, 1991 the Center for Disease Control has approximated 
305 American Indians diagnosed with AIDS. Dr. Emmett Chase AIDS coordinator 
for Indian Health Service estimates that there are 12 to 13 new Indian AIDS 
cases identified each month. The fact is the annual rate of increase of 
new AIDS diagnosis is greater for Indian people than for any other racial 
group. The number of Indians diagnosed with AIDS grew by 91% from 1989 to 1990. 
While other racial groups have a higher number of individuals with AIDS, the 
number of Indians with AIDS is rising at a rate proportionately faster than 
for other groups. 
PERCENTAGE INCREASE IN AIDS CASES FROM 1989-1990 
Whites 8% 
African Americans 13% 
Hispanics 5% 
Asian/Pacific Islander 17% 
Indian/ Alaska Native 91% 
The time of PREVENTION IS NOW. Indian people can benefit from the experiences 
of other populations which have dealt with the AIDS virus for the past eight 
years. We must ACT now, before the virus wipes us out like the smal1pox epidemic 
disease of the early 1800's. 
According to the study for the Centers for Disease Control found that 
Indians and Alaskan ~atives experienced higher rate of gonorrhea and syphilis 
than did non-Indians from 1984 to 1988 in 13 selected states with large 
Indian populations. This study indicates that we are at risk. 
The transmission categories for these cases are 54% homosexual/bisexual 
transmission, and the rest by" blood or blood product transmission. This 
contrasts with White Transmission which is 76% homosexual/bisexual and 15% 
shared needle and 2% heterosexual .. The percentage of Alaska Native and 
American Indian women with AIDS is 13% of the total number of American Indian 
and Alaska Native cases, in contrast to 47. of White women. According to 
CDC has been working with IHS to evaluate the HIV in the American Indian 
population. It is estimated that for every 1 million American Indians and 
Alaskan Natives approxia~tely 1,000 individuals are currently HIV infected. 
Then it could be estimated that over 85% of these individuals do not know 
they are HIV infected. 

